1	PHARMACOEPIDEMIOLOGY	NNP	MISC	PHARMACOEPIDEMIOLOGY	_	0	SENT_1	[p1l34t90r527b113],
2	AND	CC	O	and	_	0	SENT_1	[p1l545t90r625b113],
3	DRUG	NN	O	drug	nn	4	SENT_1	[p1l642t90r746b113],
4	SAFETY	NN	O	safety	conj_and	1	SENT_1	[p1l764t90r902b113],
5	2010	CD	DATE	2010	dep	4	SENT_1	[p1l920t82r1025b119],
6	;	:	O	;	_	0	SENT_1	[p1l920t82r1025b119],
7	19	CD	NUMBER	19	num	9	SENT_1	[p1l1047t81r1101b113],
8	:	:	O	:	_	0	SENT_1	[p1l1047t81r1101b113],
9	75-81	CD	NUMBER	75-81	dep	1	SENT_1	[p1l1123t81r1236b113],
10	Published	VBN	O	publish	partmod	9	SENT_1	[p1l34t132r192b159],
11	online	NN	O	online	prep	10	SENT_1	[p1l207t132r307b159],
12	2	CD	DATE	2	dep	11	SENT_1	[p1l322t133r339b159],
13	October	NNP	DATE	October	tmod	10	SENT_1	[p1l355t132r484b159],
14	2009	CD	DATE	2009	num	13	SENT_1	[p1l498t132r575b160],
15	in	IN	O	in	_	0	SENT_1	[p1l591t132r620b159],
16	Wiley	NNP	ORGANIZATION	Wiley	nn	17	SENT_1	[p1l635t132r730b167],
17	InterScience	NNP	ORGANIZATION	InterScience	prep_in	10	SENT_1	[p1l745t132r947b159],
18	(	CD	NUMBER	(	num	21	SENT_1	[p1l964t132r1455b167],
19	www.interscience.wiley.com	NNP	O	www.interscience.wiley.com	nn	21	SENT_1	[p1l964t132r1455b167],
20	)	CD	NUMBER	)	num	21	SENT_1	[p1l964t132r1455b167],
21	DOI	NNP	O	DOI	dep	17	SENT_1	[p1l1471t132r1553b159],
22	:	:	O	:	_	0	SENT_1	[p1l1471t132r1553b159],
23	l0	NN	O	l0	dep	17	SENT_1	[p1l1574t132r1859b167],
24	.	.	O	.	_	0	SENT_1	[p1l1574t132r1859b167],

1	l002/pds	NNS	O	l002/pds	_	0	SENT_2	[p1l1574t132r1859b167],
2	.	.	O	.	_	0	SENT_2	[p1l1574t132r1859b167],

1	l866	NN	O	l866	_	0	SENT_3	[p1l1574t132r1859b167],

1	ORIGINAL	JJ	O	original	amod	2	SENT_4	[p1l879t229r1095b261],
2	REPORT	NN	O	report	_	0	SENT_4	[p1l1110t229r1281b261],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_5	[p1l35t352r310b404],
2	of	IN	O	of	_	0	SENT_5	[p1l339t352r403b404],
3	genetic	JJ	O	genetic	amod	4	SENT_5	[p1l426t352r638b420],
4	variation	NN	O	variation	prep_of	1	SENT_5	[p1l667t352r930b404],
5	in	IN	O	in	_	0	SENT_5	[p1l957t352r1014b404],
6	C	NN	O	c	nn	7	SENT_5	[p1l1044t353r1091b405],
7	YP3A4	NN	O	yp3a4	prep_in	1	SENT_5	[p1l1095t352r1295b404],
8	and	CC	O	and	_	0	SENT_5	[p1l1325t352r1430b404],
9	ABCBI	NN	O	abcbus	prep_in	1	SENT_5	[p1l1451t352r1673b405],
10	on	IN	O	on	dep	1	SENT_5	[p1l1707t369r1779b404],
11	dose	NN	O	dose	nn	12	SENT_5	[p1l1806t352r1940b404],
12	decrease	NN	O	decrease	pobj	10	SENT_5	[p1l35t436r290b488],
13	or	CC	O	or	_	0	SENT_5	[p1l319t452r379b488],
14	switching	NN	O	switching	conj_or	12	SENT_5	[p1l407t436r693b503],
15	during	IN	O	during	dep	1	SENT_5	[p1l722t436r913b503],
16	simvastatin	NN	O	simvastatin	nn	19	SENT_5	[p1l944t435r1279b488],
17	and	CC	O	and	_	0	SENT_5	[p1l1308t436r1412b488],
18	atorvastatin	NN	O	atorvastatin	nn	19	SENT_5	[p1l1441t436r1786b488],
19	therapyl	NN	O	therapyl	pobj	15	SENT_5	[p1l1812t418r2058b503],

1	Matthijs	NNP	PERSON	Matthijs	nn	5	SENT_6	[p1l34t584r194b625],
2	L.	NNP	PERSON	L.	nn	5	SENT_6	[p1l212t584r250b615],
3	Becker	NNP	PERSON	Becker	nn	5	SENT_6	[p1l270t584r406b615],
4	PharmD1	NN	O	pharmd1	nn	5	SENT_6	[p1l423t574r637b621],
5	’	NN	O	’	_	0	SENT_6	[p1l423t574r637b621],
6	2	CD	NUMBER	2	dep	5	SENT_6	[p1l423t574r637b621],
7	,	,	O	,	_	0	SENT_6	[p1l423t574r637b621],
8	Loes	NNP	PERSON	Loes	nn	11	SENT_6	[p1l657t584r748b615],
9	E.	NNP	PERSON	E.	nn	11	SENT_6	[p1l766t584r803b615],
10	Visser	NNP	PERSON	Visser	nn	11	SENT_6	[p1l824t584r944b615],
11	PhD	NNP	O	PhD	appos	6	SENT_6	[p1l961t584r1043b615],
12	PharmD1	NN	O	pharmd1	nn	13	SENT_6	[p1l1061t574r1276b621],
13	’	NN	O	’	dep	5	SENT_6	[p1l1061t574r1276b621],
14	2	CD	NUMBER	2	dep	13	SENT_6	[p1l1061t574r1276b621],
15	,	,	O	,	_	0	SENT_6	[p1l1061t574r1276b621],
16	Ron	NNP	PERSON	Ron	nn	21	SENT_6	[p1l1295t584r1373b615],
17	H.	NNP	PERSON	H.	nn	21	SENT_6	[p1l1391t584r1432b615],
18	N.	NNP	PERSON	N.	nn	21	SENT_6	[p1l1452t584r1494b616],
19	van	NNP	PERSON	van	nn	21	SENT_6	[p1l1515t594r1581b616],
20	Schaik	NNP	PERSON	Schaik	nn	21	SENT_6	[p1l1600t584r1730b616],
21	PhD3	NN	O	phd3	appos	5	SENT_6	[p1l1747t574r1886b621],
22	’	CD	NUMBER	’	number	23	SENT_6	[p1l1747t574r1886b621],
23	4	CD	NUMBER	4	dep	21	SENT_6	[p1l1747t574r1886b621],
24	,	,	O	,	_	0	SENT_6	[p1l1747t574r1886b621],
25	Albert	NNP	PERSON	Albert	nn	28	SENT_6	[p1l34t633r157b665],
26	Hofman	NNP	PERSON	Hofman	nn	28	SENT_6	[p1l174t633r330b665],
27	PhD	NNP	O	PhD	nn	28	SENT_6	[p1l347t633r429b665],
28	MDL5	NN	O	mdl5	appos	5	SENT_6	[p1l447t623r577b671],
29	,	,	O	,	_	0	SENT_6	[p1l447t623r577b671],
30	André	NNP	PERSON	André	nn	32	SENT_6	[p1l597t632r715b665],
31	G.	NNP	PERSON	G.	nn	32	SENT_6	[p1l734t633r775b665],
32	Uitterlinden	NNP	PERSON	Uitterlinden	appos	28	SENT_6	[p1l795t633r1030b665],
33	PhD1	NN	O	phd1	dep	5	SENT_6	[p1l1048t623r1204b665],
34	’	CD	NUMBER	’	number	35	SENT_6	[p1l1048t623r1204b665],
35	5	CD	NUMBER	5	num	36	SENT_6	[p1l1048t623r1204b665],
36	’	NN	O	’	dep	33	SENT_6	[p1l1048t623r1204b665],
37	6	CD	NUMBER	6	dep	5	SENT_6	[p1l1048t623r1204b665],
38	and	CC	O	and	_	0	SENT_6	[p1l1223t633r1290b665],
39	Bruno	NNP	PERSON	Bruno	nn	41	SENT_6	[p1l1308t634r1425b665],
40	H.	NNP	PERSON	H.	nn	41	SENT_6	[p1l1444t634r1486b665],
41	Ch	NNP	PERSON	Ch	dep	5	SENT_6	[p1l1506t633r1570b665],
42	.	.	O	.	_	0	SENT_6	[p1l1506t633r1570b665],

1	Stricker	NNP	PERSON	Stricker	nn	2	SENT_7	[p1l1591t633r1744b665],
2	MB	NNP	O	MB	dep	11	SENT_7	[p1l1761t634r1829b665],
3	PhD1	NN	O	phd1	dep	2	SENT_7	[p1l1850t623r2056b665],
4	’	CD	NUMBER	’	number	5	SENT_7	[p1l1850t623r2056b665],
5	5	CD	NUMBER	5	dep	3	SENT_7	[p1l1850t623r2056b665],
6	’	NN	O	’	dep	11	SENT_7	[p1l1850t623r2056b665],
7	6	CD	NUMBER	6	num	6	SENT_7	[p1l1850t623r2056b665],
8	’	NN	O	’	nn	11	SENT_7	[p1l1850t623r2056b665],
9	7	CD	NUMBER	7	num	11	SENT_7	[p1l1850t623r2056b665],
10	*	NN	O	*	nn	11	SENT_7	[p1l1850t623r2056b665],
11	1Department	NN	O	1department	dep	74	SENT_7	[p1l37t710r228b752],
12	of	IN	O	of	_	0	SENT_7	[p1l241t718r275b752],
13	Epidemiology	NNP	O	Epidemiology	prep_of	11	SENT_7	[p1l282t718r493b752],
14	,	,	O	,	_	0	SENT_7	[p1l282t718r493b752],
15	Erasmus	NNP	ORGANIZATION	Erasmus	nn	16	SENT_7	[p1l509t719r639b744],
16	MC	NNP	ORGANIZATION	MC	appos	13	SENT_7	[p1l651t718r713b749],
17	,	,	O	,	_	0	SENT_7	[p1l651t718r713b749],
18	Rotterdam	NNP	LOCATION	Rotterdam	appos	16	SENT_7	[p1l729t718r892b748],
19	,	,	O	,	_	0	SENT_7	[p1l729t718r892b748],
20	the	DT	O	the	det	23	SENT_7	[p1l910t718r953b744],
21	Netherlands	NNP	LOCATION	Netherlands	nn	23	SENT_7	[p1l966t718r1149b745],
22	2Hospital	NNP	O	2Hospital	nn	23	SENT_7	[p1l34t752r178b794],
23	Pharmacy	NNP	O	Pharmacy	appos	16	SENT_7	[p1l190t760r347b794],
24	,	,	O	,	_	0	SENT_7	[p1l190t760r347b794],
25	Erasmus	NNP	ORGANIZATION	Erasmus	nn	26	SENT_7	[p1l364t761r493b786],
26	MC	NNP	ORGANIZATION	MC	appos	16	SENT_7	[p1l505t761r567b791],
27	,	,	O	,	_	0	SENT_7	[p1l505t761r567b791],
28	Rotterdam	NNP	LOCATION	Rotterdam	appos	16	SENT_7	[p1l583t760r746b791],
29	,	,	O	,	_	0	SENT_7	[p1l583t760r746b791],
30	the	DT	O	the	det	32	SENT_7	[p1l764t760r807b786],
31	Netherlands	NNP	LOCATION	Netherlands	nn	32	SENT_7	[p1l820t760r1003b787],
32	3Department	NN	O	3department	appos	16	SENT_7	[p1l35t794r228b836],
33	of	IN	O	of	_	0	SENT_7	[p1l241t802r275b836],
34	Clinical	JJ	O	clinical	amod	35	SENT_7	[p1l284t802r403b829],
35	Chemistry	NNP	O	Chemistry	prep_of	32	SENT_7	[p1l417t802r572b836],
36	,	,	O	,	_	0	SENT_7	[p1l417t802r572b836],
37	Erasmus	NNP	ORGANIZATION	Erasmus	nn	38	SENT_7	[p1l589t803r718b828],
38	MC	NNP	ORGANIZATION	MC	appos	16	SENT_7	[p1l730t802r792b833],
39	,	,	O	,	_	0	SENT_7	[p1l730t802r792b833],
40	Rotterdam	NNP	LOCATION	Rotterdam	appos	38	SENT_7	[p1l808t802r971b833],
41	,	,	O	,	_	0	SENT_7	[p1l808t802r971b833],
42	the	DT	O	the	det	45	SENT_7	[p1l989t802r1032b828],
43	Netherlands	NNP	LOCATION	Netherlands	nn	45	SENT_7	[p1l1045t802r1228b829],
44	4STAR	NNP	O	4STAR	nn	45	SENT_7	[p1l34t836r132b870],
45	Medical	NNP	MISC	Medical	appos	38	SENT_7	[p1l145t844r268b870],
46	Diagnostic	NNP	MISC	Diagnostic	nn	64	SENT_7	[p1l280t845r444b877],
47	Center	NNP	MISC	Center	nn	64	SENT_7	[p1l459t844r560b874],
48	;	:	O	;	_	0	SENT_7	[p1l459t844r560b874],
49	Rotterdam	NNP	LOCATION	Rotterdam	dep	64	SENT_7	[p1l577t844r739b874],
50	,	,	O	,	_	0	SENT_7	[p1l577t844r739b874],
51	the	DT	O	the	det	53	SENT_7	[p1l757t844r800b870],
52	Netherlands	NNP	LOCATION	Netherlands	nn	53	SENT_7	[p1l813t844r996b870],
53	5Member	NN	O	5member	appos	49	SENT_7	[p1l34t877r175b911],
54	of	IN	O	of	_	0	SENT_7	[p1l185t885r219b919],
55	the	DT	O	the	det	57	SENT_7	[p1l227t885r271b911],
56	Netherlands	NNP	LOCATION	Netherlands	nn	57	SENT_7	[p1l283t885r466b912],
57	Consortium	NNP	LOCATION	Consortium	prep_of	53	SENT_7	[p1l482t886r655b912],
58	on	IN	O	on	_	0	SENT_7	[p1l669t894r705b911],
59	Healthy	JJ	O	healthy	amod	60	SENT_7	[p1l718t885r836b919],
60	Aging	NN	O	aging	prep_on	57	SENT_7	[p1l847t885r944b919],
61	,	,	O	,	_	0	SENT_7	[p1l847t885r944b919],
62	Leiden	NNP	LOCATION	Leiden	appos	49	SENT_7	[p1l960t885r1061b912],
63	/	:	O	/	punct	49	SENT_7	[p1l1073t885r1089b912],
64	Rotterdam	NNP	LOCATION	Rotterdam	dep	45	SENT_7	[p1l1097t885r1260b916],
65	,	,	O	,	_	0	SENT_7	[p1l1097t885r1260b916],
66	the	DT	O	the	det	68	SENT_7	[p1l1278t885r1321b911],
67	Netherlands	NNP	LOCATION	Netherlands	nn	68	SENT_7	[p1l1334t885r1517b912],
68	6Department	NN	O	6department	appos	38	SENT_7	[p1l34t919r228b960],
69	of	IN	O	of	_	0	SENT_7	[p1l241t927r275b960],
70	Internal	JJ	ORGANIZATION	internal	amod	71	SENT_7	[p1l281t927r402b953],
71	Medicine	NN	ORGANIZATION	medicine	prep_of	68	SENT_7	[p1l414t927r559b957],
72	,	,	O	,	_	0	SENT_7	[p1l414t927r559b957],
73	Erasmus	NNP	ORGANIZATION	Erasmus	nn	74	SENT_7	[p1l576t928r706b953],
74	MC	NNP	ORGANIZATION	MC	_	0	SENT_7	[p1l718t927r780b957],
75	,	,	O	,	_	0	SENT_7	[p1l718t927r780b957],
76	Rotterdam	NNP	LOCATION	Rotterdam	appos	74	SENT_7	[p1l796t927r958b957],
77	,	,	O	,	_	0	SENT_7	[p1l796t927r958b957],
78	the	DT	O	the	det	82	SENT_7	[p1l976t927r1020b953],
79	Netherlands	NNP	LOCATION	Netherlands	nn	82	SENT_7	[p1l1033t927r1216b953],
80	7Drug	NNP	O	7Drug	nn	82	SENT_7	[p1l34t961r127b1002],
81	Safety	NNP	ORGANIZATION	Safety	nn	82	SENT_7	[p1l141t969r231b1002],
82	Unit	NNP	ORGANIZATION	Unit	appos	74	SENT_7	[p1l248t969r316b999],
83	,	,	O	,	_	0	SENT_7	[p1l248t969r316b999],
84	Inspectorate	NNP	ORGANIZATION	Inspectorate	appos	74	SENT_7	[p1l332t969r518b1002],
85	for	IN	ORGANIZATION	for	_	0	SENT_7	[p1l526t969r577b1002],
86	Health	NNP	ORGANIZATION	Health	nn	87	SENT_7	[p1l587t968r689b995],
87	Care	NNP	ORGANIZATION	Care	prep_for	84	SENT_7	[p1l705t969r781b999],
88	,	,	O	,	_	0	SENT_7	[p1l705t969r781b999],
89	The	DT	O	the	det	90	SENT_7	[p1l800t968r852b995],
90	Hague	NNP	O	Hague	appos	87	SENT_7	[p1l866t969r971b1002],
91	,	,	O	,	_	0	SENT_7	[p1l866t969r971b1002],
92	the	DT	O	the	det	93	SENT_7	[p1l989t968r1032b995],
93	Netherlands	NNP	LOCATION	Netherlands	appos	74	SENT_7	[p1l1045t968r1228b995],

1	SUMMARY	NN	O	summary	nn	3	SENT_8	[p1l35t1077r244b1106],
2	Purpose	NN	O	purpose	nn	3	SENT_8	[p1l34t1134r163b1168],
3	Simvastatin	NN	O	simvastatin	nsubjpass	13	SENT_8	[p1l203t1134r377b1160],
4	and	CC	O	and	_	0	SENT_8	[p1l392t1134r444b1160],
5	atorvastatin	NN	O	atorvastatin	conj_and	3	SENT_8	[p1l458t1134r631b1160],
6	are	VBP	O	be	auxpass	7	SENT_8	[p1l645t1142r688b1160],
7	metabolized	VBN	O	metabolize	_	0	SENT_8	[p1l703t1134r885b1160],
8	by	IN	O	by	_	0	SENT_8	[p1l898t1134r935b1168],
9	the	DT	O	the	det	11	SENT_8	[p1l948t1134r993b1160],
10	CYP3A4	NN	O	cyp3a4	nn	11	SENT_8	[p1l1007t1134r1142b1160],
11	enzyme	NN	O	enzyme	agent	7	SENT_8	[p1l1156t1142r1271b1168],
12	and	CC	O	and	_	0	SENT_8	[p1l1286t1134r1338b1160],
13	transported	VBN	O	transport	conj_and	7	SENT_8	[p1l1352t1134r1519b1168],
14	by	IN	O	by	_	0	SENT_8	[p1l1532t1134r1569b1168],
15	the	DT	O	the	det	17	SENT_8	[p1l1582t1134r1627b1160],
16	ABCBl	NNP	O	ABCBl	nn	17	SENT_8	[p1l1641t1134r1757b1160],
17	transporter	NN	O	transporter	prep_by	13	SENT_8	[p1l1774t1138r1940b1168],
18	.	.	O	.	_	0	SENT_8	[p1l1774t1138r1940b1168],

1	We	PRP	O	we	nsubj	2	SENT_9	[p1l1955t1135r2004b1160],
2	studied	VBD	O	study	_	0	SENT_9	[p1l2019t1134r2125b1160],
3	whether	IN	O	whether	complm	24	SENT_9	[p1l34t1175r154b1201],
4	the	DT	O	the	det	9	SENT_9	[p1l163t1175r208b1201],
5	polymorphism	NN	O	polymorphism	nn	9	SENT_9	[p1l218t1175r436b1209],
6	CYP3A4	NN	O	cyp3a4	nn	9	SENT_9	[p1l447t1172r603b1201],
7	*	CD	NUMBER	*	num	9	SENT_9	[p1l447t1172r603b1201],
8	]	NN	O	]	nn	9	SENT_9	[p1l447t1172r603b1201],
9	B	NN	O	b	tmod	24	SENT_9	[p1l606t1176r628b1201],
10	and	CC	O	and	_	0	SENT_9	[p1l639t1175r692b1201],
11	the	DT	O	the	det	13	SENT_9	[p1l701t1175r746b1201],
12	polymorphisms	NNS	O	polymorphism	nn	13	SENT_9	[p1l755t1175r987b1209],
13	Cl236T	NN	O	cl236t	tmod	24	SENT_9	[p1l998t1175r1124b1206],
14	,	,	O	,	_	0	SENT_9	[p1l998t1175r1124b1206],
15	G2677A/T	NN	O	g2677a/t	nsubjpass	24	SENT_9	[p1l1136t1175r1296b1201],
16	and	CC	O	and	_	0	SENT_9	[p1l1304t1175r1357b1201],
17	C3435T	NN	O	c3435t	nsubjpass	24	SENT_9	[p1l1367t1175r1488b1201],
18	in	IN	O	in	_	0	SENT_9	[p1l1497t1175r1525b1201],
19	the	DT	O	the	det	22	SENT_9	[p1l1535t1175r1579b1201],
20	ABCB	NN	O	abcb	nn	22	SENT_9	[p1l1587t1175r1698b1201],
21	]	NN	O	]	nn	22	SENT_9	[p1l1587t1175r1698b1201],
22	gene	NN	O	gene	prep_in	15	SENT_9	[p1l1711t1183r1780b1209],
23	were	VBD	O	be	auxpass	24	SENT_9	[p1l1790t1183r1861b1201],
24	associated	VBN	O	associate	ccomp	2	SENT_9	[p1l1872t1175r2024b1201],
25	with	IN	O	with	_	0	SENT_9	[p1l2034t1175r2100b1201],
26	a	DT	O	a	det	27	SENT_9	[p1l2110t1183r2126b1201],
27	decrease	NN	O	decrease	prep_with	24	SENT_9	[p1l34t1216r162b1242],
28	of	IN	O	of	_	0	SENT_9	[p1l171t1216r203b1242],
29	the	DT	O	the	det	31	SENT_9	[p1l209t1216r253b1242],
30	prescribed	VBN	O	prescribe	amod	31	SENT_9	[p1l261t1216r417b1250],
31	dose	NN	O	dose	prep_of	27	SENT_9	[p1l425t1216r492b1242],
32	or	CC	O	or	_	0	SENT_9	[p1l501t1224r532b1242],
33	a	DT	O	a	det	34	SENT_9	[p1l540t1224r555b1242],
34	switch	NN	O	switch	prep_of	27	SENT_9	[p1l564t1216r660b1242],
35	to	TO	O	to	_	0	SENT_9	[p1l668t1220r696b1242],
36	another	DT	O	another	det	37	SENT_9	[p1l705t1216r817b1242],
37	cholesterol	NN	O	cholesterol	prep_to	34	SENT_9	[p1l824t1216r987b1242],
38	lowering	VBG	O	lower	partmod	37	SENT_9	[p1l996t1216r1127b1250],
39	drug	NN	O	drug	dobj	38	SENT_9	[p1l1136t1216r1203b1250],
40	during	IN	O	during	_	0	SENT_9	[p1l1212t1216r1308b1250],
41	simvastatin	NN	O	simvastatin	nn	44	SENT_9	[p1l1317t1216r1485b1242],
42	and	CC	O	and	_	0	SENT_9	[p1l1494t1216r1546b1242],
43	atorvastatin	NN	O	atorvastatin	conj_and	41	SENT_9	[p1l1555t1216r1728b1242],
44	therapy	NN	O	therapy	prep_during	38	SENT_9	[p1l1736t1216r1853b1250],
45	.	.	O	.	_	0	SENT_9	[p1l1736t1216r1853b1250],

1	These	DT	O	these	det	2	SENT_10	[p1l1863t1216r1951b1242],
2	events	NNS	O	event	nsubj	4	SENT_10	[p1l1960t1220r2052b1242],
3	may	MD	O	may	aux	4	SENT_10	[p1l2061t1224r2125b1250],
4	indicate	VB	O	indicate	_	0	SENT_10	[p1l34t1257r151b1283],
5	that	IN	O	that	complm	11	SENT_10	[p1l165t1257r221b1283],
6	statin	NN	O	statin	nn	8	SENT_10	[p1l235t1257r315b1283],
7	plasma	NN	O	plasma	nn	8	SENT_10	[p1l327t1257r434b1291],
8	levels	NNS	O	level	nsubj	13	SENT_10	[p1l447t1257r531b1283],
9	were	VBD	O	be	cop	11	SENT_10	[p1l546t1265r617b1283],
10	too	RB	O	too	advmod	11	SENT_10	[p1l631t1261r677b1283],
11	high	JJ	O	high	ccomp	4	SENT_10	[p1l691t1257r757b1291],
12	and	CC	O	and	_	0	SENT_10	[p1l771t1257r823b1283],
13	resulted	VBD	O	result	conj_and	11	SENT_10	[p1l836t1257r954b1283],
14	in	IN	O	in	_	0	SENT_10	[p1l968t1257r996b1283],
15	an	DT	O	a	det	18	SENT_10	[p1l1010t1265r1044b1283],
16	adverse	JJ	O	adverse	amod	18	SENT_10	[p1l1058t1257r1170b1283],
17	drug	NN	O	drug	nn	18	SENT_10	[p1l1184t1257r1251b1291],
18	reaction	NN	O	reaction	prep_in	13	SENT_10	[p1l1264t1257r1385b1283],
19	or	CC	O	or	_	0	SENT_10	[p1l1399t1265r1429b1283],
20	a	DT	O	a	det	23	SENT_10	[p1l1442t1265r1458b1283],
21	too	RB	O	too	advmod	22	SENT_10	[p1l1471t1261r1517b1283],
22	strong	JJ	O	strong	amod	23	SENT_10	[p1l1532t1261r1623b1291],
23	reduction	NN	O	reduction	prep_in	13	SENT_10	[p1l1636t1257r1777b1283],
24	in	IN	O	in	_	0	SENT_10	[p1l1791t1257r1819b1283],
25	cholesterol	NN	O	cholesterol	nn	26	SENT_10	[p1l1833t1257r1996b1283],
26	level	NN	O	level	prep_in	13	SENT_10	[p1l2010t1257r2088b1283],
27	.	.	O	.	_	0	SENT_10	[p1l2010t1257r2088b1283],

1	Methods	NNS	O	method	nsubj	3	SENT_11	[p1l34t1298r172b1324],
2	We	PRP	O	we	nsubj	3	SENT_11	[p1l210t1299r258b1324],
3	identiﬁed	VBD	O	identiﬁed	_	0	SENT_11	[p1l277t1298r418b1324],
4	1239	CD	DATE	1239	num	6	SENT_11	[p1l440t1298r509b1325],
5	incident	NN	O	incident	nn	6	SENT_11	[p1l529t1298r650b1324],
6	simvastatin	NN	O	simvastatin	dobj	3	SENT_11	[p1l669t1298r837b1324],
7	and	CC	O	and	_	0	SENT_11	[p1l857t1298r909b1324],
8	atorvastatin	NN	O	atorvastatin	nn	9	SENT_11	[p1l929t1298r1101b1324],
9	users	NNS	O	user	dobj	3	SENT_11	[p1l1120t1306r1195b1324],
10	in	IN	O	in	_	0	SENT_11	[p1l1215t1298r1243b1324],
11	the	DT	O	the	det	13	SENT_11	[p1l1262t1298r1306b1324],
12	Rotterdam	NNP	LOCATION	Rotterdam	nn	13	SENT_11	[p1l1325t1298r1483b1324],
13	Study	NNP	O	Study	prep_in	6	SENT_11	[p1l1503t1298r1594b1332],
14	,	,	O	,	_	0	SENT_11	[p1l1503t1298r1594b1332],
15	a	DT	O	a	det	18	SENT_11	[p1l1615t1306r1630b1324],
16	population-based	JJ	O	population-based	amod	18	SENT_11	[p1l1648t1298r1906b1332],
17	cohort	NN	O	cohort	nn	18	SENT_11	[p1l1925t1298r2019b1324],
18	study	NN	O	study	appos	13	SENT_11	[p1l2039t1298r2123b1332],
19	.	.	O	.	_	0	SENT_11	[p1l2039t1298r2123b1332],

1	Associations	NNS	O	association	nsubjpass	29	SENT_12	[p1l34t1339r223b1365],
2	between	IN	O	between	_	0	SENT_12	[p1l232t1339r356b1365],
3	the	DT	O	the	det	4	SENT_12	[p1l364t1339r409b1365],
4	polymorphisms	NNS	O	polymorphism	prep_between	1	SENT_12	[p1l417t1339r648b1373],
5	in	IN	O	in	_	0	SENT_12	[p1l657t1339r685b1365],
6	the	DT	O	the	det	8	SENT_12	[p1l693t1339r738b1365],
7	C	NN	O	c	nn	8	SENT_12	[p1l748t1340r772b1366],
8	YP3A4	NN	O	yp3a4	prep_in	4	SENT_12	[p1l774t1339r874b1365],
9	and	CC	O	and	_	0	SENT_12	[p1l883t1339r936b1365],
10	ABCB1	NN	O	abcb1	nn	11	SENT_12	[p1l941t1339r1052b1366],
11	gene	NN	O	gene	prep_in	4	SENT_12	[p1l1064t1347r1133b1373],
12	and	CC	O	and	_	0	SENT_12	[p1l1142t1339r1194b1365],
13	the	DT	O	the	det	14	SENT_12	[p1l1203t1339r1247b1365],
14	time	NN	O	time	conj_and	4	SENT_12	[p1l1256t1339r1321b1365],
15	to	TO	O	to	_	0	SENT_12	[p1l1330t1343r1358b1365],
16	a	DT	O	a	det	17	SENT_12	[p1l1367t1347r1382b1365],
17	decrease	NN	O	decrease	prep_to	14	SENT_12	[p1l1390t1339r1518b1365],
18	in	IN	O	in	_	0	SENT_12	[p1l1526t1339r1555b1365],
19	dose	NN	O	dose	prep_in	17	SENT_12	[p1l1563t1339r1630b1365],
20	or	CC	O	or	_	0	SENT_12	[p1l1639t1347r1669b1365],
21	a	DT	O	a	det	22	SENT_12	[p1l1678t1347r1693b1365],
22	switch	NN	O	switch	prep_to	14	SENT_12	[p1l1702t1339r1797b1365],
23	to	TO	O	to	_	0	SENT_12	[p1l1806t1343r1833b1365],
24	another	DT	O	another	det	25	SENT_12	[p1l1843t1339r1954b1365],
25	cholesterol	NN	O	cholesterol	prep_to	22	SENT_12	[p1l1962t1339r2125b1365],
26	lowering	VBG	O	lower	partmod	25	SENT_12	[p1l34t1380r165b1414],
27	drug	NN	O	drug	dobj	26	SENT_12	[p1l179t1380r246b1414],
28	were	VBD	O	be	auxpass	29	SENT_12	[p1l260t1388r331b1406],
29	studied	VBN	O	study	_	0	SENT_12	[p1l346t1380r452b1406],
30	using	VBG	O	use	xcomp	29	SENT_12	[p1l465t1380r545b1414],
31	Cox	NN	O	cox	nn	33	SENT_12	[p1l559t1380r620b1406],
32	proportional	JJ	O	proportional	amod	33	SENT_12	[p1l633t1380r817b1414],
33	hazards	NNS	O	hazard	dobj	30	SENT_12	[p1l831t1380r952b1406],
34	.	.	O	.	_	0	SENT_12	[p1l831t1380r952b1406],

1	Results	NNS	O	result	nsubj	15	SENT_13	[p1l34t1421r149b1447],
2	Simvastatin	NNP	O	Simvastatin	dep	1	SENT_13	[p1l188t1421r362b1447],
3	and	CC	O	and	_	0	SENT_13	[p1l375t1421r428b1447],
4	atorvastatin	NN	O	atorvastatin	nn	5	SENT_13	[p1l440t1421r613b1447],
5	users	NNS	O	user	nsubj	15	SENT_13	[p1l625t1429r700b1447],
6	with	IN	O	with	_	0	SENT_13	[p1l713t1421r778b1447],
7	the	DT	O	the	det	14	SENT_13	[p1l790t1421r834b1447],
8	CYP3A4	NN	O	cyp3a4	nn	14	SENT_13	[p1l849t1418r1005b1447],
9	*	NN	O	*	nn	14	SENT_13	[p1l849t1418r1005b1447],
10	I	NN	O	i	nn	14	SENT_13	[p1l849t1418r1005b1447],
11	B	NN	O	b	nn	14	SENT_13	[p1l1008t1422r1030b1447],
12	variant	JJ	O	variant	amod	14	SENT_13	[p1l1043t1421r1145b1447],
13	G	NN	O	g	nn	14	SENT_13	[p1l1157t1421r1183b1447],
14	allele	NN	O	allele	prep_with	5	SENT_13	[p1l1195t1421r1275b1447],
15	had	VBD	O	have	_	0	SENT_13	[p1l1287t1421r1341b1447],
16	a	DT	O	a	det	18	SENT_13	[p1l1353t1429r1369b1447],
17	lower	JJR	O	lower	amod	18	SENT_13	[p1l1380t1421r1464b1447],
18	risk	NN	O	risk	dobj	15	SENT_13	[p1l1475t1421r1531b1447],
19	(	CD	NUMBER	(	num	20	SENT_13	[p1l1544t1421r1606b1453],
20	HR	NN	DURATION	hr	dep	28	SENT_13	[p1l1544t1421r1606b1453],
21	0.46	CD	NUMBER	0.46	dep	20	SENT_13	[p1l1618t1421r1691b1452],
22	;	:	O	;	_	0	SENT_13	[p1l1618t1421r1691b1452],
23	95	CD	PERCENT	95	num	24	SENT_13	[p1l1705t1421r1810b1448],
24	%	NN	PERCENT	%	dep	21	SENT_13	[p1l1705t1421r1810b1448],
25	CI	NN	O	ci	dep	28	SENT_13	[p1l1705t1421r1810b1448],
26	0.24-0	CD	NUMBER	0.24-0	num	25	SENT_13	[p1l1822t1421r1981b1453],
27	.90	CD	NUMBER	.90	num	28	SENT_13	[p1l1822t1421r1981b1453],
28	)	NN	O	)	dep	15	SENT_13	[p1l1822t1421r1981b1453],
29	for	IN	O	for	_	0	SENT_13	[p1l1995t1421r2038b1447],
30	these	DT	O	these	det	31	SENT_13	[p1l2049t1421r2125b1447],
31	events	NNS	O	event	prep_for	28	SENT_13	[p1l34t1466r127b1488],
32	than	IN	O	than	_	0	SENT_13	[p1l139t1462r203b1488],
33	users	NNS	O	user	prep_than	15	SENT_13	[p1l214t1470r289b1488],
34	with	IN	O	with	_	0	SENT_13	[p1l301t1462r367b1488],
35	the	DT	O	the	det	38	SENT_13	[p1l378t1462r423b1488],
36	wild-type	JJ	O	wild-type	amod	38	SENT_13	[p1l434t1462r576b1496],
37	AA	NN	O	aa	nn	38	SENT_13	[p1l588t1463r641b1488],
38	genotype	NN	O	genotype	prep_with	33	SENT_13	[p1l653t1466r796b1496],
39	.	.	O	.	_	0	SENT_13	[p1l653t1466r796b1496],

1	No	DT	O	no	det	3	SENT_14	[p1l809t1463r854b1488],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_14	[p1l867t1462r1021b1496],
3	associations	NNS	O	association	nsubjpass	5	SENT_14	[p1l1033t1462r1211b1488],
4	were	VBD	O	be	auxpass	5	SENT_14	[p1l1224t1470r1295b1488],
5	found	VBN	O	find	_	0	SENT_14	[p1l1307t1462r1393b1488],
6	for	IN	O	for	_	0	SENT_14	[p1l1404t1462r1448b1488],
7	the	DT	O	the	det	9	SENT_14	[p1l1458t1462r1503b1488],
8	ABCBI	NNP	O	ABCBI	nn	9	SENT_14	[p1l1512t1463r1624b1489],
9	polymorphisms	NNS	O	polymorphism	prep_for	5	SENT_14	[p1l1638t1462r1877b1496],
10	.	.	O	.	_	0	SENT_14	[p1l1638t1462r1877b1496],

1	The	DT	O	the	det	2	SENT_15	[p1l1891t1462r1948b1488],
2	association	NN	O	association	nsubj	14	SENT_15	[p1l1960t1462r2125b1488],
3	with	IN	O	with	_	0	SENT_15	[p1l34t1503r100b1529],
4	the	DT	O	the	det	6	SENT_15	[p1l112t1503r156b1529],
5	C	NN	O	c	nn	6	SENT_15	[p1l171t1503r195b1530],
6	YP3A4	NN	O	yp3a4	prep_with	2	SENT_15	[p1l197t1500r353b1529],
7	*	CD	NUMBER	*	num	9	SENT_15	[p1l197t1500r353b1529],
8	IB	NNP	O	IB	nn	9	SENT_15	[p1l197t1500r353b1529],
9	polymorphism	NN	O	polymorphism	nsubjpass	11	SENT_15	[p1l365t1503r583b1537],
10	was	VBD	O	be	auxpass	11	SENT_15	[p1l596t1511r651b1529],
11	found	VBN	O	find	rcmod	6	SENT_15	[p1l665t1503r751b1529],
12	in	IN	O	in	_	0	SENT_15	[p1l764t1503r792b1529],
13	women	NNS	O	woman	prep_in	11	SENT_15	[p1l805t1511r913b1529],
14	(	VBP	O	(	_	0	SENT_15	[p1l927t1503r989b1535],
15	HR	NN	DURATION	hr	dobj	14	SENT_15	[p1l927t1503r989b1535],
16	0.33	CD	NUMBER	0.33	num	15	SENT_15	[p1l1002t1503r1075b1534],
17	;	:	O	;	_	0	SENT_15	[p1l1002t1503r1075b1534],
18	95	CD	PERCENT	95	number	19	SENT_15	[p1l1090t1503r1194b1530],
19	%	NN	PERCENT	%	amod	20	SENT_15	[p1l1090t1503r1194b1530],
20	CI	NN	O	ci	dep	15	SENT_15	[p1l1090t1503r1194b1530],
21	0.12-0	CD	NUMBER	0.12-0	num	23	SENT_15	[p1l1207t1503r1366b1535],
22	.89	CD	NUMBER	.89	num	23	SENT_15	[p1l1207t1503r1366b1535],
23	)	NN	O	)	dep	20	SENT_15	[p1l1207t1503r1366b1535],
24	and	CC	O	and	_	0	SENT_15	[p1l1381t1503r1433b1529],
25	was	VBD	O	be	cop	26	SENT_15	[p1l1446t1511r1502b1529],
26	non-signiﬁcant	JJ	O	non-signiﬁcant	conj_and	14	SENT_15	[p1l1515t1503r1738b1537],
27	in	IN	O	in	_	0	SENT_15	[p1l1751t1503r1779b1529],
28	men	NNS	O	man	prep_in	26	SENT_15	[p1l1791t1511r1855b1529],
29	(	CD	NUMBER	(	num	30	SENT_15	[p1l1869t1503r1931b1535],
30	HR	NN	DURATION	hr	dep	28	SENT_15	[p1l1869t1503r1931b1535],
31	0.69	CD	PERCENT	0.69	num	34	SENT_15	[p1l1944t1503r2007b1530],
32	95	CD	PERCENT	95	number	33	SENT_15	[p1l2021t1503r2125b1530],
33	%	NN	PERCENT	%	amod	34	SENT_15	[p1l2021t1503r2125b1530],
34	CI	NN	O	ci	dep	30	SENT_15	[p1l2021t1503r2125b1530],
35	0.28-1	CD	NUMBER	0.28-1	num	37	SENT_15	[p1l34t1544r202b1576],
36	.70	CD	NUMBER	.70	num	37	SENT_15	[p1l34t1544r202b1576],
37	)	NN	O	)	dobj	14	SENT_15	[p1l34t1544r202b1576],
38	.	.	O	.	_	0	SENT_15	[p1l34t1544r202b1576],

1	This	DT	O	this	det	2	SENT_16	[p1l217t1544r282b1570],
2	association	NN	O	association	nsubj	4	SENT_16	[p1l297t1544r462b1570],
3	was	VBD	O	be	cop	4	SENT_16	[p1l476t1552r532b1570],
4	stronger	JJR	O	stronger	_	0	SENT_16	[p1l547t1548r668b1578],
5	in	IN	O	in	_	0	SENT_16	[p1l681t1544r709b1570],
6	patients	NNS	O	patient	prep_in	4	SENT_16	[p1l722t1544r837b1578],
7	with	IN	O	with	_	0	SENT_16	[p1l852t1544r917b1570],
8	the	DT	O	the	det	12	SENT_16	[p1l931t1544r975b1570],
9	ABCBI	NNP	O	ABCBI	nn	12	SENT_16	[p1l987t1544r1098b1570],
10	3435T	NN	O	3435t	nn	12	SENT_16	[p1l1115t1544r1211b1570],
11	variant	JJ	O	variant	amod	12	SENT_16	[p1l1224t1544r1327b1570],
12	allele	NN	O	allele	prep_with	6	SENT_16	[p1l1341t1544r1420b1570],
13	versus	CC	O	versus	prep	12	SENT_16	[p1l1434t1553r1528b1570],
14	the	DT	O	the	det	16	SENT_16	[p1l1542t1544r1586b1570],
15	G	NN	O	g	nn	16	SENT_16	[p1l1601t1544r1626b1570],
16	allele	NN	O	allele	dep	13	SENT_16	[p1l1640t1544r1727b1570],
17	.	.	O	.	_	0	SENT_16	[p1l1640t1544r1727b1570],

1	Conclusion	NN	O	conclusion	npadvmod	16	SENT_17	[p1l35t1584r211b1612],
2	In	IN	O	in	_	0	SENT_17	[p1l249t1585r280b1611],
3	simvastatin	NN	O	simvastatin	nn	6	SENT_17	[p1l291t1585r459b1611],
4	and	CC	O	and	_	0	SENT_17	[p1l471t1585r523b1611],
5	atorvastatin	NN	O	atorvastatin	conj_and	3	SENT_17	[p1l534t1585r707b1611],
6	users	NNS	O	user	prep_in	16	SENT_17	[p1l717t1593r801b1616],
7	,	,	O	,	_	0	SENT_17	[p1l717t1593r801b1616],
8	the	DT	O	the	det	9	SENT_17	[p1l813t1585r857b1611],
9	CYP3A4	NN	O	cyp3a4	nsubjpass	16	SENT_17	[p1l870t1582r1026b1611],
10	*	CD	NUMBER	*	dep	9	SENT_17	[p1l870t1582r1026b1611],
11	I	PRP	O	I	dep	9	SENT_17	[p1l870t1582r1026b1611],
12	B	NN	O	b	nn	14	SENT_17	[p1l1029t1586r1051b1611],
13	G	NN	O	g	nn	14	SENT_17	[p1l1063t1585r1088b1611],
14	allele	NN	O	allele	dep	11	SENT_17	[p1l1099t1585r1179b1611],
15	is	VBZ	O	be	auxpass	16	SENT_17	[p1l1190t1585r1213b1611],
16	associated	VBN	O	associate	_	0	SENT_17	[p1l1225t1585r1377b1611],
17	with	IN	O	with	_	0	SENT_17	[p1l1388t1585r1454b1611],
18	a	DT	O	a	det	20	SENT_17	[p1l1465t1593r1480b1611],
19	lower	JJR	O	lower	amod	20	SENT_17	[p1l1490t1585r1574b1611],
20	risk	NN	O	risk	prep_with	16	SENT_17	[p1l1584t1585r1640b1611],
21	of	IN	O	of	_	0	SENT_17	[p1l1650t1585r1682b1611],
22	elevated	JJ	O	elevated	amod	25	SENT_17	[p1l1691t1585r1813b1611],
23	statin	NN	O	statin	nn	25	SENT_17	[p1l1825t1585r1904b1611],
24	plasma	NN	O	plasma	nn	25	SENT_17	[p1l1914t1585r2020b1619],
25	levels	NNS	O	level	prep_of	20	SENT_17	[p1l2030t1585r2124b1616],
26	,	,	O	,	_	0	SENT_17	[p1l2030t1585r2124b1616],
27	particularly	RB	O	particularly	advmod	16	SENT_17	[p1l33t1626r206b1660],
28	in	IN	O	in	_	0	SENT_17	[p1l220t1626r248b1652],
29	women	NNS	O	woman	prep_in	16	SENT_17	[p1l261t1635r370b1652],
30	and	CC	O	and	_	0	SENT_17	[p1l385t1626r437b1652],
31	in	IN	O	in	_	0	SENT_17	[p1l450t1626r478b1652],
32	users	NNS	O	user	prep_in	16	SENT_17	[p1l492t1635r567b1652],
33	with	IN	O	with	_	0	SENT_17	[p1l581t1626r647b1652],
34	the	DT	O	the	det	38	SENT_17	[p1l660t1626r704b1652],
35	ABCBI	NNP	O	ABCBI	nn	38	SENT_17	[p1l716t1627r827b1653],
36	3435T	NN	O	3435t	nn	38	SENT_17	[p1l844t1626r940b1653],
37	variant	JJ	O	variant	amod	38	SENT_17	[p1l953t1626r1056b1652],
38	allele	NN	O	allele	prep_with	32	SENT_17	[p1l1070t1626r1157b1652],
39	.	.	O	.	_	0	SENT_17	[p1l1070t1626r1157b1652],

1	Copyright	NN	O	copyright	nn	5	SENT_18	[p1l1173t1626r1324b1660],
2	©	CD	NUMBER	©	num	5	SENT_18	[p1l1339t1627r1371b1658],
3	2009	CD	DATE	2009	num	5	SENT_18	[p1l1387t1626r1460b1653],
4	John	NNP	PERSON	John	nn	5	SENT_18	[p1l1474t1626r1543b1653],
5	Wiley	NNP	PERSON	Wiley	_	0	SENT_18	[p1l1556t1626r1646b1660],
6	&	CC	O	&	_	0	SENT_18	[p1l1661t1626r1687b1653],
7	Sons	NNP	O	Sons	conj_and	5	SENT_18	[p1l1702t1626r1780b1657],
8	,	,	O	,	_	0	SENT_18	[p1l1702t1626r1780b1657],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_18	[p1l1795t1626r1854b1652],
10	.	.	O	.	_	0	SENT_18	[p1l1795t1626r1854b1652],

1	KEY	JJ	O	key	amod	2	SENT_19	[p1l34t1724r93b1743],
2	WoRDs	NNS	O	word	_	0	SENT_19	[p1l106t1717r437b1748],
3	—	JJ	O	—	amod	4	SENT_19	[p1l106t1717r437b1748],
4	simvastatin	NN	O	simvastatin	dep	2	SENT_19	[p1l106t1717r437b1748],
5	;	:	O	;	_	0	SENT_19	[p1l106t1717r437b1748],
6	atorvastatin	NN	O	atorvastatin	dep	2	SENT_19	[p1l453t1717r635b1748],
7	;	:	O	;	_	0	SENT_19	[p1l453t1717r635b1748],
8	pharmacogenetics	NNS	O	pharmacogenetic	dep	6	SENT_19	[p1l649t1717r928b1751],
9	;	:	O	;	_	0	SENT_19	[p1l649t1717r928b1751],
10	ABCBl	NN	O	abcbl	dep	8	SENT_19	[p1l944t1717r1072b1748],
11	;	:	O	;	_	0	SENT_19	[p1l944t1717r1072b1748],
12	CYP3A4	NNP	O	CYP3A4	nsubj	13	SENT_19	[p1l1087t1717r1222b1743],
13	Received	VBD	O	receive	dep	10	SENT_19	[p1l33t1808r170b1835],
14	28	CD	DATE	28	dobj	13	SENT_19	[p1l182t1808r219b1834],
15	January	NNP	DATE	January	tmod	13	SENT_19	[p1l231t1809r352b1842],
16	2009	CD	DATE	2009	num	15	SENT_19	[p1l365t1808r449b1839],
17	,	,	O	,	_	0	SENT_19	[p1l365t1808r449b1839],
18	‘	CD	NUMBER	‘	num	15	SENT_19	[p1l365t1808r449b1839],
19	Revised	VBN	O	revise	dep	13	SENT_19	[p1l464t1808r582b1835],
20	30	CD	DATE	30	dobj	19	SENT_19	[p1l593t1808r630b1834],
21	July	NNP	DATE	July	tmod	19	SENT_19	[p1l643t1808r703b1842],
22	2009	CD	DATE	2009	num	21	SENT_19	[p1l717t1808r801b1839],
23	;	:	O	;	_	0	SENT_19	[p1l717t1808r801b1839],
24	Accepted	JJ	O	accepted	amod	25	SENT_19	[p1l814t1808r955b1842],
25	27	CD	DATE	27	dep	2	SENT_19	[p1l966t1808r1005b1834],
26	August	NNP	DATE	August	tmod	25	SENT_19	[p1l1014t1808r1120b1842],
27	2009	CD	DATE	2009	num	26	SENT_19	[p1l1132t1808r1206b1835],

1	INTRODUCTION	NN	O	introduction	_	0	SENT_20	[p1l7t2004r744b2072],

1	HMG	NN	O	hmg	_	0	SENT_21	[p1l7t2209r452b2278],
2	.	.	O	.	_	0	SENT_21	[p1l7t2209r452b2278],

1	—	NN	O	—	_	0	SENT_22	[p1l7t2209r452b2278],
2	.	.	O	.	_	0	SENT_22	[p1l7t2209r452b2278],

1	CoA	NN	O	coa	nn	3	SENT_23	[p1l7t2209r452b2278],
2	reductase	NN	O	reductase	nn	3	SENT_23	[p1l491t2209r861b2277],
3	inhibitors	NNS	O	inhibitor	nsubjpass	8	SENT_23	[p1l903t2208r1277b2278],
4	or	CC	O	or	_	0	SENT_23	[p1l1321t2231r1401b2278],
5	statins	NNS	O	statin	nsubjpass	8	SENT_23	[p1l1443t2209r1687b2278],
6	are	VBP	O	be	auxpass	8	SENT_23	[p1l1732t2231r1847b2278],
7	widely	RB	O	widely	advmod	8	SENT_23	[p1l1888t2209r2153b2298],
8	prescribed	VBN	O	prescribe	_	0	SENT_23	[p1l6t2315r416b2405],
9	for	IN	O	for	_	0	SENT_23	[p1l453t2315r566b2384],
10	the	DT	O	the	det	11	SENT_23	[p1l601t2315r719b2384],
11	treatment	NN	O	treatment	prep_for	8	SENT_23	[p1l756t2326r1129b2384],
12	of	IN	O	of	_	0	SENT_23	[p1l1166t2315r1251b2384],
13	hypercholesterolemia	NN	O	hypercholesterolemia	prep_of	11	SENT_23	[p1l1280t2315r2148b2405],
14	.	.	O	.	_	0	SENT_23	[p1l1280t2315r2148b2405],

1	Statins	NNS	O	statin	nsubj	2	SENT_24	[p1l10t2422r271b2491],
2	reduce	VBP	O	reduce	_	0	SENT_24	[p1l321t2422r581b2490],
3	morbidity	NN	O	morbidity	dobj	2	SENT_24	[p1l631t2422r1017b2518],
4	and	CC	O	and	_	0	SENT_24	[p1l1068t2422r1207b2490],
5	mortality	NN	O	mortality	conj_and	3	SENT_24	[p1l1254t2422r1614b2511],
6	by	IN	O	by	_	0	SENT_24	[p1l1661t2422r1758b2511],
7	lowering	VBG	O	lower	prepc_by	2	SENT_24	[p1l1808t2422r2152b2511],
8	LDL	NN	O	ldl	nn	10	SENT_24	[p1l7t2532r196b2598],
9	cholesterol	NN	O	cholesterol	nn	10	SENT_24	[p1l245t2530r675b2599],
10	levels	NNS	O	level	nsubj	11	SENT_24	[p1l724t2519r1003b2599],
11	}	VBP	O	}	ccomp	7	SENT_24	[p1l724t2519r1003b2599],
12	In	IN	O	in	dep	15	SENT_24	[p1l1059t2532r1138b2598],
13	general	JJ	O	general	amod	14	SENT_24	[p1l1188t2530r1474b2619],
14	statins	NNS	O	statin	pobj	12	SENT_24	[p1l1527t2530r1770b2599],
15	are	VBP	O	be	ccomp	11	SENT_24	[p1l1823t2552r1938b2599],
16	well	RB	O	well	advmod	17	SENT_24	[p1l1987t2531r2152b2599],
17	tolerated	VBN	O	tolerate	dep	15	SENT_24	[p1l7t2636r351b2705],
18	and	CC	O	and	_	0	SENT_24	[p1l404t2636r542b2705],
19	safe	JJ	O	safe	conj_and	17	SENT_24	[p1l596t2636r769b2718],
20	,	,	O	,	_	0	SENT_24	[p1l596t2636r769b2718],
21	although	IN	O	although	mark	30	SENT_24	[p1l825t2636r1167b2726],
22	myopathy	NN	O	myopathy	nsubjpass	30	SENT_24	[p1l1217t2636r1608b2726],
23	and	CC	O	and	_	0	SENT_24	[p1l1661t2636r1799b2705],
24	rhabdo	NN	O	rhabdo	nn	26	SENT_24	[p1l1848t2636r2150b2705],
25	—	NN	O	—	nn	26	SENT_24	[p1l1848t2636r2150b2705],
26	myolysis	NN	O	myolysis	nsubjpass	30	SENT_24	[p1l7t2743r358b2832],
27	are	VBP	O	be	auxpass	30	SENT_24	[p1l419t2765r534b2812],
28	well	RB	O	well	advmod	30	SENT_24	[p1l590t2743r1055b2812],
29	—	RB	O	—	advmod	30	SENT_24	[p1l590t2743r1055b2812],
30	known	VBN	O	know	advcl	2	SENT_24	[p1l590t2743r1055b2812],
31	serious	JJ	O	serious	amod	33	SENT_24	[p1l1116t2743r1386b2812],
32	adverse	JJ	O	adverse	amod	33	SENT_24	[p1l1447t2743r1741b2812],
33	reactions	NNS	O	reaction	dobj	30	SENT_24	[p1l1798t2743r2151b2812],
34	associated	VBN	O	associate	partmod	33	SENT_24	[p1l9t2850r411b2919],
35	with	IN	O	with	_	0	SENT_24	[p1l446t2850r619b2919],
36	statin	NN	O	statin	nn	37	SENT_24	[p1l657t2850r865b2919],
37	therapy	NN	O	therapy	prep_with	34	SENT_24	[p1l901t2830r1249b2940],
38	?	.	O	?	_	0	SENT_24	[p1l901t2830r1249b2940],

1	*	NN	O	*	nn	2	SENT_25	[p1l10t3075r37b3105],
2	Correspondence	NN	O	correspondence	_	0	SENT_25	[p1l55t3074r517b3139],
3	to	TO	O	to	infmod	2	SENT_25	[p1l540t3082r609b3125],
4	:	:	O	:	_	0	SENT_25	[p1l540t3082r609b3125],
5	Dr	NNP	O	Dr	nn	8	SENT_25	[p1l637t3076r712b3124],
6	B.	NNP	PERSON	B.	nn	8	SENT_25	[p1l733t3076r793b3125],
7	H.	NNP	PERSON	H.	nn	8	SENT_25	[p1l820t3076r884b3125],
8	Ch	NNP	PERSON	Ch	dep	2	SENT_25	[p1l911t3074r1006b3125],
9	.	.	O	.	_	0	SENT_25	[p1l911t3074r1006b3125],

1	Stricker	NNP	PERSON	Stricker	nn	3	SENT_26	[p1l1034t3074r1270b3134],
2	,	,	O	,	_	0	SENT_26	[p1l1034t3074r1270b3134],
3	Department	NNP	ORGANIZATION	Department	_	0	SENT_26	[p1l1295t3076r1634b3139],
4	of	IN	ORGANIZATION	of	_	0	SENT_26	[p1l1656t3074r1718b3125],
5	Epidemiology	NNP	ORGANIZATION	Epidemiology	prep_of	3	SENT_26	[p1l1735t3074r2151b3139],
6	,	,	O	,	_	0	SENT_26	[p1l1735t3074r2151b3139],
7	Erasmus	NNP	ORGANIZATION	Erasmus	nn	8	SENT_26	[p1l6t3162r250b3211],
8	MC	NNP	ORGANIZATION	MC	appos	3	SENT_26	[p1l276t3161r401b3220],
9	,	,	O	,	_	0	SENT_26	[p1l276t3161r401b3220],
10	PO	NNP	O	PO	nn	11	SENT_26	[p1l430t3161r518b3211],
11	Box	NNP	O	Box	appos	3	SENT_26	[p1l544t3162r661b3210],
12	2040	CD	DATE	2040	num	11	SENT_26	[p1l688t3161r843b3220],
13	,	,	O	,	_	0	SENT_26	[p1l688t3161r843b3220],
14	3000	CD	NUMBER	3000	num	11	SENT_26	[p1l873t3161r1012b3211],
15	CA	NNP	O	CA	nn	16	SENT_26	[p1l1039t3161r1136b3211],
16	Rotterdam	NNP	LOCATION	Rotterdam	dep	11	SENT_26	[p1l1161t3161r1477b3220],
17	,	,	O	,	_	0	SENT_26	[p1l1161t3161r1477b3220],
18	the	DT	O	the	det	22	SENT_26	[p1l1506t3161r1591b3211],
19	Netherlands	NNP	LOCATION	Netherlands	nn	22	SENT_26	[p1l1617t3161r1960b3211],
20	E	NN	O	e	nn	22	SENT_26	[p1l6t3248r216b3298],
21	—	CD	NUMBER	—	num	22	SENT_26	[p1l6t3248r216b3298],
22	mail	NN	O	mail	appos	3	SENT_26	[p1l6t3248r216b3298],
23	:	:	O	:	_	0	SENT_26	[p1l6t3248r216b3298],
24	b.stricker@erasmusmc.nl	NN	O	b.stricker@erasmusmc.nl	dep	3	SENT_26	[p1l245t3248r972b3298],
25	‘	CD	NUMBER	‘	num	24	SENT_26	[p1l8t3318r140b3385],
26	The	DT	O	the	det	27	SENT_26	[p1l8t3318r140b3385],
27	authors	NNS	O	author	nsubj	28	SENT_26	[p1l167t3335r373b3385],
28	declare	VBP	O	declare	rcmod	24	SENT_26	[p1l401t3335r605b3385],
29	that	IN	O	that	complm	31	SENT_26	[p1l631t3335r738b3385],
30	there	EX	O	there	expl	31	SENT_26	[p1l763t3335r904b3385],
31	is	VBZ	O	be	ccomp	28	SENT_26	[p1l930t3335r975b3385],
32	no	DT	O	no	det	33	SENT_26	[p1l1002t3351r1071b3385],
33	conﬂict	NN	O	conﬂict	nsubj	31	SENT_26	[p1l1098t3335r1312b3385],
34	of	IN	O	of	_	0	SENT_26	[p1l1337t3335r1399b3385],
35	interest	NN	O	interest	prep_of	33	SENT_26	[p1l1419t3335r1643b3385],
36	.	.	O	.	_	0	SENT_26	[p1l1419t3335r1643b3385],

1	Copyright	NN	O	copyright	nn	5	SENT_27	[p1l8t3543r333b3615],
2	©	CD	NUMBER	©	num	5	SENT_27	[p1l366t3544r434b3612],
3	2009	CD	DATE	2009	num	5	SENT_27	[p1l469t3543r625b3600],
4	John	NNP	PERSON	John	nn	5	SENT_27	[p1l655t3543r805b3599],
5	Wiley	NNP	PERSON	Wiley	_	0	SENT_27	[p1l833t3543r1027b3615],
6	&	CC	O	&	_	0	SENT_27	[p1l1057t3543r1115b3599],
7	Sons	NNP	O	Sons	conj_and	5	SENT_27	[p1l1147t3543r1316b3609],
8	,	,	O	,	_	0	SENT_27	[p1l1147t3543r1316b3609],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_27	[p1l1347t3543r1474b3599],
10	.	.	O	.	_	0	SENT_27	[p1l1347t3543r1474b3599],

1	Two	CD	NUMBER	two	dep	102	SENT_28	[p2l96t20r264b87],
2	regularly	RB	O	regularly	dep	102	SENT_28	[p2l296t19r648b107],
3	used	VBN	O	use	dep	102	SENT_28	[p2l678t18r857b87],
4	statins	NNS	O	statin	dep	102	SENT_28	[p2l890t19r1156b99],
5	,	,	O	,	_	0	SENT_28	[p2l890t19r1156b99],
6	simvastatin	NN	O	simvastatin	dep	102	SENT_28	[p2l1194t19r1634b87],
7	and	CC	O	and	dep	102	SENT_28	[p2l1667t19r1805b87],
8	atorvastatin	NN	O	atorvastatin	dep	102	SENT_28	[p2l1837t29r2144b87, p2l7t124r201b205],
9	,	,	O	,	_	0	SENT_28	[p2l1837t29r2144b87, p2l7t124r201b205],
10	are	VBP	O	be	dep	102	SENT_28	[p2l232t146r347b193],
11	mainly	RB	O	mainly	dep	102	SENT_28	[p2l373t124r644b213],
12	metabolized	VBN	O	metabolize	dep	102	SENT_28	[p2l670t124r1150b193],
13	by	IN	O	by	dep	102	SENT_28	[p2l1173t124r1269b213],
14	the	DT	O	the	dep	102	SENT_28	[p2l1295t124r1412b193],
15	Cytochrome	NNP	O	Cytochrome	dep	102	SENT_28	[p2l1440t124r1922b213],
16	P450	NN	O	p450	dep	102	SENT_28	[p2l1948t124r2146b193],
17	(	CD	NUMBER	(	dep	102	SENT_28	[p2l10t232r257b316],
18	CYP	NN	O	cyp	dep	102	SENT_28	[p2l10t232r257b316],
19	)	CD	NUMBER	)	dep	102	SENT_28	[p2l10t232r257b316],
20	3A4	NN	O	3a4	dep	102	SENT_28	[p2l286t232r448b301],
21	enzyme	NN	O	enzyme	dep	102	SENT_28	[p2l474t210r911b320],
22	.3	NN	NUMBER	.3	dep	102	SENT_28	[p2l474t210r911b320],
23	‘	CD	NUMBER	‘	dep	102	SENT_28	[p2l474t210r911b320],
24	6	CD	NUMBER	6	dep	102	SENT_28	[p2l474t210r911b320],
25	The	DT	O	the	dep	102	SENT_28	[p2l936t231r1086b300],
26	area	NN	O	area	dep	102	SENT_28	[p2l1112t253r1273b300],
27	under	IN	O	under	dep	102	SENT_28	[p2l1295t232r1519b300],
28	curve	NN	O	curve	dep	102	SENT_28	[p2l1541t253r1755b300],
29	(	CD	NUMBER	(	dep	102	SENT_28	[p2l1783t232r2040b316],
30	AUC	NN	O	auc	dep	102	SENT_28	[p2l1783t232r2040b316],
31	)	NN	O	)	dep	102	SENT_28	[p2l1783t232r2040b316],
32	of	IN	O	of	dep	102	SENT_28	[p2l2069t231r2153b300],
33	simvastatin	NN	O	simvastatin	dep	102	SENT_28	[p2l10t337r450b406],
34	increases	NNS	O	increase	dep	102	SENT_28	[p2l475t337r831b405],
35	ﬁve	VBP	O	ﬁve	dep	102	SENT_28	[p2l860t337r1031b406],
36	—	NN	O	—	dep	102	SENT_28	[p2l860t337r1031b406],
37	to	TO	O	to	dep	102	SENT_28	[p2l1059t348r1132b405],
38	twentyfold	JJ	O	twentyfold	dep	102	SENT_28	[p2l1157t337r1581b426],
39	if	IN	O	if	dep	102	SENT_28	[p2l1605t337r1669b405],
40	itraconazol	NN	O	itraconazol	dep	102	SENT_28	[p2l1686t337r2143b418],
41	,	,	O	,	_	0	SENT_28	[p2l1686t337r2143b418],
42	a	DT	O	a	dep	102	SENT_28	[p2l9t465r49b511],
43	potent	JJ	O	potent	dep	102	SENT_28	[p2l85t453r331b532],
44	CYP3A4	NN	O	cyp3a4	dep	102	SENT_28	[p2l368t443r722b512],
45	inhibitor	NN	O	inhibitor	dep	102	SENT_28	[p2l761t443r1115b524],
46	,	,	O	,	_	0	SENT_28	[p2l761t443r1115b524],
47	is	VBZ	O	be	dep	102	SENT_28	[p2l1156t443r1217b511],
48	co	NN	O	co	dep	102	SENT_28	[p2l1258t443r1810b532],
49	—	NN	O	—	dep	102	SENT_28	[p2l1258t443r1810b532],
50	prescribed	VBN	O	prescribe	dep	102	SENT_28	[p2l1258t443r1810b532],
51	,	,	O	,	_	0	SENT_28	[p2l1258t443r1810b532],
52	and	CC	O	and	dep	102	SENT_28	[p2l1854t443r1992b511],
53	the	DT	O	the	dep	102	SENT_28	[p2l2028t443r2146b511],
54	AUC	NN	O	auc	dep	102	SENT_28	[p2l7t550r204b618],
55	of	IN	O	of	dep	102	SENT_28	[p2l250t550r334b618],
56	atorvastatin	NN	O	atorvastatin	dep	102	SENT_28	[p2l372t550r825b618],
57	increases	VBZ	O	increase	dep	102	SENT_28	[p2l868t550r1223b618],
58	two	CD	NUMBER	two	dep	102	SENT_28	[p2l1268t560r1411b618],
59	to	TO	O	to	dep	102	SENT_28	[p2l1456t560r1528b618],
60	fourfold	RB	O	fourfold	dep	102	SENT_28	[p2l1573t530r1951b618],
61	.7	CD	NUMBER	.7	dep	102	SENT_28	[p2l1573t530r1951b618],
62	The	DT	O	the	dep	102	SENT_28	[p2l1996t550r2146b618],
63	risk	NN	O	risk	dep	102	SENT_28	[p2l6t656r153b725],
64	of	IN	O	of	dep	102	SENT_28	[p2l221t656r305b725],
65	myopathy	NN	O	myopathy	dep	102	SENT_28	[p2l365t656r755b745],
66	with	IN	O	with	dep	102	SENT_28	[p2l824t656r996b725],
67	these	DT	O	these	dep	102	SENT_28	[p2l1063t656r1262b725],
68	statins	NNS	O	statin	dep	102	SENT_28	[p2l1334t656r1577b725],
69	is	VBZ	O	be	dep	102	SENT_28	[p2l1647t656r1707b725],
70	markedly	RB	O	markedly	dep	102	SENT_28	[p2l1778t656r2146b745],
71	increased	VBN	O	increase	dep	102	SENT_28	[p2l7t763r377b831],
72	if	IN	O	if	dep	102	SENT_28	[p2l410t763r474b831],
73	combined	VBN	O	combine	dep	102	SENT_28	[p2l502t763r888b831],
74	with	IN	O	with	dep	102	SENT_28	[p2l922t763r1093b832],
75	drugs	NNS	O	drug	dep	102	SENT_28	[p2l1128t763r1340b852],
76	inhibiting	VBG	O	inhibit	dep	102	SENT_28	[p2l1376t763r1756b852],
77	CYP3A4	NN	O	cyp3a4	dep	102	SENT_28	[p2l1792t763r2146b832],
78	enzymes	NNS	O	enzyme	dep	102	SENT_28	[p2l8t849r462b959],
79	.7	CD	NUMBER	.7	dep	102	SENT_28	[p2l8t849r462b959],
80	’	CD	NUMBER	’	dep	102	SENT_28	[p2l8t849r462b959],
81	8	CD	NUMBER	8	dep	102	SENT_28	[p2l8t849r462b959],
82	Genetic	JJ	O	genetic	dep	102	SENT_28	[p2l521t870r820b939],
83	variation	NN	O	variation	dep	102	SENT_28	[p2l876t870r1222b939],
84	in	IN	O	in	dep	102	SENT_28	[p2l1275t870r1349b938],
85	the	DT	O	the	dep	102	SENT_28	[p2l1402t870r1520b939],
86	C	NN	O	c	dep	102	SENT_28	[p2l1579t872r1640b939],
87	YP3A4	NN	O	yp3a4	dep	102	SENT_28	[p2l1645t871r1909b938],
88	gene	NN	O	gene	dep	102	SENT_28	[p2l1965t892r2146b959],
89	affects	VBZ	O	affect	dep	102	SENT_28	[p2l9t977r262b1046],
90	the	DT	O	the	dep	102	SENT_28	[p2l286t978r403b1046],
91	metabolism	NN	O	metabolism	dep	102	SENT_28	[p2l425t977r883b1046],
92	of	IN	O	of	dep	102	SENT_28	[p2l905t977r990b1046],
93	simvastatin	NN	O	simvastatin	dep	102	SENT_28	[p2l1008t977r1448b1046],
94	and	CC	O	and	dep	102	SENT_28	[p2l1472t978r1610b1046],
95	atorvastatin	NN	O	atorvastatin	dep	102	SENT_28	[p2l1632t957r2145b1046],
96	.9	CD	NUMBER	.9	dep	102	SENT_28	[p2l1632t957r2145b1046],
97	The	DT	O	the	dep	102	SENT_28	[p2l7t1084r156b1153],
98	polymorphism	NN	O	polymorphism	dep	102	SENT_28	[p2l242t1084r815b1173],
99	CYP3A4	NN	O	cyp3a4	dep	102	SENT_28	[p2l904t1077r1380b1154],
100	*	CD	NUMBER	*	dep	102	SENT_28	[p2l904t1077r1380b1154],
101	IB	NN	O	ib	dep	102	SENT_28	[p2l904t1077r1380b1154],
102	(	NN	O	(	_	0	SENT_28	[p2l1469t1085r1790b1169],
103	.	.	O	.	_	0	SENT_28	[p2l1469t1085r1790b1169],

1	—	NN	O	—	_	0	SENT_29	[p2l1469t1085r1790b1169],
2	.	.	O	.	_	0	SENT_29	[p2l1469t1085r1790b1169],

1	392A	CD	NUMBER	392a	nsubj	6	SENT_30	[p2l1469t1085r1790b1169],
2	>	JJR	O	>	amod	4	SENT_30	[p2l1815t1098r1875b1156],
3	G	NN	O	g	nn	4	SENT_30	[p2l1899t1085r1995b1169],
4	)	NN	O	)	dep	1	SENT_30	[p2l1899t1085r1995b1169],
5	is	VBZ	O	be	cop	6	SENT_30	[p2l2084t1084r2144b1153],
6	located	JJ	O	located	_	0	SENT_30	[p2l7t1190r290b1258],
7	in	IN	O	in	_	0	SENT_30	[p2l328t1190r402b1258],
8	the	DT	O	the	det	10	SENT_30	[p2l441t1190r559b1258],
9	promotor	NN	O	promotor	nn	10	SENT_30	[p2l598t1201r964b1279],
10	region	NN	O	region	prep_in	6	SENT_30	[p2l1000t1190r1249b1279],
11	of	IN	O	of	_	0	SENT_30	[p2l1290t1190r1374b1258],
12	the	DT	O	the	det	15	SENT_30	[p2l1407t1190r1524b1258],
13	C	NN	O	c	nn	15	SENT_30	[p2l1569t1192r1631b1259],
14	YP3A4	NN	O	yp3a4	nn	15	SENT_30	[p2l1636t1191r1899b1258],
15	gene	NN	O	gene	prep_of	10	SENT_30	[p2l1940t1212r2142b1279],
16	,	,	O	,	_	0	SENT_30	[p2l1940t1212r2142b1279],
17	and	CC	O	and	_	0	SENT_30	[p2l9t1295r147b1363],
18	the	DT	O	the	det	20	SENT_30	[p2l180t1295r297b1363],
19	G	NN	O	g	nn	20	SENT_30	[p2l333t1295r400b1364],
20	allele	NN	O	allele	nsubjpass	22	SENT_30	[p2l436t1295r644b1363],
21	is	VBZ	O	be	auxpass	22	SENT_30	[p2l679t1295r740b1363],
22	assumed	VBN	O	assume	conj_and	6	SENT_30	[p2l778t1295r1112b1363],
23	by	IN	O	by	_	0	SENT_30	[p2l1144t1295r1240b1383],
24	some	DT	O	some	agent	22	SENT_30	[p2l1278t1316r1478b1363],
25	to	TO	O	to	aux	27	SENT_30	[p2l1512t1305r1585b1363],
26	be	VB	O	be	auxpass	27	SENT_30	[p2l1619t1295r1710b1363],
27	associated	VBN	O	associate	xcomp	22	SENT_30	[p2l1747t1295r2147b1363],

1	76	CD	NUMBER	76	_	0	SENT_31	[p2l476t1458r516b1487],
2	M.	NNP	NUMBER	M.	nn	5	SENT_31	[p2l1360t1466r1395b1487],
3	L.	NNP	PERSON	L.	nn	5	SENT_31	[p2l1413t1466r1440b1487],
4	BECKER	NNP	PERSON	BECKER	nn	5	SENT_31	[p2l1458t1466r1583b1487],
5	ETAL	NNP	O	ETAL	dep	1	SENT_31	[p2l1598t1465r1683b1487],
6	.	.	O	.	_	0	SENT_31	[p2l1598t1465r1683b1487],

1	with	IN	O	with	_	0	SENT_32	[p2l7t1588r179b1656],
2	enhanced	VBN	O	enhance	amod	4	SENT_32	[p2l230t1588r599b1656],
3	CYP3A4	NN	O	cyp3a4	nn	4	SENT_32	[p2l651t1588r1005b1657],
4	expression	NN	O	expression	prep_with	33	SENT_32	[p2l1056t1588r1472b1676],
5	due	JJ	O	due	_	0	SENT_32	[p2l1524t1588r1661b1656],
6	to	TO	O	to	_	0	SENT_32	[p2l1712t1598r1785b1656],
7	reduced	VBN	O	reduce	amod	8	SENT_32	[p2l1837t1588r2147b1656],
8	binding	NN	O	binding	prep_due_to	4	SENT_32	[p2l6t1695r304b1783],
9	of	IN	O	of	_	0	SENT_32	[p2l355t1694r439b1763],
10	a	DT	O	a	det	12	SENT_32	[p2l484t1716r524b1763],
11	transcriptional	JJ	O	transcriptional	amod	12	SENT_32	[p2l573t1694r1138b1783],
12	repressor	NN	O	repressor	prep_of	8	SENT_32	[p2l1187t1716r1563b1783],
13	,	,	O	,	_	0	SENT_32	[p2l1187t1716r1563b1783],
14	although	IN	O	although	mark	18	SENT_32	[p2l1618t1695r1958b1783],
15	this	DT	O	this	det	16	SENT_32	[p2l2007t1695r2144b1763],
16	effect	NN	O	effect	nsubjpass	18	SENT_32	[p2l8t1802r228b1870],
17	was	VBD	O	be	auxpass	18	SENT_32	[p2l252t1824r399b1870],
18	disputed	VBN	O	dispute	advcl	33	SENT_32	[p2l427t1802r757b1891],
19	by	IN	O	by	_	0	SENT_32	[p2l779t1801r875b1891],
20	others	NNS	O	other	agent	18	SENT_32	[p2l902t1781r1236b1870],
21	.10	CD	NUMBER	.10	dep	18	SENT_32	[p2l902t1781r1236b1870],
22	In	IN	O	in	dep	21	SENT_32	[p2l1261t1804r1340b1869],
23	microsomal	JJ	O	microsomal	amod	24	SENT_32	[p2l1365t1802r1826b1870],
24	studies	NNS	O	study	pobj	22	SENT_32	[p2l1855t1802r2143b1882],
25	,	,	O	,	_	0	SENT_32	[p2l1855t1802r2143b1882],
26	no	DT	O	no	det	27	SENT_32	[p2l7t1930r101b1977],
27	effect	NN	O	effect	nsubjpass	33	SENT_32	[p2l129t1909r349b1977],
28	on	IN	O	on	_	0	SENT_32	[p2l374t1930r469b1977],
29	CYP3A4	NN	O	cyp3a4	nn	31	SENT_32	[p2l495t1909r849b1978],
30	enzyme	NN	O	enzyme	nn	31	SENT_32	[p2l877t1930r1178b1997],
31	expression	NN	O	expression	prep_on	27	SENT_32	[p2l1206t1909r1621b1997],
32	was	VBD	O	be	auxpass	33	SENT_32	[p2l1647t1930r1794b1977],
33	found	VBN	O	find	_	0	SENT_32	[p2l1822t1888r2140b1977],
34	.	.	O	.	_	0	SENT_32	[p2l1822t1888r2140b1977],

1	”	NN	O	”	nsubjpass	8	SENT_33	[p2l1822t1888r2140b1977],
2	The	DT	O	the	det	6	SENT_33	[p2l7t2016r157b2085],
3	CYP3A4	NN	O	cyp3a4	nn	6	SENT_33	[p2l205t2009r680b2086],
4	*	CD	NUMBER	*	num	6	SENT_33	[p2l205t2009r680b2086],
5	IB	NNP	O	IB	nn	6	SENT_33	[p2l205t2009r680b2086],
6	polymorphism	NN	O	polymorphism	dep	1	SENT_33	[p2l723t2016r1296b2105],
7	was	VBD	O	be	auxpass	8	SENT_33	[p2l1338t2038r1485b2085],
8	associated	VBN	O	associate	_	0	SENT_33	[p2l1532t2016r1932b2085],
9	with	IN	O	with	_	0	SENT_33	[p2l1975t2016r2147b2085],
10	the	DT	O	the	det	12	SENT_33	[p2l7t2122r124b2190],
11	clinical	JJ	O	clinical	amod	12	SENT_33	[p2l178t2122r465b2190],
12	stage	NN	O	stage	prep_with	8	SENT_33	[p2l521t2132r716b2210],
13	of	IN	O	of	_	0	SENT_33	[p2l771t2122r855b2190],
14	prostate	NN	O	prostate	nn	15	SENT_33	[p2l900t2132r1209b2210],
15	tumors	NNS	O	tumor	prep_of	12	SENT_33	[p2l1262t2132r1530b2190],
16	and	CC	O	and	_	0	SENT_33	[p2l1586t2122r1725b2190],
17	treatment	NN	O	treatment	nn	19	SENT_33	[p2l1776t2132r2148b2190],
18	related	JJ	O	related	amod	19	SENT_33	[p2l6t2229r274b2297],
19	leukemia	NN	O	leukemia	conj_and	12	SENT_33	[p2l303t2207r848b2297],
20	.12	CD	NUMBER	.12	number	21	SENT_33	[p2l303t2207r848b2297],
21	’13	CD	NUMBER	’13	num	22	SENT_33	[p2l303t2207r848b2297],
22	Hesselink	NNP	O	Hesselink	dep	19	SENT_33	[p2l882t2229r1268b2297],
23	et	FW	O	et	nn	24	SENT_33	[p2l1297t2242r1368b2297],
24	al.	FW	O	al.	dobj	8	SENT_33	[p2l1395t2208r1567b2297],
25	14	CD	NUMBER	14	nsubj	26	SENT_33	[p2l1395t2208r1567b2297],
26	found	VBD	O	find	rcmod	24	SENT_33	[p2l1597t2229r1824b2297],
27	that	IN	O	that	complm	31	SENT_33	[p2l1853t2229r1999b2297],
28	the	DT	O	the	det	29	SENT_33	[p2l2028t2229r2145b2297],
29	polymorphism	NN	O	polymorphism	nsubjpass	31	SENT_33	[p2l6t2335r578b2424],
30	is	VBZ	O	be	auxpass	31	SENT_33	[p2l637t2335r698b2403],
31	associated	VBN	O	associate	ccomp	26	SENT_33	[p2l762t2335r1163b2403],
32	with	IN	O	with	_	0	SENT_33	[p2l1223t2335r1394b2404],
33	lower	JJR	O	lower	amod	35	SENT_33	[p2l1454t2335r1675b2404],
34	tacrolimus	NN	O	tacrolimus	nn	35	SENT_33	[p2l1733t2335r2145b2403],
35	levels	NNS	O	level	prep_with	31	SENT_33	[p2l7t2441r251b2522],
36	,	,	O	,	_	0	SENT_33	[p2l7t2441r251b2522],
37	suggesting	VBG	O	suggest	xcomp	31	SENT_33	[p2l309t2441r722b2540],
38	a	DT	O	a	det	41	SENT_33	[p2l776t2463r816b2509],
39	higher	JJR	O	higher	amod	41	SENT_33	[p2l864t2441r1115b2530],
40	CYP3A4	NN	O	cyp3a4	nn	41	SENT_33	[p2l1165t2441r1519b2510],
41	activity	NN	O	activity	dobj	37	SENT_33	[p2l1572t2441r1876b2530],
42	,	,	O	,	_	0	SENT_33	[p2l1572t2441r1876b2530],
43	while	IN	O	while	_	0	SENT_33	[p2l1931t2441r2146b2510],
44	Felix	NNP	PERSON	Felix	prep_while	31	SENT_33	[p2l6t2549r206b2618],
45	et	FW	O	et	nn	47	SENT_33	[p2l256t2562r327b2618],
46	al.	FW	O	al.	nn	47	SENT_33	[p2l372t2541r541b2618],
47	”	FW	O	”	dobj	48	SENT_33	[p2l372t2541r541b2618],
48	suggested	VBN	O	suggest	partmod	44	SENT_33	[p2l596t2549r978b2638],
49	in	IN	O	in	_	0	SENT_33	[p2l1025t2549r1100b2617],
50	their	PRP$	O	they	poss	51	SENT_33	[p2l1148t2549r1328b2618],
51	study	NN	O	study	prep_in	48	SENT_33	[p2l1378t2549r1583b2638],
52	on	IN	O	on	_	0	SENT_33	[p2l1634t2571r1728b2618],
53	treatment	NN	O	treatment	nn	55	SENT_33	[p2l1776t2559r2148b2618],
54	related	JJ	O	related	amod	55	SENT_33	[p2l6t2655r274b2724],
55	leukemia	NN	O	leukemia	prep_on	51	SENT_33	[p2l306t2655r665b2724],
56	that	IN	O	that	complm	60	SENT_33	[p2l697t2655r844b2724],
57	this	DT	O	this	det	58	SENT_33	[p2l874t2655r1012b2724],
58	polymorphism	NN	O	polymorphism	nsubjpass	60	SENT_33	[p2l1045t2655r1618b2744],
59	is	VBZ	O	be	auxpass	60	SENT_33	[p2l1649t2655r1710b2724],
60	associated	VBN	O	associate	ccomp	8	SENT_33	[p2l1746t2655r2147b2724],
61	with	IN	O	with	_	0	SENT_33	[p2l7t2760r179b2828],
62	decreased	VBN	O	decrease	amod	64	SENT_33	[p2l227t2760r612b2828],
63	CYP3A4	NN	O	cyp3a4	nn	64	SENT_33	[p2l661t2760r1015b2829],
64	activity	NN	O	activity	prep_with	60	SENT_33	[p2l1065t2760r1367b2848],
65	.	.	O	.	_	0	SENT_33	[p2l1065t2760r1367b2848],

1	Increased	VBN	O	increase	amod	3	SENT_34	[p2l1421t2760r1795b2828],
2	enzyme	NN	O	enzyme	nn	3	SENT_34	[p2l1843t2781r2146b2848],
3	activity	NN	O	activity	nsubj	16	SENT_34	[p2l9t2868r297b2956],
4	will	MD	O	will	aux	5	SENT_34	[p2l352t2868r502b2936],
5	lead	VB	O	lead	_	0	SENT_34	[p2l556t2868r718b2936],
6	to	TO	O	to	_	0	SENT_34	[p2l771t2878r844b2936],
7	a	DT	O	a	det	8	SENT_34	[p2l900t2889r940b2936],
8	decrease	NN	O	decrease	prep_to	5	SENT_34	[p2l994t2868r1328b2936],
9	in	IN	O	in	_	0	SENT_34	[p2l1382t2868r1456b2935],
10	simvastatin	NN	O	simvastatin	nn	13	SENT_34	[p2l1513t2868r1954b2936],
11	and	CC	O	and	_	0	SENT_34	[p2l2009t2868r2147b2936],
12	atorvastatin	NN	O	atorvastatin	conj_and	10	SENT_34	[p2l9t2972r462b3040],
13	levels	NNS	O	level	prep_in	8	SENT_34	[p2l502t2972r723b3041],
14	and	CC	O	and	_	0	SENT_34	[p2l767t2972r905b3040],
15	eventually	RB	O	eventually	advmod	5	SENT_34	[p2l944t2972r1348b3060],
16	affect	VB	O	affect	conj_and	5	SENT_34	[p2l1390t2972r1609b3040],
17	their	PRP$	O	they	poss	18	SENT_34	[p2l1647t2972r1827b3040],
18	cholesterol	NN	O	cholesterol	dobj	16	SENT_34	[p2l1866t2972r2143b3040, p2l7t3080r184b3148],
19	lowering	VBG	O	lower	xcomp	16	SENT_34	[p2l221t3080r564b3168],
20	effect	NN	O	effect	dobj	19	SENT_34	[p2l601t3080r839b3148],
21	.	.	O	.	_	0	SENT_34	[p2l601t3080r839b3148],

1	The	DT	O	the	det	3	SENT_35	[p2l96t3185r245b3253],
2	CYP3A4	NN	O	cyp3a4	nn	3	SENT_35	[p2l296t3186r650b3254],
3	enzymes	NNS	O	enzyme	nsubj	6	SENT_35	[p2l700t3207r1039b3274],
4	are	VBP	O	be	cop	6	SENT_35	[p2l1092t3207r1206b3253],
5	mainly	RB	O	mainly	advmod	6	SENT_35	[p2l1255t3185r1526b3274],
6	located	JJ	O	located	_	0	SENT_35	[p2l1575t3185r1858b3253],
7	in	IN	O	in	_	0	SENT_35	[p2l1906t3185r1980b3253],
8	the	DT	O	the	det	9	SENT_35	[p2l2028t3185r2145b3253],
9	cells	NNS	O	cell	prep_in	6	SENT_35	[p2l8t3290r183b3358],
10	in	IN	O	in	_	0	SENT_35	[p2l218t3290r292b3357],
11	the	DT	O	the	det	13	SENT_35	[p2l325t3290r442b3358],
12	intestinal	JJ	O	intestinal	amod	13	SENT_35	[p2l475t3290r834b3358],
13	wall	NN	O	wall	prep_in	9	SENT_35	[p2l868t3290r1034b3358],
14	and	CC	O	and	_	0	SENT_35	[p2l1069t3290r1207b3358],
15	hepatocytes	NNS	O	hepatocyte	conj_and	13	SENT_35	[p2l1239t3290r1720b3378],
16	.	.	O	.	_	0	SENT_35	[p2l1239t3290r1720b3378],

1	The	DT	O	the	det	3	SENT_36	[p2l1758t3290r1908b3358],
2	ATPbinding	NN	O	atpbinding	nn	3	SENT_36	[p2l1942t3291r2143b3357, p2l6t3397r304b3486],
3	cassette	NN	O	cassette	nsubjpass	81	SENT_36	[p2l326t3408r627b3466],
4	Bl	NNP	O	Bl	nsubj	19	SENT_36	[p2l650t3398r753b3465],
5	(	CD	NUMBER	(	num	4	SENT_36	[p2l785t3398r1074b3482],
6	ABCB	NN	O	abcb	nn	9	SENT_36	[p2l785t3398r1074b3482],
7	1	CD	NUMBER	1	num	9	SENT_36	[p2l1092t3398r1158b3482],
8	)	NN	O	)	nn	9	SENT_36	[p2l1092t3398r1158b3482],
9	protein	NN	O	protein	dep	4	SENT_36	[p2l1180t3397r1478b3486],
10	,	,	O	,	_	0	SENT_36	[p2l1180t3397r1478b3486],
11	also	RB	O	also	advmod	12	SENT_36	[p2l1505t3398r1657b3466],
12	known	VBN	O	know	partmod	4	SENT_36	[p2l1679t3398r1941b3466],
13	as	IN	O	as	_	0	SENT_36	[p2l1964t3419r2039b3466],
14	Pglycoprotein	NN	PERSON	pglycoprotein	prep_as	12	SENT_36	[p2l2062t3399r2143b3465, p2l8t3503r523b3592],
15	,	,	O	,	_	0	SENT_36	[p2l2062t3399r2143b3465, p2l8t3503r523b3592],
16	is	VBZ	O	be	cop	19	SENT_36	[p2l555t3503r616b3572],
17	an	DT	O	a	det	19	SENT_36	[p2l649t3525r737b3572],
18	efﬂux	NN	O	efﬂux	nn	19	SENT_36	[p2l766t3503r991b3572],
19	transporter	NN	O	transporter	rcmod	3	SENT_36	[p2l1020t3514r1446b3592],
20	that	WDT	O	that	nsubj	23	SENT_36	[p2l1472t3503r1619b3572],
21	is	VBZ	O	be	cop	23	SENT_36	[p2l1647t3503r1707b3572],
22	co	NN	O	co	nn	23	SENT_36	[p2l1739t3503r2147b3572],
23	—	NN	O	—	rcmod	19	SENT_36	[p2l1739t3503r2147b3572],
24	located	JJ	O	located	amod	23	SENT_36	[p2l1739t3503r2147b3572],
25	in	IN	O	in	_	0	SENT_36	[p2l7t3611r81b3678],
26	the	DT	O	the	det	27	SENT_36	[p2l116t3611r233b3679],
27	cells	NNS	O	cell	prep_in	24	SENT_36	[p2l270t3611r445b3679],
28	expressing	VBG	O	express	partmod	27	SENT_36	[p2l484t3611r898b3699],
29	CYP3A4	NN	O	cyp3a4	dobj	28	SENT_36	[p2l935t3589r1480b3680],
30	.15	CD	NUMBER	.15	number	31	SENT_36	[p2l935t3589r1480b3680],
31	’16	CD	NUMBER	’16	num	33	SENT_36	[p2l935t3589r1480b3680],
32	This	DT	O	this	det	33	SENT_36	[p2l1515t3611r1685b3679],
33	transporter	NN	O	transporter	nsubj	34	SENT_36	[p2l1723t3621r2148b3699],
34	moves	VBZ	O	move	rcmod	29	SENT_36	[p2l7t3739r256b3786],
35	statins	NNS	O	statin	dobj	34	SENT_36	[p2l290t3718r533b3786],
36	from	IN	O	from	_	0	SENT_36	[p2l564t3718r753b3786],
37	the	DT	O	the	det	38	SENT_36	[p2l780t3718r897b3786],
38	cells	NNS	O	cell	prep_from	34	SENT_36	[p2l927t3718r1103b3786],
39	in	IN	O	in	_	0	SENT_36	[p2l1133t3718r1207b3785],
40	the	DT	O	the	det	42	SENT_36	[p2l1235t3718r1351b3786],
41	intestinal	JJ	O	intestinal	amod	42	SENT_36	[p2l1381t3718r1739b3786],
42	wall	NN	O	wall	prep_in	38	SENT_36	[p2l1768t3718r1934b3786],
43	back	RB	O	back	advmod	42	SENT_36	[p2l1962t3718r2149b3786],
44	into	IN	O	into	_	0	SENT_36	[p3l7t35r156b104],
45	the	DT	O	the	det	46	SENT_36	[p3l184t35r302b104],
46	lumen	NN	O	luman	prep_into	42	SENT_36	[p3l330t35r574b104],
47	and	CC	O	and	_	0	SENT_36	[p3l603t35r741b104],
48	from	IN	O	from	_	0	SENT_36	[p3l768t35r957b104],
49	the	DT	O	the	det	50	SENT_36	[p3l982t35r1100b104],
50	hepatocytes	NNS	O	hepatocyte	prep_from	42	SENT_36	[p3l1127t35r1587b124],
51	into	IN	O	into	_	0	SENT_36	[p3l1617t35r1766b104],
52	the	DT	O	the	det	53	SENT_36	[p3l1794t35r1911b104],
53	bile	NN	O	bile	prep_into	50	SENT_36	[p3l1938t16r2145b104],
54	.7	CD	NUMBER	.7	num	56	SENT_36	[p3l1938t16r2145b104],
55	Three	CD	NUMBER	three	num	56	SENT_36	[p3l96t143r322b211],
56	polymorphisms	NNS	O	polymorphism	dep	53	SENT_36	[p3l383t143r991b231],
57	in	IN	O	in	_	0	SENT_36	[p3l1054t143r1128b210],
58	the	DT	O	the	det	60	SENT_36	[p3l1189t143r1306b211],
59	ABCBI	NN	O	abcbus	nn	60	SENT_36	[p3l1361t143r1653b212],
60	gene	NN	O	gene	prep_in	56	SENT_36	[p3l1723t164r1926b231],
61	,	,	O	,	_	0	SENT_36	[p3l1723t164r1926b231],
62	previously	RB	DATE	previously	advmod	63	SENT_36	[p3l1989t164r2143b231, p3l7t248r293b337],
63	identiﬁed	VBN	O	identiﬁed	partmod	53	SENT_36	[p3l331t248r701b317],
64	as	IN	O	as	_	0	SENT_36	[p3l740t270r815b317],
65	multidrug	JJ	O	multidrug	amod	66	SENT_36	[p3l856t248r1240b337],
66	resistance	NN	O	resistance	prep_as	63	SENT_36	[p3l1279t248r1664b317],
67	1	CD	NUMBER	1	number	68	SENT_36	[p3l1712t249r1740b316],
68	(	CD	NUMBER	(	dep	66	SENT_36	[p3l1791t249r2142b333],
69	MDR1	NN	O	mdr1	dep	42	SENT_36	[p3l1791t249r2142b333],
70	)	CD	NUMBER	)	num	69	SENT_36	[p3l1791t249r2142b333],
71	,	,	O	,	_	0	SENT_36	[p3l1791t249r2142b333],
72	(	CD	NUMBER	(	num	73	SENT_36	[p3l10t354r372b438],
73	Cl236T	NN	O	cl236t	dep	42	SENT_36	[p3l10t354r372b438],
74	,	,	O	,	_	0	SENT_36	[p3l10t354r372b438],
75	G2677A/T	NN	O	g2677a/t	dep	42	SENT_36	[p3l402t354r836b435],
76	,	,	O	,	_	0	SENT_36	[p3l402t354r836b435],
77	and	CC	O	and	_	0	SENT_36	[p3l867t354r1005b422],
78	C3435T	NN	O	c3435t	nn	79	SENT_36	[p3l1030t354r1378b438],
79	)	NN	O	)	dep	42	SENT_36	[p3l1030t354r1378b438],
80	are	VBP	O	be	auxpass	81	SENT_36	[p3l1407t376r1522b422],
81	associated	VBN	O	associate	_	0	SENT_36	[p3l1550t354r1950b422],
82	with	IN	O	with	_	0	SENT_36	[p3l1975t354r2147b423],
83	an	DT	O	a	det	86	SENT_36	[p3l9t483r97b530],
84	impaired	JJ	O	impaired	amod	86	SENT_36	[p3l140t461r489b550],
85	efﬂux	NN	O	efﬂux	nn	86	SENT_36	[p3l531t462r756b530],
86	pump	NN	O	pump	prep_with	81	SENT_36	[p3l798t483r1019b550],
87	of	IN	O	of	_	0	SENT_36	[p3l1064t461r1149b530],
88	the	DT	O	the	det	90	SENT_36	[p3l1185t462r1302b530],
89	ABCBI	NNP	O	ABCBI	nn	90	SENT_36	[p3l1346t462r1650b530],
90	transporter	NN	O	transporter	prep_of	86	SENT_36	[p3l1701t472r2142b550],
91	,	,	O	,	_	0	SENT_36	[p3l1701t472r2142b550],
92	resulting	VBG	O	result	partmod	86	SENT_36	[p3l6t569r347b658],
93	in	IN	O	in	_	0	SENT_36	[p3l395t569r470b637],
94	increased	VBN	O	increase	amod	96	SENT_36	[p3l517t569r887b638],
95	drug	NN	O	drug	nn	96	SENT_36	[p3l935t569r1109b658],
96	levels	NNS	O	level	prep_in	92	SENT_36	[p3l1157t548r1478b638],
97	.	.	O	.	_	0	SENT_36	[p3l1157t548r1478b638],

1	”	NN	O	”	dep	8	SENT_37	[p3l1157t548r1478b638],
2	Since	IN	O	since	dep	8	SENT_37	[p3l1530t569r1742b638],
3	CYP3A4	NN	O	cyp3a4	nsubj	8	SENT_37	[p3l1792t569r2145b638],
4	and	CC	O	and	_	0	SENT_37	[p3l9t675r147b743],
5	ABCBI	NN	O	abcbus	nsubj	8	SENT_37	[p3l170t675r475b744],
6	are	VBP	O	be	cop	8	SENT_37	[p3l509t697r624b743],
7	co	NN	O	co	nn	8	SENT_37	[p3l650t675r1058b743],
8	—	NN	O	—	advcl	22	SENT_37	[p3l650t675r1058b743],
9	located	JJ	O	located	amod	8	SENT_37	[p3l650t675r1058b743],
10	in	IN	O	in	_	0	SENT_37	[p3l1081t675r1156b743],
11	the	DT	O	the	det	13	SENT_37	[p3l1179t675r1296b743],
12	same	JJ	O	same	amod	13	SENT_37	[p3l1325t697r1520b743],
13	cells	NNS	O	cell	prep_in	9	SENT_37	[p3l1546t675r1744b756],
14	,	,	O	,	_	0	SENT_37	[p3l1546t675r1744b756],
15	a	DT	O	a	det	17	SENT_37	[p3l1774t697r1814b743],
16	reduced	VBN	O	reduce	amod	17	SENT_37	[p3l1837t675r2147b743],
17	efﬂux	NN	O	efﬂux	nsubj	22	SENT_37	[p3l8t783r233b851],
18	by	IN	O	by	_	0	SENT_37	[p3l270t783r366b871],
19	the	DT	O	the	det	21	SENT_37	[p3l405t783r521b851],
20	ABCBI	NNP	O	ABCBI	nn	21	SENT_37	[p3l561t783r865b851],
21	transporter	NN	O	transporter	prep_by	17	SENT_37	[p3l911t793r1337b871],
22	results	VBZ	O	result	_	0	SENT_37	[p3l1372t783r1625b851],
23	in	IN	O	in	_	0	SENT_37	[p3l1665t783r1739b850],
24	increased	VBN	O	increase	amod	27	SENT_37	[p3l1777t783r2147b851],
25	intracellular	JJ	O	intracellular	amod	27	SENT_37	[p3l7t887r483b955],
26	plasma	NN	O	plasma	nn	27	SENT_37	[p3l541t887r820b975],
27	levels	NNS	O	level	prep_in	22	SENT_37	[p3l881t887r1103b955],
28	and	CC	O	and	_	0	SENT_37	[p3l1169t887r1307b955],
29	increased	VBD	O	increase	amod	31	SENT_37	[p3l1369t887r1738b955],
30	substrate	JJ	O	substrate	amod	31	SENT_37	[p3l1803t887r2145b955],
31	availability	NN	O	availability	conj_and	27	SENT_37	[p3l9t995r444b1083],
32	for	IN	O	for	prep	31	SENT_37	[p3l467t994r580b1063],
33	the	DT	O	the	det	35	SENT_37	[p3l598t995r715b1063],
34	CYP3A4	NN	O	cyp3a4	nn	35	SENT_37	[p3l738t995r1092b1063],
35	enzymes	NNS	O	enzyme	npadvmod	38	SENT_37	[p3l1114t1016r1453b1083],
36	and	CC	O	and	_	0	SENT_37	[p3l1478t994r1616b1063],
37	vice	NN	O	vice	conj_and	35	SENT_37	[p3l1636t997r1791b1063],
38	versa	RB	O	versa	pcomp	32	SENT_37	[p3l1812t1018r2041b1063],
39	.	.	O	.	_	0	SENT_37	[p3l1812t1018r2041b1063],

1	In	IN	O	in	_	0	SENT_38	[p3l2067t996r2146b1062],
2	women	NNS	O	woman	prep_in	10	SENT_38	[p3l7t1122r314b1181],
3	,	,	O	,	_	0	SENT_38	[p3l7t1122r314b1181],
4	the	DT	O	the	det	5	SENT_38	[p3l338t1100r456b1169],
5	expression	NN	O	expression	nsubj	10	SENT_38	[p3l478t1100r894b1189],
6	of	IN	O	of	_	0	SENT_38	[p3l916t1100r1000b1169],
7	AB	NNP	ORGANIZATION	AB	nn	8	SENT_38	[p3l1014t1101r1142b1168],
8	CB	NNP	O	CB	prep_of	5	SENT_38	[p3l1152t1101r1273b1169],
9	1	CD	NUMBER	1	num	8	SENT_38	[p3l1291t1101r1319b1168],
10	is	VBZ	O	be	_	0	SENT_38	[p3l1349t1100r1409b1169],
11	lower	JJR	O	lower	dep	12	SENT_38	[p3l1433t1100r1653b1169],
12	than	IN	O	than	advmod	10	SENT_38	[p3l1672t1100r1839b1169],
13	in	IN	O	in	_	0	SENT_38	[p3l1860t1100r1934b1168],
14	men	NNS	O	man	prep_in	10	SENT_38	[p3l1955t1122r2142b1181],
15	,	,	O	,	_	0	SENT_38	[p3l1955t1122r2142b1181],
16	and	CC	O	and	cc	10	SENT_38	[p3l9t1205r147b1273],
17	therefore	RB	O	therefore	advmod	10	SENT_38	[p3l180t1205r532b1273],
18	a	DT	O	a	det	19	SENT_38	[p3l570t1227r611b1273],
19	change	NN	O	change	nsubj	24	SENT_38	[p3l645t1205r919b1293],
20	in	IN	O	in	_	0	SENT_38	[p3l955t1205r1029b1272],
21	CYP3A4	NN	O	cyp3a4	nn	22	SENT_38	[p3l1065t1205r1419b1274],
22	activity	NN	O	activity	prep_in	19	SENT_38	[p3l1456t1205r1745b1293],
23	will	MD	O	will	aux	24	SENT_38	[p3l1780t1205r1929b1273],
24	have	VB	O	have	ccomp	10	SENT_38	[p3l1965t1205r2147b1274],
25	more	RBR	O	more	advmod	24	SENT_38	[p3l7t1334r206b1381],
26	impact	NN	O	impact	dobj	24	SENT_38	[p3l239t1313r507b1401],
27	in	IN	O	in	_	0	SENT_38	[p3l539t1312r613b1380],
28	women	NNS	O	woman	prep_in	26	SENT_38	[p3l647t1334r933b1381],
29	than	IN	O	than	prep	28	SENT_38	[p3l966t1312r1134b1381],
30	in	IN	O	in	pcomp	29	SENT_38	[p3l1167t1313r1240b1380],
31	men	NNS	O	man	pobj	30	SENT_38	[p3l1274t1334r1461b1381],
32	.	.	O	.	_	0	SENT_38	[p3l1274t1334r1461b1381],

1	In	IN	O	in	_	0	SENT_39	[p3l1499t1314r1578b1380],
2	our	PRP$	O	we	poss	3	SENT_39	[p3l1613t1334r1741b1381],
3	study	NN	O	study	prep_in	6	SENT_39	[p3l1777t1313r1997b1401],
4	,	,	O	,	_	0	SENT_39	[p3l1777t1313r1997b1401],
5	we	PRP	O	we	nsubj	6	SENT_39	[p3l2035t1334r2145b1381],
6	assessed	VBD	O	assess	_	0	SENT_39	[p3l9t1419r337b1487],
7	whether	IN	O	whether	complm	23	SENT_39	[p3l374t1419r690b1488],
8	the	DT	O	the	det	10	SENT_39	[p3l725t1419r842b1487],
9	C	NN	O	c	nn	10	SENT_39	[p3l885t1420r947b1488],
10	YP3A4	NN	O	yp3a4	nsubjpass	23	SENT_39	[p3l952t1412r1294b1487],
11	*	CD	NUMBER	*	dep	10	SENT_39	[p3l952t1412r1294b1487],
12	I	PRP	O	I	dep	10	SENT_39	[p3l952t1412r1294b1487],
13	B	NN	O	b	nn	14	SENT_39	[p3l1302t1422r1361b1487],
14	polymorphism	NN	O	polymorphism	dep	12	SENT_39	[p3l1398t1419r1971b1508],
15	and	CC	O	and	_	0	SENT_39	[p3l2009t1419r2147b1487],
16	the	DT	O	the	det	17	SENT_39	[p3l7t1524r124b1592],
17	polymorphisms	NNS	O	polymorphism	conj_and	12	SENT_39	[p3l155t1524r763b1612],
18	in	IN	O	in	_	0	SENT_39	[p3l797t1524r871b1591],
19	the	DT	O	the	det	21	SENT_39	[p3l903t1524r1020b1592],
20	ABCBI	NN	O	abcbus	nn	21	SENT_39	[p3l1048t1525r1339b1593],
21	gene	NN	O	gene	prep_in	17	SENT_39	[p3l1380t1546r1561b1612],
22	are	VBP	O	be	auxpass	23	SENT_39	[p3l1596t1545r1711b1592],
23	associated	VBN	O	associate	ccomp	6	SENT_39	[p3l1747t1524r2147b1592],
24	with	IN	O	with	_	0	SENT_39	[p3l7t1632r179b1700],
25	the	DT	O	the	det	26	SENT_39	[p3l212t1632r330b1700],
26	occurrence	NN	O	occurrence	prep_with	23	SENT_39	[p3l365t1653r792b1700],
27	of	IN	O	of	_	0	SENT_39	[p3l828t1632r913b1700],
28	a	DT	O	a	det	30	SENT_39	[p3l942t1653r983b1700],
29	dose	NN	O	dose	nn	30	SENT_39	[p3l1017t1632r1192b1700],
30	decrease	NN	O	decrease	prep_of	26	SENT_39	[p3l1227t1632r1562b1700],
31	or	CC	O	or	_	0	SENT_39	[p3l1598t1653r1678b1700],
32	a	DT	O	a	det	33	SENT_39	[p3l1711t1654r1752b1700],
33	switch	NN	O	switch	conj_or	30	SENT_39	[p3l1788t1632r2039b1700],
34	to	TO	O	to	_	0	SENT_39	[p3l2072t1642r2145b1700],
35	another	DT	O	another	det	36	SENT_39	[p3l9t1737r302b1805],
36	cholesterol	NN	O	cholesterol	prep_to	23	SENT_39	[p3l338t1737r766b1805],
37	lowering	VBG	O	lower	partmod	36	SENT_39	[p3l805t1737r1147b1825],
38	drug	NN	O	drug	dobj	37	SENT_39	[p3l1187t1737r1383b1825],
39	.	.	O	.	_	0	SENT_39	[p3l1187t1737r1383b1825],

1	These	DT	O	these	det	2	SENT_40	[p3l1426t1737r1657b1805],
2	events	NNS	O	event	nsubj	6	SENT_40	[p3l1697t1747r1939b1805],
3	may	MD	O	may	aux	6	SENT_40	[p3l1979t1758r2146b1825],
4	be	VB	O	be	cop	6	SENT_40	[p3l6t1845r96b1913],
5	the	DT	O	the	det	6	SENT_40	[p3l127t1845r244b1913],
6	consequence	NN	O	consequence	_	0	SENT_40	[p3l277t1866r774b1933],
7	of	IN	O	of	_	0	SENT_40	[p3l807t1845r891b1913],
8	an	DT	O	a	det	12	SENT_40	[p3l917t1866r1006b1913],
9	elevated	JJ	O	elevated	amod	12	SENT_40	[p3l1037t1845r1359b1913],
10	statin	NN	O	statin	nn	12	SENT_40	[p3l1392t1845r1599b1913],
11	plasma	NN	O	plasma	nn	12	SENT_40	[p3l1628t1845r1906b1933],
12	level	NN	O	level	prep_of	6	SENT_40	[p3l1936t1845r2142b1925],
13	,	,	O	,	_	0	SENT_40	[p3l1936t1845r2142b1925],
14	resulting	VBG	O	result	partmod	6	SENT_40	[p3l6t1950r347b2039],
15	in	IN	O	in	_	0	SENT_40	[p3l391t1950r464b2018],
16	either	CC	O	either	preconj	20	SENT_40	[p3l508t1950r731b2019],
17	an	DT	O	a	det	20	SENT_40	[p3l773t1972r861b2019],
18	adverse	JJ	O	adverse	amod	20	SENT_40	[p3l906t1950r1199b2019],
19	drug	NN	O	drug	nn	20	SENT_40	[p3l1243t1950r1418b2039],
20	reaction	NN	O	reaction	prep_in	14	SENT_40	[p3l1460t1950r1776b2019],
21	or	CC	O	or	_	0	SENT_40	[p3l1820t1972r1900b2019],
22	a	DT	O	a	det	25	SENT_40	[p3l1942t1972r1982b2019],
23	too	RB	O	too	advmod	24	SENT_40	[p3l2023t1961r2145b2019],
24	strong	JJ	O	strong	amod	25	SENT_40	[p3l10t2065r248b2143],
25	reduction	NN	O	reduction	prep_in	14	SENT_40	[p3l277t2055r648b2123],
26	in	IN	O	in	_	0	SENT_40	[p3l676t2055r750b2122],
27	cholesterol	NN	O	cholesterol	nn	28	SENT_40	[p3l779t2055r1207b2123],
28	level	NN	O	level	prep_in	14	SENT_40	[p3l1237t2055r1442b2123],
29	.	.	O	.	_	0	SENT_40	[p3l1237t2055r1442b2123],

1	We	PRP	O	we	nsubj	3	SENT_41	[p3l1475t2057r1603b2123],
2	also	RB	O	also	advmod	3	SENT_41	[p3l1634t2055r1787b2123],
3	assessed	VBD	O	assess	_	0	SENT_41	[p3l1819t2055r2147b2123],
4	whether	IN	O	whether	complm	8	SENT_41	[p3l7t2163r323b2231],
5	these	DT	O	these	det	6	SENT_41	[p3l344t2163r543b2231],
6	effects	NNS	O	effect	nsubj	8	SENT_41	[p3l568t2162r822b2231],
7	are	VBP	O	be	cop	8	SENT_41	[p3l850t2184r965b2231],
8	different	JJ	O	different	ccomp	3	SENT_41	[p3l991t2162r1325b2231],
9	for	IN	O	for	_	0	SENT_41	[p3l1348t2162r1461b2231],
10	men	NNS	O	man	prep_for	8	SENT_41	[p3l1482t2184r1650b2231],
11	and	CC	O	and	_	0	SENT_41	[p3l1674t2163r1812b2231],
12	women	NNS	O	woman	prep_for	8	SENT_41	[p3l1836t2184r2143b2244],
13	,	,	O	,	_	0	SENT_41	[p3l1836t2184r2143b2244],
14	and	CC	O	and	_	0	SENT_41	[p3l9t2269r147b2338],
15	whether	IN	O	whether	complm	17	SENT_41	[p3l180t2269r495b2338],
16	there	EX	O	there	expl	17	SENT_41	[p3l526t2269r720b2338],
17	is	VBZ	O	be	ccomp	3	SENT_41	[p3l754t2269r814b2338],
18	interaction	NN	O	interaction	nsubj	17	SENT_41	[p3l850t2269r1269b2338],
19	between	IN	O	between	_	0	SENT_41	[p3l1300t2269r1627b2338],
20	the	DT	O	the	det	24	SENT_41	[p3l1659t2269r1777b2338],
21	CYP3A4	NN	O	cyp3a4	nn	24	SENT_41	[p3l1815t2270r2146b2338],
22	and	CC	O	and	_	0	SENT_41	[p3l9t2375r147b2443],
23	ABCBI	NN	O	abcbus	nn	24	SENT_41	[p3l175t2376r466b2444],
24	polymorphisms	NNS	O	polymorphism	prep_between	18	SENT_41	[p3l508t2375r1137b2463],
25	.	.	O	.	_	0	SENT_41	[p3l508t2375r1137b2463],

1	METHODS	NNS	O	method	_	0	SENT_42	[p3l6t2624r473b2692],

1	Setting	NNP	O	Setting	nn	2	SENT_43	[p3l7t2780r277b2866],
2	Data	NNP	O	Data	nsubjpass	7	SENT_43	[p3l7t2903r184b2970],
3	for	IN	O	for	_	0	SENT_43	[p3l204t2902r312b2970],
4	these	DT	O	these	det	5	SENT_43	[p3l331t2902r520b2970],
5	analyses	NNS	O	analysis	prep_for	2	SENT_43	[p3l543t2902r853b2990],
6	were	VBD	O	be	auxpass	7	SENT_43	[p3l876t2923r1055b2970],
7	obtained	VBN	O	obtain	_	0	SENT_43	[p3l1079t2902r1398b2970],
8	from	IN	O	from	_	0	SENT_43	[p3l1419t2902r1599b2970],
9	the	DT	O	the	det	11	SENT_43	[p3l1620t2902r1731b2970],
10	Rotterdam	NNP	LOCATION	Rotterdam	nn	11	SENT_43	[p3l1753t2901r2148b2970],
11	Study	NNP	O	Study	prep_from	7	SENT_43	[p3l9t3007r247b3096],
12	,	,	O	,	_	0	SENT_43	[p3l9t3007r247b3096],
13	a	DT	O	a	det	16	SENT_43	[p3l286t3029r326b3076],
14	prospective	JJ	O	prospective	amod	16	SENT_43	[p3l356t3007r805b3096],
15	population	NN	O	population	nn	16	SENT_43	[p3l836t3007r1512b3096],
16	—	NN	O	—	appos	11	SENT_43	[p3l836t3007r1512b3096],
17	based	VBN	O	base	partmod	16	SENT_43	[p3l836t3007r1512b3096],
18	cohort	NN	O	cohort	nn	19	SENT_43	[p3l1545t3007r1794b3076],
19	study	NN	O	study	dobj	17	SENT_43	[p3l1828t3007r2034b3096],
20	of	IN	O	of	_	0	SENT_43	[p3l2068t3007r2153b3076],
21	7983	CD	DATE	7983	num	22	SENT_43	[p3l8t3113r195b3181],
22	Caucasians	NNPS	MISC	Caucasians	prep_of	19	SENT_43	[p3l227t3112r663b3181],
23	aged	JJ	O	aged	amod	22	SENT_43	[p3l693t3112r875b3200],
24	55	CD	DURATION	55	num	25	SENT_43	[p3l901t3112r990b3181],
25	years	NNS	NUMBER	year	tmod	23	SENT_43	[p3l1020t3133r1223b3200],
26	and	CC	O	and	_	0	SENT_43	[p3l1252t3112r1390b3180],
27	older	JJR	O	older	amod	22	SENT_43	[p3l1417t3112r1617b3180],
28	in	IN	O	in	_	0	SENT_43	[p3l1640t3112r1714b3179],
29	the	DT	O	the	det	31	SENT_43	[p3l1740t3112r1857b3180],
30	suburb	NN	O	suburb	nn	31	SENT_43	[p3l1886t3112r2145b3180],
31	Ommoord	NN	O	ommoord	prep_in	17	SENT_43	[p3l9t3218r409b3287],
32	in	IN	O	in	_	0	SENT_43	[p3l470t3218r544b3286],
33	Rotterdam	NNP	LOCATION	Rotterdam	prep_in	31	SENT_43	[p3l605t3218r1038b3286],
34	.	.	O	.	_	0	SENT_43	[p3l605t3218r1038b3286],

1	Participants	NNS	O	participant	nsubjpass	3	SENT_44	[p3l1105t3218r1564b3307],
2	were	VBD	O	be	auxpass	3	SENT_44	[p3l1628t3240r1815b3287],
3	invited	VBN	O	invite	_	0	SENT_44	[p3l1878t3218r2147b3287],

1	Copyright	NN	O	copyright	nn	5	SENT_45	[p3l8t3462r332b3534],
2	©	CD	NUMBER	©	num	5	SENT_45	[p3l364t3462r432b3531],
3	2009	CD	DATE	2009	num	5	SENT_45	[p3l467t3462r622b3519],
4	John	NNP	PERSON	John	nn	5	SENT_45	[p3l653t3462r803b3518],
5	Wiley	NNP	PERSON	Wiley	_	0	SENT_45	[p3l830t3462r1023b3534],
6	&	CC	O	&	_	0	SENT_45	[p3l1054t3462r1111b3518],
7	Sons	NNP	O	Sons	conj_and	5	SENT_45	[p3l1143t3462r1311b3528],
8	,	,	O	,	_	0	SENT_45	[p3l1143t3462r1311b3528],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_45	[p3l1342t3462r1469b3518],
10	.	.	O	.	_	0	SENT_45	[p3l1342t3462r1469b3518],

1	between	IN	O	between	_	0	SENT_46	[p4l6t87r333b155],
2	1990	CD	DATE	1990	pobj	1	SENT_46	[p4l382t87r566b156],
3	and	CC	DATE	and	_	0	SENT_46	[p4l608t87r746b155],
4	1993	CD	DATE	1993	conj_and	2	SENT_46	[p4l795t88r974b156],
5	and	CC	O	and	_	0	SENT_46	[p4l1021t87r1159b155],
6	have	VBP	O	have	aux	9	SENT_46	[p4l1197t87r1379b155],
7	been	VBN	O	be	auxpass	9	SENT_46	[p4l1418t87r1602b155],
8	continuously	RB	O	continuously	advmod	9	SENT_46	[p4l1643t87r2147b175],
9	followed	VBN	O	follow	conj_and	1	SENT_46	[p4l8t194r353b263],
10	since	IN	O	since	prep	9	SENT_46	[p4l386t195r581b263],
11	then	RB	O	then	pobj	10	SENT_46	[p4l613t195r799b263],
12	.	.	O	.	_	0	SENT_46	[p4l613t195r799b263],

1	All	DT	O	all	det	2	SENT_47	[p4l835t194r957b262],
2	participants	NNS	O	participant	nsubj	7	SENT_47	[p4l987t195r1443b283],
3	of	IN	O	of	_	0	SENT_47	[p4l1478t194r1562b263],
4	the	DT	O	the	det	6	SENT_47	[p4l1586t195r1703b263],
5	Rotterdam	NNP	LOCATION	Rotterdam	nn	6	SENT_47	[p4l1734t195r2148b263],
6	Study	NNP	O	Study	prep_of	2	SENT_47	[p4l10t300r233b389],
7	gave	VBD	O	give	_	0	SENT_47	[p4l262t322r442b389],
8	written	VBN	O	write	amod	10	SENT_47	[p4l467t300r743b369],
9	informed	VBN	O	inform	amod	10	SENT_47	[p4l770t300r1129b369],
10	consent	NN	O	consent	dobj	7	SENT_47	[p4l1156t311r1472b369],
11	.	.	O	.	_	0	SENT_47	[p4l1156t311r1472b369],

1	Ethical	JJ	O	ethical	amod	2	SENT_48	[p4l1504t300r1781b369],
2	approval	NN	O	approval	nsubjpass	4	SENT_48	[p4l1811t300r2146b389],
3	was	VBD	O	be	auxpass	4	SENT_48	[p4l8t428r155b475],
4	obtained	VBN	O	obtain	_	0	SENT_48	[p4l192t406r528b474],
5	from	IN	O	from	_	0	SENT_48	[p4l561t406r750b474],
6	the	DT	O	the	det	9	SENT_48	[p4l782t406r900b474],
7	Medical	NNP	ORGANIZATION	Medical	nn	9	SENT_48	[p4l934t406r1253b474],
8	Ethical	NNP	ORGANIZATION	Ethical	nn	9	SENT_48	[p4l1288t406r1565b474],
9	Committee	NNP	ORGANIZATION	Committee	prep_from	4	SENT_48	[p4l1600t406r2034b475],
10	of	IN	O	of	_	0	SENT_48	[p4l2069t406r2153b474],
11	the	DT	O	the	det	13	SENT_48	[p4l7t514r124b582],
12	Erasmus	NNP	O	Erasmus	nn	13	SENT_48	[p4l162t515r495b582],
13	MC	NNP	O	MC	prep_of	9	SENT_48	[p4l534t514r703b582],
14	.	.	O	.	_	0	SENT_48	[p4l534t514r703b582],

1	The	DT	O	the	det	5	SENT_49	[p4l745t514r894b582],
2	rationale	NN	O	rationale	nn	5	SENT_49	[p4l930t513r1295b595],
3	,	,	O	,	_	0	SENT_49	[p4l930t513r1295b595],
4	ethical	JJ	O	ethical	amod	5	SENT_49	[p4l1336t514r1596b582],
5	approval	NN	O	approval	nsubjpass	13	SENT_49	[p4l1635t514r1970b603],
6	and	CC	O	and	_	0	SENT_49	[p4l2010t514r2148b582],
7	design	NN	O	design	conj_and	5	SENT_49	[p4l9t621r262b709],
8	of	IN	O	of	_	0	SENT_49	[p4l303t621r387b689],
9	this	DT	O	this	det	10	SENT_49	[p4l420t621r557b689],
10	study	NN	O	study	prep_of	5	SENT_49	[p4l603t621r809b709],
11	have	VBP	O	have	aux	13	SENT_49	[p4l849t621r1031b689],
12	been	VBN	O	be	auxpass	13	SENT_49	[p4l1069t621r1254b689],
13	described	VBN	O	describe	_	0	SENT_49	[p4l1295t621r1669b689],
14	before	IN	O	before	_	0	SENT_49	[p4l1707t600r2146b689],
15	.18	CD	NUMBER	.18	number	16	SENT_49	[p4l1707t600r2146b689],
16	’19	CD	NUMBER	’19	prep_before	13	SENT_49	[p4l1707t600r2146b689],
17	The	DT	O	the	det	19	SENT_49	[p4l8t728r157b796],
18	seven	CD	NUMBER	seven	num	19	SENT_49	[p4l228t749r442b796],
19	pharmacies	NNS	O	pharmacy	tmod	13	SENT_49	[p4l507t728r952b816],
20	in	IN	O	in	_	0	SENT_49	[p4l1021t728r1094b795],
21	Ommoord	NNP	LOCATION	Ommoord	prep_in	19	SENT_49	[p4l1163t728r1563b796],
22	dispense	VB	O	dispense	ccomp	13	SENT_49	[p4l1628t728r1962b816],
23	the	DT	O	the	det	24	SENT_49	[p4l2029t728r2146b796],
24	prescriptions	NNS	O	prescription	dobj	22	SENT_49	[p4l6t833r493b922],
25	of	IN	O	of	_	0	SENT_49	[p4l521t833r604b901],
26	more	JJR	O	more	mwe	27	SENT_49	[p4l621t855r815b901],
27	than	IN	O	than	quantmod	28	SENT_49	[p4l839t833r1002b901],
28	99	CD	PERCENT	99	num	29	SENT_49	[p4l1027t834r1196b903],
29	%	NN	PERCENT	%	prep_of	24	SENT_49	[p4l1027t834r1196b903],
30	of	IN	O	of	_	0	SENT_49	[p4l1225t833r1308b901],
31	all	DT	O	all	det	32	SENT_49	[p4l1327t833r1418b901],
32	participants	NNS	O	participant	prep_of	29	SENT_49	[p4l1441t833r1902b922],
33	.	.	O	.	_	0	SENT_49	[p4l1441t833r1902b922],

1	Information	NN	O	information	nsubj	15	SENT_50	[p4l1930t833r2145b901, p4l8t938r272b1006],
2	on	IN	O	on	_	0	SENT_50	[p4l301t959r394b1006],
3	all	DT	O	all	det	5	SENT_50	[p4l425t938r516b1006],
4	ﬁlled	JJ	O	ﬁlled	amod	5	SENT_50	[p4l547t938r740b1006],
5	prescriptions	NNS	O	prescription	prep_on	1	SENT_50	[p4l767t938r1254b1026],
6	from	IN	O	from	_	0	SENT_50	[p4l1285t938r1469b1006],
7	1st	CD	DATE	1st	prep_from	5	SENT_50	[p4l1507t939r1608b1006],
8	January	NNP	DATE	January	tmod	5	SENT_50	[p4l1635t940r1929b1026],
9	1991	CD	DATE	1991	num	8	SENT_50	[p4l1968t939r2139b1007],
10	until	IN	O	until	_	0	SENT_50	[p4l7t1046r185b1114],
11	1st	CD	DATE	1st	prep_until	1	SENT_50	[p4l227t1046r331b1114],
12	January	NNP	DATE	January	tmod	1	SENT_50	[p4l362t1047r664b1134],
13	2008	CD	DATE	2008	num	12	SENT_50	[p4l699t1046r887b1114],
14	was	VBD	O	be	cop	15	SENT_50	[p4l924t1067r1071b1114],
15	available	JJ	O	available	_	0	SENT_50	[p4l1107t1046r1455b1114],
16	and	CC	O	and	_	0	SENT_50	[p4l1491t1046r1629b1114],
17	included	VBD	O	include	conj_and	15	SENT_50	[p4l1660t1046r1998b1114],
18	the	DT	O	the	det	20	SENT_50	[p4l2029t1046r2146b1114],
19	product	NN	O	product	nn	20	SENT_50	[p4l6t1151r307b1240],
20	name	NN	O	name	dobj	17	SENT_50	[p4l334t1173r544b1220],
21	of	IN	O	of	_	0	SENT_50	[p4l575t1151r659b1220],
22	the	DT	O	the	det	23	SENT_50	[p4l681t1151r798b1220],
23	drug	NN	O	drug	prep_of	20	SENT_50	[p4l828t1151r1025b1240],
24	,	,	O	,	_	0	SENT_50	[p4l828t1151r1025b1240],
25	the	DT	O	the	det	32	SENT_50	[p4l1058t1151r1175b1220],
26	Anatomical	NNP	ORGANIZATION	Anatomical	nn	32	SENT_50	[p4l1204t1151r1661b1220],
27	Therapeutical	NNP	ORGANIZATION	Therapeutical	nn	32	SENT_50	[p4l1690t1151r2144b1240, p4l8t1256r120b1324],
28	Chemical	NNP	ORGANIZATION	Chemical	nn	32	SENT_50	[p4l158t1256r532b1325],
29	(	CD	NUMBER	(	num	32	SENT_50	[p4l572t1256r815b1340],
30	ATC	NN	ORGANIZATION	atc	nn	32	SENT_50	[p4l572t1256r815b1340],
31	)	CD	NUMBER	)	num	32	SENT_50	[p4l572t1256r815b1340],
32	code	NN	O	code	nsubj	50	SENT_50	[p4l856t1256r1059b1337],
33	,	,	O	,	_	0	SENT_50	[p4l856t1256r1059b1337],
34	the	DT	O	the	det	35	SENT_50	[p4l1099t1256r1216b1324],
35	amount	NN	O	amount	nsubj	36	SENT_50	[p4l1256t1266r1548b1324],
36	dispensed	VBD	O	dispense	parataxis	50	SENT_50	[p4l1584t1256r1989b1344],
37	,	,	O	,	_	0	SENT_50	[p4l1584t1256r1989b1344],
38	the	DT	O	the	det	41	SENT_50	[p4l2029t1256r2146b1324],
39	prescribed	VBN	O	prescribe	amod	41	SENT_50	[p4l6t1364r416b1452],
40	dosage	NN	O	dosage	nn	41	SENT_50	[p4l467t1364r735b1452],
41	regimen	NNS	O	regimen	nsubj	50	SENT_50	[p4l786t1364r1106b1452],
42	and	CC	O	and	_	0	SENT_50	[p4l1160t1364r1298b1432],
43	the	DT	O	the	det	44	SENT_50	[p4l1348t1364r1465b1432],
44	date	NN	O	date	nsubj	50	SENT_50	[p4l1518t1364r1678b1432],
45	of	IN	O	of	_	0	SENT_50	[p4l1732t1364r1816b1432],
46	dispensing	VBG	O	dispense	prepc_of	41	SENT_50	[p4l1862t1364r2144b1452, p4l11t1450r266b1559],
47	.20	CD	NUMBER	.20	num	49	SENT_50	[p4l1862t1364r2144b1452, p4l11t1450r266b1559],
48	General	NNP	O	General	nn	49	SENT_50	[p4l337t1470r644b1540],
49	practitioners	NNS	O	practitioner	dobj	46	SENT_50	[p4l713t1470r1202b1559],
50	introduced	VBD	O	introduce	ccomp	15	SENT_50	[p4l1273t1470r1692b1539],
51	electronic	JJ	O	electronic	amod	53	SENT_50	[p4l1762t1470r2145b1539],
52	patient	NN	O	patient	nn	53	SENT_50	[p4l6t1578r275b1666],
53	records	NNS	O	record	dobj	50	SENT_50	[p4l298t1578r583b1646],
54	from	IN	O	from	_	0	SENT_50	[p4l610t1577r799b1646],
55	1997	CD	DATE	1997	num	56	SENT_50	[p4l834t1578r1014b1647],
56	onwards	NNS	O	onward	prep_from	50	SENT_50	[p4l1043t1578r1392b1659],
57	,	,	O	,	_	0	SENT_50	[p4l1043t1578r1392b1659],
58	although	IN	O	although	mark	78	SENT_50	[p4l1423t1578r1764b1666],
59	complete	JJ	O	complete	amod	61	SENT_50	[p4l1789t1578r2146b1666],
60	patient	NN	O	patient	nn	61	SENT_50	[p4l6t1683r275b1772],
61	ﬁles	NNS	O	ﬁles	nsubj	78	SENT_50	[p4l306t1683r464b1752],
62	including	VBG	O	include	_	0	SENT_50	[p4l497t1683r888b1772],
63	,	,	O	,	_	0	SENT_50	[p4l497t1683r888b1772],
64	for	IN	O	for	dep	61	SENT_50	[p4l923t1683r1036b1752],
65	example	NN	O	example	pobj	64	SENT_50	[p4l1066t1683r1416b1772],
66	,	,	O	,	_	0	SENT_50	[p4l1066t1683r1416b1772],
67	the	DT	O	the	det	68	SENT_50	[p4l1452t1683r1568b1752],
68	reason	NN	O	reason	prep_including	61	SENT_50	[p4l1600t1705r1855b1752],
69	for	IN	O	for	_	0	SENT_50	[p4l1886t1683r1999b1752],
70	the	DT	O	the	det	74	SENT_50	[p4l2029t1683r2146b1752],
71	visit	NN	O	visit	nn	74	SENT_50	[p4l8t1788r176b1857],
72	and	CC	O	and	_	0	SENT_50	[p4l214t1788r352b1856],
73	laboratory	NN	O	laboratory	conj_and	71	SENT_50	[p4l389t1788r790b1876],
74	assessments	NNS	O	assessment	prep_for	68	SENT_50	[p4l830t1798r1320b1869],
75	,	,	O	,	_	0	SENT_50	[p4l830t1798r1320b1869],
76	were	VBD	O	be	cop	78	SENT_50	[p4l1362t1810r1549b1857],
77	only	RB	O	only	advmod	78	SENT_50	[p4l1588t1788r1758b1876],
78	available	JJ	O	available	dep	15	SENT_50	[p4l1798t1788r2146b1856],
79	for	IN	O	for	_	0	SENT_50	[p4l8t1895r121b1964],
80	the	DT	O	the	det	83	SENT_50	[p4l172t1896r289b1964],
81	most	RBS	O	most	advmod	83	SENT_50	[p4l343t1906r532b1964],
82	recent	JJ	DURATION	recent	amod	83	SENT_50	[p4l582t1906r823b1964],
83	years	NNS	DURATION	year	prep_for	78	SENT_50	[p4l875t1917r1099b1984],
84	.	.	O	.	_	0	SENT_50	[p4l875t1917r1099b1984],

1	These	DT	O	these	det	4	SENT_51	[p4l1157t1896r1388b1964],
2	electronic	JJ	O	electronic	amod	4	SENT_51	[p4l1443t1896r1826b1964],
3	patient	NN	O	patient	nn	4	SENT_51	[p4l1880t1896r2148b1984],
4	records	NNS	O	record	nsubj	6	SENT_51	[p4l7t2001r292b2070],
5	were	VBD	O	be	cop	6	SENT_51	[p4l330t2023r517b2070],
6	available	JJ	O	available	_	0	SENT_51	[p4l556t2001r903b2070],
7	for	IN	O	for	_	0	SENT_51	[p4l941t2001r1054b2070],
8	most	JJS	O	most	prep_for	6	SENT_51	[p4l1088t2012r1278b2070],
9	of	IN	O	of	_	0	SENT_51	[p4l1313t2001r1397b2070],
10	the	DT	O	the	det	11	SENT_51	[p4l1427t2001r1544b2070],
11	participants	NNS	O	participant	prep_of	8	SENT_51	[p4l1579t2001r2035b2090],
12	in	IN	O	in	_	0	SENT_51	[p4l2073t2001r2147b2069],
13	the	DT	O	the	det	15	SENT_51	[p4l7t2106r124b2174],
14	Rotterdam	NNP	LOCATION	Rotterdam	nn	15	SENT_51	[p4l161t2106r575b2174],
15	Study	NNP	O	Study	prep_in	6	SENT_51	[p4l612t2106r849b2194],
16	.	.	O	.	_	0	SENT_51	[p4l612t2106r849b2194],

1	Study	NNP	O	Study	_	0	SENT_52	[p4l8t2355r223b2442],
2	sample	NN	O	sample	dep	1	SENT_52	[p4l259t2355r533b2442],

1	All	DT	O	all	det	2	SENT_53	[p4l7t2510r130b2578],
2	participants	NNS	O	participant	nsubjpass	14	SENT_53	[p4l157t2510r614b2599],
3	with	IN	O	with	_	0	SENT_53	[p4l644t2510r816b2579],
4	at	IN	O	at	quantmod	6	SENT_53	[p4l845t2521r913b2578],
5	least	JJS	O	least	mwe	4	SENT_53	[p4l940t2510r1119b2578],
6	one	CD	NUMBER	one	prep_with	2	SENT_53	[p4l1147t2532r1284b2578],
7	ﬁlled	VBN	O	ﬁlled	partmod	2	SENT_53	[p4l1314t2510r1513b2578],
8	prescription	NN	O	prescription	dobj	7	SENT_53	[p4l1539t2510r2008b2599],
9	for	IN	O	for	_	0	SENT_53	[p4l2036t2510r2149b2578],
10	simvastatin	NN	O	simvastatin	prep_for	8	SENT_53	[p4l11t2615r451b2683],
11	or	CC	O	or	_	0	SENT_53	[p4l486t2636r566b2683],
12	atorvastatin	NN	O	atorvastatin	conj_or	10	SENT_53	[p4l599t2615r1053b2683],
13	were	VBD	O	be	auxpass	14	SENT_53	[p4l1086t2636r1273b2684],
14	included	VBN	O	include	_	0	SENT_53	[p4l1308t2615r1646b2683],
15	in	IN	O	in	_	0	SENT_53	[p4l1678t2615r1752b2682],
16	the	DT	O	the	det	18	SENT_53	[p4l1786t2615r1903b2683],
17	study	NN	O	study	nn	18	SENT_53	[p4l1941t2615r2146b2703],
18	sample	NN	O	sample	prep_in	14	SENT_53	[p4l11t2723r303b2811],
19	.	.	O	.	_	0	SENT_53	[p4l11t2723r303b2811],

1	Follow	VB	O	follow	_	0	SENT_54	[p4l368t2723r770b2811],
2	—	CD	NUMBER	—	npadvmod	3	SENT_54	[p4l368t2723r770b2811],
3	up	IN	O	up	advmod	4	SENT_54	[p4l368t2723r770b2811],
4	started	VBN	O	start	dep	1	SENT_54	[p4l835t2723r1092b2791],
5	at	IN	O	at	_	0	SENT_54	[p4l1153t2733r1221b2791],
6	the	DT	O	the	det	7	SENT_54	[p4l1280t2723r1397b2791],
7	date	NN	O	date	prep_at	4	SENT_54	[p4l1459t2723r1619b2791],
8	of	IN	O	of	_	0	SENT_54	[p4l1682t2722r1766b2791],
9	the	DT	O	the	det	11	SENT_54	[p4l1819t2723r1936b2791],
10	ﬁrst	NN	O	ﬁrst	nn	11	SENT_54	[p4l1999t2722r2149b2791],
11	prescription	NN	O	prescription	prep_of	7	SENT_54	[p4l6t2828r475b2917],
12	for	IN	O	for	_	0	SENT_54	[p4l529t2828r643b2897],
13	simvastatin	NN	O	simvastatin	prep_for	11	SENT_54	[p4l699t2828r1139b2897],
14	or	CC	O	or	_	0	SENT_54	[p4l1195t2850r1274b2897],
15	atorvastatin	NN	O	atorvastatin	prep_for	11	SENT_54	[p4l1329t2828r1801b2897],
16	.	.	O	.	_	0	SENT_54	[p4l1329t2828r1801b2897],

1	Participants	NNS	O	participant	nsubjpass	3	SENT_55	[p4l1860t2828r2144b2897, p4l6t2943r210b3021],
2	were	VBD	O	be	auxpass	3	SENT_55	[p4l241t2954r428b3002],
3	followed	VBN	O	follow	_	0	SENT_55	[p4l457t2933r803b3001],
4	until	IN	O	until	_	0	SENT_55	[p4l829t2933r1007b3001],
5	lst	NN	O	lst	prep_until	3	SENT_55	[p4l1046t2934r1150b3001],
6	January	NNP	DATE	January	tmod	5	SENT_55	[p4l1176t2935r1479b3021],
7	2008	CD	DATE	2008	num	6	SENT_55	[p4l1509t2933r1723b3014],
8	,	,	O	,	_	0	SENT_55	[p4l1509t2933r1723b3014],
9	the	DT	O	the	det	10	SENT_55	[p4l1754t2933r1871b3001],
10	end	NN	O	end	appos	5	SENT_55	[p4l1901t2933r2040b3001],
11	of	IN	O	of	_	0	SENT_55	[p4l2069t2933r2153b3001],
12	the	DT	O	the	det	14	SENT_55	[p4l7t3041r124b3109],
13	last	JJ	O	last	amod	14	SENT_55	[p4l157t3041r292b3109],
14	prescription	NN	O	prescription	prep_of	10	SENT_55	[p4l320t3041r789b3129],
15	for	IN	O	for	_	0	SENT_55	[p4l820t3041r933b3109],
16	simvastatin	NN	O	simvastatin	prep_for	14	SENT_55	[p4l966t3041r1406b3109],
17	or	CC	O	or	_	0	SENT_55	[p4l1438t3062r1518b3109],
18	atorvastatin	NN	O	atorvastatin	prep_for	14	SENT_55	[p4l1549t3041r2022b3122],
19	,	,	O	,	_	0	SENT_55	[p4l1549t3041r2022b3122],
20	an	DT	O	a	det	21	SENT_55	[p4l2059t3062r2147b3109],
21	increase	NN	O	increase	appos	5	SENT_55	[p4l8t3145r327b3213],
22	in	IN	O	in	_	0	SENT_55	[p4l373t3145r448b3212],
23	prescribed	VBN	O	prescribe	amod	24	SENT_55	[p4l492t3145r901b3233],
24	dose	NN	O	dose	prep_in	21	SENT_55	[p4l947t3145r1122b3213],
25	or	CC	O	or	_	0	SENT_55	[p4l1169t3166r1249b3213],
26	the	DT	O	the	det	27	SENT_55	[p4l1293t3145r1410b3213],
27	occurrence	NN	O	occurrence	prep_in	21	SENT_55	[p4l1458t3166r1885b3213],
28	of	IN	O	of	_	0	SENT_55	[p4l1934t3145r2018b3213],
29	an	DT	O	a	det	30	SENT_55	[p4l2059t3166r2147b3213],
30	event	NN	O	event	prep_of	27	SENT_55	[p4l8t3263r236b3333],
31	,	,	O	,	_	0	SENT_55	[p4l8t3263r236b3333],
32	whichever	WDT	O	whichever	nsubj	33	SENT_55	[p4l276t3253r681b3321],
33	came	VBD	O	come	rcmod	30	SENT_55	[p4l716t3274r920b3321],
34	ﬁrst	NN	O	ﬁrst	dobj	33	SENT_55	[p4l957t3253r1125b3321],
35	.	.	O	.	_	0	SENT_55	[p4l957t3253r1125b3321],

1	In	IN	O	in	dep	115	SENT_56	[p4l1166t3254r1245b3320],
2	an	DT	O	a	dep	115	SENT_56	[p4l1282t3274r1370b3321],
3	additional	JJ	O	additional	dep	115	SENT_56	[p4l1408t3253r1797b3321],
4	analysis	NN	O	analysis	dep	115	SENT_56	[p4l1835t3252r2145b3341],
5	we	PRP	O	we	dep	115	SENT_56	[p4l8t3380r118b3427],
6	excluded	VBD	O	exclude	dep	115	SENT_56	[p4l145t3358r496b3427],
7	all	DT	O	all	dep	115	SENT_56	[p4l522t3358r616b3427],
8	simvastatin	NN	O	simvastatin	dep	115	SENT_56	[p4l644t3358r1085b3427],
9	and	CC	O	and	dep	115	SENT_56	[p4l1111t3358r1249b3427],
10	atorvastatin	NN	O	atorvastatin	dep	115	SENT_56	[p4l1275t3358r1728b3427],
11	users	NNS	O	user	dep	115	SENT_56	[p4l1751t3380r1949b3427],
12	with	IN	O	with	dep	115	SENT_56	[p4l1975t3358r2147b3427],
13	a	DT	O	a	dep	115	SENT_56	[p5l9t46r50b93],
14	ﬁrst	JJ	O	ﬁrst	dep	115	SENT_56	[p5l80t25r230b93],
15	prescription	NN	O	prescription	dep	115	SENT_56	[p5l257t25r725b113],
16	before	IN	O	before	dep	115	SENT_56	[p5l754t25r1003b93],
17	1st	CD	DATE	1st	dep	115	SENT_56	[p5l1043t26r1147b93],
18	July	NNP	DATE	July	dep	115	SENT_56	[p5l1175t25r1335b113],
19	1991	CD	DATE	1991	dep	115	SENT_56	[p5l1376t26r1581b106],
20	,	,	O	,	_	0	SENT_56	[p5l1376t26r1581b106],
21	to	TO	O	to	dep	115	SENT_56	[p5l1614t35r1687b93],
22	ensure	VB	O	ensure	dep	115	SENT_56	[p5l1719t46r1971b93],
23	that	IN	O	that	dep	115	SENT_56	[p5l2001t25r2149b93],
24	all	DT	O	all	dep	115	SENT_56	[p5l9t133r103b201],
25	participants	NNS	O	participant	dep	115	SENT_56	[p5l149t133r605b221],
26	were	VBD	O	be	dep	115	SENT_56	[p5l654t154r841b201],
27	incident	NN	O	incident	dep	115	SENT_56	[p5l889t133r1205b201],
28	users	NNS	O	user	dep	115	SENT_56	[p5l1249t154r1446b201],
29	and	CC	O	and	dep	115	SENT_56	[p5l1497t133r1635b201],
30	did	VBD	O	do	dep	115	SENT_56	[p5l1681t133r1804b201],
31	not	RB	O	not	dep	115	SENT_56	[p5l1850t143r1974b201],
32	use	VB	O	use	dep	115	SENT_56	[p5l2018t154r2146b201],
33	these	DT	O	these	dep	115	SENT_56	[p5l7t238r206b307],
34	drugs	NNS	O	drug	dep	115	SENT_56	[p5l240t238r452b327],
35	before	IN	O	before	dep	115	SENT_56	[p5l484t238r733b307],
36	1st	CD	DATE	1st	dep	115	SENT_56	[p5l775t239r878b307],
37	January	NNP	DATE	January	dep	115	SENT_56	[p5l908t240r1211b327],
38	1991	CD	DATE	1991	dep	115	SENT_56	[p5l1253t239r1428b308],
39	for	IN	O	for	dep	115	SENT_56	[p5l1469t238r1582b307],
40	which	WDT	O	which	dep	115	SENT_56	[p5l1612t238r1850b307],
41	we	PRP	O	we	dep	115	SENT_56	[p5l1881t260r1992b307],
42	did	VBD	O	do	dep	115	SENT_56	[p5l2025t238r2148b307],
43	not	RB	O	not	dep	115	SENT_56	[p5l7t353r132b411],
44	have	VB	O	have	dep	115	SENT_56	[p5l176t343r356b411],
45	the	DT	O	the	dep	115	SENT_56	[p5l403t343r520b411],
46	prescription	NN	O	prescription	dep	115	SENT_56	[p5l565t343r1034b431],
47	data	NNS	O	datum	dep	115	SENT_56	[p5l1081t343r1262b424],
48	,	,	O	,	_	0	SENT_56	[p5l1081t343r1262b424],
49	and	CC	O	and	dep	115	SENT_56	[p5l1313t343r1451b411],
50	we	PRP	O	we	dep	115	SENT_56	[p5l1496t364r1607b411],
51	excluded	VBD	O	exclude	dep	115	SENT_56	[p5l1654t343r2006b411],
52	all	DT	O	all	dep	115	SENT_56	[p5l2053t343r2146b411],
53	participants	NNS	O	participant	dep	115	SENT_56	[p5l6t451r463b539],
54	with	IN	O	with	dep	115	SENT_56	[p5l509t451r681b519],
55	a	DT	O	a	dep	115	SENT_56	[p5l727t472r767b519],
56	prescription	NN	O	prescription	dep	115	SENT_56	[p5l810t451r1279b539],
57	for	IN	O	for	dep	115	SENT_56	[p5l1323t451r1436b519],
58	any	DT	O	any	dep	115	SENT_56	[p5l1481t472r1617b539],
59	of	IN	O	of	dep	115	SENT_56	[p5l1663t451r1747b519],
60	the	DT	O	the	dep	115	SENT_56	[p5l1785t451r1902b519],
61	other	JJ	O	other	dep	115	SENT_56	[p5l1949t451r2149b519],
62	statins	NNS	O	statin	dep	115	SENT_56	[p5l11t555r277b636],
63	,	,	O	,	_	0	SENT_56	[p5l11t555r277b636],
64	not	RB	O	not	dep	115	SENT_56	[p5l326t565r450b623],
65	metabolized	VBN	O	metabolize	dep	115	SENT_56	[p5l495t555r975b623],
66	by	IN	O	by	dep	115	SENT_56	[p5l1018t555r1114b643],
67	CYP3A4	NN	O	cyp3a4	dep	115	SENT_56	[p5l1161t555r1515b624],
68	before	IN	O	before	dep	115	SENT_56	[p5l1560t555r1809b623],
69	start	NN	O	start	dep	115	SENT_56	[p5l1859t565r2024b623],
70	of	IN	O	of	dep	115	SENT_56	[p5l2069t555r2153b623],
71	simvastatin	NN	O	simvastatin	dep	115	SENT_56	[p5l11t663r451b731],
72	or	CC	O	or	dep	115	SENT_56	[p5l527t684r607b731],
73	atorvastatin	NN	O	atorvastatin	dep	115	SENT_56	[p5l683t663r1136b731],
74	therapy	NN	O	therapy	dep	115	SENT_56	[p5l1211t663r1503b751],
75	to	TO	O	to	dep	115	SENT_56	[p5l1579t673r1651b731],
76	exclude	VB	O	exclude	dep	115	SENT_56	[p5l1729t663r2030b731],
77	a	DT	O	a	dep	115	SENT_56	[p5l2108t684r2148b731],
78	possible	JJ	O	possible	dep	115	SENT_56	[p5l6t768r326b857],
79	effect	NN	O	effect	dep	115	SENT_56	[p5l368t768r589b836],
80	of	IN	O	of	dep	115	SENT_56	[p5l631t768r715b836],
81	the	DT	O	the	dep	115	SENT_56	[p5l750t768r866b836],
82	CYP3A4	NN	O	cyp3a4	dep	115	SENT_56	[p5l910t769r1264b837],
83	enzyme	NN	O	enzyme	dep	115	SENT_56	[p5l1307t790r1609b857],
84	on	IN	O	on	dep	115	SENT_56	[p5l1653t790r1747b836],
85	the	DT	O	the	dep	115	SENT_56	[p5l1788t768r1905b836],
86	other	JJ	O	other	dep	115	SENT_56	[p5l1949t768r2149b836],
87	statins	NNS	O	statin	dep	115	SENT_56	[p5l11t873r276b941],
88	,	,	O	,	_	0	SENT_56	[p5l11t873r276b941],
89	In	IN	O	in	dep	115	SENT_56	[p5l332t875r411b940],
90	another	DT	O	another	dep	115	SENT_56	[p5l464t873r756b941],
91	additional	JJ	O	additional	dep	115	SENT_56	[p5l808t873r1196b941],
92	analysis	NN	O	analysis	dep	115	SENT_56	[p5l1250t873r1583b961],
93	,	,	O	,	_	0	SENT_56	[p5l1250t873r1583b961],
94	we	PRP	O	we	dep	115	SENT_56	[p5l1638t894r1748b941],
95	censored	VBD	O	censor	dep	115	SENT_56	[p5l1801t873r2148b941],
96	participants	NNS	O	participant	dep	115	SENT_56	[p5l6t981r463b1069],
97	at	IN	O	at	dep	115	SENT_56	[p5l492t991r560b1049],
98	the	DT	O	the	dep	115	SENT_56	[p5l583t981r701b1049],
99	time	NN	O	time	dep	115	SENT_56	[p5l727t980r899b1049],
100	of	IN	O	of	dep	115	SENT_56	[p5l926t981r1010b1049],
101	a	DT	O	a	dep	115	SENT_56	[p5l1031t1002r1072b1049],
102	prescription	NN	O	prescription	dep	115	SENT_56	[p5l1094t980r1563b1069],
103	for	IN	O	for	dep	115	SENT_56	[p5l1588t980r1702b1049],
104	a	DT	O	a	dep	115	SENT_56	[p5l1727t1002r1767b1049],
105	CYP3A4	NN	O	cyp3a4	dep	115	SENT_56	[p5l1792t981r2146b1049],
106	inhibitor	NN	O	inhibitor	dep	115	SENT_56	[p5l8t1086r346b1155],
107	or	CC	O	or	dep	115	SENT_56	[p5l367t1108r447b1155],
108	inducer	NN	O	inducer	dep	115	SENT_56	[p5l466t1086r761b1155],
109	to	TO	O	to	dep	115	SENT_56	[p5l780t1097r853b1155],
110	exclude	VB	O	exclude	dep	115	SENT_56	[p5l877t1086r1178b1155],
111	possible	JJ	O	possible	dep	115	SENT_56	[p5l1199t1086r1519b1175],
112	effects	NNS	O	effect	dep	115	SENT_56	[p5l1542t1086r1796b1155],
113	of	IN	O	of	dep	115	SENT_56	[p5l1822t1086r1906b1155],
114	drugdrug	NN	O	drugdrug	dep	115	SENT_56	[p5l1922t1086r2149b1175, p5l9t1191r184b1279],
115	interactions	NNS	O	interaction	_	0	SENT_56	[p5l213t1191r689b1259],
116	.	.	O	.	_	0	SENT_56	[p5l213t1191r689b1259],

1	We	PRP	O	we	nsubj	2	SENT_57	[p5l722t1193r849b1259],
2	stratiﬁed	VBD	O	stratiﬁed	_	0	SENT_57	[p5l882t1191r1221b1259],
3	the	DT	O	the	det	4	SENT_57	[p5l1248t1191r1365b1259],
4	analysis	NN	O	analysis	dobj	2	SENT_57	[p5l1396t1191r1706b1279],
5	on	IN	O	on	_	0	SENT_57	[p5l1738t1212r1833b1259],
6	gender	NN	O	gender	prep_on	2	SENT_57	[p5l1862t1191r2143b1279],
7	,	,	O	,	_	0	SENT_57	[p5l1862t1191r2143b1279],
8	because	IN	O	because	mark	10	SENT_57	[p5l6t1299r316b1367],
9	women	NNS	O	woman	nsubj	10	SENT_57	[p5l378t1320r664b1367],
10	have	VBP	O	have	advcl	2	SENT_57	[p5l725t1299r907b1367],
11	a	DT	O	a	det	14	SENT_57	[p5l972t1320r1012b1367],
12	lower	JJR	O	lower	amod	14	SENT_57	[p5l1074t1299r1295b1367],
13	ABCB1	NN	O	abcb1	nn	14	SENT_57	[p5l1355t1299r1660b1367],
14	expression	NN	O	expression	dobj	10	SENT_57	[p5l1732t1299r2147b1387],
15	resulting	VBG	O	result	partmod	14	SENT_57	[p5l7t1405r348b1493],
16	in	IN	O	in	_	0	SENT_57	[p5l415t1405r489b1472],
17	higher	JJR	O	higher	amod	19	SENT_57	[p5l554t1405r805b1493],
18	statin	NN	O	statin	nn	19	SENT_57	[p5l873t1405r1080b1473],
19	levels	NNS	O	level	prep_in	15	SENT_57	[p5l1146t1405r1367b1473],
20	available	JJ	O	available	amod	19	SENT_57	[p5l1438t1405r1785b1473],
21	for	IN	O	for	_	0	SENT_57	[p5l1853t1405r1965b1473],
22	the	DT	O	the	det	24	SENT_57	[p5l2029t1405r2146b1473],
23	CYP3A4	NN	O	cyp3a4	nn	24	SENT_57	[p5l9t1511r363b1579],
24	enzyme	NN	O	enzyme	prep_for	20	SENT_57	[p5l399t1532r722b1599],
25	.	.	O	.	_	0	SENT_57	[p5l399t1532r722b1599],

1	Outcome	NN	O	outcome	_	0	SENT_58	[p5l12t1760r358b1828],

1	As	IN	O	as	mark	10	SENT_59	[p5l7t1916r111b1984],
2	adverse	JJ	O	adverse	amod	3	SENT_59	[p5l180t1915r474b1984],
3	reactions	NNS	O	reaction	nsubjpass	10	SENT_59	[p5l539t1915r891b1984],
4	due	JJ	O	due	_	0	SENT_59	[p5l960t1915r1097b1984],
5	to	TO	O	to	_	0	SENT_59	[p5l1163t1926r1236b1984],
6	statin	NN	O	statin	nn	7	SENT_59	[p5l1306t1915r1514b1984],
7	use	NN	O	use	prep_due_to	3	SENT_59	[p5l1579t1937r1706b1984],
8	were	VBD	O	be	auxpass	10	SENT_59	[p5l1770t1937r1957b1984],
9	not	RB	O	not	neg	10	SENT_59	[p5l2024t1926r2148b1984],
10	registered	VBN	O	register	advcl	18	SENT_59	[p5l7t2021r393b2109],
11	as	IN	O	as	_	0	SENT_59	[p5l439t2042r514b2089],
12	such	JJ	O	such	prep_such_as	10	SENT_59	[p5l564t2021r738b2089],
13	in	IN	O	in	_	0	SENT_59	[p5l783t2021r857b2088],
14	our	PRP$	O	we	poss	15	SENT_59	[p5l903t2043r1032b2089],
15	database	NN	O	database	prep_in	10	SENT_59	[p5l1075t2021r1432b2102],
16	,	,	O	,	_	0	SENT_59	[p5l1075t2021r1432b2102],
17	we	PRP	O	we	nsubj	18	SENT_59	[p5l1481t2042r1591b2090],
18	analyzed	VBD	O	analyze	_	0	SENT_59	[p5l1639t2021r1985b2109],
19	the	DT	O	the	det	20	SENT_59	[p5l2029t2021r2146b2089],
20	occurrence	NN	O	occurrence	dobj	18	SENT_59	[p5l9t2149r436b2196],
21	of	IN	O	of	_	0	SENT_59	[p5l483t2127r567b2196],
22	either	CC	O	either	preconj	25	SENT_59	[p5l608t2127r831b2196],
23	a	DT	O	a	det	25	SENT_59	[p5l876t2149r916b2196],
24	dose	NN	O	dose	nn	25	SENT_59	[p5l961t2127r1136b2196],
25	decrease	NN	O	decrease	prep_of	20	SENT_59	[p5l1183t2127r1518b2196],
26	or	CC	O	or	_	0	SENT_59	[p5l1565t2149r1644b2196],
27	a	DT	O	a	det	28	SENT_59	[p5l1690t2149r1730b2196],
28	switch	NN	O	switch	prep_of	20	SENT_59	[p5l1778t2127r2028b2196],
29	to	TO	O	to	prep	18	SENT_59	[p5l2072t2138r2146b2196],

1	Pharmacoepidemiology	NNP	O	Pharmacoepidemiology	nn	4	SENT_60	[p5l231t2358r998b2429],
2	and	CC	O	and	_	0	SENT_60	[p5l1028t2358r1150b2414],
3	Drug	NNP	O	Drug	nn	4	SENT_60	[p5l1173t2360r1341b2429],
4	Safety	NNP	O	Safety	_	0	SENT_60	[p5l1370t2358r1578b2430],
5	,	,	O	,	_	0	SENT_60	[p5l1370t2358r1578b2430],
6	2010	CD	DATE	2010	appos	4	SENT_60	[p5l1610t2358r1787b2424],
7	;	:	O	;	_	0	SENT_60	[p5l1610t2358r1787b2424],
8	19	CD	NUMBER	19	dep	4	SENT_60	[p5l1823t2357r1914b2414],
9	:	:	O	:	_	0	SENT_60	[p5l1823t2357r1914b2414],
10	75-81	CD	NUMBER	75-81	num	11	SENT_60	[p5l1949t2358r2140b2414],
11	DOI	NNP	O	DOI	dep	8	SENT_60	[p5l1563t2446r1720b2502],
12	:	:	O	:	_	0	SENT_60	[p5l1563t2446r1720b2502],
13	10.1002	CD	NUMBER	10.1002	dep	11	SENT_60	[p5l1762t2446r2146b2518],
14	/	:	O	/	punct	11	SENT_60	[p5l1762t2446r2146b2518],
15	pds	NNS	O	pd	dep	8	SENT_60	[p5l1762t2446r2146b2518],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_61	[p5l416t2598r527b2627],
2	,	,	O	,	_	0	SENT_61	[p5l416t2598r527b2627],
3	ABCB1	NN	O	abcb1	appos	1	SENT_61	[p5l542t2598r641b2627],
4	,	,	O	,	_	0	SENT_61	[p5l542t2598r641b2627],
5	AND	CC	O	and	_	0	SENT_61	[p5l657t2601r718b2622],
6	STATIN	JJ	O	statin	amod	7	SENT_61	[p5l734t2601r836b2622],
7	THERAPY	NN	O	therapy	conj_and	1	SENT_61	[p5l851t2601r984b2622],
8	77	CD	NUMBER	77	dep	1	SENT_61	[p5l1704t2593r1743b2622],

1	another	DT	O	another	det	2	SENT_62	[p5l9t2717r302b2785],
2	statin	NN	O	statin	_	0	SENT_62	[p5l363t2717r570b2785],
3	as	IN	O	as	_	0	SENT_62	[p5l632t2738r706b2785],
4	an	DT	O	a	det	5	SENT_62	[p5l770t2739r859b2785],
5	indicator	NN	O	indicator	prep_as	2	SENT_62	[p5l918t2717r1267b2785],
6	of	IN	O	of	_	0	SENT_62	[p5l1326t2717r1411b2785],
7	an	DT	O	a	det	10	SENT_62	[p5l1466t2738r1554b2785],
8	adverse	JJ	O	adverse	amod	10	SENT_62	[p5l1615t2717r1909b2785],
9	drug	NN	O	drug	nn	10	SENT_62	[p5l1971t2717r2146b2805],
10	reaction	NN	O	reaction	prep_of	5	SENT_62	[p5l6t2824r322b2892],
11	or	CC	O	or	_	0	SENT_62	[p5l355t2845r435b2892],
12	a	DT	O	a	det	15	SENT_62	[p5l467t2845r507b2892],
13	too	RB	O	too	advmod	14	SENT_62	[p5l538t2834r660b2892],
14	strong	JJ	O	strong	amod	15	SENT_62	[p5l697t2834r935b2912],
15	reduction	NN	O	reduction	prep_as	2	SENT_62	[p5l967t2824r1337b2892],
16	in	IN	O	in	_	0	SENT_62	[p5l1368t2823r1442b2891],
17	cholesterol	NN	O	cholesterol	nn	18	SENT_62	[p5l1476t2824r1903b2892],
18	level	NN	O	level	prep_in	15	SENT_62	[p5l1936t2824r2141b2892],
19	.	.	O	.	_	0	SENT_62	[p5l1936t2824r2141b2892],

1	The	DT	O	the	det	3	SENT_63	[p5l7t2929r157b2998],
2	ﬁrst	JJ	O	ﬁrst	amod	3	SENT_63	[p5l192t2929r341b2998],
3	time	NN	O	time	nsubj	10	SENT_63	[p5l373t2929r546b2998],
4	after	IN	O	after	_	0	SENT_63	[p5l581t2929r760b2998],
5	start	NN	O	start	prep_after	3	SENT_63	[p5l794t2940r959b2998],
6	of	IN	O	of	_	0	SENT_63	[p5l992t2929r1076b2998],
7	simvastatin	NN	O	simvastatin	prep_of	5	SENT_63	[p5l1106t2929r1547b2998],
8	or	CC	O	or	_	0	SENT_63	[p5l1581t2951r1661b2998],
9	atorvastatin	NN	O	atorvastatin	prep_of	5	SENT_63	[p5l1694t2929r2147b2998],
10	use	VBP	O	use	dep	45	SENT_63	[p5l7t3056r134b3103],
11	that	IN	O	that	complm	14	SENT_63	[p5l172t3035r318b3103],
12	a	DT	O	a	det	13	SENT_63	[p5l355t3056r396b3103],
13	patient	NN	O	patient	nsubj	19	SENT_63	[p5l430t3035r699b3123],
14	had	VBD	O	have	ccomp	10	SENT_63	[p5l734t3035r874b3103],
15	a	DT	O	a	det	17	SENT_63	[p5l912t3057r952b3103],
16	dose	NN	O	dose	nn	17	SENT_63	[p5l989t3035r1164b3103],
17	decrease	NN	O	decrease	dobj	14	SENT_63	[p5l1202t3035r1537b3103],
18	or	CC	O	or	_	0	SENT_63	[p5l1576t3057r1655b3103],
19	switched	VBN	O	switch	conj_or	14	SENT_63	[p5l1693t3035r2037b3103],
20	to	TO	O	to	_	0	SENT_63	[p5l2073t3045r2146b3103],
21	another	DT	O	another	det	22	SENT_63	[p5l9t3143r302b3211],
22	cholesterol	NN	O	cholesterol	prep_to	19	SENT_63	[p5l323t3143r751b3211],
23	lowering	VBG	O	lower	partmod	22	SENT_63	[p5l774t3143r1117b3231],
24	drug	NN	O	drug	nn	26	SENT_63	[p5l1141t3143r1316b3231],
25	(	NN	O	(	nn	26	SENT_63	[p5l1343t3143r1642b3227],
26	statins	NNS	O	statin	dobj	23	SENT_63	[p5l1343t3143r1642b3227],
27	,	,	O	,	_	0	SENT_63	[p5l1343t3143r1642b3227],
28	ﬁbrates	NNS	O	ﬁbrates	conj_or	26	SENT_63	[p5l1669t3143r1976b3224],
29	,	,	O	,	_	0	SENT_63	[p5l1669t3143r1976b3224],
30	bile	NN	O	bile	nn	32	SENT_63	[p5l2000t3143r2146b3211],
31	acid	NN	O	acid	nn	32	SENT_63	[p5l9t3247r170b3315],
32	sequestrants	NNS	O	sequestrant	dobj	23	SENT_63	[p5l216t3257r711b3335],
33	,	,	O	,	_	0	SENT_63	[p5l216t3257r711b3335],
34	nicotinic	JJ	O	nicotinic	amod	35	SENT_63	[p5l758t3247r1099b3315],
35	acid	NN	O	acid	dobj	23	SENT_63	[p5l1147t3247r1327b3328],
36	,	,	O	,	_	0	SENT_63	[p5l1147t3247r1327b3328],
37	acipimox	NN	O	acipimox	dobj	23	SENT_63	[p5l1377t3247r1760b3335],
38	,	,	O	,	_	0	SENT_63	[p5l1377t3247r1760b3335],
39	or	CC	O	or	_	0	SENT_63	[p5l1808t3268r1888b3315],
40	ezeti	FW	O	ezeti	dobj	23	SENT_63	[p5l1930t3247r2143b3315],
41	—	FW	O	—	nn	43	SENT_63	[p5l1930t3247r2143b3315],
42	mibe	FW	O	mibe	nn	43	SENT_63	[p5l7t3355r232b3439],
43	)	NN	O	)	nsubjpass	45	SENT_63	[p5l7t3355r232b3439],
44	was	VBD	O	be	auxpass	45	SENT_63	[p5l262t3376r409b3423],
45	regarded	VBN	O	regard	_	0	SENT_63	[p5l438t3355r780b3443],
46	as	IN	O	as	_	0	SENT_63	[p5l809t3376r884b3423],
47	an	DT	O	a	det	48	SENT_63	[p5l915t3376r1004b3423],
48	event	NN	O	event	prep_as	45	SENT_63	[p5l1032t3365r1258b3423],
49	.	.	O	.	_	0	SENT_63	[p5l1032t3365r1258b3423],

1	After	IN	O	after	_	0	SENT_64	[p5l1291t3354r1497b3423],
2	identiﬁcation	NN	O	identiﬁcation	prep_after	12	SENT_64	[p5l1523t3354r2040b3423],
3	of	IN	O	of	_	0	SENT_64	[p5l2069t3354r2153b3423],
4	these	DT	O	these	det	5	SENT_64	[p5l7t3460r206b3528],
5	events	NNS	O	event	prep_of	2	SENT_64	[p5l236t3471r478b3528],
6	in	IN	O	in	_	0	SENT_64	[p5l509t3460r582b3528],
7	the	DT	O	the	det	9	SENT_64	[p5l611t3460r728b3528],
8	dispensing	VBG	O	dispense	amod	9	SENT_64	[p5l758t3460r1173b3549],
9	data	NNS	O	datum	prep_in	5	SENT_64	[p5l1204t3460r1385b3541],
10	,	,	O	,	_	0	SENT_64	[p5l1204t3460r1385b3541],
11	we	PRP	O	we	nsubj	12	SENT_64	[p5l1417t3482r1527b3529],
12	searched	VBD	O	search	_	0	SENT_64	[p5l1560t3460r1899b3528],
13	in	IN	O	in	_	0	SENT_64	[p5l1927t3460r2000b3528],
14	the	DT	O	the	det	16	SENT_64	[p5l2028t3460r2146b3528],
15	patient	NN	O	patient	nn	16	SENT_64	[p5l6t3565r275b3653],
16	records	NNS	O	record	prep_in	12	SENT_64	[p5l296t3565r582b3633],
17	that	WDT	O	that	nsubj	19	SENT_64	[p5l609t3565r756b3633],
18	were	VBD	O	be	cop	19	SENT_64	[p5l780t3586r966b3633],
19	available	JJ	O	available	rcmod	16	SENT_64	[p5l994t3565r1342b3633],
20	for	IN	O	for	_	0	SENT_64	[p5l1368t3565r1481b3633],
21	the	DT	O	the	det	22	SENT_64	[p5l1504t3565r1621b3633],
22	reason	NN	O	reason	prep_for	19	SENT_64	[p5l1646t3586r1901b3633],
23	of	IN	O	of	_	0	SENT_64	[p5l1926t3565r2010b3633],
24	the	DT	O	the	det	26	SENT_64	[p5l2028t3565r2146b3633],
25	dose	NN	O	dose	nn	26	SENT_64	[p5l8t3673r183b3741],
26	decrease	NN	O	decrease	prep_of	22	SENT_64	[p5l207t3673r542b3741],
27	or	CC	O	or	_	0	SENT_64	[p5l566t3694r645b3741],
28	switch	NN	O	switch	conj_or	26	SENT_64	[p5l669t3673r920b3741],
29	to	TO	O	to	_	0	SENT_64	[p5l941t3683r1013b3741],
30	another	DT	O	another	det	31	SENT_64	[p5l1039t3673r1331b3741],
31	cholesterol	NN	O	cholesterol	prep_to	19	SENT_64	[p5l1352t3673r1779b3741],
32	lowering	VBG	O	lower	partmod	31	SENT_64	[p5l1802t3673r2146b3761],
33	drug	NN	O	drug	dobj	32	SENT_64	[p6l8t15r204b104],
34	.	.	O	.	_	0	SENT_64	[p6l8t15r204b104],

1	These	DT	O	these	det	2	SENT_65	[p6l292t15r523b84],
2	outcomes	NNS	O	outcome	nsubjpass	4	SENT_65	[p6l608t26r979b84],
3	were	VBD	O	be	auxpass	4	SENT_65	[p6l1065t37r1252b84],
4	chosen	VBN	O	choose	_	0	SENT_65	[p6l1337t15r1627b96],
5	,	,	O	,	_	0	SENT_65	[p6l1337t15r1627b96],
6	because	IN	O	because	mark	22	SENT_65	[p6l1712t15r2021b84],
7	a	DT	O	a	det	8	SENT_65	[p6l2108t37r2148b84],
8	physician	NN	O	physician	nsubj	22	SENT_65	[p6l6t120r382b208],
9	facing	VBG	O	face	partmod	8	SENT_65	[p6l432t120r674b208],
10	an	DT	O	a	det	13	SENT_65	[p6l727t142r815b188],
11	adverse	JJ	O	adverse	amod	13	SENT_65	[p6l867t120r1160b189],
12	drug	NN	O	drug	nn	13	SENT_65	[p6l1212t120r1388b208],
13	reaction	NN	O	reaction	dobj	9	SENT_65	[p6l1438t120r1753b188],
14	or	CC	O	or	_	0	SENT_65	[p6l1805t141r1885b188],
15	a	DT	O	a	det	18	SENT_65	[p6l1935t141r1975b188],
16	too	RB	O	too	advmod	17	SENT_65	[p6l2024t130r2146b188],
17	strong	JJ	O	strong	amod	18	SENT_65	[p6l10t238r249b316],
18	reduction	NN	O	reduction	dobj	9	SENT_65	[p6l284t228r654b296],
19	in	IN	O	in	_	0	SENT_65	[p6l690t228r763b295],
20	cholesterol	NN	O	cholesterol	nn	21	SENT_65	[p6l799t228r1227b296],
21	level	NN	O	level	prep_in	18	SENT_65	[p6l1264t228r1449b296],
22	has	VBZ	O	have	advcl	4	SENT_65	[p6l1484t228r1611b296],
23	two	CD	NUMBER	two	num	25	SENT_65	[p6l1648t238r1791b296],
24	possible	JJ	O	possible	amod	25	SENT_65	[p6l1826t228r2146b316],
25	options	NNS	O	option	dobj	22	SENT_65	[p6l8t332r313b420],
26	.	.	O	.	_	0	SENT_65	[p6l8t332r313b420],

1	First	RB	ORDINAL	first	advmod	6	SENT_66	[p6l343t332r542b413],
2	,	,	O	,	_	0	SENT_66	[p6l343t332r542b413],
3	the	DT	O	the	det	4	SENT_66	[p6l571t332r688b400],
4	physician	NN	O	physician	nsubj	6	SENT_66	[p6l714t332r1090b420],
5	can	MD	O	can	aux	6	SENT_66	[p6l1116t353r1250b400],
6	lower	VB	O	lower	_	0	SENT_66	[p6l1276t332r1497b400],
7	the	DT	O	the	det	8	SENT_66	[p6l1521t332r1638b400],
8	dose	NN	O	dose	dobj	6	SENT_66	[p6l1666t332r1841b400],
9	if	IN	O	if	mark	13	SENT_66	[p6l1868t332r1932b399],
10	he	PRP	O	he	nsubj	13	SENT_66	[p6l1951t332r2041b400],
11	or	CC	O	or	_	0	SENT_66	[p6l2069t354r2149b400],
12	she	PRP	O	she	conj_or	10	SENT_66	[p6l10t440r134b508],
13	suspects	VBZ	O	suspect	advcl	6	SENT_66	[p6l218t450r537b528],
14	a	DT	O	a	det	18	SENT_66	[p6l621t461r662b508],
15	dose	NN	O	dose	nn	18	SENT_66	[p6l741t440r1190b508],
16	—	NN	O	—	nn	18	SENT_66	[p6l741t440r1190b508],
17	effect	NN	O	effect	nn	18	SENT_66	[p6l741t440r1190b508],
18	relationship	NN	O	relationship	dobj	13	SENT_66	[p6l1268t440r1751b528],
19	.	.	O	.	_	0	SENT_66	[p6l1268t440r1751b528],

1	Second	RB	ORDINAL	second	advmod	3	SENT_67	[p6l1838t440r2143b520],
2	,	,	O	,	_	0	SENT_67	[p6l1838t440r2143b520],
3	switching	VBG	O	switch	_	0	SENT_67	[p6l10t545r386b634],
4	to	TO	O	to	_	0	SENT_67	[p6l427t556r500b613],
5	another	DT	O	another	det	6	SENT_67	[p6l545t545r837b613],
6	cholesterol	NN	O	cholesterol	prep_to	3	SENT_67	[p6l878t545r1306b613],
7	lowering	VBG	O	lower	partmod	6	SENT_67	[p6l1348t545r1691b634],
8	drug	NN	O	drug	dobj	7	SENT_67	[p6l1735t545r1910b634],
9	is	VBZ	O	be	cop	11	SENT_67	[p6l1953t545r2013b613],
10	an	DT	O	a	det	11	SENT_67	[p6l2058t567r2147b613],
11	option	NN	O	option	dep	3	SENT_67	[p6l8t650r275b738],
12	.	.	O	.	_	0	SENT_67	[p6l8t650r275b738],

1	In	IN	O	in	_	0	SENT_68	[p6l319t652r398b717],
2	case	NN	O	case	_	0	SENT_68	[p6l437t672r602b718],
3	of	IN	O	of	_	0	SENT_68	[p6l643t650r727b718],
4	ineffective	JJ	O	ineffective	amod	5	SENT_68	[p6l758t650r1171b719],
5	therapy	NN	O	therapy	prep_in_case_of	10	SENT_68	[p6l1210t650r1502b738],
6	the	DT	O	the	det	9	SENT_68	[p6l1541t650r1659b718],
7	most	RBS	O	most	advmod	8	SENT_68	[p6l1698t660r1888b718],
8	likely	JJ	O	likely	amod	9	SENT_68	[p6l1925t650r2146b738],
9	decision	NN	O	decision	nsubj	10	SENT_68	[p6l8t757r333b826],
10	is	VBZ	O	be	_	0	SENT_68	[p6l378t758r438b826],
11	to	TO	O	to	aux	12	SENT_68	[p6l485t768r558b826],
12	increase	VB	O	increase	xcomp	10	SENT_68	[p6l605t758r923b826],
13	the	DT	O	the	det	14	SENT_68	[p6l970t758r1087b826],
14	dose	NN	O	dose	dobj	12	SENT_68	[p6l1134t758r1308b826],
15	before	IN	O	before	_	0	SENT_68	[p6l1353t758r1602b826],
16	switching	VBG	O	switch	prepc_before	12	SENT_68	[p6l1652t757r2026b846],
17	to	TO	O	to	_	0	SENT_68	[p6l2073t768r2146b826],
18	another	DT	O	another	det	19	SENT_68	[p6l9t863r302b932],
19	drug	NN	O	drug	prep_to	16	SENT_68	[p6l326t863r501b952],
20	and	CC	O	and	_	0	SENT_68	[p6l530t863r668b932],
21	therefore	RB	O	therefore	advmod	22	SENT_68	[p6l692t863r1044b932],
22	follow	VB	O	follow	xcomp	10	SENT_68	[p6l1071t863r1452b952],
23	—	CD	NUMBER	—	dobj	22	SENT_68	[p6l1071t863r1452b952],
24	up	IN	O	up	advmod	25	SENT_68	[p6l1071t863r1452b952],
25	ended	VBN	O	end	partmod	23	SENT_68	[p6l1480t863r1712b932],
26	at	IN	O	at	_	0	SENT_68	[p6l1738t874r1806b932],
27	the	DT	O	the	det	28	SENT_68	[p6l1830t863r1947b932],
28	time	NN	O	time	prep_at	25	SENT_68	[p6l1974t863r2146b932],
29	of	IN	O	of	_	0	SENT_68	[p6l8t969r93b1037],
30	the	DT	O	the	det	33	SENT_68	[p6l121t969r238b1037],
31	ﬁrst	NN	O	ﬁrst	nn	33	SENT_68	[p6l276t969r425b1037],
32	dose	NN	O	dose	nn	33	SENT_68	[p6l461t969r636b1037],
33	increase	NN	O	increase	prep_of	28	SENT_68	[p6l672t969r1011b1037],
34	.	.	O	.	_	0	SENT_68	[p6l672t969r1011b1037],

1	C	NN	O	c	nn	2	SENT_69	[p6l12t1199r74b1266],
2	ofactors	NNS	O	ofactor	nsubjpass	20	SENT_69	[p6l74t1198r391b1285],
3	Age	NNP	O	Age	dep	2	SENT_69	[p6l7t1321r189b1409],
4	,	,	O	,	_	0	SENT_69	[p6l7t1321r189b1409],
5	gender	NN	O	gender	appos	3	SENT_69	[p6l254t1320r535b1409],
6	,	,	O	,	_	0	SENT_69	[p6l254t1320r535b1409],
7	and	CC	O	and	_	0	SENT_69	[p6l601t1320r739b1388],
8	the	DT	O	the	det	10	SENT_69	[p6l798t1320r915b1388],
9	prescribed	VBN	O	prescribe	amod	10	SENT_69	[p6l975t1320r1384b1409],
10	dose	NN	O	dose	nsubjpass	20	SENT_69	[p6l1444t1320r1619b1388],
11	of	IN	O	of	_	0	SENT_69	[p6l1682t1320r1766b1388],
12	the	DT	O	the	det	14	SENT_69	[p6l1819t1320r1936b1388],
13	ﬁrst	NN	O	ﬁrst	nn	14	SENT_69	[p6l1999t1320r2148b1388],
14	prescription	NN	O	prescription	prep_of	10	SENT_69	[p6l6t1425r475b1513],
15	for	IN	O	for	_	0	SENT_69	[p6l554t1425r667b1493],
16	simvastatin	NN	O	simvastatin	prep_for	10	SENT_69	[p6l747t1425r1188b1494],
17	or	CC	O	or	_	0	SENT_69	[p6l1268t1446r1347b1493],
18	atorvastatin	NN	O	atorvastatin	prep_for	10	SENT_69	[p6l1426t1425r1879b1493],
19	were	VBD	O	be	auxpass	20	SENT_69	[p6l1959t1446r2146b1493],
20	considered	VBN	O	consider	_	0	SENT_69	[p6l8t1532r432b1600],
21	as	IN	O	as	_	0	SENT_69	[p6l463t1553r538b1600],
22	potential	JJ	O	potential	amod	23	SENT_69	[p6l568t1532r911b1620],
23	confounders	NNS	O	confounder	prep_as	20	SENT_69	[p6l943t1531r1423b1600],
24	of	IN	O	of	_	0	SENT_69	[p6l1456t1532r1540b1600],
25	the	DT	O	the	det	26	SENT_69	[p6l1564t1532r1681b1600],
26	association	NN	O	association	prep_of	23	SENT_69	[p6l1714t1532r2147b1600],
27	between	IN	O	between	_	0	SENT_69	[p6l6t1637r333b1706],
28	the	DT	O	the	det	32	SENT_69	[p6l363t1637r479b1706],
29	CYP3A4	NN	O	cyp3a4	nn	32	SENT_69	[p6l516t1638r846b1706],
30	and	CC	O	and	_	0	SENT_69	[p6l879t1637r1017b1706],
31	ABCBI	NN	O	abcbus	nn	32	SENT_69	[p6l1039t1638r1331b1706],
32	polymorphisms	NNS	O	polymorphism	prep_between	26	SENT_69	[p6l1368t1637r1976b1726],
33	and	CC	O	and	_	0	SENT_69	[p6l2010t1637r2148b1706],
34	the	DT	O	the	det	35	SENT_69	[p6l7t1743r124b1811],
35	occurrence	NN	O	occurrence	prep_of	23	SENT_69	[p6l162t1765r589b1811],
36	of	IN	O	of	_	0	SENT_69	[p6l626t1743r711b1811],
37	the	DT	O	the	det	38	SENT_69	[p6l739t1743r857b1811],
38	events	NNS	O	event	prep_of	35	SENT_69	[p6l894t1753r1158b1812],
39	.	.	O	.	_	0	SENT_69	[p6l894t1753r1158b1812],

1	Genotyping	VBG	O	genotype	partmod	46	SENT_70	[p6l11t1973r462b2058],
2	Genotyping	NN	O	genotyping	dobj	1	SENT_70	[p6l9t2095r467b2184],
3	CYP3A4	NN	O	cyp3a4	nn	5	SENT_70	[p6l536t2088r1033b2176],
4	*	CD	NUMBER	*	num	5	SENT_70	[p6l536t2088r1033b2176],
5	IB	NNP	O	IB	nsubjpass	17	SENT_70	[p6l536t2088r1033b2176],
6	,	,	O	,	_	0	SENT_70	[p6l536t2088r1033b2176],
7	ABCBI	NNP	O	ABCBI	nn	8	SENT_70	[p6l1093t2096r1385b2164],
8	C1236T	NNP	O	C1236T	conj_and	5	SENT_70	[p6l1456t2094r1788b2176],
9	,	,	O	,	_	0	SENT_70	[p6l1456t2094r1788b2176],
10	ABCBI	NNP	O	ABCBI	nn	11	SENT_70	[p6l1848t2095r2139b2164],
11	G2677T/A	NNP	O	G2677T/A	conj_and	5	SENT_70	[p6l9t2200r450b2281],
12	,	,	O	,	_	0	SENT_70	[p6l9t2200r450b2281],
13	and	CC	O	and	_	0	SENT_70	[p6l523t2200r661b2268],
14	ABCBI	NNP	O	ABCBI	nn	15	SENT_70	[p6l721t2201r1012b2269],
15	C3435T	NN	O	c3435t	conj_and	5	SENT_70	[p6l1088t2200r1405b2269],
16	was	VBD	O	be	auxpass	17	SENT_70	[p6l1466t2222r1613b2269],
17	done	VBN	O	do	rcmod	2	SENT_70	[p6l1683t2200r1869b2268],
18	using	VBG	O	use	xcomp	17	SENT_70	[p6l1936t2200r2146b2288],
19	Taqman	NNP	MISC	Taqman	nn	22	SENT_70	[p6l7t2309r320b2396],
20	allelic	JJ	O	allelic	amod	22	SENT_70	[p6l346t2308r581b2376],
21	discrimination	NN	O	discrimination	nn	22	SENT_70	[p6l609t2308r1174b2376],
22	assays	NNS	O	assay	dobj	18	SENT_70	[p6l1200t2329r1443b2396],
23	on	IN	O	on	_	0	SENT_70	[p6l1471t2329r1565b2376],
24	the	DT	O	the	det	30	SENT_70	[p6l1589t2308r1706b2376],
25	ABI	NNP	O	ABI	nn	30	SENT_70	[p6l1730t2308r1896b2375],
26	Prism	NNP	O	Prism	nn	30	SENT_70	[p6l1921t2308r2148b2376],
27	7900	CD	NUMBER	7900	num	30	SENT_70	[p6l8t2414r200b2483],
28	HT	NNP	O	HT	nn	30	SENT_70	[p6l287t2415r414b2481],
29	Sequence	NN	O	sequence	nn	30	SENT_70	[p6l504t2414r874b2502],
30	Detection	NN	O	detection	prep_on	22	SENT_70	[p6l961t2413r1341b2482],
31	System	NNP	O	System	nn	34	SENT_70	[p6l1430t2414r1715b2502],
32	(	NNP	O	(	nn	34	SENT_70	[p6l1803t2413r2148b2502],
33	Applied	NNP	O	Applied	nn	34	SENT_70	[p6l1803t2413r2148b2502],
34	Biosystems	NNP	O	Biosystems	dep	30	SENT_70	[p6l7t2518r478b2606],
35	,	,	O	,	_	0	SENT_70	[p6l7t2518r478b2606],
36	Foster	NNP	LOCATION	Foster	nn	37	SENT_70	[p6l538t2520r782b2586],
37	City	NNP	LOCATION	City	appos	30	SENT_70	[p6l839t2518r1019b2606],
38	,	,	O	,	_	0	SENT_70	[p6l839t2518r1019b2606],
39	CA	NNP	LOCATION	CA	nn	40	SENT_70	[p6l1081t2518r1243b2602],
40	)	NNP	O	)	nsubj	46	SENT_70	[p6l1081t2518r1243b2602],
41	on	IN	O	on	_	0	SENT_70	[p6l1305t2539r1399b2586],
42	lng	NN	O	lng	prep_on	40	SENT_70	[p6l1465t2519r1616b2606],
43	of	IN	O	of	_	0	SENT_70	[p6l1675t2518r1759b2586],
44	genomic	JJ	O	genomic	amod	45	SENT_70	[p6l1811t2518r2145b2606],
45	DNA	NN	O	dna	prep_of	42	SENT_70	[p6l7t2626r213b2694],
46	extracted	VBN	O	extract	_	0	SENT_70	[p6l305t2625r663b2694],
47	from	IN	O	from	_	0	SENT_70	[p6l754t2625r943b2694],
48	leukocytes	NNS	O	leukocyte	prep_from	46	SENT_70	[p6l1034t2625r1471b2714],
49	,	,	O	,	_	0	SENT_70	[p6l1034t2625r1471b2714],
50	as	IN	O	as	mark	52	SENT_70	[p6l1568t2647r1643b2694],
51	previously	RB	DATE	previously	advmod	52	SENT_70	[p6l1736t2625r2146b2714],
52	reported	VBN	O	report	dep	48	SENT_70	[p6l6t2712r424b2821],
53	.	.	O	.	_	0	SENT_70	[p6l6t2712r424b2821],

1	”	NN	O	”	nsubjpass	8	SENT_71	[p6l6t2712r424b2821],
2	The	DT	O	the	det	6	SENT_71	[p6l491t2732r640b2801],
3	primer	NN	O	primer	nn	6	SENT_71	[p6l700t2732r963b2821],
4	and	CC	O	and	_	0	SENT_71	[p6l1024t2733r1162b2801],
5	probe	NN	O	probe	nn	6	SENT_71	[p6l1220t2732r1441b2821],
6	sequences	NNS	O	sequence	dep	1	SENT_71	[p6l1506t2754r1896b2821],
7	were	VBD	O	be	auxpass	8	SENT_71	[p6l1959t2754r2146b2801],
8	designed	VBN	O	design	_	0	SENT_71	[p6l8t2840r355b2928],
9	by	IN	O	by	_	0	SENT_71	[p6l408t2840r504b2928],
10	Applied	NNP	O	Applied	nn	11	SENT_71	[p6l560t2840r875b2928],
11	Biosystems	NNPS	O	Biosystems	agent	8	SENT_71	[p6l929t2840r1398b2928],
12	.	.	O	.	_	0	SENT_71	[p6l929t2840r1398b2928],

1	For	IN	O	for	_	0	SENT_72	[p6l1458t2841r1592b2908],
2	the	DT	O	the	det	6	SENT_72	[p6l1646t2840r1763b2908],
3	triallelic	JJ	O	triallelic	amod	6	SENT_72	[p6l1820t2840r2145b2908],
4	variant	JJ	O	variant	amod	6	SENT_72	[p6l7t2945r277b3014],
5	ABCBI	NN	O	abcbus	nn	6	SENT_72	[p6l308t2946r600b3014],
6	G2677T/A	NN	O	g2677t/a	prep_for	12	SENT_72	[p6l647t2945r1089b3026],
7	,	,	O	,	_	0	SENT_72	[p6l647t2945r1089b3026],
8	two	CD	NUMBER	two	num	10	SENT_72	[p6l1130t2956r1274b3014],
9	separate	JJ	O	separate	amod	10	SENT_72	[p6l1317t2956r1633b3034],
10	assays	NNS	O	assay	nsubjpass	12	SENT_72	[p6l1674t2967r1918b3034],
11	were	VBD	O	be	auxpass	12	SENT_72	[p6l1959t2967r2146b3014],
12	designed	VBN	O	design	_	0	SENT_72	[p6l8t3050r375b3138],
13	,	,	O	,	_	0	SENT_72	[p6l8t3050r375b3138],
14	one	CD	NUMBER	one	dobj	12	SENT_72	[p6l432t3071r569b3118],
15	detecting	VBG	O	detect	partmod	14	SENT_72	[p6l624t3050r980b3138],
16	G2677T	NN	O	g2677t	nsubj	19	SENT_72	[p6l1036t3050r1358b3119],
17	and	CC	O	and	_	0	SENT_72	[p6l1406t3050r1544b3118],
18	one	CD	NUMBER	one	nsubj	19	SENT_72	[p6l1597t3072r1734b3118],
19	detecting	VBG	O	detect	dep	15	SENT_72	[p6l1789t3050r2146b3138],
20	G2677A	NN	O	g2677a	dobj	19	SENT_72	[p6l9t3157r361b3226],
21	.	.	O	.	_	0	SENT_72	[p6l9t3157r361b3226],

1	Haplotypes	NNS	O	haplotype	nsubj	21	SENT_73	[p6l455t3158r898b3246],
2	were	VBD	O	be	auxpass	3	SENT_73	[p6l989t3179r1176b3226],
3	estimated	VBN	O	estimate	rcmod	1	SENT_73	[p6l1267t3158r1642b3226],
4	using	VBG	O	use	partmod	1	SENT_73	[p6l1729t3158r1939b3246],
5	the	DT	O	the	det	6	SENT_73	[p6l2029t3158r2146b3226],
6	estimation	NN	O	estimation	dobj	4	SENT_73	[p6l8t3263r415b3332],
7	maximization	NN	O	maximization	dep	6	SENT_73	[p6l472t3263r1012b3332],
8	algorithm	NN	O	algorithm	advmod	4	SENT_73	[p6l1071t3263r1450b3352],
9	with	IN	O	with	_	0	SENT_73	[p6l1506t3263r1678b3332],
10	Haplostats	NNPS	O	Haplostats	prep_with	8	SENT_73	[p6l1735t3263r2145b3352],
11	1.3.0	CD	NUMBER	1.3.0	dep	8	SENT_73	[p6l17t3368r200b3437],
12	package	NN	O	package	dep	4	SENT_73	[p6l250t3368r570b3456],
13	for	IN	O	for	_	0	SENT_73	[p6l622t3368r735b3436],
14	R	NN	O	r	nn	16	SENT_73	[p6l784t3370r847b3435],
15	(	CD	NUMBER	(	num	16	SENT_73	[p6l900t3368r2149b3456],
16	http2	NN	O	http2	prep_for	12	SENT_73	[p6l900t3368r2149b3456],
17	/	:	O	/	punct	12	SENT_73	[p6l900t3368r2149b3456],
18	/	:	O	/	punct	12	SENT_73	[p6l900t3368r2149b3456],
19	mayoresearch.mayo.edu	FW	O	mayoresearch.mayo.edu	dep	12	SENT_73	[p6l900t3368r2149b3456],
20	/	:	O	/	punct	19	SENT_73	[p6l900t3368r2149b3456],
21	mayo/research/schaid	VBN	O	mayo/research/schaid	_	0	SENT_73	[p6l7t3475r1622b3564],
22	_	CD	NUMBER	_	num	23	SENT_73	[p6l7t3475r1622b3564],
23	lab/software	NN	O	lab/software	dobj	21	SENT_73	[p6l7t3475r1622b3564],
24	.	.	O	.	_	0	SENT_73	[p6l7t3475r1622b3564],

1	cfm	NN	O	cfm	_	0	SENT_74	[p6l7t3475r1622b3564],
2	)	NN	O	)	dep	1	SENT_74	[p6l7t3475r1622b3564],
3	.	.	O	.	_	0	SENT_74	[p6l7t3475r1622b3564],

1	Statistical	JJ	O	statistical	amod	2	SENT_75	[p7l7t87r400b156],
2	analysis	NN	O	analysis	nsubjpass	7	SENT_75	[p7l435t87r753b175],
3	A	DT	O	a	det	5	SENT_75	[p7l7t211r75b278],
4	X2	NN	O	x2	nn	5	SENT_75	[p7l113t190r199b297],
5	test	NN	O	test	dep	2	SENT_75	[p7l234t221r369b279],
6	was	VBD	O	be	auxpass	7	SENT_75	[p7l402t232r549b279],
7	used	VBN	O	use	_	0	SENT_75	[p7l584t210r763b279],
8	to	TO	O	to	aux	9	SENT_75	[p7l795t221r868b279],
9	test	VB	O	test	xcomp	7	SENT_75	[p7l903t221r1038b279],
10	for	IN	O	for	_	0	SENT_75	[p7l1071t210r1184b279],
11	deviations	NNS	O	deviation	prep_for	9	SENT_75	[p7l1217t210r1614b279],
12	from	IN	O	from	_	0	SENT_75	[p7l1650t210r1839b279],
13	HardyWeinberg	NN	O	hardyweinberg	nn	14	SENT_75	[p7l1871t210r2143b299, p7l6t317r383b405],
14	equilibrium	NN	O	equilibrium	prep_from	11	SENT_75	[p7l479t317r955b405],
15	.	.	O	.	_	0	SENT_75	[p7l479t317r955b405],

1	Cox	NN	ORGANIZATION	cox	nn	4	SENT_76	[p7l1055t317r1214b385],
2	proportional	JJ	O	proportional	amod	4	SENT_76	[p7l1308t317r1792b405],
3	hazard	NN	O	hazard	nn	4	SENT_76	[p7l1886t317r2148b385],
4	models	NNS	O	model	nsubjpass	6	SENT_76	[p7l7t422r287b491],
5	were	VBD	O	be	auxpass	6	SENT_76	[p7l345t444r532b491],
6	constructed	VBN	O	construct	_	0	SENT_76	[p7l590t422r1040b491],
7	to	TO	O	to	aux	8	SENT_76	[p7l1096t433r1169b491],
8	test	VB	O	test	xcomp	6	SENT_76	[p7l1226t433r1362b491],
9	for	IN	O	for	_	0	SENT_76	[p7l1416t422r1530b491],
10	differences	NNS	O	difference	prep_for	8	SENT_76	[p7l1585t422r2014b491],
11	in	IN	O	in	_	0	SENT_76	[p7l2073t422r2147b490],
12	the	DT	O	the	det	13	SENT_76	[p7l7t528r124b596],
13	incidence	NN	O	incidence	prep_in	10	SENT_76	[p7l172t528r547b596],
14	of	IN	O	of	_	0	SENT_76	[p7l597t528r681b596],
15	medication	NN	O	medication	nn	17	SENT_76	[p7l722t528r1158b596],
16	change	NN	O	change	nn	17	SENT_76	[p7l1206t528r1480b616],
17	events	NNS	O	event	prep_of	13	SENT_76	[p7l1529t538r1772b596],
18	between	IN	O	between	_	0	SENT_76	[p7l1820t528r2147b596],
19	genotypes	NNS	O	genotype	prep_between	17	SENT_76	[p7l8t645r422b723],
20	.	.	O	.	_	0	SENT_76	[p7l8t645r422b723],

1	Additive	JJ	O	additive	amod	2	SENT_77	[p7l468t634r807b703],
2	models	NNS	O	model	dep	4	SENT_77	[p7l848t634r1127b702],
3	were	VBD	O	be	auxpass	4	SENT_77	[p7l1170t656r1357b703],
4	used	VBN	O	use	_	0	SENT_77	[p7l1399t634r1597b715],
5	,	,	O	,	_	0	SENT_77	[p7l1399t634r1597b715],
6	in	IN	O	in	_	0	SENT_77	[p7l1642t634r1716b702],
7	which	WDT	O	which	prep_in	4	SENT_77	[p7l1757t634r1994b703],
8	we	PRP	O	we	nsubjpass	4	SENT_77	[p7l2035t656r2146b703],

1	Copyright	NN	O	copyright	nn	5	SENT_78	[p7l8t878r332b950],
2	©	CD	NUMBER	©	num	5	SENT_78	[p7l365t879r433b947],
3	2009	CD	DATE	2009	num	5	SENT_78	[p7l467t878r623b935],
4	John	NNP	ORGANIZATION	John	nn	5	SENT_78	[p7l653t878r803b934],
5	Wiley	NNP	ORGANIZATION	Wiley	nsubj	10	SENT_78	[p7l831t878r1024b950],
6	&	CC	ORGANIZATION	&	_	0	SENT_78	[p7l1054t878r1111b934],
7	Sons	NNP	ORGANIZATION	Sons	nsubj	10	SENT_78	[p7l1143t878r1312b944],
8	,	,	ORGANIZATION	,	_	0	SENT_78	[p7l1143t878r1312b944],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_78	[p7l1343t878r1469b934],
10	analyzed	VBD	O	analyze	_	0	SENT_78	[p7l13t971r360b1059],
11	the	DT	O	the	det	12	SENT_78	[p7l385t971r502b1039],
12	association	NN	O	association	dobj	10	SENT_78	[p7l533t971r965b1039],
13	between	IN	O	between	_	0	SENT_78	[p7l990t971r1317b1039],
14	the	DT	O	the	det	15	SENT_78	[p7l1343t971r1460b1039],
15	number	NN	O	number	prep_between	12	SENT_78	[p7l1488t971r1788b1039],
16	of	IN	O	of	_	0	SENT_78	[p7l1814t971r1898b1039],
17	minor	JJ	O	minor	amod	21	SENT_78	[p7l1919t971r2153b1039],
18	(	NN	O	(	nn	21	SENT_78	[p7l14t1079r343b1163],
19	variant	JJ	O	variant	amod	21	SENT_78	[p7l14t1079r343b1163],
20	)	NN	O	)	nn	21	SENT_78	[p7l14t1079r343b1163],
21	alleles	NNS	O	allele	prep_of	15	SENT_78	[p7l368t1079r614b1147],
22	and	CC	O	and	_	0	SENT_78	[p7l639t1079r777b1147],
23	the	DT	O	the	det	24	SENT_78	[p7l797t1079r914b1147],
24	occurrence	NN	O	occurrence	prep_between	12	SENT_78	[p7l936t1100r1364b1147],
25	of	IN	O	of	_	0	SENT_78	[p7l1387t1079r1471b1147],
26	events	NNS	O	event	prep_of	24	SENT_78	[p7l1486t1089r1750b1147],
27	.	.	O	.	_	0	SENT_78	[p7l1486t1089r1750b1147],

1	We	PRP	O	we	nsubj	2	SENT_79	[p7l1774t1080r1902b1147],
2	tested	VBD	O	test	_	0	SENT_79	[p7l1923t1079r2151b1147],
3	for	IN	O	for	_	0	SENT_79	[p7l11t1185r125b1254],
4	additive	JJ	O	additive	amod	7	SENT_79	[p7l153t1185r462b1254],
5	and	CC	O	and	_	0	SENT_79	[p7l494t1185r632b1254],
6	multiplicative	JJ	O	multiplicative	amod	7	SENT_79	[p7l660t1185r1203b1274],
7	interaction	NN	O	interaction	prep_for	2	SENT_79	[p7l1231t1185r1651b1254],
8	between	IN	O	between	_	0	SENT_79	[p7l1678t1185r2005b1254],
9	the	DT	O	the	det	13	SENT_79	[p7l2032t1185r2150b1254],
10	CYP3A4	NN	O	cyp3a4	nn	13	SENT_79	[p7l16t1290r346b1359],
11	and	CC	O	and	_	0	SENT_79	[p7l418t1290r555b1358],
12	ABCB1	NN	O	abcb1	conj_and	10	SENT_79	[p7l617t1290r908b1359],
13	polymorphisms	NNS	O	polymorphism	prep_between	7	SENT_79	[p7l983t1290r1591b1378],
14	in	IN	O	in	_	0	SENT_79	[p7l1661t1290r1735b1357],
15	the	DT	O	the	det	17	SENT_79	[p7l1803t1290r1920b1358],
16	Cox	NN	O	cox	nn	17	SENT_79	[p7l1991t1290r2150b1359],
17	models	NNS	O	model	prep_in	2	SENT_79	[p7l11t1398r312b1466],
18	.	.	O	.	_	0	SENT_79	[p7l11t1398r312b1466],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_80	[p7l382t1398r932b1486],
2	.	.	O	.	_	0	SENT_80	[p7l382t1398r932b1486],

1	—	NN	O	—	_	0	SENT_81	[p7l382t1398r932b1486],
2	.	.	O	.	_	0	SENT_81	[p7l382t1398r932b1486],

1	Meier	NNP	PERSON	Meier	nn	2	SENT_82	[p7l382t1398r932b1486],
2	curves	NNS	O	curve	nsubjpass	4	SENT_82	[p7l994t1419r1244b1466],
3	were	VBD	O	be	auxpass	4	SENT_82	[p7l1310t1419r1497b1466],
4	constructed	VBN	O	construct	_	0	SENT_82	[p7l1563t1398r2014b1466],
5	to	TO	O	to	aux	6	SENT_82	[p7l2077t1408r2150b1466],
6	present	VB	DATE	present	xcomp	4	SENT_82	[p7l10t1512r294b1590],
7	the	DT	O	the	det	8	SENT_82	[p7l327t1502r444b1570],
8	results	NNS	O	result	dobj	6	SENT_82	[p7l478t1502r731b1570],
9	visually	RB	O	visually	advmod	6	SENT_82	[p7l768t1502r1090b1590],
10	.	.	O	.	_	0	SENT_82	[p7l768t1502r1090b1590],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_83	[p7l1129t1502r1484b1590],
2	were	VBD	O	be	auxpass	3	SENT_83	[p7l1522t1524r1708b1571],
3	performed	VBN	O	perform	_	0	SENT_83	[p7l1742t1502r2152b1590],
4	with	IN	O	with	prep	3	SENT_83	[p7l11t1609r183b1678],
5	SPSS	NN	ORGANIZATION	spss	nn	8	SENT_83	[p7l210t1610r417b1678],
6	software	NN	O	software	nn	8	SENT_83	[p7l448t1610r779b1678],
7	(	NN	O	(	nn	8	SENT_83	[p7l808t1610r1123b1694],
8	version	NN	O	version	dep	4	SENT_83	[p7l808t1610r1123b1694],
9	11.0.1	CD	NUMBER	11.0.1	dep	8	SENT_83	[p7l1156t1610r1413b1690],
10	;	:	O	;	_	0	SENT_83	[p7l1156t1610r1413b1690],
11	SPSS	NNP	ORGANIZATION	SPSS	nn	14	SENT_83	[p7l1443t1610r1650b1678],
12	Chicago	NNP	ORGANIZATION	Chicago	nn	14	SENT_83	[p7l1680t1610r2003b1698],
13	IL	NN	ORGANIZATION	il	nn	14	SENT_83	[p7l2028t1610r2148b1694],
14	)	NN	O	)	dep	9	SENT_83	[p7l2028t1610r2148b1694],
15	and	CC	O	and	_	0	SENT_83	[p7l13t1715r148b1783],
16	SAS	NNP	O	SAS	nn	19	SENT_83	[p7l169t1716r335b1784],
17	software	NN	O	software	nn	19	SENT_83	[p7l363t1715r684b1784],
18	(	NN	O	(	nn	19	SENT_83	[p7l707t1715r1012b1799],
19	version	NN	O	version	dep	9	SENT_83	[p7l707t1715r1012b1799],
20	8.02	CD	NUMBER	8.02	dep	19	SENT_83	[p7l1035t1716r1218b1796],
21	;	:	O	;	_	0	SENT_83	[p7l1035t1716r1218b1796],
22	SAS	NNP	ORGANIZATION	SAS	nn	26	SENT_83	[p7l1244t1716r1410b1784],
23	Institute	NNP	ORGANIZATION	Institute	nn	26	SENT_83	[p7l1434t1715r1741b1783],
24	Cary	NNP	ORGANIZATION	Cary	nn	26	SENT_83	[p7l1763t1716r1944b1804],
25	NC	NNP	ORGANIZATION	NC	nn	26	SENT_83	[p7l1964t1716r2146b1799],
26	)	NNP	O	)	dep	9	SENT_83	[p7l1964t1716r2146b1799],
27	.	.	O	.	_	0	SENT_83	[p7l1964t1716r2146b1799],

1	RESULTS	NNS	O	result	_	0	SENT_84	[p7l11t1965r421b2034],

1	In	IN	O	in	_	0	SENT_85	[p7l11t2123r90b2189],
2	the	DT	O	the	det	4	SENT_85	[p7l112t2121r229b2190],
3	Rotterdam	NNP	LOCATION	Rotterdam	nn	4	SENT_85	[p7l252t2121r666b2190],
4	Study	NNP	O	Study	prep_in	7	SENT_85	[p7l690t2121r928b2210],
5	,	,	O	,	_	0	SENT_85	[p7l690t2121r928b2210],
6	we	PRP	O	we	nsubj	7	SENT_85	[p7l954t2143r1064b2190],
7	identiﬁed	VBD	O	identiﬁed	_	0	SENT_85	[p7l1087t2121r1458b2190],
8	1380	CD	NUMBER	1380	num	9	SENT_85	[p7l1488t2122r1671b2190],
9	participants	NNS	O	participant	dobj	7	SENT_85	[p7l1693t2121r2149b2210],
10	who	WP	O	who	nsubjpass	12	SENT_85	[p7l11t2228r176b2296],
11	were	VBD	O	be	auxpass	12	SENT_85	[p7l200t2249r387b2296],
12	prescribed	VBN	O	prescribe	rcmod	9	SENT_85	[p7l412t2228r821b2316],
13	simvastatin	NN	O	simvastatin	dobj	12	SENT_85	[p7l848t2227r1289b2296],
14	or	CC	O	or	_	0	SENT_85	[p7l1315t2249r1394b2296],
15	atorvastatin	NN	O	atorvastatin	conj_or	13	SENT_85	[p7l1419t2227r1872b2296],
16	during	IN	O	during	prep	12	SENT_85	[p7l1898t2228r2150b2316],
17	follow	VB	O	follow	dep	7	SENT_85	[p7l11t2333r413b2422],
18	—	RB	O	—	advmod	17	SENT_85	[p7l11t2333r413b2422],
19	up	RB	O	up	advmod	17	SENT_85	[p7l11t2333r413b2422],
20	.	.	O	.	_	0	SENT_85	[p7l11t2333r413b2422],

1	1058	CD	NUMBER	1058	num	2	SENT_86	[p7l452t2333r633b2402],
2	participants	NNS	O	participant	nsubj	3	SENT_86	[p7l660t2333r1116b2422],
3	had	VBD	O	have	_	0	SENT_86	[p7l1142t2333r1283b2401],
4	a	DT	O	a	det	6	SENT_86	[p7l1309t2355r1349b2401],
5	ﬁrst	JJ	O	ﬁrst	amod	6	SENT_86	[p7l1374t2333r1523b2401],
6	prescription	NN	O	prescription	dobj	3	SENT_86	[p7l1546t2333r2014b2422],
7	for	IN	O	for	_	0	SENT_86	[p7l2040t2333r2153b2401],
8	simvastatin	NN	O	simvastatin	prep_for	6	SENT_86	[p7l14t2438r455b2506],
9	in	IN	O	in	_	0	SENT_86	[p7l500t2438r574b2505],
10	the	DT	O	the	det	11	SENT_86	[p7l619t2438r736b2506],
11	database	NN	O	database	prep_in	3	SENT_86	[p7l783t2438r1117b2506],
12	and	CC	O	and	_	0	SENT_86	[p7l1165t2438r1303b2506],
13	322	CD	NUMBER	322	num	14	SENT_86	[p7l1350t2438r1491b2507],
14	participants	NNS	O	participant	conj_and	11	SENT_86	[p7l1536t2438r1992b2526],
15	for	IN	O	for	_	0	SENT_86	[p7l2039t2438r2152b2506],
16	atorvastatin	NN	O	atorvastatin	prep_for	14	SENT_86	[p7l13t2546r485b2614],
17	.	.	O	.	_	0	SENT_86	[p7l13t2546r485b2614],

1	For	IN	O	for	_	0	SENT_87	[p7l525t2547r660b2614],
2	the	DT	O	the	det	3	SENT_87	[p7l693t2546r809b2614],
3	CYP3A4	NN	O	cyp3a4	prep_for	12	SENT_87	[p7l851t2546r1181b2615],
4	genotyping	VBG	O	genotype	partmod	3	SENT_87	[p7l1217t2546r1654b2634],
5	1239	CD	DATE	1239	dobj	4	SENT_87	[p7l1700t2546r1881b2615],
6	of	IN	O	of	_	0	SENT_87	[p7l1920t2545r2004b2614],
7	the	DT	O	the	det	9	SENT_87	[p7l2033t2546r2150b2614],
8	1380	CD	DATE	1380	num	9	SENT_87	[p7l20t2652r204b2720],
9	blood	NN	O	blood	prep_of	5	SENT_87	[p7l252t2651r475b2720],
10	samples	NNS	O	sample	nsubj	12	SENT_87	[p7l527t2651r836b2740],
11	were	VBD	O	be	cop	12	SENT_87	[p7l887t2673r1074b2720],
12	available	JJ	O	available	_	0	SENT_87	[p7l1125t2651r1473b2720],
13	and	CC	O	and	_	0	SENT_87	[p7l1525t2651r1663b2720],
14	genotyping	NN	O	genotyping	nsubj	15	SENT_87	[p7l1712t2651r2150b2740],
15	failed	VBD	O	fail	conj_and	12	SENT_87	[p7l11t2756r234b2824],
16	in	IN	O	in	_	0	SENT_87	[p7l283t2756r357b2823],
17	41	CD	NUMBER	41	num	18	SENT_87	[p7l406t2756r493b2823],
18	participants	NNS	O	participant	prep_in	15	SENT_87	[p7l550t2756r1006b2844],
19	(	RB	O	(	dep	20	SENT_87	[p7l1062t2756r1305b2840],
20	Table	NNP	O	Table	dep	18	SENT_87	[p7l1062t2756r1305b2840],
21	1	CD	NUMBER	1	number	22	SENT_87	[p7l1365t2757r1454b2840],
22	)	CD	NUMBER	)	num	20	SENT_87	[p7l1365t2757r1454b2840],
23	.	.	O	.	_	0	SENT_87	[p7l1365t2757r1454b2840],

1	For	IN	O	for	_	0	SENT_88	[p7l1509t2758r1643b2824],
2	the	DT	O	the	det	3	SENT_88	[p7l1691t2756r1808b2824],
3	ABCBI	NNP	O	ABCBI	prep_for	9	SENT_88	[p7l1852t2757r2144b2825],
4	genotyping	VBG	O	genotype	csubj	9	SENT_88	[p7l12t2864r450b2952],
5	1255	CD	DATE	1255	num	7	SENT_88	[p7l509t2863r689b2932],
6	blood	NN	O	blood	nn	7	SENT_88	[p7l741t2864r964b2932],
7	samples	NNS	O	sample	dobj	4	SENT_88	[p7l1015t2864r1324b2952],
8	were	VBD	O	be	cop	9	SENT_88	[p7l1375t2885r1562b2932],
9	available	JJ	O	available	_	0	SENT_88	[p7l1614t2863r1961b2932],
10	and	CC	O	and	_	0	SENT_88	[p7l2013t2864r2151b2932],
11	genotyping	NN	O	genotyping	nsubj	12	SENT_88	[p7l12t2969r450b3058],
12	failed	VBD	O	fail	conj_and	9	SENT_88	[p7l478t2969r701b3038],
13	in	IN	O	in	_	0	SENT_88	[p7l727t2969r801b3037],
14	23	CD	NUMBER	23	number	15	SENT_88	[p7l829t2970r918b3038],
15	(	CD	NUMBER	(	num	22	SENT_88	[p7l953t2969r1355b3054],
16	C1236T	NN	O	c1236t	nn	22	SENT_88	[p7l953t2969r1355b3054],
17	)	NN	O	)	nn	22	SENT_88	[p7l953t2969r1355b3054],
18	,	,	O	,	_	0	SENT_88	[p7l953t2969r1355b3054],
19	46	CD	NUMBER	46	number	20	SENT_88	[p7l1385t2969r1479b3038],
20	(	CD	NUMBER	(	num	22	SENT_88	[p7l1511t2969r1981b3054],
21	G2677TA	NN	O	g2677ta	nn	22	SENT_88	[p7l1511t2969r1981b3054],
22	)	NN	O	)	prep_in	12	SENT_88	[p7l1511t2969r1981b3054],
23	,	,	O	,	_	0	SENT_88	[p7l1511t2969r1981b3054],
24	and	CC	O	and	_	0	SENT_88	[p7l2013t2969r2151b3038],
25	50	CD	NUMBER	50	number	26	SENT_88	[p7l12t3075r106b3144],
26	(	CD	NUMBER	(	prep_in	12	SENT_88	[p7l139t3075r518b3160],
27	C3435T	NN	O	c3435t	nn	29	SENT_88	[p7l139t3075r518b3160],
28	)	NN	O	)	nn	29	SENT_88	[p7l139t3075r518b3160],
29	participants	NNS	O	participant	dep	26	SENT_88	[p7l549t3076r1026b3164],
30	.	.	O	.	_	0	SENT_88	[p7l549t3076r1026b3164],

1	The	DT	O	the	det	3	SENT_89	[p7l1061t3076r1210b3144],
2	allele	NN	O	allele	nn	3	SENT_89	[p7l1243t3076r1452b3144],
3	frequencies	NNS	O	frequency	nsubj	7	SENT_89	[p7l1482t3075r1931b3164],
4	were	VBD	O	be	cop	7	SENT_89	[p7l1963t3097r2150b3144],
5	0.04	CD	NUMBER	0.04	number	6	SENT_89	[p7l12t3181r179b3249],
6	(	CD	NUMBER	(	num	7	SENT_89	[p7l266t3173r776b3264],
7	CYP3A4	NN	O	cyp3a4	_	0	SENT_89	[p7l266t3173r776b3264],
8	*	CD	NUMBER	*	num	9	SENT_89	[p7l266t3173r776b3264],
9	IB	NN	O	ib	dep	7	SENT_89	[p7l266t3173r776b3264],
10	A	DT	O	a	det	13	SENT_89	[p7l856t3181r924b3248],
11	>	JJR	O	>	amod	13	SENT_89	[p7l949t3195r1009b3252],
12	G	NN	O	g	nn	13	SENT_89	[p7l1033t3181r1153b3265],
13	)	NNS	O	)	dep	7	SENT_89	[p7l1033t3181r1153b3265],
14	,	,	O	,	_	0	SENT_89	[p7l1033t3181r1153b3265],
15	0.44	CD	NUMBER	0.44	number	16	SENT_89	[p7l1240t3181r1407b3249],
16	(	CD	NUMBER	(	num	18	SENT_89	[p7l1493t3181r1896b3265],
17	C1236T	NN	O	c1236t	nn	18	SENT_89	[p7l1493t3181r1896b3265],
18	)	NN	O	)	appos	7	SENT_89	[p7l1493t3181r1896b3265],
19	,	,	O	,	_	0	SENT_89	[p7l1493t3181r1896b3265],
20	0.42	CD	NUMBER	0.42	appos	18	SENT_89	[p7l1983t3181r2150b3249],

1	(	NN	O	(	nn	2	SENT_90	[p8l14t17r422b101],
2	G2677T	NN	O	g2677t	_	0	SENT_90	[p8l14t17r422b101],
3	)	CD	NUMBER	)	dep	2	SENT_90	[p8l14t17r422b101],
4	,	,	O	,	_	0	SENT_90	[p8l14t17r422b101],
5	0.03	CD	NUMBER	0.03	appos	3	SENT_90	[p8l463t18r626b86],
6	(	CD	NUMBER	(	num	8	SENT_90	[p8l671t17r1089b101],
7	G2677A	NN	O	g2677a	nn	8	SENT_90	[p8l671t17r1089b101],
8	)	NN	O	)	dep	5	SENT_90	[p8l671t17r1089b101],
9	,	,	O	,	_	0	SENT_90	[p8l671t17r1089b101],
10	and	CC	O	and	_	0	SENT_90	[p8l1131t17r1269b85],
11	0.53	CD	NUMBER	0.53	number	12	SENT_90	[p8l1306t17r1469b86],
12	(	CD	NUMBER	(	num	14	SENT_90	[p8l1515t17r1916b101],
13	C3435T	NN	O	c3435t	nn	14	SENT_90	[p8l1515t17r1916b101],
14	)	NN	O	)	conj_and	3	SENT_90	[p8l1515t17r1916b101],
15	.	.	O	.	_	0	SENT_90	[p8l1515t17r1916b101],

1	Only	RB	O	only	advmod	3	SENT_91	[p8l1959t17r2150b105],
2	one	CD	NUMBER	one	num	3	SENT_91	[p8l12t147r149b194],
3	patient	NN	O	patient	nsubj	4	SENT_91	[p8l199t125r468b214],
4	had	VBD	O	have	_	0	SENT_91	[p8l516t125r657b194],
5	the	DT	O	the	det	6	SENT_91	[p8l706t125r823b194],
6	CYP3A4	NN	O	cyp3a4	nn	11	SENT_91	[p8l879t118r1355b195],
7	*	CD	NUMBER	*	num	10	SENT_91	[p8l879t118r1355b195],
8	]	NN	O	]	nn	10	SENT_91	[p8l879t118r1355b195],
9	B	NN	O	b	nn	10	SENT_91	[p8l879t118r1355b195],
10	GG	NNS	O	gg	dep	6	SENT_91	[p8l1408t125r1546b194],
11	genotype	NN	O	genotype	dobj	4	SENT_91	[p8l1596t135r1973b214],
12	.	.	O	.	_	0	SENT_91	[p8l1596t135r1973b214],

1	All	DT	O	all	det	3	SENT_92	[p8l2027t125r2150b193],
2	genotype	NN	O	genotype	nn	3	SENT_92	[p8l12t242r368b320],
3	frequencies	NNS	O	frequency	nsubj	4	SENT_92	[p8l473t231r921b320],
4	were	VBD	O	be	_	0	SENT_92	[p8l1027t253r1214b300],
5	in	IN	O	in	_	0	SENT_92	[p8l1319t231r1393b299],
6	Hardy	NNP	LOCATION	Hardy	prep_in	4	SENT_92	[p8l1496t231r2149b320],
7	.	.	O	.	_	0	SENT_92	[p8l1496t231r2149b320],

1	—	NN	O	—	_	0	SENT_93	[p8l1496t231r2149b320],
2	.	.	O	.	_	0	SENT_93	[p8l1496t231r2149b320],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_94	[p8l1496t231r2149b320],
2	equilibrium	NN	O	equilibrium	_	0	SENT_94	[p8l12t336r469b424],
3	(	CD	NUMBER	(	num	2	SENT_94	[p8l522t337r609b423],
4	[	CD	NUMBER	[	number	5	SENT_94	[p8l522t337r609b423],
5	9	CD	NUMBER	9	num	6	SENT_94	[p8l522t337r609b423],
6	>	JJR	O	>	dep	2	SENT_94	[p8l636t350r696b407],
7	0.01	CD	NUMBER	0.01	num	8	SENT_94	[p8l722t337r942b420],
8	)	NN	O	)	dep	6	SENT_94	[p8l722t337r942b420],
9	.	.	O	.	_	0	SENT_94	[p8l722t337r942b420],

1	The	DT	O	the	det	3	SENT_95	[p8l998t336r1148b404],
2	ABCB1	NN	O	abcb1	nn	3	SENT_95	[p8l1193t337r1484b405],
3	polymorphisms	NNS	O	polymorphism	nsubj	14	SENT_95	[p8l1541t336r2149b424],
4	were	VBD	O	be	cop	14	SENT_95	[p8l12t465r199b512],
5	in	IN	O	in	_	0	SENT_95	[p8l271t444r345b511],
6	strong	JJ	O	strong	amod	8	SENT_95	[p8l419t454r657b532],
7	linkage	NN	O	linkage	nn	8	SENT_95	[p8l729t444r1016b532],
8	disequilibrium	NN	O	disequilibrium	prep_in	14	SENT_95	[p8l1088t444r1660b532],
9	with	IN	O	with	_	0	SENT_95	[p8l1730t444r1902b512],
10	each	DT	O	each	det	13	SENT_95	[p8l1973t444r2151b512],
11	other	JJ	O	other	amod	13	SENT_95	[p8l12t551r213b620],
12	(	NN	O	(	nn	13	SENT_95	[p8l337t530r438b636],
13	r2	NN	O	r2	prep_with	8	SENT_95	[p8l337t530r438b636],
14	>	JJR	O	>	_	0	SENT_95	[p8l464t565r524b622],
15	0.8	CD	NUMBER	0.8	num	16	SENT_95	[p8l550t552r721b636],
16	)	NN	O	)	dep	14	SENT_95	[p8l550t552r721b636],
17	.	.	O	.	_	0	SENT_95	[p8l550t552r721b636],

1	Simyastatin	NNP	PERSON	Simyastatin	nn	4	SENT_96	[p8l852t551r1310b620],
2	and	CC	O	and	_	0	SENT_96	[p8l1436t551r1574b620],
3	atorvastatin	NN	O	atorvastatin	conj_and	1	SENT_96	[p8l1698t551r2151b620],
4	users	NNS	O	user	nsubjpass	6	SENT_96	[p8l10t680r208b727],
5	were	VBD	O	be	auxpass	6	SENT_96	[p8l237t680r424b727],
6	followed	VBN	O	follow	_	0	SENT_96	[p8l452t658r797b727],
7	on	IN	O	on	_	0	SENT_96	[p8l825t680r919b727],
8	average	JJ	O	average	amod	9	SENT_96	[p8l947t680r1246b747],
9	5.3	CD	DURATION	5.3	prep_on	6	SENT_96	[p8l1275t658r1389b727],
10	year	NN	NUMBER	year	tmod	6	SENT_96	[p8l1412t680r1581b747],
11	(	CD	NUMBER	(	num	10	SENT_96	[p8l1610t659r1760b743],
12	SD	NN	O	sd	nn	15	SENT_96	[p8l1610t659r1760b743],
13	4.8	CD	DURATION	4.8	num	15	SENT_96	[p8l1787t659r1904b727],
14	year	NN	NUMBER	year	nn	15	SENT_96	[p8l1926t659r2145b747],
15	)	NN	O	)	dep	10	SENT_96	[p8l1926t659r2145b747],
16	.	.	O	.	_	0	SENT_96	[p8l1926t659r2145b747],

1	In	IN	O	in	_	0	SENT_97	[p8l11t766r90b832],
2	250	CD	NUMBER	250	num	3	SENT_97	[p8l144t764r286b833],
3	patients	NNS	O	patient	prep_in	13	SENT_97	[p8l337t764r663b853],
4	,	,	O	,	_	0	SENT_97	[p8l337t764r663b853],
5	the	DT	O	the	det	7	SENT_97	[p8l719t764r836b833],
6	prescribed	VBN	O	prescribe	amod	7	SENT_97	[p8l887t764r1296b853],
7	dose	NN	O	dose	nsubjpass	13	SENT_97	[p8l1348t764r1523b833],
8	of	IN	O	of	_	0	SENT_97	[p8l1578t764r1662b833],
9	simvastatin	NN	O	simvastatin	prep_of	7	SENT_97	[p8l1711t764r2151b833],
10	or	CC	O	or	_	0	SENT_97	[p8l12t892r92b938],
11	atorvastatin	NN	O	atorvastatin	prep_of	7	SENT_97	[p8l156t870r609b939],
12	was	VBD	O	be	auxpass	13	SENT_97	[p8l673t892r820b939],
13	increased	VBN	O	increase	_	0	SENT_97	[p8l886t870r1275b938],
14	.	.	O	.	_	0	SENT_97	[p8l886t870r1275b938],

1	Events	NNS	O	event	nsubj	2	SENT_98	[p8l1343t872r1606b939],
2	occurred	VBD	O	occur	_	0	SENT_98	[p8l1673t870r2014b938],
3	in	IN	O	in	prep	2	SENT_98	[p8l2077t870r2151b938],

1	Table	NNP	O	Table	_	0	SENT_99	[p8l11t1100r166b1151],
2	1	CD	NUMBER	1	dep	1	SENT_99	[p8l199t1101r240b1151],
3	.	.	O	.	_	0	SENT_99	[p8l199t1101r240b1151],

1	Baseline	NN	O	baseline	nn	2	SENT_100	[p8l317t1100r561b1151],
2	characteristics	NNS	O	characteristic	_	0	SENT_100	[p8l590t1100r995b1151],
3	of	IN	O	of	_	0	SENT_100	[p8l1027t1100r1088b1151],
4	1198	CD	DATE	1198	num	6	SENT_100	[p8l1119t1101r1250b1151],
5	incident	NN	O	incident	nn	6	SENT_100	[p8l1280t1100r1510b1151],
6	atorvastatin	NN	O	atorvastatin	prep_of	2	SENT_100	[p8l1539t1100r1869b1151],
7	and	CC	O	and	_	0	SENT_100	[p8l1898t1100r1998b1151],
8	simVastatin	NN	O	simvastatin	nn	9	SENT_100	[p8l2028t1100r2149b1151, p8l11t1180r230b1230],
9	users	NNS	O	user	prep_of	2	SENT_100	[p8l255t1196r399b1230],
10	by	IN	O	by	_	0	SENT_100	[p8l425t1180r494b1245],
11	CYP3A4	NN	O	cyp3a4	nn	14	SENT_100	[p8l522t1175r885b1230],
12	*	CD	NUMBER	*	num	14	SENT_100	[p8l522t1175r885b1230],
13	1B	NN	O	1b	nn	14	SENT_100	[p8l522t1175r885b1230],
14	genotype	NN	O	genotype	prep_by	6	SENT_100	[p8l915t1188r1174b1245],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_101	[p8l14t1344r254b1394],
2	*	CD	NUMBER	*	number	3	SENT_101	[p8l282t1339r376b1394],
3	1	CD	NUMBER	1	dep	1	SENT_101	[p8l282t1339r376b1394],
4	]	NN	O	]	dep	3	SENT_101	[p8l282t1339r376b1394],
5	?	.	O	?	_	0	SENT_101	[p8l282t1339r376b1394],

1	Genotype	NN	O	genotype	nn	3	SENT_102	[p8l403t1344r677b1409],
2	AA	NN	O	aa	nn	3	SENT_102	[p8l1139t1344r1240b1393],
3	AG	NNP	O	AG	nsubj	6	SENT_102	[p8l1750t1344r1849b1394],
4	or	CC	O	or	_	0	SENT_102	[p8l1875t1360r1933b1394],
5	GG	NNS	O	gg	nsubj	6	SENT_102	[p8l1957t1339r2081b1394],
6	*	VBP	O	*	_	0	SENT_102	[p8l1957t1339r2081b1394],

1	Number	NN	O	number	dep	13	SENT_103	[p8l10t1521r244b1571],
2	1102	CD	DATE	1102	number	3	SENT_103	[p8l1126t1522r1259b1572],
3	96	CD	NUMBER	96	num	4	SENT_103	[p8l1883t1521r1951b1572],
4	Gender	NN	O	gender	dep	1	SENT_103	[p8l12t1602r232b1660],
5	,	,	O	,	_	0	SENT_103	[p8l12t1602r232b1660],
6	male	JJ	O	male	amod	8	SENT_103	[p8l260t1602r397b1651],
7	474	CD	PERCENT	474	number	8	SENT_103	[p8l1036t1602r1141b1651],
8	(	CD	PERCENT	(	appos	4	SENT_103	[p8l1169t1602r1341b1663],
9	43	CD	PERCENT	43	num	10	SENT_103	[p8l1169t1602r1341b1663],
10	%	NN	PERCENT	%	dep	13	SENT_103	[p8l1169t1602r1341b1663],
11	)	CD	NUMBER	)	num	13	SENT_103	[p8l1169t1602r1341b1663],
12	40	CD	NUMBER	40	num	13	SENT_103	[p8l1781t1602r1850b1651],
13	(	NN	O	(	dep	36	SENT_103	[p8l1879t1602r2051b1663],
14	42	CD	PERCENT	42	num	15	SENT_103	[p8l1879t1602r2051b1663],
15	%	NN	PERCENT	%	dep	13	SENT_103	[p8l1879t1602r2051b1663],
16	)	CD	NUMBER	)	num	32	SENT_103	[p8l1879t1602r2051b1663],
17	Age	NNP	O	Age	nn	32	SENT_103	[p8l11t1681r127b1745],
18	(	CD	NUMBER	(	num	32	SENT_103	[p8l155t1681r288b1742],
19	SD	NN	O	sd	nn	32	SENT_103	[p8l155t1681r288b1742],
20	)	CD	NUMBER	)	num	32	SENT_103	[p8l155t1681r288b1742],
21	71.3	CD	NUMBER	71.3	num	32	SENT_103	[p8l975t1681r1094b1731],
22	(	NN	O	(	nn	32	SENT_103	[p8l1125t1681r1256b1742],
23	7.0	CD	NUMBER	7.0	num	32	SENT_103	[p8l1125t1681r1256b1742],
24	)	CD	NUMBER	)	num	32	SENT_103	[p8l1125t1681r1256b1742],
25	year	NN	NUMBER	year	nn	32	SENT_103	[p8l1283t1697r1406b1745],
26	71.9	CD	NUMBER	71.9	num	32	SENT_103	[p8l1703t1681r1823b1732],
27	(	CD	NUMBER	(	num	32	SENT_103	[p8l1853t1681r1983b1742],
28	6.9	CD	NUMBER	6.9	num	32	SENT_103	[p8l1853t1681r1983b1742],
29	)	CD	NUMBER	)	num	32	SENT_103	[p8l1853t1681r1983b1742],
30	year	NN	NUMBER	year	nn	32	SENT_103	[p8l2010t1697r2133b1745],
31	Body	NN	O	body	nn	32	SENT_103	[p8l11t1761r163b1826],
32	mass	NN	O	mass	rcmod	15	SENT_103	[p8l189t1777r328b1811],
33	index	NN	O	index	nn	36	SENT_103	[p8l355t1761r511b1811],
34	(	CD	NUMBER	(	num	36	SENT_103	[p8l539t1744r694b1822],
35	SD	NN	O	sd	nn	36	SENT_103	[p8l539t1744r694b1822],
36	)	NN	O	)	dep	44	SENT_103	[p8l539t1744r694b1822],
37	1	CD	NUMBER	1	num	39	SENT_103	[p8l539t1744r694b1822],
38	26.6	CD	NUMBER	26.6	num	39	SENT_103	[p8l956t1761r1077b1811],
39	(	NN	O	(	dep	36	SENT_103	[p8l1106t1761r1236b1823],
40	3.4	CD	NUMBER	3.4	number	41	SENT_103	[p8l1106t1761r1236b1823],
41	)	CD	NUMBER	)	num	42	SENT_103	[p8l1106t1761r1236b1823],
42	kg/m2	NN	O	kg/m2	dep	39	SENT_103	[p8l1251t1745r1423b1826],
43	26.8	CD	NUMBER	26.8	num	44	SENT_103	[p8l1684t1761r1803b1811],
44	(	NN	O	(	_	0	SENT_103	[p8l1834t1761r1964b1822],
45	3.8	CD	NUMBER	3.8	number	46	SENT_103	[p8l1834t1761r1964b1822],
46	)	CD	NUMBER	)	num	48	SENT_103	[p8l1834t1761r1964b1822],
47	kg/m2	NN	O	kg/m2	nn	48	SENT_103	[p8l1979t1745r2151b1826],
48	Simyastatin	NN	O	simyastatin	nsubj	49	SENT_103	[p8l13t1840r346b1890],
49	start	VB	O	start	rcmod	44	SENT_103	[p8l373t1848r493b1890],
50	851	CD	PERCENT	851	number	51	SENT_103	[p8l1039t1840r1135b1890],
51	(	CD	PERCENT	(	dobj	49	SENT_103	[p8l1169t1841r1341b1901],
52	77	CD	PERCENT	77	num	53	SENT_103	[p8l1169t1841r1341b1901],
53	%	NN	PERCENT	%	dep	51	SENT_103	[p8l1169t1841r1341b1901],
54	)	CD	NUMBER	)	number	55	SENT_103	[p8l1169t1841r1341b1901],
55	74	CD	NUMBER	74	num	56	SENT_103	[p8l1782t1840r1850b1889],
56	(	NN	O	(	dep	51	SENT_103	[p8l1879t1841r2051b1901],
57	77	CD	PERCENT	77	number	58	SENT_103	[p8l1879t1841r2051b1901],
58	%	NN	PERCENT	%	amod	56	SENT_103	[p8l1879t1841r2051b1901],
59	)	CD	NUMBER	)	num	61	SENT_103	[p8l1879t1841r2051b1901],
60	Atorvastatin	NN	O	atorvastatin	nn	61	SENT_103	[p8l10t1920r361b1969],
61	start	NN	O	start	dep	70	SENT_103	[p8l389t1927r508b1969],
62	251	CD	NUMBER	251	num	63	SENT_103	[p8l1037t1920r1135b1969],
63	(	NN	O	(	dep	61	SENT_103	[p8l1169t1920r1341b1981],
64	23	CD	PERCENT	23	num	65	SENT_103	[p8l1169t1920r1341b1981],
65	%	NN	PERCENT	%	dep	63	SENT_103	[p8l1169t1920r1341b1981],
66	)	CD	NUMBER	)	number	67	SENT_103	[p8l1169t1920r1341b1981],
67	22	CD	NUMBER	22	num	65	SENT_103	[p8l1782t1920r1850b1969],
68	(	NN	O	(	dep	70	SENT_103	[p8l1879t1920r2051b1981],
69	23	CD	PERCENT	23	num	70	SENT_103	[p8l1879t1920r2051b1981],
70	%	NN	PERCENT	%	dep	51	SENT_103	[p8l1879t1920r2051b1981],
71	)	CD	NUMBER	)	num	73	SENT_103	[p8l1879t1920r2051b1981],
72	ACBC1	NN	O	acbc1	nn	73	SENT_103	[p8l6t1999r220b2049],
73	genotypes	NNS	O	genotype	dep	70	SENT_103	[p8l252t2006r537b2064],

1	1236CC	NN	O	1236cc	dep	128	SENT_104	[p8l89t2078r316b2128],
2	343	CD	NUMBER	343	dep	128	SENT_104	[p8l1038t2079r1138b2128],
3	(	NN	O	(	dep	128	SENT_104	[p8l1169t2078r1341b2139],
4	31	CD	PERCENT	31	dep	128	SENT_104	[p8l1169t2078r1341b2139],
5	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2078r1341b2139],
6	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1169t2078r1341b2139],
7	22	CD	NUMBER	22	dep	128	SENT_104	[p8l1782t2079r1850b2127],
8	(	NN	O	(	dep	128	SENT_104	[p8l1879t2079r2051b2139],
9	23	CD	PERCENT	23	dep	128	SENT_104	[p8l1879t2079r2051b2139],
10	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2079r2051b2139],
11	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2079r2051b2139],
12	1236CT	NN	O	1236ct	dep	128	SENT_104	[p8l89t2158r314b2207],
13	548	CD	NUMBER	548	dep	128	SENT_104	[p8l1037t2158r1139b2207],
14	(	NN	O	(	dep	128	SENT_104	[p8l1169t2158r1341b2219],
15	50	CD	PERCENT	50	dep	128	SENT_104	[p8l1169t2158r1341b2219],
16	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2158r1341b2219],
17	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1169t2158r1341b2219],
18	57	CD	NUMBER	57	dep	128	SENT_104	[p8l1782t2158r1848b2207],
19	(	NN	O	(	dep	128	SENT_104	[p8l1879t2158r2051b2219],
20	60	CD	PERCENT	60	dep	128	SENT_104	[p8l1879t2158r2051b2219],
21	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2158r2051b2219],
22	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2158r2051b2219],
23	1236TT	NN	O	1236tt	dep	128	SENT_104	[p8l89t2236r310b2286],
24	201	CD	NUMBER	201	dep	128	SENT_104	[p8l1037t2236r1135b2286],
25	(	NN	O	(	dep	128	SENT_104	[p8l1169t2236r1341b2297],
26	18	CD	PERCENT	18	dep	128	SENT_104	[p8l1169t2236r1341b2297],
27	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2236r1341b2297],
28	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1169t2236r1341b2297],
29	16	CD	NUMBER	16	dep	128	SENT_104	[p8l1788t2236r1850b2286],
30	(	NN	O	(	dep	128	SENT_104	[p8l1879t2236r2051b2297],
31	17	CD	PERCENT	17	dep	128	SENT_104	[p8l1879t2236r2051b2297],
32	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2236r2051b2297],
33	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2236r2051b2297],
34	2677GG	NN	O	2677gg	dep	128	SENT_104	[p8l82t2315r326b2365],
35	324	CD	PERCENT	324	dep	128	SENT_104	[p8l1038t2316r1141b2365],
36	(	CD	PERCENT	(	dep	128	SENT_104	[p8l1169t2316r1341b2377],
37	30	CD	PERCENT	30	dep	128	SENT_104	[p8l1169t2316r1341b2377],
38	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2316r1341b2377],
39	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1169t2316r1341b2377],
40	21	CD	NUMBER	21	dep	128	SENT_104	[p8l1782t2316r1845b2364],
41	(	NN	O	(	dep	128	SENT_104	[p8l1879t2316r2051b2377],
42	23	CD	PERCENT	23	dep	128	SENT_104	[p8l1879t2316r2051b2377],
43	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2316r2051b2377],
44	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2316r2051b2377],
45	2677GT	NN	O	2677gt	dep	128	SENT_104	[p8l83t2394r318b2444],
46	515	CD	NUMBER	515	dep	128	SENT_104	[p8l1037t2394r1138b2444],
47	(	NN	O	(	dep	128	SENT_104	[p8l1169t2394r1341b2455],
48	48	CD	PERCENT	48	dep	128	SENT_104	[p8l1169t2394r1341b2455],
49	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2394r1341b2455],
50	)	CD	PERCENT	)	dep	128	SENT_104	[p8l1169t2394r1341b2455],
51	50	CD	PERCENT	50	dep	128	SENT_104	[p8l1782t2394r1850b2444],
52	(	CD	PERCENT	(	dep	128	SENT_104	[p8l1879t2394r2051b2455],
53	54	CD	PERCENT	54	dep	128	SENT_104	[p8l1879t2394r2051b2455],
54	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2394r2051b2455],
55	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2394r2051b2455],
56	2677GA	NN	O	2677ga	dep	128	SENT_104	[p8l83t2474r326b2523],
57	27	CD	NUMBER	27	dep	128	SENT_104	[p8l1072t2474r1139b2523],
58	(	NN	O	(	dep	128	SENT_104	[p8l1169t2474r1305b2535],
59	3	CD	PERCENT	3	dep	128	SENT_104	[p8l1169t2474r1305b2535],
60	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2474r1305b2535],
61	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1169t2474r1305b2535],
62	3	CD	NUMBER	3	dep	128	SENT_104	[p8l1819t2474r1847b2523],
63	(	NN	O	(	dep	128	SENT_104	[p8l1879t2474r2015b2535],
64	3	CD	PERCENT	3	dep	128	SENT_104	[p8l1879t2474r2015b2535],
65	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2474r2015b2535],
66	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2474r2015b2535],
67	2677TT	NN	O	2677tt	dep	128	SENT_104	[p8l83t2552r310b2602],
68	185	CD	NUMBER	185	dep	128	SENT_104	[p8l1043t2552r1138b2602],
69	(	NN	O	(	dep	128	SENT_104	[p8l1169t2553r1341b2614],
70	17	CD	PERCENT	17	dep	128	SENT_104	[p8l1169t2553r1341b2614],
71	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2553r1341b2614],
72	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1169t2553r1341b2614],
73	16	CD	NUMBER	16	dep	128	SENT_104	[p8l1788t2552r1850b2602],
74	(	NN	O	(	dep	128	SENT_104	[p8l1879t2553r2051b2614],
75	17	CD	PERCENT	17	dep	128	SENT_104	[p8l1879t2553r2051b2614],
76	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2553r2051b2614],
77	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2553r2051b2614],
78	2677TA	NN	O	2677ta	dep	128	SENT_104	[p8l83t2631r312b2681],
79	21	CD	NUMBER	21	dep	128	SENT_104	[p8l1073t2632r1135b2680],
80	(	NN	O	(	dep	128	SENT_104	[p8l1169t2631r1305b2692],
81	2	CD	PERCENT	2	dep	128	SENT_104	[p8l1169t2631r1305b2692],
82	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2631r1305b2692],
83	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1169t2631r1305b2692],
84	2	CD	NUMBER	2	dep	128	SENT_104	[p8l1818t2632r1850b2680],
85	(	NN	O	(	dep	128	SENT_104	[p8l1879t2631r2015b2692],
86	2	CD	PERCENT	2	dep	128	SENT_104	[p8l1879t2631r2015b2692],
87	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2631r2015b2692],
88	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2631r2015b2692],
89	2677AA	NN	O	2677aa	dep	128	SENT_104	[p8l83t2710r325b2760],
90	3	CD	PERCENT	3	dep	128	SENT_104	[p8l1092t2711r1120b2760],
91	(	NN	PERCENT	(	dep	128	SENT_104	[p8l1151t2710r1288b2771],
92	o	NN	PERCENT	o	dep	128	SENT_104	[p8l1151t2710r1288b2771],
93	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1151t2710r1288b2771],
94	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1151t2710r1288b2771],
95	o	NN	O	o	dep	128	SENT_104	[p8l1901t2711r1934b2760],
96	3435CC	NN	O	3435cc	dep	128	SENT_104	[p8l83t2789r317b2839],
97	242	CD	NUMBER	242	dep	128	SENT_104	[p8l1037t2789r1140b2838],
98	(	NN	O	(	dep	128	SENT_104	[p8l1169t2789r1341b2850],
99	23	CD	PERCENT	23	dep	128	SENT_104	[p8l1169t2789r1341b2850],
100	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2789r1341b2850],
101	)	CD	PERCENT	)	dep	128	SENT_104	[p8l1169t2789r1341b2850],
102	12	CD	PERCENT	12	dep	128	SENT_104	[p8l1788t2789r1850b2838],
103	(	CD	PERCENT	(	dep	128	SENT_104	[p8l1879t2789r2051b2850],
104	13	CD	PERCENT	13	dep	128	SENT_104	[p8l1879t2789r2051b2850],
105	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2789r2051b2850],
106	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2789r2051b2850],
107	3435CT	NN	O	3435ct	dep	128	SENT_104	[p8l84t2868r314b2918],
108	547	CD	NUMBER	547	dep	128	SENT_104	[p8l1037t2868r1139b2918],
109	(	NN	O	(	dep	128	SENT_104	[p8l1169t2868r1341b2930],
110	51	CD	PERCENT	51	dep	128	SENT_104	[p8l1169t2868r1341b2930],
111	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2868r1341b2930],
112	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1169t2868r1341b2930],
113	55	CD	NUMBER	55	dep	128	SENT_104	[p8l1782t2868r1847b2918],
114	(	NN	O	(	dep	128	SENT_104	[p8l1879t2868r2051b2930],
115	58	CD	PERCENT	58	dep	128	SENT_104	[p8l1879t2868r2051b2930],
116	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2868r2051b2930],
117	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1879t2868r2051b2930],
118	3435TT	NN	O	3435tt	dep	128	SENT_104	[p8l83t2947r310b2997],
119	286	CD	NUMBER	286	dep	128	SENT_104	[p8l1037t2947r1140b2997],
120	(	NN	O	(	dep	128	SENT_104	[p8l1169t2948r1341b3008],
121	27	CD	PERCENT	27	dep	128	SENT_104	[p8l1169t2948r1341b3008],
122	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1169t2948r1341b3008],
123	)	CD	NUMBER	)	dep	128	SENT_104	[p8l1169t2948r1341b3008],
124	28	CD	NUMBER	28	dep	128	SENT_104	[p8l1782t2948r1848b2997],
125	(	NN	O	(	dep	128	SENT_104	[p8l1879t2947r2051b3008],
126	29	CD	PERCENT	29	dep	128	SENT_104	[p8l1879t2947r2051b3008],
127	%	NN	PERCENT	%	dep	128	SENT_104	[p8l1879t2947r2051b3008],
128	)	CD	NUMBER	)	_	0	SENT_104	[p8l1879t2947r2051b3008],

1	*	NN	O	*	nn	2	SENT_105	[p8l13t3127r271b3182],
2	Number	NN	O	number	nsubj	10	SENT_105	[p8l13t3127r271b3182],
3	of	IN	O	of	_	0	SENT_105	[p8l289t3132r350b3182],
4	participants	NNS	O	participant	prep_of	2	SENT_105	[p8l363t3132r693b3197],
5	with	IN	O	with	_	0	SENT_105	[p8l714t3132r838b3182],
6	the	DT	O	the	det	8	SENT_105	[p8l856t3132r942b3182],
7	AG	NNP	O	AG	nn	8	SENT_105	[p8l960t3132r1059b3182],
8	genotype	NN	O	genotype	prep_with	4	SENT_105	[p8l1077t3140r1336b3197],
9	is	VBZ	O	be	cop	10	SENT_105	[p8l1355t3132r1399b3182],
10	95	CD	NUMBER	95	_	0	SENT_105	[p8l1419t3132r1484b3183],
11	and	CC	O	and	_	0	SENT_105	[p8l1507t3132r1607b3182],
12	with	IN	O	with	mark	17	SENT_105	[p8l1625t3132r1750b3182],
13	the	DT	O	the	det	15	SENT_105	[p8l1768t3132r1853b3182],
14	GG	NNS	O	gg	nn	15	SENT_105	[p8l1873t3132r1973b3182],
15	genotype	NN	O	genotype	nsubj	17	SENT_105	[p8l1992t3148r2149b3197, p8l11t3220r132b3277],
16	is	VBZ	O	be	cop	17	SENT_105	[p8l157t3213r202b3262],
17	1	CD	NUMBER	1	conj_and	10	SENT_105	[p8l236t3213r277b3262],
18	.	.	O	.	_	0	SENT_105	[p8l236t3213r277b3262],

1	1At	NN	O	1at	_	0	SENT_106	[p8l12t3276r104b3342],
2	the	DT	O	the	det	3	SENT_106	[p8l129t3292r214b3342],
3	time	NN	O	time	dep	1	SENT_106	[p8l240t3292r365b3342],
4	of	IN	O	of	_	0	SENT_106	[p8l393t3292r454b3342],
5	entrance	NN	O	entrance	prep_of	3	SENT_106	[p8l476t3300r716b3342],
6	in	IN	O	in	_	0	SENT_106	[p8l741t3292r795b3342],
7	the	DT	O	the	det	9	SENT_106	[p8l821t3292r906b3342],
8	Rotterdam	NNP	LOCATION	Rotterdam	nn	9	SENT_106	[p8l932t3292r1233b3342],
9	Study	NNP	O	Study	prep_in	5	SENT_106	[p8l1259t3292r1432b3357],
10	.	.	O	.	_	0	SENT_106	[p8l1259t3292r1432b3357],

1	Pharmacoepidemiology	NNP	O	Pharmacoepidemiology	nn	4	SENT_107	[p8l235t3519r1002b3590],
2	and	CC	O	and	_	0	SENT_107	[p8l1032t3519r1153b3575],
3	Drug	NNP	O	Drug	nn	4	SENT_107	[p8l1177t3521r1345b3590],
4	Safety	NNP	O	Safety	_	0	SENT_107	[p8l1374t3519r1581b3591],
5	,	,	O	,	_	0	SENT_107	[p8l1374t3519r1581b3591],
6	2010	CD	DATE	2010	appos	4	SENT_107	[p8l1614t3519r1791b3585],
7	;	:	O	;	_	0	SENT_107	[p8l1614t3519r1791b3585],
8	19	CD	NUMBER	19	dep	4	SENT_107	[p8l1827t3518r1918b3575],
9	:	:	O	:	_	0	SENT_107	[p8l1827t3518r1918b3575],
10	75-81	CD	NUMBER	75-81	num	11	SENT_107	[p8l1953t3519r2144b3575],
11	DOI	NNP	O	DOI	dep	8	SENT_107	[p8l1567t3607r1724b3663],
12	:	:	O	:	_	0	SENT_107	[p8l1567t3607r1724b3663],
13	10.1002	CD	NUMBER	10.1002	dep	11	SENT_107	[p8l1766t3607r2149b3679],
14	/	:	O	/	punct	11	SENT_107	[p8l1766t3607r2149b3679],
15	pds	NNS	O	pd	dep	8	SENT_107	[p8l1766t3607r2149b3679],

1	78	CD	NUMBER	78	_	0	SENT_108	[p8l476t3754r515b3783],
2	M.	NNP	NUMBER	M.	nn	5	SENT_108	[p8l1360t3762r1395b3783],
3	L.	NNP	PERSON	L.	nn	5	SENT_108	[p8l1413t3762r1440b3783],
4	BECKER	NNP	PERSON	BECKER	nn	5	SENT_108	[p8l1458t3762r1583b3783],
5	ETAL	NNP	O	ETAL	dep	1	SENT_108	[p8l1598t3761r1683b3783],
6	.	.	O	.	_	0	SENT_108	[p8l1598t3761r1683b3783],

1	Table	NNP	O	Table	_	0	SENT_109	[p9l8t90r163b141],
2	2	CD	NUMBER	2	dep	1	SENT_109	[p9l190t91r237b141],
3	.	.	O	.	_	0	SENT_109	[p9l190t91r237b141],

1	Reason	NN	O	reason	_	0	SENT_110	[p9l315t92r523b141],
2	for	IN	O	for	dep	1	SENT_110	[p9l552t90r635b141],
3	the	DT	O	the	det	5	SENT_110	[p9l663t90r748b141],
4	dose	NN	O	dose	nn	5	SENT_110	[p9l779t90r907b141],
5	decrease	NN	O	decrease	nsubj	11	SENT_110	[p9l938t90r1182b141],
6	or	CC	O	or	_	0	SENT_110	[p9l1212t106r1270b141],
7	switch	NN	O	switch	conj_or	5	SENT_110	[p9l1301t90r1484b141],
8	to	TO	O	to	_	0	SENT_110	[p9l1513t98r1566b141],
9	another	DT	O	another	det	10	SENT_110	[p9l1598t90r1811b141],
10	cholesterol	NN	O	cholesterol	prep_to	5	SENT_110	[p9l1839t90r2151b141],
11	lowering	VBG	O	lower	pcomp	2	SENT_110	[p9l8t171r257b236],
12	drug	NN	O	drug	dobj	11	SENT_110	[p9l285t171r412b236],
13	for	IN	O	for	_	0	SENT_110	[p9l439t170r521b221],
14	all	DT	O	all	det	15	SENT_110	[p9l547t171r615b221],
15	events	NNS	O	event	prep_for	11	SENT_110	[p9l642t179r818b221],
16	after	IN	O	after	_	0	SENT_110	[p9l847t171r976b221],
17	1st	CD	DATE	1st	prep_after	11	SENT_110	[p9l1008t171r1083b221],
18	January	NNP	DATE	January	tmod	11	SENT_110	[p9l1107t172r1328b236],
19	1997	CD	DATE	1997	num	18	SENT_110	[p9l1360t171r1492b221],

1	Data	NNS	O	datum	_	0	SENT_111	[p9l7t327r142b376],
2	retrieval	NN	O	retrieval	nn	3	SENT_111	[p9l165t326r400b376],
3	N	NN	O	n	dep	1	SENT_111	[p9l1674t328r1728b376],

1	Patient	NN	O	patient	nn	2	SENT_112	[p9l7t484r204b533],
2	ﬁle	NN	O	ﬁle	_	0	SENT_112	[p9l230t484r318b533],
3	not	RB	O	not	neg	4	SENT_112	[p9l345t491r435b533],
4	available	JJ	O	available	dep	2	SENT_112	[p9l461t484r715b533],
5	42	CD	PERCENT	42	number	6	SENT_112	[p9l1676t484r1745b532],
6	(	CD	PERCENT	(	prep	4	SENT_112	[p9l1977t484r2149b545],
7	28	CD	PERCENT	28	num	8	SENT_112	[p9l1977t484r2149b545],
8	%	NN	PERCENT	%	dep	6	SENT_112	[p9l1977t484r2149b545],
9	)	CD	NUMBER	)	dobj	29	SENT_112	[p9l1977t484r2149b545],
10	By	IN	O	by	_	0	SENT_112	[p9l8t564r88b627],
11	specialist	NN	O	specialist	prep_by	9	SENT_112	[p9l117t562r395b627],
12	,	,	O	,	_	0	SENT_112	[p9l117t562r395b627],
13	reason	NN	O	reason	appos	11	SENT_112	[p9l422t578r608b613],
14	unknown	JJ	O	unknown	amod	13	SENT_112	[p9l632t562r895b613],
15	14	CD	PERCENT	14	number	16	SENT_112	[p9l1683t563r1745b612],
16	(	CD	PERCENT	(	prep	14	SENT_112	[p9l1977t563r2113b624],
17	9	CD	PERCENT	9	num	18	SENT_112	[p9l1977t563r2113b624],
18	%	NN	PERCENT	%	dep	16	SENT_112	[p9l1977t563r2113b624],
19	)	CD	NUMBER	)	num	26	SENT_112	[p9l1977t563r2113b624],
20	Unknown	JJ	O	unknown	amod	26	SENT_112	[p9l7t642r285b692],
21	64	CD	PERCENT	64	number	22	SENT_112	[p9l1677t642r1745b692],
22	(	CD	PERCENT	(	prep	20	SENT_112	[p9l1977t642r2149b703],
23	42	CD	PERCENT	42	num	24	SENT_112	[p9l1977t642r2149b703],
24	%	NN	PERCENT	%	dep	22	SENT_112	[p9l1977t642r2149b703],
25	)	CD	NUMBER	)	tmod	20	SENT_112	[p9l1977t642r2149b703],
26	Reason	NN	O	reason	nsubj	29	SENT_112	[p9l8t723r216b772],
27	given	VBN	O	give	partmod	26	SENT_112	[p9l243t722r397b787],
28	(	CD	NUMBER	(	dobj	27	SENT_112	[p9l425t722r535b784],
29	see	VBP	O	see	ccomp	4	SENT_112	[p9l425t722r535b784],
30	below	IN	O	below	_	0	SENT_112	[p9l560t722r753b783],
31	)	CD	NUMBER	)	number	32	SENT_112	[p9l560t722r753b783],
32	32	CD	NUMBER	32	num	33	SENT_112	[p9l1678t722r1745b772],
33	(	NN	O	(	prep_below	29	SENT_112	[p9l1977t722r2149b783],
34	21	CD	PERCENT	21	number	35	SENT_112	[p9l1977t722r2149b783],
35	%	NN	PERCENT	%	amod	33	SENT_112	[p9l1977t722r2149b783],
36	)	CD	NUMBER	)	tmod	29	SENT_112	[p9l1977t722r2149b783],

1	Reason	NN	O	reason	nn	3	SENT_113	[p9l8t935r216b983],
2	Adverse	JJ	O	adverse	amod	3	SENT_113	[p9l7t1014r242b1064],
3	drug	NN	O	drug	_	0	SENT_113	[p9l269t1014r396b1079],
4	reaction	NN	O	reaction	dep	3	SENT_113	[p9l422t1014r652b1064],
5	17	CD	PERCENT	17	num	4	SENT_113	[p9l1683t1014r1743b1064],
6	(	CD	PERCENT	(	number	7	SENT_113	[p9l1977t1014r2149b1076],
7	53	CD	PERCENT	53	num	8	SENT_113	[p9l1977t1014r2149b1076],
8	%	NN	PERCENT	%	dep	4	SENT_113	[p9l1977t1014r2149b1076],
9	)	CD	NUMBER	)	dep	3	SENT_113	[p9l1977t1014r2149b1076],

1	Muscle	NN	O	muscle	nn	2	SENT_114	[p9l79t1093r287b1144],
2	pain	NN	O	pain	_	0	SENT_114	[p9l312t1093r435b1158],
3	4	CD	NUMBER	4	num	4	SENT_114	[p9l1448t1094r1482b1143],
4	Malaise	NN	O	malaise	dep	6	SENT_114	[p9l78t1174r303b1224],
5	2	CD	NUMBER	2	num	6	SENT_114	[p9l1450t1174r1482b1224],
6	Allergy	NNP	O	Allergy	rcmod	2	SENT_114	[p9l79t1254r294b1319],
7	or	CC	O	or	_	0	SENT_114	[p9l321t1270r379b1304],
8	itching	VBG	O	itch	csubj	18	SENT_114	[p9l403t1254r600b1319],
9	2	CD	NUMBER	2	num	10	SENT_114	[p9l1450t1255r1482b1304],
10	Pain	NN	O	pain	num	15	SENT_114	[p9l79t1335r203b1385],
11	or	CC	O	or	_	0	SENT_114	[p9l230t1351r288b1385],
12	neuropathy	NN	O	neuropathy	conj_or	10	SENT_114	[p9l312t1335r632b1400],
13	2	CD	NUMBER	2	num	12	SENT_114	[p9l1450t1335r1482b1384],
14	Other	JJ	O	other	amod	15	SENT_114	[p9l80t1409r263b1465],
15	*	NN	O	*	dobj	8	SENT_114	[p9l80t1409r263b1465],
16	3	CD	NUMBER	3	npadvmod	17	SENT_114	[p9l1451t1415r1479b1465],
17	Not	RB	O	not	neg	18	SENT_114	[p9l78t1495r185b1544],
18	speciﬁed	VBN	O	speciﬁed	conj_or	6	SENT_114	[p9l212t1494r463b1559],
19	4	CD	NUMBER	4	dobj	18	SENT_114	[p9l1448t1494r1482b1544],

1	Too	RB	O	too	advmod	3	SENT_115	[p9l8t1576r114b1625],
2	strong	JJ	O	strong	amod	3	SENT_115	[p9l143t1582r317b1640],
3	cholesterol	NN	O	cholesterol	dep	16	SENT_115	[p9l344t1575r656b1625],
4	reduction	NN	O	reduction	dep	3	SENT_115	[p9l680t1575r950b1625],
5	(	CD	NUMBER	(	num	9	SENT_115	[p9l978t1575r1214b1637],
6	certain	JJ	O	certain	amod	9	SENT_115	[p9l978t1575r1214b1637],
7	)	CD	NUMBER	)	number	8	SENT_115	[p9l978t1575r1214b1637],
8	8	CD	NUMBER	8	dep	6	SENT_115	[p9l1679t1575r1707b1625],
9	(	NN	O	(	dep	4	SENT_115	[p9l1977t1574r2149b1636],
10	25	CD	PERCENT	25	num	11	SENT_115	[p9l1977t1574r2149b1636],
11	%	NN	PERCENT	%	dep	16	SENT_115	[p9l1977t1574r2149b1636],
12	)	CD	NUMBER	)	num	16	SENT_115	[p9l1977t1574r2149b1636],
13	Too	RB	O	too	advmod	16	SENT_115	[p9l8t1656r114b1705],
14	strong	JJ	O	strong	amod	16	SENT_115	[p9l143t1662r317b1719],
15	cholesterol	NN	O	cholesterol	nn	16	SENT_115	[p9l344t1654r656b1705],
16	reduction	NN	O	reduction	dep	30	SENT_115	[p9l680t1654r950b1705],
17	(	CD	NUMBER	(	num	19	SENT_115	[p9l978t1654r1253b1719],
18	possible	JJ	O	possible	amod	19	SENT_115	[p9l978t1654r1253b1719],
19	)	NN	O	)	dep	16	SENT_115	[p9l978t1654r1253b1719],
20	5	CD	PERCENT	5	number	21	SENT_115	[p9l1677t1654r1706b1705],
21	(	CD	PERCENT	(	amod	19	SENT_115	[p9l1977t1654r2149b1716],
22	16	CD	PERCENT	16	num	23	SENT_115	[p9l1977t1654r2149b1716],
23	%	NN	PERCENT	%	dep	21	SENT_115	[p9l1977t1654r2149b1716],
24	)	CD	NUMBER	)	num	25	SENT_115	[p9l1977t1654r2149b1716],
25	Statin	NN	O	statin	npadvmod	26	SENT_115	[p9l9t1734r173b1784],
26	not	RB	O	not	advmod	19	SENT_115	[p9l199t1742r289b1784],
27	effective	JJ	O	effective	amod	28	SENT_115	[p9l314t1734r559b1784],
28	(	NN	O	(	dep	19	SENT_115	[p9l587t1734r862b1799],
29	possible	JJ	O	possible	amod	30	SENT_115	[p9l587t1734r862b1799],
30	)	NN	O	)	dep	35	SENT_115	[p9l587t1734r862b1799],
31	2	CD	PERCENT	2	number	32	SENT_115	[p9l1677t1734r1709b1784],
32	(	CD	PERCENT	(	dep	30	SENT_115	[p9l1977t1734r2113b1796],
33	6	CD	PERCENT	6	num	34	SENT_115	[p9l1977t1734r2113b1796],
34	%	NN	PERCENT	%	dep	32	SENT_115	[p9l1977t1734r2113b1796],
35	)	CD	NUMBER	)	_	0	SENT_115	[p9l1977t1734r2113b1796],

1	*	NN	O	*	_	0	SENT_116	[p9l10t2038r210b2093],
2	Other	JJ	O	other	amod	1	SENT_116	[p9l10t2038r210b2093],
3	:	:	O	:	_	0	SENT_116	[p9l10t2038r210b2093],
4	hair	NN	O	hair	nn	5	SENT_116	[p9l240t2042r352b2093],
5	loss	NN	O	loss	dep	1	SENT_116	[p9l376t2043r483b2093],
6	(	CD	NUMBER	(	num	7	SENT_116	[p9l513t2043r567b2104],
7	n	NN	O	n	dep	5	SENT_116	[p9l513t2043r567b2104],
8	=	JJ	O	=	amod	7	SENT_116	[p9l585t2065r633b2082],
9	1	CD	NUMBER	1	num	10	SENT_116	[p9l655t2043r721b2104],
10	)	NN	O	)	tmod	8	SENT_116	[p9l655t2043r721b2104],
11	,	,	O	,	_	0	SENT_116	[p9l655t2043r721b2104],
12	diarrhea	NN	O	diarrhea	nn	14	SENT_116	[p9l751t2042r984b2093],
13	(	NN	O	(	nn	14	SENT_116	[p9l1010t2043r1065b2104],
14	n	NN	O	n	appos	10	SENT_116	[p9l1010t2043r1065b2104],
15	=	JJ	O	=	advmod	7	SENT_116	[p9l1082t2065r1130b2082],
16	1	CD	NUMBER	1	num	17	SENT_116	[p9l1153t2043r1220b2104],
17	)	NN	O	)	dep	7	SENT_116	[p9l1153t2043r1220b2104],
18	,	,	O	,	_	0	SENT_116	[p9l1153t2043r1220b2104],
19	hepatic	JJ	O	hepatic	amod	22	SENT_116	[p9l1247t2042r1451b2107],
20	failure	NN	O	failure	nn	22	SENT_116	[p9l1479t2042r1664b2093],
21	(	NN	O	(	nn	22	SENT_116	[p9l1692t2043r1746b2104],
22	n	NN	O	n	appos	17	SENT_116	[p9l1692t2043r1746b2104],
23	=	JJ	O	=	amod	25	SENT_116	[p9l1764t2065r1812b2082],
24	1	CD	NUMBER	1	tmod	23	SENT_116	[p9l1834t2043r1883b2104],
25	)	NN	O	)	dep	22	SENT_116	[p9l1834t2043r1883b2104],

1	271	CD	NUMBER	271	num	2	SENT_117	[p9l9t2251r144b2318],
2	patients	NNS	O	patient	nsubj	15	SENT_117	[p9l188t2250r514b2339],
3	,	,	O	,	_	0	SENT_117	[p9l188t2250r514b2339],
4	in	IN	O	in	_	0	SENT_117	[p9l555t2250r629b2318],
5	163	CD	NUMBER	163	num	6	SENT_117	[p9l676t2250r806b2319],
6	patients	NNS	O	patient	prep_in	2	SENT_117	[p9l847t2250r1150b2339],
7	the	DT	O	the	det	9	SENT_117	[p9l1188t2250r1306b2318],
8	prescribed	VBN	O	prescribe	amod	9	SENT_117	[p9l1342t2250r1752b2338],
9	dose	NN	O	dose	nsubjpass	11	SENT_117	[p9l1790t2250r1965b2318],
10	was	VBD	O	be	auxpass	11	SENT_117	[p9l2001t2272r2148b2319],
11	decreased	VBN	O	decrease	rcmod	6	SENT_117	[p9l9t2355r395b2423],
12	and	CC	O	and	_	0	SENT_117	[p9l471t2355r610b2423],
13	108	CD	NUMBER	108	num	14	SENT_117	[p9l694t2356r826b2424],
14	patients	NNS	O	patient	conj_and	6	SENT_117	[p9l904t2355r1207b2443],
15	switched	VBD	O	switch	_	0	SENT_117	[p9l1288t2355r1633b2423],
16	to	TO	O	to	_	0	SENT_117	[p9l1707t2365r1781b2423],
17	another	DT	O	another	det	18	SENT_117	[p9l1860t2355r2153b2423],
18	cholesterol	NN	O	cholesterol	prep_to	15	SENT_117	[p9l9t2463r438b2531],
19	lowering	VBG	O	lower	xcomp	15	SENT_117	[p9l474t2463r817b2551],
20	drug	NN	O	drug	dobj	19	SENT_117	[p9l855t2463r1051b2551],
21	.	.	O	.	_	0	SENT_117	[p9l855t2463r1051b2551],

1	One	CD	NUMBER	one	num	2	SENT_118	[p9l99t2569r257b2637],
2	hundred	CD	NUMBER	hundred	nsubj	8	SENT_118	[p9l288t2568r609b2637],
3	and	CC	O	and	_	0	SENT_118	[p9l641t2568r779b2637],
4	ﬁfty	JJ	O	ﬁfty	amod	5	SENT_118	[p9l810t2568r1149b2657],
5	—	NN	O	—	conj_and	2	SENT_118	[p9l810t2568r1149b2657],
6	two	CD	NUMBER	two	num	7	SENT_118	[p9l810t2568r1149b2657],
7	events	NNS	O	event	dep	5	SENT_118	[p9l1182t2579r1424b2637],
8	occurred	VBD	O	occur	_	0	SENT_118	[p9l1458t2568r1800b2637],
9	after	IN	O	after	_	0	SENT_118	[p9l1832t2568r2010b2637],
10	1st	CD	DATE	1st	prep_after	8	SENT_118	[p9l2048t2569r2152b2637],
11	January	NNP	DATE	January	tmod	8	SENT_118	[p9l7t2675r311b2761],
12	1997	CD	DATE	1997	num	11	SENT_118	[p9l357t2674r562b2754],
13	,	,	O	,	_	0	SENT_118	[p9l357t2674r562b2754],
14	the	DT	O	the	det	15	SENT_118	[p9l602t2673r719b2741],
15	date	NN	O	date	dobj	8	SENT_118	[p9l758t2673r918b2741],
16	that	WDT	O	that	dobj	21	SENT_118	[p9l955t2673r1102b2741],
17	electronic	JJ	O	electronic	amod	19	SENT_118	[p9l1138t2673r1522b2741],
18	patient	NN	O	patient	nn	19	SENT_118	[p9l1560t2673r1829b2761],
19	records	NNS	O	record	nsubjpass	21	SENT_118	[p9l1863t2673r2149b2741],
20	were	VBD	O	be	auxpass	21	SENT_118	[p9l8t2802r196b2849],
21	introduced	VBN	O	introduce	rcmod	15	SENT_118	[p9l236t2780r656b2849],
22	(	RB	O	(	dep	23	SENT_118	[p9l699t2781r943b2865],
23	Table	NNP	O	Table	dep	15	SENT_118	[p9l699t2781r943b2865],
24	2	CD	NUMBER	2	number	25	SENT_118	[p9l985t2781r1082b2865],
25	)	CD	NUMBER	)	num	23	SENT_118	[p9l985t2781r1082b2865],
26	.	.	O	.	_	0	SENT_118	[p9l985t2781r1082b2865],

1	Forty	CD	NUMBER	forty	number	2	SENT_119	[p9l1127t2782r1516b2869],
2	—	CD	NUMBER	—	amod	5	SENT_119	[p9l1127t2782r1516b2869],
3	two	CD	NUMBER	two	dep	2	SENT_119	[p9l1127t2782r1516b2869],
4	patient	NN	O	patient	nn	5	SENT_119	[p9l1556t2781r1825b2869],
5	records	NNS	O	record	nsubj	8	SENT_119	[p9l1863t2781r2149b2849],
6	were	VBD	O	be	cop	8	SENT_119	[p9l8t2908r196b2955],
7	not	RB	O	not	neg	8	SENT_119	[p9l226t2897r351b2955],
8	available	JJ	O	available	_	0	SENT_119	[p9l382t2886r750b2955],
9	.	.	O	.	_	0	SENT_119	[p9l382t2886r750b2955],

1	For	IN	O	for	_	0	SENT_120	[p9l785t2888r919b2955],
2	78	CD	NUMBER	78	num	3	SENT_120	[p9l948t2887r1040b2955],
3	cases	NNS	O	case	prep_for	17	SENT_120	[p9l1074t2908r1299b2967],
4	,	,	O	,	_	0	SENT_120	[p9l1074t2908r1299b2967],
5	the	DT	O	the	det	6	SENT_120	[p9l1332t2886r1450b2955],
6	reason	NN	O	reason	nsubjpass	17	SENT_120	[p9l1480t2908r1735b2955],
7	of	IN	O	of	_	0	SENT_120	[p9l1766t2886r1850b2955],
8	change	NN	O	change	prep_of	6	SENT_120	[p9l1875t2886r2150b2975],
9	in	IN	O	in	_	0	SENT_120	[p9l8t2992r82b3060],
10	the	DT	O	the	det	11	SENT_120	[p9l126t2993r243b3061],
11	cholesterol	NN	O	cholesterol	prep_in	8	SENT_120	[p9l289t2993r718b3061],
12	lowering	VBG	O	lower	partmod	11	SENT_120	[p9l763t2993r1107b3081],
13	medication	NN	O	medication	dobj	12	SENT_120	[p9l1152t2993r1588b3061],
14	could	MD	O	could	aux	17	SENT_120	[p9l1633t2993r1850b3061],
15	not	RB	O	not	neg	17	SENT_120	[p9l1892t3003r2017b3061],
16	be	VB	O	be	auxpass	17	SENT_120	[p9l2059t2993r2150b3061],
17	recovered	VBN	O	recover	conj_or	17	SENT_120	[p9l7t3098r412b3179],
18	,	,	O	,	_	0	SENT_120	[p9l7t3098r412b3179],
19	for	IN	O	for	_	0	SENT_120	[p9l461t3098r575b3166],
20	example	NN	O	example	prep_for	17	SENT_120	[p9l618t3098r947b3187],
21	because	IN	O	because	mark	26	SENT_120	[p9l991t3098r1300b3166],
22	a	DT	O	a	det	24	SENT_120	[p9l1348t3120r1389b3166],
23	medical	JJ	O	medical	amod	24	SENT_120	[p9l1431t3098r1741b3166],
24	specialist	NN	O	specialist	nsubj	26	SENT_120	[p9l1789t3098r2152b3187],
25	had	VBD	O	have	aux	26	SENT_120	[p9l7t3203r148b3271],
26	changed	VBN	O	change	dep	20	SENT_120	[p9l195t3203r521b3291],
27	the	DT	O	the	det	28	SENT_120	[p9l567t3203r684b3271],
28	medication	NN	O	medication	dobj	26	SENT_120	[p9l733t3203r1169b3271],
29	or	CC	O	or	_	0	SENT_120	[p9l1217t3225r1297b3271],
30	because	IN	O	because	_	0	SENT_120	[p9l1341t3203r1650b3271],
31	the	DT	O	the	det	33	SENT_120	[p9l1698t3203r1816b3271],
32	general	JJ	O	general	amod	33	SENT_120	[p9l1864t3203r2150b3291],
33	practitioner	NN	O	practitioner	prep_because	17	SENT_120	[p9l7t3310r463b3399],
34	used	VBN	O	use	partmod	33	SENT_120	[p9l489t3311r668b3379],
35	paper	NN	O	paper	nn	36	SENT_120	[p9l696t3332r915b3399],
36	ﬁles	NNS	O	ﬁles	dobj	34	SENT_120	[p9l944t3311r1101b3379],
37	at	IN	O	at	_	0	SENT_120	[p9l1135t3321r1203b3379],
38	the	DT	O	the	det	39	SENT_120	[p9l1232t3311r1349b3379],
39	time	NN	O	time	prep_at	34	SENT_120	[p9l1380t3311r1552b3379],
40	of	IN	O	of	_	0	SENT_120	[p9l1584t3310r1668b3379],
41	the	DT	O	the	det	42	SENT_120	[p9l1691t3311r1808b3379],
42	event	NN	O	event	prep_of	39	SENT_120	[p9l1840t3321r2048b3379],
43	to	TO	O	to	aux	44	SENT_120	[p9l2076t3321r2149b3379],
44	record	VB	O	record	xcomp	34	SENT_120	[p9l7t3416r258b3484],
45	this	DT	O	this	dobj	44	SENT_120	[p9l304t3416r464b3484],
46	.	.	O	.	_	0	SENT_120	[p9l304t3416r464b3484],

1	The	DT	O	the	det	2	SENT_121	[p9l517t3416r666b3484],
2	reason	NN	O	reason	nsubjpass	4	SENT_121	[p9l714t3438r969b3484],
3	was	VBD	O	be	auxpass	4	SENT_121	[p9l1018t3438r1165b3485],
4	given	VBN	O	give	_	0	SENT_121	[p9l1216t3416r1428b3505],
5	in	IN	O	in	_	0	SENT_121	[p9l1476t3416r1550b3484],
6	the	DT	O	the	det	9	SENT_121	[p9l1597t3416r1715b3484],
7	electronic	JJ	O	electronic	amod	9	SENT_121	[p9l1764t3416r2149b3484],
8	patient	NN	O	patient	nn	9	SENT_121	[p9l7t3521r276b3609],
9	records	NNS	O	record	prep_in	4	SENT_121	[p9l323t3521r609b3589],
10	in	IN	O	in	_	0	SENT_121	[p9l662t3521r736b3588],
11	32	CD	NUMBER	32	num	12	SENT_121	[p9l789t3522r880b3590],
12	cases	NNS	O	case	prep_in	9	SENT_121	[p9l933t3542r1156b3589],
13	.	.	O	.	_	0	SENT_121	[p9l933t3542r1156b3589],

1	In	IN	O	in	_	0	SENT_122	[p9l1212t3523r1291b3588],
2	17	CD	NUMBER	17	num	3	SENT_122	[p9l1351t3522r1434b3589],
3	cases	NNS	O	case	prep_in	4	SENT_122	[p9l1488t3542r1690b3589],
4	(	VBP	O	(	_	0	SENT_122	[p9l1745t3521r2006b3605],
5	53	CD	PERCENT	53	num	6	SENT_122	[p9l1745t3521r2006b3605],
6	%	NN	PERCENT	%	dobj	4	SENT_122	[p9l1745t3521r2006b3605],
7	)	CD	NUMBER	)	nsubj	4	SENT_122	[p9l1745t3521r2006b3605],
8	,	,	O	,	_	0	SENT_122	[p9l1745t3521r2006b3605],
9	an	DT	O	a	det	12	SENT_122	[p9l2062t3542r2151b3589],
10	adverse	JJ	O	adverse	amod	12	SENT_122	[p9l10t3628r304b3697],
11	drug	NN	O	drug	nn	12	SENT_122	[p9l327t3629r502b3717],
12	reaction	NN	O	reaction	appos	7	SENT_122	[p9l523t3629r840b3697],
13	was	VBD	O	be	cop	15	SENT_122	[p9l862t3650r1009b3697],
14	the	DT	O	the	det	15	SENT_122	[p9l1032t3629r1149b3697],
15	reason	NN	O	reason	rcmod	12	SENT_122	[p9l1170t3650r1425b3697],
16	for	IN	O	for	_	0	SENT_122	[p9l1447t3629r1560b3697],
17	the	DT	O	the	det	18	SENT_122	[p9l1579t3629r1697b3697],
18	decrease	NN	O	decrease	prep_for	15	SENT_122	[p9l1719t3629r2054b3697],
19	in	IN	O	in	_	0	SENT_122	[p9l2076t3629r2151b3696],
20	dose	NN	O	dose	prep_in	15	SENT_122	[p9l9t3734r185b3803],
21	or	CC	O	or	_	0	SENT_122	[p9l222t3756r302b3803],
22	switch	NN	O	switch	prep_in	15	SENT_122	[p9l339t3734r590b3803],
23	to	TO	O	to	_	0	SENT_122	[p9l625t3745r698b3803],
24	another	DT	O	another	det	25	SENT_122	[p9l737t3734r1030b3803],
25	cholesterol	NN	O	cholesterol	prep_to	15	SENT_122	[p9l1065t3734r1493b3803],
26	lowering	VBG	O	lower	partmod	25	SENT_122	[p9l1530t3734r1873b3823],
27	drugs	NNS	O	drug	dobj	26	SENT_122	[p9l1912t3734r2147b3823],
28	,	,	O	,	_	0	SENT_122	[p9l1912t3734r2147b3823],

1	and	CC	O	and	cc	5	SENT_123	[p10l10t19r148b87],
2	in	IN	O	in	_	0	SENT_123	[p10l193t19r267b86],
3	13	CD	NUMBER	13	num	4	SENT_123	[p10l322t19r403b87],
4	cases	NNS	O	case	prep_in	5	SENT_123	[p10l455t40r656b87],
5	(	VBP	O	(	_	0	SENT_123	[p10l708t19r944b103],
6	41	CD	PERCENT	41	num	7	SENT_123	[p10l708t19r944b103],
7	%	NN	PERCENT	%	dobj	5	SENT_123	[p10l708t19r944b103],
8	)	CD	NUMBER	)	nsubj	5	SENT_123	[p10l708t19r944b103],
9	the	DT	O	the	det	10	SENT_123	[p10l993t19r1110b87],
10	reason	NN	O	reason	nsubj	15	SENT_123	[p10l1156t40r1411b87],
11	was	VBD	O	be	cop	15	SENT_123	[p10l1457t40r1604b87],
12	a	DT	O	a	det	15	SENT_123	[p10l1654t40r1694b87],
13	too	RB	O	too	advmod	14	SENT_123	[p10l1739t29r1861b87],
14	strong	JJ	O	strong	amod	15	SENT_123	[p10l1911t29r2149b107],
15	reduction	NN	O	reduction	rcmod	8	SENT_123	[p10l7t124r378b192],
16	in	IN	O	in	_	0	SENT_123	[p10l443t124r517b192],
17	cholesterol	NN	O	cholesterol	nn	18	SENT_123	[p10l582t124r1011b192],
18	level	NN	O	level	prep_in	15	SENT_123	[p10l1077t124r1282b193],
19	.	.	O	.	_	0	SENT_123	[p10l1077t124r1282b193],

1	Two	CD	NUMBER	two	num	2	SENT_124	[p10l1353t126r1521b193],
2	patients	NNS	O	patient	nsubj	25	SENT_124	[p10l1586t124r1890b213],
3	(	CD	PERCENT	(	num	5	SENT_124	[p10l1960t124r2148b209],
4	6	CD	PERCENT	6	num	5	SENT_124	[p10l1960t124r2148b209],
5	%	NN	PERCENT	%	nsubj	7	SENT_124	[p10l1960t124r2148b209],
6	)	CD	NUMBER	)	dep	5	SENT_124	[p10l1960t124r2148b209],
7	switched	VBD	O	switch	rcmod	2	SENT_124	[p10l11t229r356b298],
8	to	TO	O	to	_	0	SENT_124	[p10l391t239r465b297],
9	another	DT	O	another	det	10	SENT_124	[p10l504t229r797b297],
10	cholesterol	NN	O	cholesterol	prep_to	7	SENT_124	[p10l833t229r1261b297],
11	lowering	VBG	O	lower	xcomp	7	SENT_124	[p10l1299t229r1643b317],
12	drug	NN	O	drug	dobj	11	SENT_124	[p10l1681t229r1857b317],
13	after	IN	O	after	_	0	SENT_124	[p10l1896t229r2074b297],
14	a	DT	O	a	det	16	SENT_124	[p10l2112t250r2152b297],
15	cholesterol	NN	O	cholesterol	nn	16	SENT_124	[p10l9t337r438b405],
16	measurement	NN	O	measurement	prep_after	11	SENT_124	[p10l471t347r995b405],
17	and	CC	O	and	_	0	SENT_124	[p10l1029t337r1167b405],
18	ineffective	JJ	O	ineffective	amod	20	SENT_124	[p10l1200t336r1613b405],
19	drug	NN	O	drug	nn	20	SENT_124	[p10l1648t337r1824b425],
20	therapy	NN	O	therapy	prep_after	11	SENT_124	[p10l1858t337r2150b425],
21	was	VBD	O	be	cop	25	SENT_124	[p10l8t464r156b511],
22	the	DT	O	the	det	25	SENT_124	[p10l193t442r310b510],
23	most	RBS	O	most	advmod	24	SENT_124	[p10l346t452r536b510],
24	likely	JJ	O	likely	amod	25	SENT_124	[p10l571t442r792b531],
25	reason	NN	O	reason	_	0	SENT_124	[p10l827t464r1083b510],
26	for	IN	O	for	_	0	SENT_124	[p10l1118t442r1232b510],
27	these	DT	O	these	det	28	SENT_124	[p10l1265t442r1464b510],
28	switches	NNS	O	switch	prep_for	25	SENT_124	[p10l1504t442r1856b511],
29	.	.	O	.	_	0	SENT_124	[p10l1504t442r1856b511],

1	The	DT	O	the	det	2	SENT_125	[p10l97t547r247b615],
2	risk	NN	O	risk	nsubj	13	SENT_125	[p10l272t547r419b615],
3	of	IN	O	of	_	0	SENT_125	[p10l443t547r527b615],
4	a	DT	O	a	det	6	SENT_125	[p10l547t568r588b615],
5	dose	NN	O	dose	nn	6	SENT_125	[p10l612t547r788b615],
6	decrease	NN	O	decrease	prep_of	2	SENT_125	[p10l814t547r1149b615],
7	or	CC	O	or	_	0	SENT_125	[p10l1176t568r1255b615],
8	switch	NN	O	switch	prep_of	2	SENT_125	[p10l1282t547r1533b615],
9	to	TO	O	to	_	0	SENT_125	[p10l1557t558r1630b615],
10	another	DT	O	another	det	11	SENT_125	[p10l1658t547r1951b615],
11	drug	NN	O	drug	prep_to	6	SENT_125	[p10l1974t547r2149b635],
12	was	VBD	O	be	cop	13	SENT_125	[p10l8t677r156b724],
13	smaller	JJR	O	smaller	_	0	SENT_125	[p10l184t655r470b724],
14	in	IN	O	in	_	0	SENT_125	[p10l491t655r565b723],
15	patients	NNS	O	patient	prep_in	13	SENT_125	[p10l587t655r890b744],
16	with	IN	O	with	_	0	SENT_125	[p10l916t655r1088b724],
17	the	DT	O	the	det	19	SENT_125	[p10l1110t655r1227b724],
18	G	NN	O	g	nn	19	SENT_125	[p10l1252t655r1320b724],
19	allele	NN	O	allele	prep_with	15	SENT_125	[p10l1343t655r1552b724],
20	at	IN	O	at	_	0	SENT_125	[p10l1578t665r1646b724],
21	CYP3A4	NN	O	cyp3a4	prep_at	13	SENT_125	[p10l1673t648r2150b724],
22	*	CD	NUMBER	*	num	23	SENT_125	[p10l1673t648r2150b724],
23	1B	NN	O	1b	npadvmod	24	SENT_125	[p10l1673t648r2150b724],
24	than	IN	O	than	advmod	13	SENT_125	[p10l8t761r175b830],
25	in	IN	O	in	_	0	SENT_125	[p10l209t761r283b829],
26	patients	NNS	O	patient	prep_in	13	SENT_125	[p10l316t761r619b850],
27	with	IN	O	with	_	0	SENT_125	[p10l656t761r828b830],
28	the	DT	O	the	det	33	SENT_125	[p10l861t761r978b830],
29	wild	JJ	O	wild	amod	33	SENT_125	[p10l1012t761r1385b850],
30	—	NN	O	—	nn	33	SENT_125	[p10l1012t761r1385b850],
31	type	NN	O	type	nn	33	SENT_125	[p10l1012t761r1385b850],
32	AA	NN	O	aa	nn	33	SENT_125	[p10l1420t762r1559b829],
33	genotype	NN	O	genotype	prep_with	26	SENT_125	[p10l1593t772r1950b850],
34	(	CD	NUMBER	(	num	35	SENT_125	[p10l1987t762r2151b846],
35	HR	NN	DURATION	hr	dep	43	SENT_125	[p10l1987t762r2151b846],
36	0.46	CD	NUMBER	0.46	dep	35	SENT_125	[p10l9t867r200b949],
37	;	:	O	;	_	0	SENT_125	[p10l9t867r200b949],
38	95	CD	PERCENT	95	num	39	SENT_125	[p10l266t867r540b937],
39	%	NN	PERCENT	%	dep	36	SENT_125	[p10l266t867r540b937],
40	CI	NN	O	ci	dep	43	SENT_125	[p10l266t867r540b937],
41	0.24-0	CD	NUMBER	0.24-0	num	40	SENT_125	[p10l601t868r1020b952],
42	.90	CD	NUMBER	.90	num	43	SENT_125	[p10l601t868r1020b952],
43	)	NN	O	)	dep	26	SENT_125	[p10l601t868r1020b952],
44	(	CD	NUMBER	(	num	45	SENT_125	[p10l1086t868r1330b952],
45	Table	NNP	O	Table	dep	43	SENT_125	[p10l1086t868r1330b952],
46	3	CD	NUMBER	3	num	45	SENT_125	[p10l1394t868r1458b948],
47	,	,	O	,	_	0	SENT_125	[p10l1394t868r1458b948],
48	Figure	NNP	O	Figure	appos	26	SENT_125	[p10l1521t868r1775b956],
49	1	CD	NUMBER	1	number	50	SENT_125	[p10l1846t868r1935b952],
50	)	CD	NUMBER	)	dep	48	SENT_125	[p10l1846t868r1935b952],
51	.	.	O	.	_	0	SENT_125	[p10l1846t868r1935b952],

1	The	DT	O	the	det	3	SENT_126	[p10l2000t868r2149b936],
2	hazard	NN	O	hazard	nn	3	SENT_126	[p10l7t973r269b1041],
3	ratios	NNS	O	ratio	nsubj	29	SENT_126	[p10l313t973r528b1041],
4	for	IN	O	for	_	0	SENT_126	[p10l577t973r690b1041],
5	participants	NNS	O	participant	prep_for	3	SENT_126	[p10l734t973r1190b1062],
6	using	VBG	O	use	partmod	5	SENT_126	[p10l1238t973r1447b1062],
7	simvastatin	NN	O	simvastatin	nn	9	SENT_126	[p10l1497t973r1938b1042],
8	(	CD	NUMBER	(	num	9	SENT_126	[p10l1987t974r2151b1058],
9	HR	NN	DURATION	hr	dobj	6	SENT_126	[p10l1987t974r2151b1058],
10	0.47	CD	PERCENT	0.47	num	13	SENT_126	[p10l9t1079r174b1148],
11	95	CD	PERCENT	95	number	12	SENT_126	[p10l236t1079r510b1148],
12	%	NN	PERCENT	%	amod	13	SENT_126	[p10l236t1079r510b1148],
13	CI	NN	O	ci	dep	5	SENT_126	[p10l236t1079r510b1148],
14	0.23-0	CD	NUMBER	0.23-0	number	15	SENT_126	[p10l568t1079r988b1163],
15	.96	CD	NUMBER	.96	num	16	SENT_126	[p10l568t1079r988b1163],
16	)	NN	O	)	dep	5	SENT_126	[p10l568t1079r988b1163],
17	and	CC	O	and	_	0	SENT_126	[p10l1050t1079r1188b1147],
18	atorvastatin	NN	O	atorvastatin	nn	20	SENT_126	[p10l1247t1079r1700b1148],
19	(	CD	NUMBER	(	num	20	SENT_126	[p10l1761t1080r1925b1163],
20	HR	NN	DURATION	hr	prep_for	3	SENT_126	[p10l1761t1080r1925b1163],
21	0.44	CD	PERCENT	0.44	num	24	SENT_126	[p10l1982t1079r2150b1148],
22	95	CD	PERCENT	95	number	23	SENT_126	[p10l9t1186r284b1256],
23	%	NN	PERCENT	%	amod	24	SENT_126	[p10l9t1186r284b1256],
24	CI	NN	O	ci	dep	20	SENT_126	[p10l9t1186r284b1256],
25	0.06-3	CD	NUMBER	0.06-3	num	27	SENT_126	[p10l317t1186r736b1271],
26	.22	CD	NUMBER	.22	num	27	SENT_126	[p10l317t1186r736b1271],
27	)	NN	O	)	dep	20	SENT_126	[p10l317t1186r736b1271],
28	were	VBD	O	be	cop	29	SENT_126	[p10l772t1208r959b1255],
29	similar	JJ	O	similar	_	0	SENT_126	[p10l996t1187r1282b1267],
30	,	,	O	,	_	0	SENT_126	[p10l996t1187r1282b1267],
31	although	IN	O	although	mark	38	SENT_126	[p10l1321t1187r1662b1275],
32	for	IN	O	for	_	0	SENT_126	[p10l1694t1186r1807b1255],
33	atorvastatin	NN	O	atorvastatin	prep_for	38	SENT_126	[p10l1841t1197r2148b1255, p10l8t1292r181b1361],
34	it	PRP	O	it	nsubj	38	SENT_126	[p10l242t1292r295b1361],
35	was	VBD	O	be	cop	38	SENT_126	[p10l355t1314r502b1361],
36	not	RB	O	not	neg	38	SENT_126	[p10l564t1303r689b1361],
37	statistically	RB	O	statistically	advmod	38	SENT_126	[p10l751t1292r1194b1381],
38	signiﬁcant	JJ	O	signiﬁcant	advcl	29	SENT_126	[p10l1259t1292r1683b1381],
39	.	.	O	.	_	0	SENT_126	[p10l1259t1292r1683b1381],

1	Excluding	VBG	O	exclude	_	0	SENT_127	[p10l1748t1292r2150b1381],
2	patients	NNS	O	patient	dobj	1	SENT_127	[p10l7t1397r310b1485],
3	with	IN	O	with	_	0	SENT_127	[p10l349t1397r521b1466],
4	a	DT	O	a	det	6	SENT_127	[p10l559t1418r600b1465],
5	ﬁrst	JJ	O	ﬁrst	amod	6	SENT_127	[p10l636t1397r786b1465],
6	prescription	NN	O	prescription	prep_with	2	SENT_127	[p10l820t1397r1289b1485],
7	before	IN	O	before	_	0	SENT_127	[p10l1324t1397r1574b1465],
8	1st	CD	DATE	1st	prep_before	6	SENT_127	[p10l1620t1398r1724b1465],
9	July	NNP	DATE	July	tmod	6	SENT_127	[p10l1759t1397r1920b1485],
10	1991	CD	DATE	1991	num	9	SENT_127	[p10l1966t1398r2142b1466],
11	(	CD	NUMBER	(	num	12	SENT_127	[p10l11t1505r175b1589],
12	HR	NN	DURATION	hr	dep	18	SENT_127	[p10l11t1505r175b1589],
13	0.45	CD	PERCENT	0.45	num	15	SENT_127	[p10l212t1504r376b1573],
14	95	CD	PERCENT	95	num	15	SENT_127	[p10l419t1504r693b1574],
15	%	NN	PERCENT	%	dep	12	SENT_127	[p10l419t1504r693b1574],
16	CI	NN	O	ci	dep	18	SENT_127	[p10l419t1504r693b1574],
17	0.21-0	CD	NUMBER	0.21-0	num	16	SENT_127	[p10l731t1504r1174b1589],
18	.95	CD	NUMBER	.95	dep	2	SENT_127	[p10l731t1504r1174b1589],
19	)	NN	O	)	dep	18	SENT_127	[p10l731t1504r1174b1589],
20	,	,	O	,	_	0	SENT_127	[p10l731t1504r1174b1589],
21	excluding	VBG	O	exclude	conj_or	1	SENT_127	[p10l1215t1505r1599b1593],
22	patients	NNS	O	patient	dobj	21	SENT_127	[p10l1636t1505r1939b1593],
23	with	IN	O	with	_	0	SENT_127	[p10l1979t1505r2151b1573],
24	prescriptions	NNS	O	prescription	prep_with	21	SENT_127	[p10l7t1610r512b1699],
25	for	IN	O	for	_	0	SENT_127	[p10l554t1610r667b1679],
26	other	JJ	O	other	amod	27	SENT_127	[p10l707t1610r907b1679],
27	statins	NNS	O	statin	prep_for	24	SENT_127	[p10l948t1610r1192b1679],
28	before	IN	O	before	mark	44	SENT_127	[p10l1233t1610r1482b1679],
29	start	NN	O	start	dep	41	SENT_127	[p10l1526t1621r1691b1679],
30	of	IN	O	of	_	0	SENT_127	[p10l1732t1610r1816b1679],
31	simVas	NN	O	simva	nn	33	SENT_127	[p10l1853t1610r2148b1679],
32	—	CD	NUMBER	—	num	33	SENT_127	[p10l1853t1610r2148b1679],
33	tatin	NN	O	tatin	prep_of	29	SENT_127	[p10l8t1716r182b1785],
34	or	CC	O	or	_	0	SENT_127	[p10l227t1738r307b1785],
35	atorvastatin	NN	O	atorvastatin	nn	36	SENT_127	[p10l351t1717r805b1785],
36	therapy	NN	O	therapy	conj_or	33	SENT_127	[p10l850t1717r1142b1805],
37	(	CD	NUMBER	(	num	38	SENT_127	[p10l1190t1717r1354b1801],
38	HR	NN	DURATION	hr	dep	41	SENT_127	[p10l1190t1717r1354b1801],
39	0.48	CD	PERCENT	0.48	num	41	SENT_127	[p10l1399t1717r1564b1785],
40	95	CD	PERCENT	95	num	41	SENT_127	[p10l1613t1716r1887b1786],
41	%	NN	PERCENT	%	dep	44	SENT_127	[p10l1613t1716r1887b1786],
42	CI	NN	O	ci	dep	41	SENT_127	[p10l1613t1716r1887b1786],
43	0.250.93	CD	NUMBER	0.250.93	num	44	SENT_127	[p10l1933t1716r2153b1785, p10l9t1823r207b1906],
44	)	CD	NUMBER	)	dep	24	SENT_127	[p10l1933t1716r2153b1785, p10l9t1823r207b1906],
45	or	CC	O	or	_	0	SENT_127	[p10l236t1844r316b1890],
46	censoring	VBG	O	censor	conj_or	1	SENT_127	[p10l341t1822r719b1911],
47	patients	NNS	O	patient	dobj	46	SENT_127	[p10l744t1822r1047b1911],
48	at	IN	O	at	_	0	SENT_127	[p10l1077t1832r1145b1890],
49	the	DT	O	the	det	50	SENT_127	[p10l1169t1822r1286b1890],
50	time	NN	O	time	prep_at	46	SENT_127	[p10l1313t1822r1485b1890],
51	of	IN	O	of	_	0	SENT_127	[p10l1512t1822r1597b1890],
52	a	DT	O	a	det	53	SENT_127	[p10l1618t1844r1659b1890],
53	prescription	NN	O	prescription	prep_of	50	SENT_127	[p10l1681t1822r2151b1911],

1	Copyright	NN	O	copyright	nn	5	SENT_128	[p10l9t2067r333b2139],
2	©	CD	NUMBER	©	num	5	SENT_128	[p10l366t2067r434b2136],
3	2009	CD	DATE	2009	num	5	SENT_128	[p10l469t2067r624b2124],
4	John	NNP	PERSON	John	nn	5	SENT_128	[p10l655t2067r805b2123],
5	Wiley	NNP	PERSON	Wiley	_	0	SENT_128	[p10l833t2067r1026b2139],
6	&	CC	O	&	_	0	SENT_128	[p10l1057t2067r1114b2123],
7	Sons	NNP	O	Sons	conj_and	5	SENT_128	[p10l1146t2067r1314b2133],
8	,	,	O	,	_	0	SENT_128	[p10l1146t2067r1314b2133],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_128	[p10l1345t2067r1472b2123],
10	.	.	O	.	_	0	SENT_128	[p10l1345t2067r1472b2123],

1	Table	NNP	O	Table	_	0	SENT_129	[p10l10t2151r166b2202],
2	3	CD	NUMBER	3	dep	1	SENT_129	[p10l194t2152r240b2202],
3	.	.	O	.	_	0	SENT_129	[p10l194t2152r240b2202],

1	The	DT	O	the	det	2	SENT_130	[p10l316t2152r425b2201],
2	association	NN	O	association	dep	10	SENT_130	[p10l462t2151r777b2202],
3	between	IN	O	between	_	0	SENT_130	[p10l811t2151r1048b2202],
4	the	DT	O	the	det	5	SENT_130	[p10l1083t2152r1168b2201],
5	CYP3A4	NN	O	cyp3a4	prep_between	2	SENT_130	[p10l1207t2147r1553b2202],
6	*	CD	NUMBER	*	num	7	SENT_130	[p10l1207t2147r1553b2202],
7	IB	NN	O	ib	dep	10	SENT_130	[p10l1207t2147r1553b2202],
8	A	DT	O	a	det	10	SENT_130	[p10l1587t2152r1764b2203],
9	>	JJR	O	>	amod	10	SENT_130	[p10l1587t2152r1764b2203],
10	G	NN	O	g	dep	15	SENT_130	[p10l1587t2152r1764b2203],
11	and	CC	O	and	_	0	SENT_130	[p10l1800t2152r1901b2201],
12	ABCBI	NN	O	abcbus	nn	14	SENT_130	[p10l1931t2152r2142b2202],
13	C3435T	NN	O	c3435t	nn	14	SENT_130	[p10l11t2231r242b2282],
14	polymorphisms	NNS	O	polymorphism	conj_and	10	SENT_130	[p10l281t2226r765b2297],
15	*	VBP	O	*	_	0	SENT_130	[p10l281t2226r765b2297],
16	,	,	O	,	_	0	SENT_130	[p10l281t2226r765b2297],
17	and	CC	O	and	dep	15	SENT_130	[p10l809t2232r909b2282],
18	dose	NN	O	dose	dep	15	SENT_130	[p10l950t2232r1077b2282],
19	decreases	VBZ	O	decrease	dep	18	SENT_130	[p10l1118t2232r1387b2282],
20	or	CC	O	or	_	0	SENT_130	[p10l1430t2248r1488b2282],
21	switching	VBG	O	switch	dep	18	SENT_130	[p10l1529t2232r1801b2297],
22	to	TO	O	to	_	0	SENT_130	[p10l1841t2240r1894b2282],
23	another	DT	O	another	det	24	SENT_130	[p10l1937t2232r2149b2282],
24	cholesterol	NN	O	cholesterol	prep_to	21	SENT_130	[p10l11t2311r322b2360],
25	lowering	VBG	O	lower	xcomp	21	SENT_130	[p10l347t2311r597b2375],
26	drug	NN	O	drug	dobj	25	SENT_130	[p10l624t2311r751b2375],
27	in	IN	O	in	_	0	SENT_130	[p10l777t2311r831b2360],
28	simvastatin	NN	O	simvastatin	nn	31	SENT_130	[p10l859t2311r1178b2360],
29	and	CC	O	and	_	0	SENT_130	[p10l1205t2311r1306b2360],
30	atorvastatin	NN	O	atorvastatin	conj_and	28	SENT_130	[p10l1332t2311r1660b2360],
31	users	NNS	O	user	prep_in	25	SENT_130	[p10l1686t2327r1829b2360],

1	Unadjusted	JJ	O	unadjusted	amod	2	SENT_131	[p10l807t2474r1130b2539],
2	Adjustedl	NN	O	adjustedl	_	0	SENT_131	[p10l1567t2458r1844b2539],

1	HR	NN	DURATION	hr	nn	2	SENT_132	[p10l920t2633r1018b2680],
2	HR	NN	DURATION	hr	_	0	SENT_132	[p10l1278t2633r1376b2680],
3	95	CD	PERCENT	95	num	4	SENT_132	[p10l1590t2631r1789b2681],
4	%	NN	PERCENT	%	dep	2	SENT_132	[p10l1590t2631r1789b2681],
5	CI	NN	O	ci	nn	6	SENT_132	[p10l1590t2631r1789b2681],
6	p	NN	O	p	dep	2	SENT_132	[p10l2045t2648r2084b2695],

1	CYP3A4	NN	O	cyp3a4	nn	3	SENT_133	[p10l14t2782r359b2837],
2	*	CD	NUMBER	*	num	3	SENT_133	[p10l14t2782r359b2837],
3	1B	NN	O	1b	dep	13	SENT_133	[p10l14t2782r359b2837],
4	A	DT	O	a	det	7	SENT_133	[p10l383t2787r432b2836],
5	>	JJR	O	>	amod	7	SENT_133	[p10l451t2797r495b2839],
6	G	NN	O	g	nn	7	SENT_133	[p10l512t2787r560b2837],
7	Simvastatin	NN	O	simvastatin	dep	3	SENT_133	[p10l12t2866r344b2916],
8	0.47	CD	NUMBER	0.47	num	9	SENT_133	[p10l908t2867r1028b2916],
9	0.47	CD	NUMBER	0.47	dep	7	SENT_133	[p10l1266t2867r1386b2916],
10	(	NN	O	(	dep	13	SENT_133	[p10l1526t2866r1851b2927],
11	0.23-0	CD	NUMBER	0.23-0	num	10	SENT_133	[p10l1526t2866r1851b2927],
12	.96	CD	NUMBER	.96	num	13	SENT_133	[p10l1526t2866r1851b2927],
13	)	NN	O	)	dep	31	SENT_133	[p10l1526t2866r1851b2927],
14	0.039	CD	NUMBER	0.039	num	23	SENT_133	[p10l1990t2867r2146b2917],
15	Atorvastatin	NNP	O	Atorvastatin	nn	23	SENT_133	[p10l10t2945r360b2994],
16	0.30	CD	NUMBER	0.30	num	23	SENT_133	[p10l908t2945r1029b2995],
17	0.44	CD	NUMBER	0.44	num	23	SENT_133	[p10l1266t2945r1388b2995],
18	(	NN	O	(	nn	23	SENT_133	[p10l1526t2945r1851b3006],
19	0.06-3	CD	NUMBER	0.06-3	num	23	SENT_133	[p10l1526t2945r1851b3006],
20	.23	CD	NUMBER	.23	num	23	SENT_133	[p10l1526t2945r1851b3006],
21	)	NN	O	)	nn	23	SENT_133	[p10l1526t2945r1851b3006],
22	0.42	CD	NUMBER	0.42	num	23	SENT_133	[p10l2008t2945r2129b2995],
23	Simva	NN	O	simva	rcmod	13	SENT_133	[p10l12t3024r190b3074],
24	and	CC	O	and	_	0	SENT_133	[p10l216t3024r317b3074],
25	atorvastatin	NN	O	atorvastatin	dep	31	SENT_133	[p10l343t3024r672b3074],
26	0.44	CD	NUMBER	0.44	num	25	SENT_133	[p10l908t3024r1029b3074],
27	0.46	CD	NUMBER	0.46	num	28	SENT_133	[p10l1266t3024r1387b3074],
28	(	NN	O	(	dep	25	SENT_133	[p10l1526t3025r1851b3085],
29	0.24-0	CD	NUMBER	0.24-0	num	31	SENT_133	[p10l1526t3025r1851b3085],
30	.90	CD	NUMBER	.90	num	31	SENT_133	[p10l1526t3025r1851b3085],
31	)	NN	O	)	dep	38	SENT_133	[p10l1526t3025r1851b3085],
32	0.023	CD	NUMBER	0.023	num	35	SENT_133	[p10l1990t3025r2144b3074],
33	ABCBI	NN	O	abcbus	nn	35	SENT_133	[p10l6t3103r218b3152],
34	C3435T	NN	O	c3435t	nn	35	SENT_133	[p10l249t3103r480b3152],
35	Simvastatin	NN	O	simvastatin	dep	31	SENT_133	[p10l12t3181r344b3231],
36	1.16	CD	NUMBER	1.16	number	37	SENT_133	[p10l914t3181r1029b3231],
37	1.15	CD	NUMBER	1.15	dep	35	SENT_133	[p10l1272t3181r1385b3231],
38	(	NN	O	(	dep	41	SENT_133	[p10l1526t3182r1851b3242],
39	0.93-1	CD	NUMBER	0.93-1	num	38	SENT_133	[p10l1526t3182r1851b3242],
40	.42	CD	NUMBER	.42	num	41	SENT_133	[p10l1526t3182r1851b3242],
41	)	NN	O	)	dep	56	SENT_133	[p10l1526t3182r1851b3242],
42	0.20	CD	NUMBER	0.20	num	51	SENT_133	[p10l2008t3182r2129b3231],
43	Atorvastatin	NNP	O	Atorvastatin	nn	51	SENT_133	[p10l10t3260r360b3309],
44	1.12	CD	NUMBER	1.12	num	51	SENT_133	[p10l914t3260r1029b3309],
45	1.07	CD	NUMBER	1.07	num	51	SENT_133	[p10l1272t3260r1386b3310],
46	(	NN	O	(	nn	51	SENT_133	[p10l1526t3260r1851b3321],
47	0.69-1	CD	NUMBER	0.69-1	num	51	SENT_133	[p10l1526t3260r1851b3321],
48	.67	CD	NUMBER	.67	num	51	SENT_133	[p10l1526t3260r1851b3321],
49	)	NN	O	)	nn	51	SENT_133	[p10l1526t3260r1851b3321],
50	0.76	CD	NUMBER	0.76	num	51	SENT_133	[p10l2008t3260r2129b3310],
51	Simva	NN	O	simva	rcmod	41	SENT_133	[p10l12t3339r190b3388],
52	and	CC	O	and	_	0	SENT_133	[p10l216t3339r317b3388],
53	atorvastatin	NN	O	atorvastatin	dep	56	SENT_133	[p10l343t3339r672b3388],
54	1.14	CD	NUMBER	1.14	number	55	SENT_133	[p10l914t3339r1029b3388],
55	1.14	CD	NUMBER	1.14	dep	53	SENT_133	[p10l1272t3339r1388b3388],
56	(	NN	O	(	dep	59	SENT_133	[p10l1526t3339r1851b3400],
57	0.94-1	CD	NUMBER	0.94-1	num	56	SENT_133	[p10l1526t3339r1851b3400],
58	.38	CD	NUMBER	.38	num	59	SENT_133	[p10l1526t3339r1851b3400],
59	)	NN	O	)	dep	60	SENT_133	[p10l1526t3339r1851b3400],
60	0.18	CD	NUMBER	0.18	_	0	SENT_133	[p10l2008t3339r2127b3388],

1	*	NN	O	*	nn	3	SENT_134	[p10l13t3510r282b3564],
2	AdditiVe	NN	O	additive	nn	3	SENT_134	[p10l13t3510r282b3564],
3	model	NN	O	model	_	0	SENT_134	[p10l321t3514r498b3564],
4	with	IN	O	with	_	0	SENT_134	[p10l537t3514r662b3564],
5	the	DT	O	the	det	7	SENT_134	[p10l701t3515r786b3564],
6	AA	NN	O	aa	nn	7	SENT_134	[p10l825t3515r926b3563],
7	(	NN	O	(	prep_with	3	SENT_134	[p10l967t3514r1071b3575],
8	for	IN	O	for	_	0	SENT_134	[p10l967t3514r1071b3575],
9	CYP3A4	NN	O	cyp3a4	nn	12	SENT_134	[p10l1112t3510r1479b3575],
10	*	CD	NUMBER	*	num	12	SENT_134	[p10l1112t3510r1479b3575],
11	IB	NN	O	ib	nn	12	SENT_134	[p10l1112t3510r1479b3575],
12	)	NN	O	)	prep_for	7	SENT_134	[p10l1112t3510r1479b3575],
13	and	CC	O	and	_	0	SENT_134	[p10l1521t3515r1622b3564],
14	CC	NN	O	cc	nn	15	SENT_134	[p10l1660t3515r1752b3564],
15	(	NN	O	(	conj_and	7	SENT_134	[p10l1794t3514r1898b3575],
16	for	IN	O	for	_	0	SENT_134	[p10l1794t3514r1898b3575],
17	ABCBI	NNP	O	ABCBI	nn	18	SENT_134	[p10l1931t3515r2142b3564],
18	C3435T	NN	O	c3435t	prep_for	15	SENT_134	[p10l11t3594r264b3655],
19	)	CD	NUMBER	)	num	20	SENT_134	[p10l11t3594r264b3655],
20	genotype	NN	O	genotype	dep	3	SENT_134	[p10l292t3602r550b3659],
21	as	IN	O	as	_	0	SENT_134	[p10l578t3610r632b3644],
22	reference	NN	O	reference	prep_as	20	SENT_134	[p10l659t3594r938b3644],
23	.	.	O	.	_	0	SENT_134	[p10l659t3594r938b3644],

1	‘	NN	O	‘	nsubj	9	SENT_135	[p10l12t3658r290b3739],
2	Adjusted	VBN	O	adjust	_	0	SENT_135	[p10l12t3658r290b3739],
3	for	IN	O	for	_	0	SENT_135	[p10l314t3674r397b3724],
4	age	NN	O	age	prep_for	2	SENT_135	[p10l423t3690r534b3739],
5	,	,	O	,	_	0	SENT_135	[p10l423t3690r534b3739],
6	gender	NN	O	gender	appos	4	SENT_135	[p10l563t3674r767b3739],
7	,	,	O	,	_	0	SENT_135	[p10l563t3674r767b3739],
8	and	CC	O	and	_	0	SENT_135	[p10l797t3674r897b3724],
9	starting	VBG	O	start	conj_and	2	SENT_135	[p10l924t3674r1133b3739],
10	dose	NN	O	dose	dobj	9	SENT_135	[p10l1160t3674r1302b3724],
11	.	.	O	.	_	0	SENT_135	[p10l1160t3674r1302b3724],

1	for	IN	O	for	_	0	SENT_136	[p11l11t101r124b169],
2	a	DT	O	a	det	4	SENT_136	[p11l164t122r204b169],
3	CYP3A4	NN	O	cyp3a4	nn	4	SENT_136	[p11l243t101r596b170],
4	inhibitor	NN	O	inhibitor	prep_for	18	SENT_136	[p11l636t101r974b169],
5	or	CC	O	or	_	0	SENT_136	[p11l1012t122r1092b169],
6	inducer	NN	O	inducer	nn	8	SENT_136	[p11l1129t101r1423b169],
7	(	CD	NUMBER	(	num	8	SENT_136	[p11l1463t102r1626b185],
8	HR	NN	DURATION	hr	conj_or	4	SENT_136	[p11l1463t102r1626b185],
9	0.53	CD	PERCENT	0.53	num	12	SENT_136	[p11l1665t101r1828b170],
10	95	CD	PERCENT	95	number	11	SENT_136	[p11l1874t101r2147b170],
11	%	NN	PERCENT	%	amod	12	SENT_136	[p11l1874t101r2147b170],
12	CI	NN	O	ci	dep	8	SENT_136	[p11l1874t101r2147b170],
13	0.31-0	CD	NUMBER	0.31-0	number	14	SENT_136	[p11l11t209r430b293],
14	.91	CD	NUMBER	.91	num	15	SENT_136	[p11l11t209r430b293],
15	)	NN	O	)	nsubj	18	SENT_136	[p11l11t209r430b293],
16	did	VBD	O	do	aux	18	SENT_136	[p11l461t208r584b277],
17	not	RB	O	not	neg	18	SENT_136	[p11l610t219r734b277],
18	change	VB	O	change	_	0	SENT_136	[p11l762t209r1036b297],
19	the	DT	O	the	det	20	SENT_136	[p11l1064t209r1181b277],
20	results	NNS	O	result	dobj	18	SENT_136	[p11l1208t209r1461b277],
21	substantially	RB	O	substantially	advmod	18	SENT_136	[p11l1494t209r1998b297],
22	.	.	O	.	_	0	SENT_136	[p11l1494t209r1998b297],

1	No	DT	O	no	det	2	SENT_137	[p11l2030t210r2146b277],
2	differences	NNS	O	difference	nsubjpass	7	SENT_137	[p11l12t314r441b383],
3	in	IN	O	in	_	0	SENT_137	[p11l472t314r546b382],
4	hazard	NN	O	hazard	nn	5	SENT_137	[p11l574t314r835b383],
5	ratio	NN	O	ratio	prep_in	2	SENT_137	[p11l862t314r1040b383],
6	were	VBD	O	be	auxpass	7	SENT_137	[p11l1069t336r1256b383],
7	found	VBN	O	find	_	0	SENT_137	[p11l1286t314r1512b383],
8	for	IN	O	for	prep	7	SENT_137	[p11l1541t314r1655b383],
9	the	DT	O	the	det	11	SENT_137	[p11l1681t314r1798b383],
10	C3435T	NN	O	c3435t	nn	11	SENT_137	[p11l1830t314r2147b383],
11	polymorphism	NN	O	polymorphism	dep	21	SENT_137	[p11l9t422r582b510],
12	in	IN	O	in	_	0	SENT_137	[p11l622t421r696b489],
13	the	DT	O	the	det	16	SENT_137	[p11l737t422r854b490],
14	ABCB	NN	O	abcb	nn	16	SENT_137	[p11l890t422r1181b491],
15	]	NN	O	]	nn	16	SENT_137	[p11l890t422r1181b491],
16	gene	NN	O	gene	prep_in	11	SENT_137	[p11l1231t443r1412b510],
17	(	CD	NUMBER	(	num	18	SENT_137	[p11l1458t422r1622b506],
18	HR	NN	DURATION	hr	dep	21	SENT_137	[p11l1458t422r1622b506],
19	1.14	CD	PERCENT	1.14	num	21	SENT_137	[p11l1672t422r1830b490],
20	95	CD	PERCENT	95	num	21	SENT_137	[p11l1874t421r2147b491],
21	%	NN	PERCENT	%	dep	25	SENT_137	[p11l1874t421r2147b491],
22	CI	NN	O	ci	dep	21	SENT_137	[p11l1874t421r2147b491],
23	0.94-1	CD	NUMBER	0.94-1	num	22	SENT_137	[p11l11t528r452b611],
24	.38	CD	NUMBER	.38	num	25	SENT_137	[p11l11t528r452b611],
25	)	NN	O	)	dep	8	SENT_137	[p11l11t528r452b611],
26	.	.	O	.	_	0	SENT_137	[p11l11t528r452b611],

1	The	DT	O	the	det	2	SENT_138	[p11l482t527r632b595],
2	results	NNS	O	result	nsubj	12	SENT_138	[p11l656t527r909b595],
3	for	IN	O	for	_	0	SENT_138	[p11l937t527r1050b595],
4	the	DT	O	the	det	6	SENT_138	[p11l1073t527r1190b595],
5	other	JJ	O	other	amod	6	SENT_138	[p11l1218t527r1418b595],
6	polymorphisms	NNS	O	polymorphism	prep_for	2	SENT_138	[p11l1439t527r2046b616],
7	in	IN	O	in	_	0	SENT_138	[p11l2073t527r2147b595],
8	the	DT	O	the	det	10	SENT_138	[p11l10t632r128b700],
9	ABCB1	NN	O	abcb1	nn	10	SENT_138	[p11l178t633r469b701],
10	gene	NN	O	gene	prep_in	6	SENT_138	[p11l533t653r715b720],
11	were	VBD	O	be	cop	12	SENT_138	[p11l769t653r956b700],
12	comparable	JJ	O	comparable	_	0	SENT_138	[p11l1014t632r1468b720],
13	to	TO	O	to	_	0	SENT_138	[p11l1525t642r1598b700],
14	the	DT	O	the	det	16	SENT_138	[p11l1655t632r1772b700],
15	C3435T	NN	O	c3435t	nn	16	SENT_138	[p11l1830t632r2147b701],
16	polymorphism	NN	O	polymorphism	prep_to	12	SENT_138	[p11l9t739r600b828],
17	.	.	O	.	_	0	SENT_138	[p11l9t739r600b828],

1	The	DT	O	the	det	3	SENT_139	[p11l661t740r810b808],
2	hazard	NN	O	hazard	nn	3	SENT_139	[p11l866t739r1127b808],
3	rates	NNS	O	rate	nsubj	8	SENT_139	[p11l1181t750r1363b808],
4	for	IN	O	for	_	0	SENT_139	[p11l1422t739r1535b808],
5	the	DT	O	the	det	7	SENT_139	[p11l1588t740r1705b808],
6	haplotype	NN	O	haplotype	nn	7	SENT_139	[p11l1761t740r2146b828],
7	analysis	NN	O	analysis	prep_for	3	SENT_139	[p11l13t845r323b934],
8	gave	VBD	O	give	_	0	SENT_139	[p11l376t867r556b934],
9	similar	JJ	O	similar	amod	10	SENT_139	[p11l610t845r879b913],
10	results	NNS	O	result	dobj	8	SENT_139	[p11l926t845r1179b913],
11	with	IN	O	with	_	0	SENT_139	[p11l1232t845r1403b914],
12	wider	JJR	O	wider	amod	14	SENT_139	[p11l1454t845r1676b914],
13	conﬁdence	NN	O	conﬁdence	nn	14	SENT_139	[p11l1725t845r2147b913],
14	intervals	NNS	O	interval	prep_with	8	SENT_139	[p11l11t950r342b1018],
15	due	JJ	O	due	_	0	SENT_139	[p11l382t950r519b1018],
16	to	TO	O	to	_	0	SENT_139	[p11l555t960r628b1018],
17	lower	JJR	O	lower	amod	18	SENT_139	[p11l665t950r885b1019],
18	numbers	NNS	O	number	prep_due_to	14	SENT_139	[p11l920t950r1253b1018],
19	of	IN	O	of	_	0	SENT_139	[p11l1292t950r1376b1018],
20	patients	NNS	O	patient	prep_of	18	SENT_139	[p11l1404t950r1707b1038],
21	in	IN	O	in	_	0	SENT_139	[p11l1745t950r1819b1017],
22	each	DT	O	each	prep_in	8	SENT_139	[p11l1855t950r2033b1018],
23	of	IN	O	of	_	0	SENT_139	[p11l2069t950r2153b1018],
24	the	DT	O	the	det	25	SENT_139	[p11l11t1058r128b1126],
25	subgroups	NNS	O	subgroup	prep_of	22	SENT_139	[p11l167t1058r583b1146],
26	.	.	O	.	_	0	SENT_139	[p11l167t1058r583b1146],

1	The	DT	O	the	det	3	SENT_140	[p11l100t1164r249b1233],
2	hazard	NN	O	hazard	nn	3	SENT_140	[p11l280t1164r541b1233],
3	ratio	NN	O	ratio	dep	9	SENT_140	[p11l569t1164r746b1233],
4	for	IN	O	for	_	0	SENT_140	[p11l778t1164r891b1233],
5	the	DT	O	the	det	6	SENT_140	[p11l919t1164r1036b1233],
6	C	NN	O	c	prep_for	3	SENT_140	[p11l1072t1165r1133b1233],
7	YP3A4	NN	O	yp3a4	dep	9	SENT_140	[p11l1138t1157r1480b1232],
8	*	CD	NUMBER	*	num	7	SENT_140	[p11l1138t1157r1480b1232],
9	I	PRP	O	I	dep	14	SENT_140	[p11l1138t1157r1480b1232],
10	B	NN	O	b	nn	11	SENT_140	[p11l1488t1167r1547b1232],
11	polymorphism	NN	O	polymorphism	dep	9	SENT_140	[p11l1576t1164r2149b1253],
12	was	VBD	O	be	cop	14	SENT_140	[p11l11t1292r158b1339],
13	0.33	CD	PERCENT	0.33	number	14	SENT_140	[p11l212t1271r375b1339],
14	(	CD	PERCENT	(	_	0	SENT_140	[p11l434t1270r739b1355],
15	95	CD	PERCENT	95	num	16	SENT_140	[p11l434t1270r739b1355],
16	%	NN	PERCENT	%	dep	14	SENT_140	[p11l434t1270r739b1355],
17	CI	NN	O	ci	dep	32	SENT_140	[p11l434t1270r739b1355],
18	0.12-0	CD	NUMBER	0.12-0	num	17	SENT_140	[p11l791t1271r1210b1355],
19	.89	CD	NUMBER	.89	num	20	SENT_140	[p11l791t1271r1210b1355],
20	)	NN	O	)	dep	17	SENT_140	[p11l791t1271r1210b1355],
21	for	IN	O	for	_	0	SENT_140	[p11l1263t1270r1376b1339],
22	women	NNS	O	woman	prep_for	20	SENT_140	[p11l1426t1292r1733b1352],
23	,	,	O	,	_	0	SENT_140	[p11l1426t1292r1733b1352],
24	and	CC	O	and	_	0	SENT_140	[p11l1790t1270r1928b1339],
25	0.69	CD	PERCENT	0.69	number	26	SENT_140	[p11l1979t1270r2145b1340],
26	(	CD	PERCENT	(	conj_and	20	SENT_140	[p11l14t1377r319b1462],
27	95	CD	PERCENT	95	num	28	SENT_140	[p11l14t1377r319b1462],
28	%	NN	PERCENT	%	dep	26	SENT_140	[p11l14t1377r319b1462],
29	CI	NN	O	ci	dep	32	SENT_140	[p11l14t1377r319b1462],
30	0.28-1	CD	NUMBER	0.28-1	num	29	SENT_140	[p11l354t1378r772b1461],
31	.70	CD	NUMBER	.70	num	32	SENT_140	[p11l354t1378r772b1461],
32	)	NN	O	)	dep	14	SENT_140	[p11l354t1378r772b1461],
33	for	IN	O	for	_	0	SENT_140	[p11l810t1377r923b1446],
34	men	NNS	O	man	prep_for	32	SENT_140	[p11l956t1399r1142b1446],
35	.	.	O	.	_	0	SENT_140	[p11l956t1399r1142b1446],

1	In	IN	O	in	_	0	SENT_141	[p11l1182t1379r1261b1445],
2	men	NNS	O	man	prep_in	9	SENT_141	[p11l1296t1399r1483b1458],
3	,	,	O	,	_	0	SENT_141	[p11l1296t1399r1483b1458],
4	the	DT	O	the	det	6	SENT_141	[p11l1522t1377r1639b1446],
5	hazard	NN	O	hazard	nn	6	SENT_141	[p11l1674t1377r1935b1446],
6	ratio	NN	O	ratio	nsubj	9	SENT_141	[p11l1968t1377r2146b1446],
7	did	VBD	O	do	aux	9	SENT_141	[p11l12t1483r135b1551],
8	not	RB	O	not	neg	9	SENT_141	[p11l173t1493r297b1551],
9	differ	VB	O	differ	_	0	SENT_141	[p11l337t1483r551b1551],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_141	[p11l592t1483r1071b1571],
11	from	IN	O	from	_	0	SENT_141	[p11l1112t1483r1301b1551],
12	zero	CD	NUMBER	zero	prep_from	9	SENT_141	[p11l1340t1504r1525b1551],
13	.	.	O	.	_	0	SENT_141	[p11l1340t1504r1525b1551],

1	In	IN	O	in	dep	4	SENT_142	[p11l1570t1485r1650b1550],
2	Table	NNP	O	Table	pobj	1	SENT_142	[p11l1689t1483r1902b1551],
3	4	CD	NUMBER	4	num	2	SENT_142	[p11l1942t1483r1988b1551],
4	the	DT	O	the	_	0	SENT_142	[p11l2029t1483r2146b1551],

1	In	IN	O	in	_	0	SENT_143	[p11l230t1677r338b1704],
2	;	:	O	;	_	0	SENT_143	[p11l230t1677r338b1704],

1	E	NN	O	e	_	0	SENT_144	[p11l225t1902r284b1929],

1	EImnIal	NNP	O	EImnIal	_	0	SENT_145	[p11l150t2482r188b2717],
2	:	:	O	:	_	0	SENT_145	[p11l150t2482r188b2717],
3	I.	NN	O	i.	nn	6	SENT_145	[p11l150t2482r188b2717],
4	l	NN	O	l	nn	6	SENT_145	[p11l150t2482r188b2717],
5	|	NN	O	|	nn	6	SENT_145	[p11l150t2482r188b2717],
6	n	NN	O	n	dep	1	SENT_145	[p11l150t2482r188b2717],
7	midi	JJ	O	midi	amod	9	SENT_145	[p11l150t2391r187b2466],
8	lmnn-illim	NN	O	lmnn-illim	nn	9	SENT_145	[p11l150t2144r188b2380],
9	lﬂllﬂi	NNS	O	lﬂllﬂi	dep	6	SENT_145	[p11l160t2015r188b2128],

1	5	CD	NUMBER	5	num	2	SENT_146	[p11l225t2803r284b2830],
2	E	NN	O	e	_	0	SENT_146	[p11l225t2578r284b2606],
3	E	NN	O	e	nn	4	SENT_146	[p11l225t2353r284b2380],
4	E	NN	O	e	dep	2	SENT_146	[p11l225t2128r284b2155],

1	5	CD	NUMBER	5	_	0	SENT_147	[p11l225t3028r284b3060],
2	:	:	O	:	_	0	SENT_147	[p11l225t3028r284b3060],
3	“	CD	NUMBER	“	dep	1	SENT_147	[p11l225t3028r284b3060],
4	.	.	O	.	_	0	SENT_147	[p11l1584t3055r1588b3060],

1	1	CD	NUMBER	1	num	2	SENT_148	[p11l2023t3044r2024b3060],
2	Hill	NNP	O	Hill	_	0	SENT_148	[p11l279t3071r338b3098],
3	5.5	CD	NUMBER	5.5	num	2	SENT_148	[p11l708t3071r767b3098],
4	H13	NN	O	h13	dep	2	SENT_148	[p11l1138t3071r1192b3098],
5	1	CD	NUMBER	1	num	4	SENT_148	[p11l1563t3071r1622b3098],
6	&	CC	O	&	_	0	SENT_148	[p11l1563t3071r1622b3098],
7	5	CD	NUMBER	5	num	8	SENT_148	[p11l1563t3071r1622b3098],
8	”	NN	O	”	dep	2	SENT_148	[p11l1563t3071r1622b3098],
9	511	CD	NUMBER	511	dep	2	SENT_148	[p11l1986t3071r2040b3098],

1	Fromm	NNP	PERSON	Fromm	_	0	SENT_149	[p11l993t3119r1123b3152],
2	up	IN	O	up	dep	1	SENT_149	[p11l1138t3124r1187b3162],
3	ﬂlﬂalﬂa	NN	O	ﬂlﬂalﬂa	nn	4	SENT_149	[p11l1203t3119r1342b3162],
4	}	NN	O	}	pobj	2	SENT_149	[p11l1203t3119r1342b3162],

1	Hmnm	NN	O	hmnm	_	0	SENT_150	[p11l117t3188r295b3226],
2	-:1	CD	NUMBER	-:1	num	1	SENT_150	[p11l117t3188r295b3226],
3	:	:	O	:	_	0	SENT_150	[p11l117t3188r295b3226],
4	cit	NN	O	cit	nn	6	SENT_150	[p11l306t3188r354b3226],
5	‘	CD	NUMBER	‘	num	6	SENT_150	[p11l306t3188r354b3226],
6	praizinnlm	NN	O	praizinnlm	dep	1	SENT_150	[p11l364t3188r531b3236],
7	at	IN	O	at	_	0	SENT_150	[p11l547t3193r585b3226],
8	risk	NN	O	risk	prep_at	6	SENT_150	[p11l596t3188r681b3226],
9	.	.	O	.	_	0	SENT_150	[p11l596t3188r681b3226],

1	n.	NN	O	n.	_	0	SENT_151	[p11l606t3245r714b3288],
2	=	JJ	O	=	amod	5	SENT_151	[p11l606t3245r714b3288],
3	£	CD	NUMBER	£	tmod	2	SENT_151	[p11l606t3245r714b3288],
4	L5	NN	O	l5	nn	5	SENT_151	[p11l606t3245r714b3288],
5	I	NN	O	i	dep	1	SENT_151	[p11l993t3245r1101b3288],
6	:	:	O	:	_	0	SENT_151	[p11l993t3245r1101b3288],
7	E	NN	O	e	dep	1	SENT_151	[p11l993t3245r1101b3288],
8	|	CD	NUMBER	|	num	9	SENT_151	[p11l993t3245r1101b3288],
9	4IZJ	NN	O	4izj	dep	7	SENT_151	[p11l993t3245r1101b3288],
10	!	.	O	!	_	0	SENT_151	[p11l1375t3245r1439b3288],

1	=	JJ	O	=	amod	2	SENT_152	[p11l1375t3245r1439b3288],
2	1	CD	NUMBER	1	_	0	SENT_152	[p11l1375t3245r1439b3288],
3	;	:	O	;	_	0	SENT_152	[p11l1375t3245r1439b3288],
4	,5	CD	NUMBER	,5	num	5	SENT_152	[p11l1450t3245r1482b3288],
5	n.	NN	O	n.	dep	2	SENT_152	[p11l1756t3245r1869b3288],
6	=	JJ	O	=	amod	5	SENT_152	[p11l1756t3245r1869b3288],
7	2	CD	NUMBER	2	tmod	6	SENT_152	[p11l1756t3245r1869b3288],
8	.	.	O	.	_	0	SENT_152	[p11l1756t3245r1869b3288],

1	E	NN	O	e	_	0	SENT_153	[p11l1756t3245r1869b3288],
2	}	CD	NUMBER	}	dep	1	SENT_153	[p11l1756t3245r1869b3288],
3	AG	NNP	ORGANIZATION	AG	nn	5	SENT_153	[p11l117t3309r193b3347],
4	DI	NNP	O	DI	nn	5	SENT_153	[p11l209t3320r252b3347],
5	‘	NNP	O	‘	dep	2	SENT_153	[p11l209t3320r252b3347],
6	GE	NNP	O	GE	prep	5	SENT_153	[p11l268t3309r343b3347],
7	12	CD	NUMBER	12	num	8	SENT_153	[p11l638t3309r687b3347],
8	51	CD	NUMBER	51	dep	6	SENT_153	[p11l1020t3309r1074b3347],
9	'	''	O	'	_	0	SENT_153	[p11l1020t3309r1074b3347],
10	?	.	O	?	_	0	SENT_153	[p11l1020t3309r1074b3347],

1	51	CD	NUMBER	51	num	2	SENT_154	[p11l1401t3309r1450b3347],
2	4	CD	NUMBER	4	_	0	SENT_154	[p11l1783t3309r1837b3347],
3	?	.	O	?	_	0	SENT_154	[p11l1783t3309r1837b3347],

1	mi	NN	O	mi	_	0	SENT_155	[p11l118t3367r193b3405],
2	.	.	O	.	_	0	SENT_155	[p11l118t3367r193b3405],

1	7941	CD	NUMBER	7941	num	3	SENT_156	[p11l622t3367r703b3405],
2	-	:	O	-	_	0	SENT_156	[p11l622t3367r703b3405],
3	‘	CD	NUMBER	‘	_	0	SENT_156	[p11l1004t3367r1085b3410],
4	ET	NNP	O	ET	dep	3	SENT_156	[p11l1004t3367r1085b3410],
5	-	:	O	-	_	0	SENT_156	[p11l1004t3367r1085b3410],
6	|	NN	O	|	nn	8	SENT_156	[p11l1004t3367r1085b3410],
7	'	''	O	'	_	0	SENT_156	[p11l1004t3367r1085b3410],
8	o	NN	O	o	dep	4	SENT_156	[p11l1391t3367r1471b3410],
9	w	NN	O	w	nn	12	SENT_156	[p11l1391t3367r1471b3410],
10	[	CD	NUMBER	[	num	12	SENT_156	[p11l1391t3367r1471b3410],
11	*	NN	O	*	nn	12	SENT_156	[p11l1391t3367r1471b3410],
12	w	NN	O	w	dep	8	SENT_156	[p11l1772t3367r1852b3410],
13	[	CD	NUMBER	[	num	14	SENT_156	[p11l1772t3367r1852b3410],
14	*	NN	O	*	dep	3	SENT_156	[p11l1772t3367r1852b3410],

1	Black	JJ	O	black	amod	2	SENT_157	[p11l117t3490r241b3533],
2	line	NN	O	line	_	0	SENT_157	[p11l257t3490r348b3533],
3	:	:	O	:	_	0	SENT_157	[p11l257t3490r348b3533],
4	L'	NN	O	l'	nn	7	SENT_157	[p11l365t3490r638b3533],
5	Z	NN	O	z	nn	7	SENT_157	[p11l365t3490r638b3533],
6	‘	NN	O	‘	nn	7	SENT_157	[p11l365t3490r638b3533],
7	l	NN	O	l	dep	2	SENT_157	[p11l365t3490r638b3533],
8	"	''	O	"	punct	7	SENT_157	[p11l365t3490r638b3533],
9	“	CD	NUMBER	“	dep	7	SENT_157	[p11l365t3490r638b3533],
10	F	NN	O	f	dep	7	SENT_157	[p11l365t3490r638b3533],
11	'	''	O	'	_	0	SENT_157	[p11l365t3490r638b3533],
12	.	.	O	.	_	0	SENT_157	[p11l365t3490r638b3533],

1	i	LS	O	i	_	0	SENT_158	[p11l365t3490r638b3533],
2	;	:	O	;	_	0	SENT_158	[p11l365t3490r638b3533],
3	-1	CD	NUMBER	-1	dep	1	SENT_158	[p11l365t3490r638b3533],
4	.	.	O	.	_	0	SENT_158	[p11l365t3490r638b3533],

1	-	:	O	-	_	0	SENT_159	[p11l365t3490r638b3533],
2	:	:	O	:	_	0	SENT_159	[p11l365t3490r638b3533],
3	|	CD	NUMBER	|	_	0	SENT_159	[p11l365t3490r638b3533],
4	*	CD	NUMBER	*	prep	3	SENT_159	[p11l365t3490r638b3533],
5	J'	NN	O	j'	nn	6	SENT_159	[p11l365t3490r638b3533],
6	H	NN	O	h	dep	4	SENT_159	[p11l365t3490r638b3533],
7	'	''	O	'	_	0	SENT_159	[p11l365t3490r638b3533],
8	.	.	O	.	_	0	SENT_159	[p11l654t3490r724b3528],

1	-	:	O	-	_	0	SENT_160	[p11l654t3490r724b3528],
2	hi	UH	O	hi	dep	3	SENT_160	[p11l654t3490r724b3528],
3	}	CD	NUMBER	}	_	0	SENT_160	[p11l654t3490r724b3528],
4	.	.	O	.	_	0	SENT_160	[p11l654t3490r724b3528],

1	gwenmg.-i	JJ	O	gwenmg.-i	amod	2	SENT_161	[p11l740t3501r939b3544],
2	_	NN	O	_	_	0	SENT_161	[p11l740t3501r939b3544],
3	,14	CD	NUMBER	,14	dep	2	SENT_161	[p11l740t3501r939b3544],
4	,	,	O	,	_	0	SENT_161	[p11l740t3501r939b3544],
5	=	JJ	O	=	advmod	2	SENT_161	[p11l740t3501r939b3544],
6	:	:	O	:	_	0	SENT_161	[p11l740t3501r939b3544],
7	o	NN	O	o	nn	8	SENT_161	[p11l117t3554r225b3602],
8	Z	NN	O	z	dep	2	SENT_161	[p11l117t3554r225b3602],
9	*	CD	NUMBER	*	num	10	SENT_161	[p11l117t3554r225b3602],
10	IiiJ1	NN	O	iiij1	dep	8	SENT_161	[p11l241t3554r317b3592],
11	;	:	O	;	_	0	SENT_161	[p11l241t3554r317b3592],
12	D	NN	O	d	dep	2	SENT_161	[p11l241t3554r317b3592],
13	:	:	O	:	_	0	SENT_161	[p11l241t3554r317b3592],
14	E'fF	NN	O	e'ff	dep	12	SENT_161	[p11l332t3554r515b3591],
15	3	CD	NUMBER	3	num	14	SENT_161	[p11l332t3554r515b3591],
16	.	.	O	.	_	0	SENT_161	[p11l332t3554r515b3591],

1	+	CC	O	+	nsubj	3	SENT_162	[p11l332t3554r515b3591],
2	H	NN	O	h	dep	3	SENT_162	[p11l332t3554r515b3591],
3	"	''	O	"	_	0	SENT_162	[p11l525t3554r606b3591],
4	'	''	O	'	_	0	SENT_162	[p11l525t3554r606b3591],
5	:	:	O	:	_	0	SENT_162	[p11l525t3554r606b3591],
6	.	.	O	.	_	0	SENT_162	[p11l525t3554r606b3591],

1	!	.	O	!	_	0	SENT_163	[p11l525t3554r606b3591],
2	'	''	O	'	_	0	SENT_163	[p11l525t3554r606b3591],

1	H	NN	O	h	_	0	SENT_164	[p11l525t3554r606b3591],
2	AG	NNP	O	AG	nn	4	SENT_164	[p11l617t3554r692b3591],
3	ctr	NN	O	ctr	nn	4	SENT_164	[p11l708t3565r756b3591],
4	13-E	NN	O	13-e	dep	1	SENT_164	[p11l767t3554r843b3591],
5	‘	CD	NUMBER	‘	dep	4	SENT_164	[p11l767t3554r843b3591],
6	:	:	O	:	_	0	SENT_164	[p11l767t3554r843b3591],
7	gill	NN	O	gill	dep	5	SENT_164	[p11l858t3559r1058b3602],
8	-	:	O	-	_	0	SENT_164	[p11l858t3559r1058b3602],
9	!	.	O	!	_	0	SENT_164	[p11l858t3559r1058b3602],

1	:	:	O	:	_	0	SENT_165	[p11l858t3559r1058b3602],
2	F	NN	O	f	nn	3	SENT_165	[p11l858t3559r1058b3602],
3	|	NN	O	|	_	0	SENT_165	[p11l858t3559r1058b3602],
4	.	.	O	.	_	0	SENT_165	[p11l858t3559r1058b3602],
5	'	''	O	'	_	0	SENT_165	[p11l858t3559r1058b3602],

1	_	NN	O	_	nn	3	SENT_166	[p11l858t3559r1058b3602],
2	*	CD	NUMBER	*	num	3	SENT_166	[p11l858t3559r1058b3602],
3	g	NN	O	g	_	0	SENT_166	[p11l858t3559r1058b3602],
4	*	CD	NUMBER	*	num	5	SENT_166	[p11l858t3559r1058b3602],
5	]	NN	O	]	dep	3	SENT_166	[p11l858t3559r1058b3602],
6	1	CD	NUMBER	1	number	7	SENT_166	[p11l858t3559r1058b3602],
7	‘	CD	NUMBER	‘	dep	8	SENT_166	[p11l858t3559r1058b3602],
8	Il	NN	O	il	dep	5	SENT_166	[p11l858t3559r1058b3602],
9	:	:	O	:	_	0	SENT_166	[p11l858t3559r1058b3602],

1	Figure	NNP	O	Figure	_	0	SENT_167	[p12l10t49r194b113],
2	1	CD	NUMBER	1	dep	1	SENT_167	[p12l227t50r268b99],
3	.	.	O	.	_	0	SENT_167	[p12l227t50r268b99],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_168	[p12l345t49r744b113],
2	.	.	O	.	_	0	SENT_168	[p12l345t49r744b113],

1	—	NN	O	—	_	0	SENT_169	[p12l345t49r744b113],
2	.	.	O	.	_	0	SENT_169	[p12l345t49r744b113],

1	Meier	NNP	PERSON	Meier	nsubj	2	SENT_170	[p12l345t49r744b113],
2	curve	NN	O	curve	_	0	SENT_170	[p12l817t65r972b99],
3	for	IN	O	for	_	0	SENT_170	[p12l1047t49r1130b99],
4	the	DT	O	the	det	5	SENT_170	[p12l1202t49r1287b99],
5	association	NN	O	association	prep_for	2	SENT_170	[p12l1364t49r1678b99],
6	between	IN	O	between	_	0	SENT_170	[p12l1751t49r1988b99],
7	the	DT	O	the	det	12	SENT_170	[p12l2062t49r2147b99],
8	CYP3A4	NN	O	cyp3a4	nn	12	SENT_170	[p12l14t123r359b179],
9	*	CD	NUMBER	*	num	12	SENT_170	[p12l14t123r359b179],
10	]	NN	O	]	nn	12	SENT_170	[p12l14t123r359b179],
11	B	NN	O	b	nn	12	SENT_170	[p12l14t123r359b179],
12	A	NN	O	a	prep_between	5	SENT_170	[p12l396t129r574b180],
13	>	JJR	O	>	amod	15	SENT_170	[p12l396t129r574b180],
14	G	NN	O	g	nn	15	SENT_170	[p12l396t129r574b180],
15	polymorphism	NN	O	polymorphism	dep	12	SENT_170	[p12l611t128r1027b193],
16	and	CC	O	and	_	0	SENT_170	[p12l1066t128r1167b178],
17	dose	NN	O	dose	conj_and	12	SENT_170	[p12l1205t128r1333b178],
18	decreases	VBZ	O	decrease	dep	17	SENT_170	[p12l1373t128r1642b178],
19	or	CC	O	or	_	0	SENT_170	[p12l1684t144r1742b178],
20	switching	VBG	O	switch	conj_or	18	SENT_170	[p12l1782t128r2054b193],
21	to	TO	O	to	_	0	SENT_170	[p12l2094t136r2147b178],
22	another	DT	O	another	det	23	SENT_170	[p12l12t208r224b257],
23	cholesterol	NN	O	cholesterol	prep_to	20	SENT_170	[p12l253t208r564b257],
24	lowering	VBG	O	lower	xcomp	20	SENT_170	[p12l593t208r843b272],
25	drug	NN	O	drug	dobj	24	SENT_170	[p12l873t208r1000b272],
26	during	IN	O	during	_	0	SENT_170	[p12l1032t208r1215b272],
27	the	DT	O	the	det	28	SENT_170	[p12l1244t208r1329b257],
28	ﬁrst	NN	O	ﬁrst	prep_during	24	SENT_170	[p12l1361t207r1468b257],
29	2	CD	DURATION	2	num	30	SENT_170	[p12l1498t208r1530b256],
30	years	NNS	NUMBER	year	tmod	28	SENT_170	[p12l1560t223r1708b272],
31	of	IN	O	of	_	0	SENT_170	[p12l1740t208r1801b257],
32	simvastatin	NN	O	simvastatin	nn	35	SENT_170	[p12l1828t208r2148b257],
33	and	CC	O	and	_	0	SENT_170	[p12l12t286r112b335],
34	atorvastatin	NN	O	atorvastatin	conj_and	32	SENT_170	[p12l139t286r467b335],
35	therapy	NN	O	therapy	prep_of	28	SENT_170	[p12l493t286r705b350],

1	Pharmacoepidemiology	NNP	O	Pharmacoepidemiology	nn	4	SENT_171	[p12l234t512r1000b583],
2	and	CC	O	and	_	0	SENT_171	[p12l1030t512r1151b568],
3	Drug	NNP	O	Drug	nn	4	SENT_171	[p12l1175t514r1342b583],
4	Safety	NNP	O	Safety	_	0	SENT_171	[p12l1372t512r1579b584],
5	,	,	O	,	_	0	SENT_171	[p12l1372t512r1579b584],
6	2010	CD	DATE	2010	appos	4	SENT_171	[p12l1611t512r1787b578],
7	;	:	O	;	_	0	SENT_171	[p12l1611t512r1787b578],
8	19	CD	NUMBER	19	dep	4	SENT_171	[p12l1823t511r1915b568],
9	:	:	O	:	_	0	SENT_171	[p12l1823t511r1915b568],
10	75-81	CD	NUMBER	75-81	num	11	SENT_171	[p12l1950t512r2140b568],
11	DOI	NNP	O	DOI	dep	8	SENT_171	[p12l1564t600r1721b656],
12	:	:	O	:	_	0	SENT_171	[p12l1564t600r1721b656],
13	10.1002	CD	NUMBER	10.1002	dep	11	SENT_171	[p12l1763t600r2146b672],
14	/	:	O	/	punct	11	SENT_171	[p12l1763t600r2146b672],
15	pds	NNS	O	pd	dep	8	SENT_171	[p12l1763t600r2146b672],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_172	[p12l416t753r527b781],
2	,	,	O	,	_	0	SENT_172	[p12l416t753r527b781],
3	ABCBl	NN	O	abcbl	appos	1	SENT_172	[p12l542t753r641b781],
4	,	,	O	,	_	0	SENT_172	[p12l542t753r641b781],
5	AND	CC	O	and	_	0	SENT_172	[p12l657t756r719b776],
6	STATIN	JJ	O	statin	amod	7	SENT_172	[p12l734t755r837b776],
7	THERAPY	NN	O	therapy	conj_and	1	SENT_172	[p12l851t756r984b776],
8	79	CD	NUMBER	79	dep	1	SENT_172	[p12l1705t747r1744b776],

1	Table	NNP	O	Table	_	0	SENT_173	[p12l12t880r168b930],
2	4	CD	NUMBER	4	dep	1	SENT_173	[p12l194t880r242b930],
3	.	.	O	.	_	0	SENT_173	[p12l194t880r242b930],

1	Association	NNP	O	Association	dep	10	SENT_174	[p12l319t879r654b930],
2	between	IN	O	between	_	0	SENT_174	[p12l671t880r909b930],
3	the	DT	O	the	det	4	SENT_174	[p12l926t880r1011b930],
4	CYP3A4	NN	O	cyp3a4	prep_between	1	SENT_174	[p12l1034t875r1380b930],
5	*	CD	NUMBER	*	num	6	SENT_174	[p12l1034t875r1380b930],
6	1B	NN	O	1b	dep	10	SENT_174	[p12l1034t875r1380b930],
7	A	DT	O	a	det	10	SENT_174	[p12l1396t880r1446b929],
8	>	JJR	O	>	amod	10	SENT_174	[p12l1465t890r1508b932],
9	G	NN	O	g	nn	10	SENT_174	[p12l1525t880r1574b930],
10	polymorphism	NN	O	polymorphism	dep	14	SENT_174	[p12l1591t875r2030b944],
11	*	NN	O	*	dep	10	SENT_174	[p12l1591t875r2030b944],
12	and	CC	O	and	_	0	SENT_174	[p12l2052t880r2153b930],
13	dose	NN	O	dose	dep	10	SENT_174	[p12l13t960r140b1010],
14	decreases	VBZ	O	decrease	_	0	SENT_174	[p12l185t960r456b1010],
15	or	CC	O	or	_	0	SENT_174	[p12l502t975r560b1010],
16	switching	VBG	O	switch	conj_or	14	SENT_174	[p12l604t960r877b1025],
17	to	TO	O	to	_	0	SENT_174	[p12l921t968r974b1010],
18	another	DT	O	another	det	19	SENT_174	[p12l1021t960r1234b1010],
19	cholesterol	NN	O	cholesterol	prep_to	16	SENT_174	[p12l1276t960r1588b1010],
20	lowering	VBG	O	lower	partmod	19	SENT_174	[p12l1631t960r1881b1025],
21	drug	NN	O	drug	dobj	20	SENT_174	[p12l1927t960r2054b1025],
22	in	IN	O	in	_	0	SENT_174	[p12l2098t960r2153b1009],
23	simvastatin	NN	O	simvastatin	nn	26	SENT_174	[p12l14t1039r335b1089],
24	and	CC	O	and	_	0	SENT_174	[p12l358t1039r459b1089],
25	atorvastatin	NN	O	atorvastatin	nn	26	SENT_174	[p12l482t1039r811b1090],
26	users	NNS	O	user	prep_in	20	SENT_174	[p12l834t1055r993b1099],
27	,	,	O	,	_	0	SENT_174	[p12l834t1055r993b1099],
28	stratiﬁed	VBN	O	stratiﬁed	partmod	26	SENT_174	[p12l1021t1039r1268b1089],
29	for	IN	O	for	_	0	SENT_174	[p12l1290t1039r1372b1089],
30	the	DT	O	the	det	33	SENT_174	[p12l1394t1039r1479b1089],
31	ABCBI	NNP	O	ABCBI	nn	33	SENT_174	[p12l1498t1040r1710b1090],
32	C3435T	NN	O	c3435t	nn	33	SENT_174	[p12l1739t1039r1969b1090],
33	genotype	NN	O	genotype	prep_for	28	SENT_174	[p12l1993t1055r2151b1104, p12l12t1127r133b1184],

1	CYP3A4	NN	O	cyp3a4	nn	3	SENT_175	[p12l16t1280r361b1335],
2	*	CD	NUMBER	*	num	3	SENT_175	[p12l16t1280r361b1335],
3	IB	NN	O	ib	_	0	SENT_175	[p12l16t1280r361b1335],
4	A	DT	O	a	det	6	SENT_175	[p12l385t1285r539b1337],
5	>	JJR	O	>	amod	6	SENT_175	[p12l385t1285r539b1337],
6	G	NN	O	g	dep	3	SENT_175	[p12l385t1285r539b1337],
7	Unadjusted	JJ	O	unadjusted	amod	8	SENT_175	[p12l799t1285r1123b1350],
8	Adjustedl	NN	O	adjustedl	dep	3	SENT_175	[p12l1561t1268r1839b1350],

1	HR	NN	DURATION	hr	nn	2	SENT_176	[p12l912t1443r1010b1491],
2	HR	NN	DURATION	hr	_	0	SENT_176	[p12l1263t1443r1360b1491],
3	95	CD	PERCENT	95	num	4	SENT_176	[p12l1584t1442r1783b1492],
4	%	NN	PERCENT	%	dep	2	SENT_176	[p12l1584t1442r1783b1492],
5	CI	NN	O	ci	nn	6	SENT_176	[p12l1584t1442r1783b1492],
6	p	NN	O	p	dep	2	SENT_176	[p12l2050t1459r2089b1505],

1	ABCBI	NN	O	abcbus	nn	2	SENT_177	[p12l7t1598r220b1647],
2	3435CC	NN	O	3435cc	dep	10	SENT_177	[p12l252t1597r485b1647],
3	1.15	CD	NUMBER	1.15	number	4	SENT_177	[p12l906t1597r1019b1647],
4	0.89	CD	NUMBER	0.89	num	5	SENT_177	[p12l1251t1598r1371b1648],
5	(	NN	O	(	dep	2	SENT_177	[p12l1520t1597r1846b1658],
6	0.2	CD	NUMBER	0.2	num	7	SENT_177	[p12l1520t1597r1846b1658],
7	l	NN	O	l	tmod	5	SENT_177	[p12l1520t1597r1846b1658],
8	—	CD	NUMBER	—	dep	10	SENT_177	[p12l1520t1597r1846b1658],
9	3.69	CD	NUMBER	3.69	num	10	SENT_177	[p12l1520t1597r1846b1658],
10	)	NN	O	)	dep	16	SENT_177	[p12l1520t1597r1846b1658],
11	0.87	CD	NUMBER	0.87	num	13	SENT_177	[p12l2012t1598r2133b1647],
12	ABCBI	NN	O	abcbus	nn	13	SENT_177	[p12l7t1676r220b1726],
13	3435CT	NN	O	3435ct	dep	10	SENT_177	[p12l252t1676r482b1726],
14	0.53	CD	NUMBER	0.53	number	15	SENT_177	[p12l899t1676r1018b1726],
15	0.55	CD	NUMBER	0.55	dep	13	SENT_177	[p12l1251t1676r1370b1726],
16	(	NN	O	(	dep	19	SENT_177	[p12l1520t1676r1846b1737],
17	0.24	CD	NUMBER	0.24	num	16	SENT_177	[p12l1520t1676r1846b1737],
18	—	CD	NUMBER	—	num	19	SENT_177	[p12l1520t1676r1846b1737],
19	l.	NN	O	l.	dep	24	SENT_177	[p12l1520t1676r1846b1737],
20	24	CD	NUMBER	24	number	21	SENT_177	[p12l1520t1676r1846b1737],
21	)	CD	NUMBER	)	dep	19	SENT_177	[p12l1520t1676r1846b1737],
22	0.15	CD	NUMBER	0.15	num	23	SENT_177	[p12l2012t1676r2132b1726],
23	ABCBI	NN	O	abcbus	dep	21	SENT_177	[p12l7t1755r220b1805],
24	3435TT	NN	O	3435tt	dep	26	SENT_177	[p12l252t1755r479b1805],
25	0.13	CD	NUMBER	0.13	num	24	SENT_177	[p12l899t1755r1018b1805],
26	0.15	CD	NUMBER	0.15	dep	27	SENT_177	[p12l1251t1755r1370b1805],
27	(	NN	O	(	dep	30	SENT_177	[p12l1502t1755r1864b1816],
28	0.021	CD	NUMBER	0.021	num	27	SENT_177	[p12l1502t1755r1864b1816],
29	—	CD	NUMBER	—	number	30	SENT_177	[p12l1502t1755r1864b1816],
30	1.09	CD	NUMBER	1.09	dep	41	SENT_177	[p12l1502t1755r1864b1816],
31	)	NN	O	)	nn	34	SENT_177	[p12l1502t1755r1864b1816],
32	0.061	CD	NUMBER	0.061	num	34	SENT_177	[p12l1995t1755r2146b1805],
33	ABCBI	NN	O	abcbus	nn	34	SENT_177	[p12l7t1834r220b1884],
34	3435CT	NN	O	3435ct	dep	30	SENT_177	[p12l252t1834r482b1883],
35	or	CC	O	or	_	0	SENT_177	[p12l503t1850r561b1883],
36	TT	NN	O	tt	conj_or	30	SENT_177	[p12l585t1835r671b1883],
37	0.37	CD	NUMBER	0.37	num	36	SENT_177	[p12l899t1834r1020b1883],
38	0.39	CD	NUMBER	0.39	num	39	SENT_177	[p12l1251t1834r1371b1884],
39	(	NN	O	(	dep	36	SENT_177	[p12l1520t1834r1846b1895],
40	0.19	CD	NUMBER	0.19	num	41	SENT_177	[p12l1520t1834r1846b1895],
41	—	CD	NUMBER	—	dep	44	SENT_177	[p12l1520t1834r1846b1895],
42	0.84	CD	NUMBER	0.84	num	43	SENT_177	[p12l1520t1834r1846b1895],
43	)	NN	O	)	dep	41	SENT_177	[p12l1520t1834r1846b1895],
44	0.016	CD	NUMBER	0.016	_	0	SENT_177	[p12l1995t1834r2152b1883],

1	*	NN	O	*	nn	3	SENT_178	[p12l14t2005r284b2060],
2	AdditiVe	NN	O	additive	nn	3	SENT_178	[p12l14t2005r284b2060],
3	model	NN	O	model	_	0	SENT_178	[p12l310t2010r487b2060],
4	with	IN	O	with	_	0	SENT_178	[p12l513t2010r638b2060],
5	the	DT	O	the	det	7	SENT_178	[p12l663t2010r748b2060],
6	AA	NNP	O	AA	nn	7	SENT_178	[p12l775t2010r876b2059],
7	genotype	NN	O	genotype	prep_with	3	SENT_178	[p12l902t2018r1161b2074],
8	as	IN	O	as	_	0	SENT_178	[p12l1188t2026r1242b2060],
9	reference	NN	O	reference	prep_as	3	SENT_178	[p12l1269t2010r1549b2060],
10	.	.	O	.	_	0	SENT_178	[p12l1269t2010r1549b2060],

1	lAdjusted	VBN	O	ladjust	_	0	SENT_179	[p12l14t2073r292b2154],
2	for	IN	O	for	_	0	SENT_179	[p12l317t2090r400b2139],
3	age	NN	O	age	prep_for	1	SENT_179	[p12l425t2106r536b2154],
4	,	,	O	,	_	0	SENT_179	[p12l425t2106r536b2154],
5	gender	NN	O	gender	appos	3	SENT_179	[p12l565t2090r770b2154],
6	,	,	O	,	_	0	SENT_179	[p12l565t2090r770b2154],
7	and	CC	O	and	_	0	SENT_179	[p12l800t2089r900b2139],
8	starting	VBG	O	start	conj_and	1	SENT_179	[p12l927t2090r1137b2154],
9	dose	NN	O	dose	dobj	8	SENT_179	[p12l1164t2090r1306b2139],
10	.	.	O	.	_	0	SENT_179	[p12l1164t2090r1306b2139],

1	association	NN	O	association	nsubjpass	13	SENT_180	[p12l15t2296r447b2365],
2	between	IN	O	between	_	0	SENT_180	[p12l502t2296r829b2365],
3	CYP3A4	NN	O	cyp3a4	nn	6	SENT_180	[p12l891t2289r1366b2366],
4	*	CD	NUMBER	*	num	6	SENT_180	[p12l891t2289r1366b2366],
5	1B	NN	O	1b	nn	6	SENT_180	[p12l891t2289r1366b2366],
6	genotype	NN	O	genotype	prep_between	1	SENT_180	[p12l1425t2307r1781b2385],
7	and	CC	O	and	_	0	SENT_180	[p12l1840t2296r1978b2365],
8	the	DT	O	the	det	9	SENT_180	[p12l2034t2296r2151b2365],
9	occurrence	NN	O	occurrence	nsubjpass	13	SENT_180	[p12l14t2425r441b2472],
10	of	IN	O	of	_	0	SENT_180	[p12l509t2403r593b2472],
11	events	NNS	O	event	prep_of	9	SENT_180	[p12l653t2414r895b2472],
12	is	VBZ	O	be	auxpass	13	SENT_180	[p12l963t2404r1024b2472],
13	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_180	[p12l1095t2403r1434b2472],
14	for	IN	O	for	_	0	SENT_180	[p12l1499t2403r1612b2472],
15	the	DT	O	the	det	18	SENT_180	[p12l1676t2404r1793b2472],
16	ABCBI	NNP	O	ABCBI	nn	18	SENT_180	[p12l1853t2404r2144b2473],
17	C3435T	NN	O	c3435t	nn	18	SENT_180	[p12l14t2510r332b2579],
18	genotype	NN	O	genotype	prep_for	13	SENT_180	[p12l374t2521r730b2599],
19	to	TO	O	to	aux	20	SENT_180	[p12l772t2521r845b2579],
20	analyze	VB	O	analyze	xcomp	13	SENT_180	[p12l890t2510r1185b2599],
21	possible	JJ	O	possible	amod	22	SENT_180	[p12l1226t2510r1546b2599],
22	interaction	NN	O	interaction	dobj	20	SENT_180	[p12l1588t2510r2026b2579],
23	.	.	O	.	_	0	SENT_180	[p12l1588t2510r2026b2579],

1	In	IN	O	in	dep	102	SENT_181	[p12l2073t2512r2152b2578],
2	patients	NNS	O	patient	dep	102	SENT_181	[p12l11t2615r314b2703],
3	with	IN	O	with	dep	102	SENT_181	[p12l357t2615r529b2684],
4	the	DT	O	the	dep	102	SENT_181	[p12l569t2615r686b2683],
5	3435CC	NN	O	3435cc	dep	102	SENT_181	[p12l730t2615r1050b2684],
6	genotype	NN	O	genotype	dep	102	SENT_181	[p12l1094t2625r1471b2703],
7	,	,	O	,	_	0	SENT_181	[p12l1094t2625r1471b2703],
8	the	DT	O	the	dep	102	SENT_181	[p12l1515t2615r1632b2683],
9	hazard	NN	O	hazard	dep	102	SENT_181	[p12l1673t2615r1934b2683],
10	ratio	NN	O	ratio	dep	102	SENT_181	[p12l1972t2615r2151b2683],
11	comparing	VBG	O	compare	dep	102	SENT_181	[p12l13t2723r430b2812],
12	the	DT	O	the	dep	102	SENT_181	[p12l462t2723r579b2792],
13	CYP3A4	NN	O	cyp3a4	dep	102	SENT_181	[p12l612t2716r1113b2792],
14	*	CD	NUMBER	*	dep	102	SENT_181	[p12l612t2716r1113b2792],
15	1B	NN	O	1b	dep	102	SENT_181	[p12l612t2716r1113b2792],
16	AG	NNP	O	AG	dep	102	SENT_181	[p12l1146t2723r1282b2792],
17	or	CC	O	or	dep	102	SENT_181	[p12l1314t2745r1394b2792],
18	GG	NNS	O	gg	dep	102	SENT_181	[p12l1425t2723r1562b2792],
19	genotype	NN	O	genotype	dep	102	SENT_181	[p12l1594t2733r1950b2812],
20	with	IN	O	with	dep	102	SENT_181	[p12l1981t2723r2153b2792],
21	the	DT	O	the	dep	102	SENT_181	[p12l12t2830r130b2898],
22	wild	JJ	O	wild	dep	102	SENT_181	[p12l179t2830r351b2899],
23	type	NN	O	type	dep	102	SENT_181	[p12l400t2840r566b2919],
24	CYP3A4	NN	O	cyp3a4	dep	102	SENT_181	[p12l618t2823r1119b2899],
25	*	CD	NUMBER	*	dep	102	SENT_181	[p12l618t2823r1119b2899],
26	1B	NN	O	1b	dep	102	SENT_181	[p12l618t2823r1119b2899],
27	AA	NN	O	aa	dep	102	SENT_181	[p12l1171t2830r1310b2898],
28	genotype	NN	O	genotype	dep	102	SENT_181	[p12l1361t2840r1717b2919],
29	(	CD	NUMBER	(	dep	102	SENT_181	[p12l1770t2831r1934b2915],
30	HR	NN	DURATION	hr	dep	102	SENT_181	[p12l1770t2831r1934b2915],
31	0.89	CD	PERCENT	0.89	dep	102	SENT_181	[p12l1984t2830r2150b2900],
32	95	CD	PERCENT	95	dep	102	SENT_181	[p12l14t2936r103b3006],
33	%	NN	PERCENT	%	dep	102	SENT_181	[p12l115t2937r288b3005],
34	CI	NN	O	ci	dep	102	SENT_181	[p12l115t2937r288b3005],
35	0.21-3	CD	NUMBER	0.21-3	dep	102	SENT_181	[p12l310t2936r729b3021],
36	.69	CD	NUMBER	.69	dep	102	SENT_181	[p12l310t2936r729b3021],
37	)	NN	O	)	dep	102	SENT_181	[p12l310t2936r729b3021],
38	was	VBD	O	be	dep	102	SENT_181	[p12l753t2958r900b3005],
39	smaller	JJR	O	smaller	dep	102	SENT_181	[p12l927t2937r1212b3005],
40	than	IN	O	than	dep	102	SENT_181	[p12l1232t2937r1399b3005],
41	in	IN	O	in	dep	102	SENT_181	[p12l1421t2937r1495b3004],
42	patients	NNS	O	patient	dep	102	SENT_181	[p12l1514t2937r1817b3025],
43	with	IN	O	with	dep	102	SENT_181	[p12l1841t2937r2013b3005],
44	the	DT	O	the	dep	102	SENT_181	[p12l2034t2937r2151b3005],
45	3435CT	NN	O	3435ct	dep	102	SENT_181	[p12l15t3042r332b3111],
46	(	CD	NUMBER	(	dep	102	SENT_181	[p12l401t3043r564b3127],
47	HR	NN	DURATION	hr	dep	102	SENT_181	[p12l401t3043r564b3127],
48	0.55	CD	PERCENT	0.55	dep	102	SENT_181	[p12l630t3042r794b3111],
49	95	CD	PERCENT	95	dep	102	SENT_181	[p12l865t3042r1139b3112],
50	%	NN	PERCENT	%	dep	102	SENT_181	[p12l865t3042r1139b3112],
51	CI	NN	O	ci	dep	102	SENT_181	[p12l865t3042r1139b3112],
52	0.24-1	CD	NUMBER	0.24-1	dep	102	SENT_181	[p12l1206t3043r1625b3126],
53	.24	CD	NUMBER	.24	dep	102	SENT_181	[p12l1206t3043r1625b3126],
54	)	NN	O	)	dep	102	SENT_181	[p12l1206t3043r1625b3126],
55	or	CC	O	or	dep	102	SENT_181	[p12l1695t3064r1774b3111],
56	3435TT	NN	O	3435tt	dep	102	SENT_181	[p12l1841t3042r2152b3111],
57	genotype	NN	O	genotype	dep	102	SENT_181	[p12l14t3158r370b3236],
58	(	CD	NUMBER	(	dep	102	SENT_181	[p12l397t3149r561b3232],
59	HR	NN	DURATION	hr	dep	102	SENT_181	[p12l397t3149r561b3232],
60	0.15	CD	PERCENT	0.15	dep	102	SENT_181	[p12l585t3148r749b3217],
61	95	CD	PERCENT	95	dep	102	SENT_181	[p12l778t3148r867b3217],
62	%	NN	PERCENT	%	dep	102	SENT_181	[p12l879t3148r1052b3217],
63	CI	NN	O	ci	dep	102	SENT_181	[p12l879t3148r1052b3217],
64	0.021	CD	NUMBER	0.021	dep	102	SENT_181	[p12l1076t3149r1544b3232],
65	—	CD	NUMBER	—	dep	102	SENT_181	[p12l1076t3149r1544b3232],
66	1.09	CD	NUMBER	1.09	dep	102	SENT_181	[p12l1076t3149r1544b3232],
67	)	CD	NUMBER	)	dep	102	SENT_181	[p12l1076t3149r1544b3232],
68	Combining	VBG	O	combine	dep	102	SENT_181	[p12l1572t3148r2010b3236],
69	the	DT	O	the	dep	102	SENT_181	[p12l2034t3148r2151b3216],
70	3435CT	NN	O	3435ct	dep	102	SENT_181	[p12l15t3255r332b3324],
71	and	CC	O	and	dep	102	SENT_181	[p12l413t3256r551b3324],
72	TT	NN	O	tt	dep	102	SENT_181	[p12l637t3257r755b3323],
73	genotypes	NNS	O	genotype	dep	102	SENT_181	[p12l843t3266r1259b3344],
74	,	,	O	,	_	0	SENT_181	[p12l843t3266r1259b3344],
75	gave	VBD	O	give	dep	102	SENT_181	[p12l1350t3277r1530b3344],
76	a	DT	O	a	dep	102	SENT_181	[p12l1619t3277r1660b3324],
77	signiﬁcant	NN	O	signiﬁcant	dep	102	SENT_181	[p12l1749t3255r2153b3344],
78	difference	NN	O	difference	dep	102	SENT_181	[p12l13t3362r406b3431],
79	between	IN	O	between	dep	102	SENT_181	[p12l458t3362r784b3431],
80	the	DT	O	the	dep	102	SENT_181	[p12l836t3362r953b3430],
81	CYP3A4	NN	O	cyp3a4	dep	102	SENT_181	[p12l1010t3355r1486b3431],
82	*	CD	NUMBER	*	dep	102	SENT_181	[p12l1010t3355r1486b3431],
83	IB	NN	O	ib	dep	102	SENT_181	[p12l1010t3355r1486b3431],
84	genotypes	NNS	O	genotype	dep	102	SENT_181	[p12l1540t3372r1933b3451],
85	(	VBP	O	(	dep	102	SENT_181	[p12l1989t3363r2153b3447],
86	HR	NN	DURATION	hr	dep	102	SENT_181	[p12l1989t3363r2153b3447],
87	0.39	CD	PERCENT	0.39	dep	102	SENT_181	[p12l13t3468r179b3537],
88	95	CD	PERCENT	95	dep	102	SENT_181	[p12l237t3468r511b3537],
89	%	NN	PERCENT	%	dep	102	SENT_181	[p12l237t3468r511b3537],
90	CI	NN	O	ci	dep	102	SENT_181	[p12l237t3468r511b3537],
91	0.19-0	CD	NUMBER	0.19-0	dep	102	SENT_181	[p12l566t3468r1009b3552],
92	.84	CD	NUMBER	.84	dep	102	SENT_181	[p12l566t3468r1009b3552],
93	)	NN	O	)	dep	102	SENT_181	[p12l566t3468r1009b3552],
94	,	,	O	,	_	0	SENT_181	[p12l566t3468r1009b3552],
95	that	WDT	O	that	dep	102	SENT_181	[p12l1067t3468r1214b3536],
96	was	VBD	O	be	dep	102	SENT_181	[p12l1267t3490r1414b3536],
97	smaller	JJR	O	smaller	dep	102	SENT_181	[p12l1474t3468r1760b3536],
98	than	IN	O	than	dep	102	SENT_181	[p12l1812t3468r1980b3536],
99	the	DT	O	the	dep	102	SENT_181	[p12l2034t3468r2151b3536],
100	overall	JJ	O	overall	dep	102	SENT_181	[p13l14t19r280b87],
101	hazard	NN	O	hazard	dep	102	SENT_181	[p13l324t18r585b87],
102	ratio	NN	O	ratio	_	0	SENT_181	[p13l626t19r825b87],
103	.	.	O	.	_	0	SENT_181	[p13l626t19r825b87],

1	Testing	VBG	O	test	prep	18	SENT_182	[p13l872t19r1158b107],
2	for	IN	O	for	pcomp	1	SENT_182	[p13l1202t19r1316b87],
3	multiplicative	JJ	O	multiplicative	amod	4	SENT_182	[p13l1357t18r1898b107],
4	interaction	NN	O	interaction	pobj	2	SENT_182	[p13l1942t18r2149b87, p13l15t125r251b194],
5	between	IN	O	between	_	0	SENT_182	[p13l274t125r601b194],
6	the	DT	O	the	det	8	SENT_182	[p13l625t125r743b193],
7	C	NN	O	c	nn	8	SENT_182	[p13l773t126r835b194],
8	YP3A4	NN	O	yp3a4	prep_between	4	SENT_182	[p13l840t118r1182b193],
9	*	CD	NUMBER	*	nsubj	18	SENT_182	[p13l840t118r1182b193],
10	I	PRP	O	I	dep	9	SENT_182	[p13l840t118r1182b193],
11	B	NN	O	b	nn	12	SENT_182	[p13l1190t128r1249b193],
12	polymorphism	NN	O	polymorphism	dep	9	SENT_182	[p13l1273t125r1847b214],
13	and	CC	O	and	_	0	SENT_182	[p13l1872t125r2010b193],
14	the	DT	O	the	det	17	SENT_182	[p13l2034t125r2151b193],
15	ABCBI	NNP	O	ABCBI	nn	17	SENT_182	[p13l6t232r298b301],
16	C3435T	NN	O	c3435t	nn	17	SENT_182	[p13l358t231r676b300],
17	polymorphism	NN	O	polymorphism	dep	9	SENT_182	[p13l726t232r1299b320],
18	revealed	VBD	O	reveal	_	0	SENT_182	[p13l1349t232r1679b300],
19	no	DT	O	no	det	20	SENT_182	[p13l1730t253r1824b300],
20	signiﬁcance	NN	O	signiﬁcance	dobj	18	SENT_182	[p13l1880t231r2149b320, p13l13t359r234b405],
21	for	IN	O	for	_	0	SENT_182	[p13l260t337r373b405],
22	patients	NNS	O	patient	prep_for	18	SENT_182	[p13l395t337r698b425],
23	with	IN	O	with	_	0	SENT_182	[p13l726t337r897b406],
24	the	DT	O	the	det	28	SENT_182	[p13l922t337r1039b405],
25	3435CT	NNP	O	3435CT	nn	28	SENT_182	[p13l1068t337r1384b406],
26	genotype	NN	O	genotype	nn	28	SENT_182	[p13l1410t347r1766b426],
27	(	CD	NUMBER	(	num	28	SENT_182	[p13l1796t338r1959b421],
28	HR	NN	DURATION	hr	prep_with	18	SENT_182	[p13l1796t338r1959b421],
29	0.53	CD	PERCENT	0.53	num	32	SENT_182	[p13l1984t337r2147b406],
30	95	CD	PERCENT	95	number	31	SENT_182	[p13l14t443r104b512],
31	%	NN	PERCENT	%	amod	32	SENT_182	[p13l115t443r288b512],
32	CI	NN	O	ci	dep	50	SENT_182	[p13l115t443r288b512],
33	0.10-2	CD	NUMBER	0.10-2	num	35	SENT_182	[p13l317t443r735b527],
34	.76	CD	NUMBER	.76	num	35	SENT_182	[p13l317t443r735b527],
35	)	NN	O	)	dep	32	SENT_182	[p13l317t443r735b527],
36	and	CC	O	and	_	0	SENT_182	[p13l768t443r906b511],
37	a	DT	O	a	det	38	SENT_182	[p13l936t465r976b511],
38	trend	NN	O	trend	conj_and	32	SENT_182	[p13l1003t443r1204b511],
39	toward	IN	O	toward	_	0	SENT_182	[p13l1231t443r1500b512],
40	an	DT	O	a	det	41	SENT_182	[p13l1530t465r1618b511],
41	effect	NN	O	effect	prep_toward	38	SENT_182	[p13l1647t443r1867b511],
42	for	IN	O	for	_	0	SENT_182	[p13l1895t443r2008b511],
43	the	DT	O	the	det	45	SENT_182	[p13l2034t443r2151b511],
44	3435TT	NNP	O	3435TT	nn	45	SENT_182	[p13l15t550r326b619],
45	genotype	NN	O	genotype	prep_for	41	SENT_182	[p13l400t561r756b639],
46	(	CD	NUMBER	(	num	47	SENT_182	[p13l833t551r996b635],
47	HR	NN	DURATION	hr	dep	50	SENT_182	[p13l833t551r996b635],
48	0.15	CD	PERCENT	0.15	num	50	SENT_182	[p13l1068t550r1232b619],
49	95	CD	PERCENT	95	num	50	SENT_182	[p13l1310t550r1584b620],
50	%	NN	PERCENT	%	dep	55	SENT_182	[p13l1310t550r1584b620],
51	CI	NN	O	ci	nn	53	SENT_182	[p13l1310t550r1584b620],
52	0.0	CD	NUMBER	0.0	num	53	SENT_182	[p13l1657t550r2149b635],
53	l3	NN	O	l3	dep	50	SENT_182	[p13l1657t550r2149b635],
54	—	CD	NUMBER	—	num	55	SENT_182	[p13l1657t550r2149b635],
55	l.	NN	O	l.	dep	57	SENT_182	[p13l1657t550r2149b635],
56	75	CD	NUMBER	75	num	57	SENT_182	[p13l1657t550r2149b635],
57	)	NN	O	)	dep	28	SENT_182	[p13l1657t550r2149b635],
58	,	,	O	,	_	0	SENT_182	[p13l1657t550r2149b635],
59	although	IN	O	although	mark	66	SENT_182	[p13l15t656r354b745],
60	not	RB	O	not	neg	66	SENT_182	[p13l395t667r519b725],
61	signiﬁcant	JJ	O	signiﬁcant	amod	66	SENT_182	[p13l563t656r968b745],
62	(	NN	O	(	nn	66	SENT_182	[p13l1011t657r1097b744],
63	p	NN	O	p	nn	66	SENT_182	[p13l1011t657r1097b744],
64	=	JJ	O	=	amod	66	SENT_182	[p13l1122t657r1431b741],
65	0.13	CD	NUMBER	0.13	num	66	SENT_182	[p13l1122t657r1431b741],
66	)	NN	O	)	advcl	18	SENT_182	[p13l1122t657r1431b741],
67	.	.	O	.	_	0	SENT_182	[p13l1122t657r1431b741],

1	The	DT	O	the	det	2	SENT_183	[p13l1477t656r1626b725],
2	results	NNS	O	result	nsubj	4	SENT_183	[p13l1668t656r1921b725],
3	were	VBD	O	be	cop	4	SENT_183	[p13l1964t678r2151b725],
4	similar	JJ	O	similar	conj_or	4	SENT_183	[p13l16t761r286b829],
5	for	IN	O	for	_	0	SENT_183	[p13l310t761r423b829],
6	the	DT	O	the	det	10	SENT_183	[p13l448t761r565b829],
7	Cl236T	NN	O	cl236t	nn	10	SENT_183	[p13l593t761r910b830],
8	and	CC	O	and	_	0	SENT_183	[p13l932t761r1070b829],
9	G2677T/A	NN	O	g2677t/a	nn	10	SENT_183	[p13l1097t761r1518b830],
10	polymorphisms	NNS	O	polymorphism	prep_for	4	SENT_183	[p13l1542t761r2151b849],
11	in	IN	O	in	_	0	SENT_183	[p13l12t868r87b936],
12	the	DT	O	the	det	14	SENT_183	[p13l120t869r236b937],
13	ABCBI	NN	O	abcbus	nn	14	SENT_183	[p13l264t869r556b938],
14	gene	NN	O	gene	prep_in	4	SENT_183	[p13l598t890r779b957],
15	or	CC	O	or	_	0	SENT_183	[p13l814t890r894b937],
16	for	IN	O	for	_	0	SENT_183	[p13l926t868r1039b937],
17	testing	NN	O	testing	nn	19	SENT_183	[p13l1070t869r1329b957],
18	additive	JJ	O	additive	amod	19	SENT_183	[p13l1365t869r1674b937],
19	interaction	NN	O	interaction	prep_for	4	SENT_183	[p13l1709t869r2147b937],
20	.	.	O	.	_	0	SENT_183	[p13l1709t869r2147b937],

1	DISCUSSION	NN	O	discussion	_	0	SENT_184	[p13l12t1118r586b1187],

1	In	IN	O	in	_	0	SENT_185	[p13l12t1276r92b1341],
2	this	DT	O	this	det	3	SENT_185	[p13l119t1274r256b1342],
3	population	NN	O	population	prep_in	5	SENT_185	[p13l284t1274r704b1362],
4	based	VBN	O	base	partmod	3	SENT_185	[p13l730t1274r953b1342],
5	closed	VBD	O	close	_	0	SENT_185	[p13l981t1274r1229b1342],
6	cohort	NN	O	cohort	nn	7	SENT_185	[p13l1256t1274r1506b1342],
7	study	NN	O	study	dobj	5	SENT_185	[p13l1535t1274r1755b1362],
8	,	,	O	,	_	0	SENT_185	[p13l1535t1274r1755b1362],
9	we	PRP	O	we	nsubj	10	SENT_185	[p13l1787t1295r1897b1343],
10	found	VBD	O	find	dep	7	SENT_185	[p13l1926t1274r2153b1342],
11	a	DT	O	a	det	15	SENT_185	[p13l15t1402r55b1449],
12	two	CD	NUMBER	two	num	13	SENT_185	[p13l76t1391r219b1449],
13	times	NNS	O	time	npadvmod	14	SENT_185	[p13l242t1381r451b1449],
14	lower	JJR	O	lower	amod	15	SENT_185	[p13l476t1381r696b1449],
15	risk	NN	O	risk	dobj	10	SENT_185	[p13l715t1381r863b1449],
16	for	IN	O	for	_	0	SENT_185	[p13l883t1380r996b1449],
17	a	DT	O	a	det	19	SENT_185	[p13l1019t1402r1059b1449],
18	dose	NN	O	dose	nn	19	SENT_185	[p13l1081t1381r1256b1449],
19	decrease	NN	O	decrease	prep_for	15	SENT_185	[p13l1281t1381r1615b1449],
20	or	CC	O	or	_	0	SENT_185	[p13l1639t1402r1719b1449],
21	a	DT	O	a	det	22	SENT_185	[p13l1741t1402r1781b1449],
22	switch	NN	O	switch	conj_or	19	SENT_185	[p13l1806t1381r2056b1449],
23	to	TO	O	to	_	0	SENT_185	[p13l2078t1391r2151b1449],
24	another	DT	O	another	det	25	SENT_185	[p13l14t1487r307b1556],
25	cholesterol	NN	O	cholesterol	prep_to	10	SENT_185	[p13l341t1487r769b1556],
26	lowering	VBG	O	lower	partmod	25	SENT_185	[p13l806t1487r1149b1576],
27	drug	NN	O	drug	dobj	26	SENT_185	[p13l1187t1487r1384b1576],
28	,	,	O	,	_	0	SENT_185	[p13l1187t1487r1384b1576],
29	in	IN	O	in	_	0	SENT_185	[p13l1424t1487r1497b1555],
30	simvastatin	NN	O	simvastatin	nn	33	SENT_185	[p13l1537t1487r1977b1556],
31	and	CC	O	and	_	0	SENT_185	[p13l2015t1487r2153b1556],
32	atorvastatin	NN	O	atorvastatin	conj_and	30	SENT_185	[p13l15t1592r467b1661],
33	users	NNS	O	user	prep_in	5	SENT_185	[p13l501t1614r699b1660],
34	with	IN	O	with	_	0	SENT_185	[p13l736t1592r908b1661],
35	the	DT	O	the	det	37	SENT_185	[p13l942t1592r1060b1660],
36	C	NN	O	c	nn	37	SENT_185	[p13l1100t1594r1162b1661],
37	YP3A4	NN	O	yp3a4	prep_with	5	SENT_185	[p13l1167t1585r1509b1660],
38	*	CD	NUMBER	*	nsubj	5	SENT_185	[p13l1167t1585r1509b1660],
39	I	PRP	O	I	dep	38	SENT_185	[p13l1167t1585r1509b1660],
40	B	NN	O	b	nn	42	SENT_185	[p13l1517t1595r1576b1660],
41	variant	JJ	O	variant	amod	42	SENT_185	[p13l1612t1592r1882b1661],
42	allele	NN	O	allele	dep	39	SENT_185	[p13l1918t1592r2147b1660],
43	.	.	O	.	_	0	SENT_185	[p13l1918t1592r2147b1660],

1	In	IN	O	in	_	0	SENT_186	[p13l12t1701r92b1767],
2	the	DT	O	the	det	3	SENT_186	[p13l169t1700r286b1768],
3	majority	NN	O	majority	prep_in	17	SENT_186	[p13l365t1700r695b1788],
4	of	IN	O	of	_	0	SENT_186	[p13l775t1699r859b1768],
5	cases	NNS	O	case	prep_of	3	SENT_186	[p13l931t1721r1155b1780],
6	,	,	O	,	_	0	SENT_186	[p13l931t1721r1155b1780],
7	the	DT	O	the	det	8	SENT_186	[p13l1237t1700r1353b1768],
8	reason	NN	O	reason	nsubj	17	SENT_186	[p13l1430t1721r1685b1768],
9	for	IN	O	for	_	0	SENT_186	[p13l1764t1700r1877b1768],
10	these	DT	O	these	det	12	SENT_186	[p13l1952t1700r2151b1768],
11	medication	NN	O	medication	nn	12	SENT_186	[p13l12t1805r448b1874],
12	changes	NNS	O	change	prep_for	8	SENT_186	[p13l490t1805r801b1894],
13	was	VBD	O	be	cop	17	SENT_186	[p13l843t1827r990b1874],
14	an	DT	O	a	det	17	SENT_186	[p13l1035t1827r1123b1874],
15	adverse	JJ	O	adverse	amod	17	SENT_186	[p13l1165t1805r1459b1874],
16	drug	NN	O	drug	nn	17	SENT_186	[p13l1501t1805r1676b1894],
17	reaction	NN	O	reaction	_	0	SENT_186	[p13l1716t1805r2033b1874],
18	or	CC	O	or	_	0	SENT_186	[p13l2074t1827r2154b1874],
19	a	DT	O	a	det	22	SENT_186	[p13l15t1931r55b1978],
20	too	RB	O	too	advmod	21	SENT_186	[p13l96t1920r219b1978],
21	strong	JJ	O	strong	amod	22	SENT_186	[p13l266t1921r504b1998],
22	reduction	NN	O	reduction	conj_or	17	SENT_186	[p13l547t1910r917b1978],
23	in	IN	O	in	_	0	SENT_186	[p13l960t1910r1034b1977],
24	cholesterol	NN	O	cholesterol	nn	25	SENT_186	[p13l1078t1910r1505b1978],
25	level	NN	O	level	prep_in	22	SENT_186	[p13l1549t1910r1755b1978],
26	.	.	O	.	_	0	SENT_186	[p13l1549t1910r1755b1978],

1	Both	DT	O	both	nsubj	4	SENT_187	[p13l1803t1910r1992b1978],
2	are	VBP	O	be	cop	4	SENT_187	[p13l2036t1931r2151b1978],
3	most	RBS	O	most	advmod	4	SENT_187	[p13l12t2027r202b2085],
4	likely	JJ	O	likely	_	0	SENT_187	[p13l223t2017r444b2106],
5	caused	VBN	O	cause	dep	4	SENT_187	[p13l466t2017r731b2085],
6	by	IN	O	by	_	0	SENT_187	[p13l751t2017r847b2106],
7	elevated	JJ	O	elevated	amod	10	SENT_187	[p13l870t2017r1192b2086],
8	statin	NN	O	statin	nn	10	SENT_187	[p13l1216t2017r1424b2085],
9	plasma	NN	O	plasma	nn	10	SENT_187	[p13l1444t2017r1722b2106],
10	levels	NNS	O	level	prep_by	5	SENT_187	[p13l1743t2017r1987b2098],
11	,	,	O	,	_	0	SENT_187	[p13l1743t2017r1987b2098],
12	due	JJ	O	due	_	0	SENT_187	[p13l2014t2017r2151b2085],
13	to	TO	O	to	_	0	SENT_187	[p13l12t2133r85b2191],
14	reduced	VBN	O	reduce	amod	15	SENT_187	[p13l111t2123r422b2191],
15	metabolism	NN	O	metabolism	prep_due_to	5	SENT_187	[p13l448t2123r906b2191],
16	of	IN	O	of	_	0	SENT_187	[p13l933t2123r1017b2191],
17	simvastatin	NN	O	simvastatin	prep_of	15	SENT_187	[p13l1040t2123r1481b2192],
18	and	CC	O	and	_	0	SENT_187	[p13l1509t2123r1647b2191],
19	atorvastatin	NN	O	atorvastatin	conj_and	17	SENT_187	[p13l1674t2123r2147b2192],
20	.	.	O	.	_	0	SENT_187	[p13l1674t2123r2147b2192],

1	The	DT	O	the	det	2	SENT_188	[p13l12t2231r162b2299],
2	association	NN	O	association	nsubj	4	SENT_188	[p13l202t2230r635b2299],
3	was	VBD	O	be	cop	4	SENT_188	[p13l671t2252r818b2299],
4	stronger	JJR	O	stronger	_	0	SENT_188	[p13l861t2241r1178b2319],
5	in	IN	O	in	_	0	SENT_188	[p13l1213t2230r1287b2298],
6	women	NNS	O	woman	prep_in	4	SENT_188	[p13l1324t2252r1610b2299],
7	than	IN	O	than	prep	4	SENT_188	[p13l1646t2231r1813b2299],
8	in	IN	O	in	pcomp	7	SENT_188	[p13l1850t2231r1924b2298],
9	men	NNS	O	man	pobj	8	SENT_188	[p13l1960t2252r2147b2299],
10	.	.	O	.	_	0	SENT_188	[p13l1960t2252r2147b2299],

1	No	DT	O	no	det	2	SENT_189	[p13l12t2338r128b2405],
2	associations	NNS	O	association	nsubjpass	4	SENT_189	[p13l155t2336r623b2405],
3	were	VBD	O	be	auxpass	4	SENT_189	[p13l649t2358r836b2405],
4	found	VBN	O	find	_	0	SENT_189	[p13l861t2336r1088b2405],
5	with	IN	O	with	_	0	SENT_189	[p13l1110t2336r1282b2405],
6	polymorphisms	NNS	O	polymorphism	prep_with	4	SENT_189	[p13l1304t2336r1912b2425],
7	in	IN	O	in	_	0	SENT_189	[p13l1937t2336r2011b2404],
8	the	DT	O	the	det	10	SENT_189	[p13l2034t2336r2151b2405],
9	ABCBI	NN	O	abcbus	nn	10	SENT_189	[p13l6t2442r298b2510],
10	gene	NN	O	gene	prep_in	6	SENT_189	[p13l332t2462r533b2529],
11	.	.	O	.	_	0	SENT_189	[p13l332t2462r533b2529],

1	Although	IN	O	although	mark	8	SENT_190	[p13l564t2441r932b2529],
2	not	RB	O	not	dep	8	SENT_190	[p13l957t2451r1081b2509],
3	statistically	RB	O	statistically	advmod	4	SENT_190	[p13l1109t2441r1551b2529],
4	signiﬁcant	JJ	O	signiﬁcant	dep	2	SENT_190	[p13l1581t2441r2005b2529],
5	,	,	O	,	_	0	SENT_190	[p13l1581t2441r2005b2529],
6	the	DT	O	the	det	7	SENT_190	[p13l2034t2441r2151b2509],
7	results	NNS	O	result	nsubj	8	SENT_190	[p13l11t2549r264b2617],
8	suggest	VBP	O	suggest	_	0	SENT_190	[p13l291t2559r580b2637],
9	that	IN	O	that	complm	27	SENT_190	[p13l600t2549r747b2617],
10	in	IN	O	in	_	0	SENT_190	[p13l767t2549r841b2616],
11	patients	NNS	O	patient	prep_in	27	SENT_190	[p13l861t2548r1164b2637],
12	with	IN	O	with	_	0	SENT_190	[p13l1187t2549r1359b2617],
13	the	DT	O	the	det	15	SENT_190	[p13l1380t2549r1497b2617],
14	ABCBI	NNP	O	ABCBI	nn	15	SENT_190	[p13l1513t2549r1804b2618],
15	C3435T	NN	O	c3435t	prep_with	11	SENT_190	[p13l1834t2548r2152b2617],
16	wild	JJ	O	wild	amod	19	SENT_190	[p13l13t2654r386b2743],
17	—	NN	O	—	nn	19	SENT_190	[p13l13t2654r386b2743],
18	type	NN	O	type	nn	19	SENT_190	[p13l13t2654r386b2743],
19	genotype	NN	O	genotype	dep	15	SENT_190	[p13l426t2665r782b2743],
20	the	DT	O	the	det	21	SENT_190	[p13l822t2654r939b2723],
21	occurrence	NN	O	occurrence	nsubjpass	27	SENT_190	[p13l981t2676r1408b2723],
22	of	IN	O	of	_	0	SENT_190	[p13l1449t2654r1533b2723],
23	these	DT	O	these	det	24	SENT_190	[p13l1566t2654r1764b2723],
24	events	NNS	O	event	prep_of	21	SENT_190	[p13l1805t2665r2048b2723],
25	is	VBZ	O	be	auxpass	27	SENT_190	[p13l2089t2654r2150b2723],
26	not	RB	O	not	neg	27	SENT_190	[p13l12t2771r137b2829],
27	associated	VBN	O	associate	ccomp	8	SENT_190	[p13l187t2760r588b2829],
28	with	IN	O	with	_	0	SENT_190	[p13l637t2760r809b2829],
29	the	DT	O	the	det	33	SENT_190	[p13l858t2760r975b2829],
30	CYP3A4	NN	O	cyp3a4	nn	33	SENT_190	[p13l1031t2753r1506b2830],
31	*	CD	NUMBER	*	num	33	SENT_190	[p13l1031t2753r1506b2830],
32	IB	NNP	O	IB	nn	33	SENT_190	[p13l1031t2753r1506b2830],
33	polymorphism	NN	O	polymorphism	prep_with	27	SENT_190	[p13l1556t2760r2149b2849],
34	,	,	O	,	_	0	SENT_190	[p13l1556t2760r2149b2849],
35	while	IN	O	while	mark	36	SENT_190	[p13l13t2867r228b2936],
36	in	IN	O	in	dep	33	SENT_190	[p13l276t2867r350b2935],
37	patients	NNS	O	patient	pobj	36	SENT_190	[p13l395t2867r698b2955],
38	with	IN	O	with	_	0	SENT_190	[p13l748t2867r920b2936],
39	one	CD	NUMBER	one	prep_with	37	SENT_190	[p13l968t2889r1105b2935],
40	or	CC	O	or	_	0	SENT_190	[p13l1155t2889r1234b2935],
41	two	CD	NUMBER	two	conj_or	39	SENT_190	[p13l1280t2878r1423b2936],
42	variant	JJ	O	variant	amod	43	SENT_190	[p13l1471t2867r1740b2936],
43	alleles	NNS	O	allele	npadvmod	44	SENT_190	[p13l1788t2867r2034b2935],
44	at	IN	O	at	advmod	27	SENT_190	[p13l2085t2877r2153b2935],

1	Copyright	NN	O	copyright	nn	5	SENT_191	[p13l13t3111r337b3183],
2	©	CD	NUMBER	©	num	5	SENT_191	[p13l370t3112r438b3180],
3	2009	CD	DATE	2009	num	5	SENT_191	[p13l473t3111r628b3168],
4	John	NNP	PERSON	John	nn	5	SENT_191	[p13l658t3111r808b3167],
5	Wiley	NNP	PERSON	Wiley	_	0	SENT_191	[p13l836t3111r1029b3183],
6	&	CC	O	&	_	0	SENT_191	[p13l1060t3111r1117b3167],
7	Sons	NNP	O	Sons	conj_and	5	SENT_191	[p13l1149t3111r1317b3177],
8	,	,	O	,	_	0	SENT_191	[p13l1149t3111r1317b3177],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_191	[p13l1349t3111r1475b3167],
10	.	.	O	.	_	0	SENT_191	[p13l1349t3111r1475b3167],

1	ABCBI	NNP	O	ABCBI	nn	2	SENT_192	[p13l7t3206r298b3274],
2	C3435T	NNP	O	C3435T	nsubj	10	SENT_192	[p13l335t3205r651b3274],
3	the	DT	O	the	det	4	SENT_192	[p13l681t3205r798b3273],
4	risk	NN	O	risk	dep	2	SENT_192	[p13l826t3205r973b3273],
5	is	VBZ	O	be	cop	10	SENT_192	[p13l1000t3205r1060b3273],
6	more	JJR	O	more	mwe	7	SENT_192	[p13l1092t3227r1290b3273],
7	than	IN	O	than	quantmod	9	SENT_192	[p13l1319t3205r1486b3273],
8	two	CD	NUMBER	two	number	9	SENT_192	[p13l1515t3216r1657b3274],
9	times	NNS	O	time	num	10	SENT_192	[p13l1688t3205r1896b3273],
10	lower	JJR	O	lower	_	0	SENT_192	[p13l1927t3205r2147b3274],
11	in	IN	O	in	_	0	SENT_192	[p13l13t3313r87b3380],
12	simvastatin	NN	O	simvastatin	prep_in	10	SENT_192	[p13l180t3313r619b3381],
13	and	CC	O	and	_	0	SENT_192	[p13l710t3313r848b3381],
14	atorvastatin	NN	O	atorvastatin	conj_and	12	SENT_192	[p13l938t3313r1390b3381],
15	users	NNS	O	user	dep	21	SENT_192	[p13l1479t3334r1675b3381],
16	with	IN	O	with	_	0	SENT_192	[p13l1767t3313r1939b3381],
17	the	DT	O	the	det	18	SENT_192	[p13l2028t3313r2144b3381],
18	C	NN	O	c	prep_with	15	SENT_192	[p13l18t3420r79b3487],
19	YP3A4	NN	O	yp3a4	dep	21	SENT_192	[p13l84t3412r426b3486],
20	*	CD	NUMBER	*	num	19	SENT_192	[p13l84t3412r426b3486],
21	I	PRP	O	I	dep	10	SENT_192	[p13l84t3412r426b3486],
22	B	NN	O	b	nn	24	SENT_192	[p13l433t3422r492b3486],
23	variant	JJ	O	variant	amod	24	SENT_192	[p13l529t3419r797b3487],
24	allele	NN	O	allele	dep	21	SENT_192	[p13l834t3419r1062b3487],
25	.	.	O	.	_	0	SENT_192	[p13l834t3419r1062b3487],

1	The	DT	O	the	det	2	SENT_193	[p14l102t25r251b93],
2	results	NNS	O	result	nsubj	6	SENT_193	[p14l294t25r546b93],
3	of	IN	O	of	_	0	SENT_193	[p14l592t25r676b93],
4	our	PRP$	O	we	poss	5	SENT_193	[p14l714t46r842b93],
5	study	NN	O	study	prep_of	2	SENT_193	[p14l887t25r1092b113],
6	are	VBP	O	be	_	0	SENT_193	[p14l1138t46r1252b93],
7	in	IN	O	in	_	0	SENT_193	[p14l1297t25r1370b92],
8	line	NN	O	line	prep_in	6	SENT_193	[p14l1413t25r1557b93],
9	with	IN	O	with	_	0	SENT_193	[p14l1599t25r1770b94],
10	previous	JJ	O	previous	amod	11	SENT_193	[p14l1812t25r2144b113],
11	publications	NNS	O	publication	prep_with	8	SENT_193	[p14l12t132r510b220],
12	.	.	O	.	_	0	SENT_193	[p14l12t132r510b220],

1	Patients	NNS	O	patient	nsubj	11	SENT_194	[p14l551t132r856b200],
2	with	IN	O	with	_	0	SENT_194	[p14l895t132r1066b200],
3	the	DT	O	the	det	8	SENT_194	[p14l1102t132r1219b200],
4	CYP3A4	NN	O	cyp3a4	nn	8	SENT_194	[p14l1262t125r1736b201],
5	*	CD	NUMBER	*	num	8	SENT_194	[p14l1262t125r1736b201],
6	]	NN	O	]	nn	8	SENT_194	[p14l1262t125r1736b201],
7	B	NN	O	b	nn	8	SENT_194	[p14l1262t125r1736b201],
8	G	NN	O	g	prep_with	1	SENT_194	[p14l1775t132r1841b200],
9	variant	JJ	O	variant	amod	10	SENT_194	[p14l1878t132r2147b200],
10	allele	NN	O	allele	dep	8	SENT_194	[p14l15t238r223b307],
11	have	VBP	O	have	_	0	SENT_194	[p14l247t238r426b307],
12	an	DT	O	a	det	15	SENT_194	[p14l452t260r540b307],
13	enhanced	VBN	O	enhance	amod	15	SENT_194	[p14l563t238r931b307],
14	CYP3A4	NN	O	cyp3a4	nn	15	SENT_194	[p14l954t239r1307b307],
15	expression	NN	O	expression	dobj	11	SENT_194	[p14l1331t218r1817b328],
16	”	CD	NUMBER	”	num	17	SENT_194	[p14l1331t218r1817b328],
17	)	NN	O	)	dep	15	SENT_194	[p14l1331t218r1817b328],
18	and	CC	O	and	_	0	SENT_194	[p14l1842t238r1980b307],
19	less	JJR	O	less	amod	20	SENT_194	[p14l2002t238r2143b307],
20	reduction	NN	O	reduction	dobj	11	SENT_194	[p14l12t346r381b415],
21	in	IN	O	in	_	0	SENT_194	[p14l426t346r500b414],
22	LDL	NN	O	ldl	nn	23	SENT_194	[p14l545t348r733b414],
23	cholesterol	NN	O	cholesterol	prep_in	20	SENT_194	[p14l779t326r1303b415],
24	.	.	O	.	_	0	SENT_194	[p14l779t326r1303b415],

1	”	NN	O	”	nsubj	3	SENT_195	[p14l779t326r1303b415],
2	This	DT	O	this	dep	1	SENT_195	[p14l1350t346r1519b415],
3	indicates	VBZ	O	indicate	_	0	SENT_195	[p14l1566t346r1911b415],
4	most	RBS	O	most	advmod	5	SENT_195	[p14l1958t357r2147b415],
5	likely	RB	O	likely	dep	3	SENT_195	[p14l13t453r234b542],
6	lower	JJR	O	lower	amod	7	SENT_195	[p14l295t453r515b522],
7	simvastatin	NN	O	simvastatin	dep	5	SENT_195	[p14l577t453r1015b522],
8	and	CC	O	and	_	0	SENT_195	[p14l1078t453r1215b522],
9	atorvastatin	NN	O	atorvastatin	nn	10	SENT_195	[p14l1277t453r1728b522],
10	levels	NNS	O	level	dep	5	SENT_195	[p14l1789t453r2009b522],
11	in	IN	O	in	_	0	SENT_195	[p14l2072t453r2146b521],
12	patients	NNS	O	patient	prep_in	7	SENT_195	[p14l12t558r314b647],
13	with	IN	O	with	_	0	SENT_195	[p14l364t558r535b627],
14	the	DT	O	the	det	15	SENT_195	[p14l582t558r699b626],
15	gYP3A4	NN	O	gyp3a4	nn	18	SENT_195	[p14l751t551r1226b656],
16	*	CD	NUMBER	*	num	15	SENT_195	[p14l751t551r1226b656],
17	IB	NNP	ORGANIZATION	IB	nn	18	SENT_195	[p14l751t551r1226b656],
18	AG	NNP	ORGANIZATION	AG	prep_with	12	SENT_195	[p14l1271t559r1407b627],
19	or	CC	O	or	_	0	SENT_195	[p14l1454t580r1534b626],
20	GG	NNS	O	gg	nn	21	SENT_195	[p14l1581t559r1718b627],
21	genotype	NN	O	genotype	conj_or	18	SENT_195	[p14l1766t569r2141b647],
22	.	.	O	.	_	0	SENT_195	[p14l1766t569r2141b647],

1	Fiegenbaum	NNP	PERSON	Fiegenbaum	nsubj	3	SENT_196	[p14l13t666r495b755],
2	et	FW	O	et	nn	3	SENT_196	[p14l543t679r612b735],
3	al.	FW	O	al.	_	0	SENT_196	[p14l657t657r849b747],
4	"	``	O	"	punct	3	SENT_196	[p14l657t657r849b747],
5	,	,	O	,	_	0	SENT_196	[p14l657t657r849b747],
6	however	RB	O	however	advmod	8	SENT_196	[p14l899t667r1247b747],
7	,	,	O	,	_	0	SENT_196	[p14l899t667r1247b747],
8	found	VBD	O	find	rcmod	3	SENT_196	[p14l1298t666r1524b735],
9	no	DT	O	no	det	10	SENT_196	[p14l1570t688r1664b735],
10	association	NN	O	association	dobj	8	SENT_196	[p14l1715t666r2146b735],
11	between	IN	O	between	_	0	SENT_196	[p14l12t772r337b840],
12	the	DT	O	the	det	13	SENT_196	[p14l379t772r496b840],
13	CYP3A4	NN	O	cyp3a4	prep_between	10	SENT_196	[p14l543t765r1017b840],
14	*	CD	NUMBER	*	num	17	SENT_196	[p14l543t765r1017b840],
15	]	NN	O	]	nn	17	SENT_196	[p14l543t765r1017b840],
16	B	NN	O	b	nn	17	SENT_196	[p14l543t765r1017b840],
17	polymorphism	NN	O	polymorphism	dep	13	SENT_196	[p14l1058t772r1629b860],
18	and	CC	O	and	dep	21	SENT_196	[p14l1672t772r1809b840],
19	adverse	JJ	O	adverse	amod	21	SENT_196	[p14l1852t772r2145b840],
20	drug	NN	O	drug	nn	21	SENT_196	[p14l14t877r188b965],
21	reactions	NNS	O	reaction	dep	3	SENT_196	[p14l235t877r586b945],
22	in	IN	O	in	_	0	SENT_196	[p14l634t877r708b944],
23	simvastatin	NN	O	simvastatin	nn	24	SENT_196	[p14l758t877r1196b946],
24	users	NNS	O	user	prep_in	21	SENT_196	[p14l1243t898r1460b945],
25	.	.	O	.	_	0	SENT_196	[p14l1243t898r1460b945],

1	For	IN	O	for	_	0	SENT_197	[p14l1511t879r1645b945],
2	the	DT	O	the	det	5	SENT_197	[p14l1690t877r1807b945],
3	ABCBI	NNP	O	ABCBI	nn	5	SENT_197	[p14l1848t878r2138b946],
4	C3435T	NN	O	c3435t	nn	5	SENT_197	[p14l14t984r331b1053],
5	polymorphism	NN	O	polymorphism	prep_for	7	SENT_197	[p14l387t985r958b1073],
6	we	PRP	O	we	nsubj	7	SENT_197	[p14l1013t1006r1123b1053],
7	found	VBD	O	find	_	0	SENT_197	[p14l1181t985r1407b1053],
8	a	DT	O	a	det	10	SENT_197	[p14l1465t1006r1505b1053],
9	non-signiﬁcant	JJ	O	non-signiﬁcant	amod	10	SENT_197	[p14l1561t985r2147b1073],
10	increase	NN	O	increase	dobj	7	SENT_197	[p14l13t1090r331b1159],
11	in	IN	O	in	_	0	SENT_197	[p14l372t1090r446b1158],
12	risk	NN	O	risk	prep_in	7	SENT_197	[p14l485t1090r632b1159],
13	for	IN	O	for	_	0	SENT_197	[p14l670t1090r782b1159],
14	the	DT	O	the	det	17	SENT_197	[p14l820t1090r937b1159],
15	variant	JJ	O	variant	amod	17	SENT_197	[p14l976t1090r1245b1159],
16	T	NN	O	t	nn	17	SENT_197	[p14l1284t1092r1341b1158],
17	allele	NN	O	allele	prep_for	7	SENT_197	[p14l1375t1090r1605b1171],
18	,	,	O	,	_	0	SENT_197	[p14l1375t1090r1605b1171],
19	suggesting	VBG	O	suggest	partmod	7	SENT_197	[p14l1652t1090r2063b1179],
20	a	DT	O	a	det	22	SENT_197	[p14l2106t1112r2147b1159],
21	decreased	VBN	O	decrease	amod	22	SENT_197	[p14l14t1196r398b1264],
22	functioning	NN	O	functioning	dobj	19	SENT_197	[p14l447t1196r895b1285],
23	of	IN	O	of	_	0	SENT_197	[p14l946t1196r1030b1264],
24	the	DT	O	the	det	26	SENT_197	[p14l1073t1196r1190b1264],
25	efﬂux	NN	O	efﬂux	nn	26	SENT_197	[p14l1240t1196r1464b1264],
26	pump	NN	O	pump	prep_of	22	SENT_197	[p14l1513t1218r1754b1284],
27	.	.	O	.	_	0	SENT_197	[p14l1513t1218r1754b1284],

1	Previous	JJ	O	previous	amod	2	SENT_198	[p14l1808t1196r2144b1265],
2	studies	NNS	O	study	_	0	SENT_198	[p14l17t1302r280b1371],
3	on	IN	O	on	_	0	SENT_198	[p14l338t1324r432b1371],
4	simvastatin23	NN	O	simvastatin23	prep_on	2	SENT_198	[p14l491t1281r1094b1371],
5	’24	CD	NUMBER	’24	num	4	SENT_198	[p14l491t1281r1094b1371],
6	and	CC	O	and	_	0	SENT_198	[p14l1152t1302r1289b1371],
7	other	JJ	O	other	conj_and	4	SENT_198	[p14l1345t1302r1544b1371],
8	substrates25	CD	NUMBER	substrates25	num	9	SENT_198	[p14l1600t1281r2144b1371],
9	’26	CD	NUMBER	’26	dep	4	SENT_198	[p14l1600t1281r2144b1371],

1	indicate	VBP	O	indicate	_	0	SENT_199	[p14l13t1408r321b1476],
2	higher	JJR	O	higher	amod	4	SENT_199	[p14l352t1408r602b1496],
3	plasma	NN	O	plasma	nn	4	SENT_199	[p14l629t1408r907b1496],
4	levels	NNS	O	level	dobj	1	SENT_199	[p14l936t1408r1157b1477],
5	and	CC	O	and	_	0	SENT_199	[p14l1191t1408r1328b1476],
6	reduced	VBN	O	reduce	amod	7	SENT_199	[p14l1357t1408r1667b1476],
7	functioning	NN	O	functioning	dobj	1	SENT_199	[p14l1697t1408r2145b1496],
8	of	IN	O	of	_	0	SENT_199	[p14l14t1516r98b1584],
9	the	DT	O	the	det	10	SENT_199	[p14l134t1516r251b1584],
10	C3435T	NN	O	c3435t	prep_of	7	SENT_199	[p14l296t1515r612b1585],
11	variant	JJ	O	variant	amod	12	SENT_199	[p14l655t1516r924b1584],
12	alleles	NNS	O	allele	dep	10	SENT_199	[p14l968t1516r1235b1597],
13	,	,	O	,	_	0	SENT_199	[p14l968t1516r1235b1597],
14	although	IN	O	although	mark	15	SENT_199	[p14l1284t1516r1623b1604],
15	Fiegenbaum	NNP	PERSON	Fiegenbaum	dep	10	SENT_199	[p14l1664t1516r2147b1604],
16	et	FW	O	et	nn	17	SENT_199	[p14l15t1636r85b1692],
17	al.	FW	O	al.	dep	15	SENT_199	[p14l139t1602r307b1692],
18	23	CD	NUMBER	23	dep	7	SENT_199	[p14l139t1602r307b1692],
19	found	VBN	O	find	partmod	18	SENT_199	[p14l368t1623r614b1704],
20	,	,	O	,	_	0	SENT_199	[p14l368t1623r614b1704],
21	contradictorily	RB	O	contradictorily	advmod	19	SENT_199	[p14l676t1623r1265b1712],
22	,	,	O	,	_	0	SENT_199	[p14l676t1623r1265b1712],
23	a	DT	O	a	det	25	SENT_199	[p14l1328t1645r1368b1692],
24	decreased	VBN	O	decrease	amod	25	SENT_199	[p14l1425t1623r1809b1692],
25	risk	NN	O	risk	dobj	19	SENT_199	[p14l1864t1623r2011b1692],
26	of	IN	O	of	_	0	SENT_199	[p14l2068t1623r2152b1692],
27	adverse	JJ	O	adverse	amod	29	SENT_199	[p14l15t1729r308b1798],
28	drug	NN	O	drug	nn	29	SENT_199	[p14l338t1729r513b1818],
29	reactions	NNS	O	reaction	prep_of	25	SENT_199	[p14l541t1729r892b1797],
30	with	IN	O	with	_	0	SENT_199	[p14l922t1729r1094b1798],
31	the	DT	O	the	det	34	SENT_199	[p14l1121t1729r1238b1797],
32	C3435T	NN	O	c3435t	nn	34	SENT_199	[p14l1269t1729r1585b1798],
33	variant	JJ	O	variant	amod	34	SENT_199	[p14l1614t1729r1883b1798],
34	allele	NN	O	allele	prep_with	29	SENT_199	[p14l1912t1729r2140b1797],
35	.	.	O	.	_	0	SENT_199	[p14l1912t1729r2140b1797],

1	Besides	IN	O	besides	_	0	SENT_200	[p14l102t1836r402b1903],
2	simvastatin	NN	O	simvastatin	prep_besides	9	SENT_200	[p14l449t1836r888b1903],
3	and	CC	O	and	_	0	SENT_200	[p14l933t1836r1070b1903],
4	atorvastatin	NN	O	atorvastatin	prep_besides	9	SENT_200	[p14l1113t1836r1585b1916],
5	,	,	O	,	_	0	SENT_200	[p14l1113t1836r1585b1916],
6	the	DT	O	the	det	8	SENT_200	[p14l1631t1836r1748b1903],
7	CYP3A4	NN	O	cyp3a4	nn	8	SENT_200	[p14l1792t1836r2145b1904],
8	enzyme	NN	O	enzyme	nsubj	9	SENT_200	[p14l14t1963r315b2030],
9	metabolizes	VBZ	O	metabolize	_	0	SENT_200	[p14l360t1941r825b2010],
10	also	RB	O	also	advmod	9	SENT_200	[p14l874t1941r1025b2010],
11	lovastatin	NN	O	lovastatin	dobj	9	SENT_200	[p14l1072t1941r1447b2010],
12	and	CC	O	and	_	0	SENT_200	[p14l1494t1941r1631b2010],
13	cerivastatin	NN	O	cerivastatin	conj_and	11	SENT_200	[p14l1676t1941r2142b2022],
14	,	,	O	,	_	0	SENT_200	[p14l1676t1941r2142b2022],
15	but	CC	O	but	_	0	SENT_200	[p14l12t2047r136b2115],
16	these	DT	O	these	det	17	SENT_200	[p14l193t2047r391b2115],
17	statins	NNS	O	statin	nsubjpass	20	SENT_200	[p14l454t2047r696b2115],
18	were	VBD	O	be	auxpass	20	SENT_200	[p14l757t2069r944b2116],
19	not	RB	O	not	neg	20	SENT_200	[p14l1003t2058r1127b2115],
20	analyzed	VBN	O	analyze	conj_but	9	SENT_200	[p14l1186t2047r1531b2136],
21	in	IN	O	in	_	0	SENT_200	[p14l1589t2047r1663b2115],
22	this	DT	O	this	det	23	SENT_200	[p14l1721t2047r1858b2115],
23	study	NN	O	study	prep_in	20	SENT_200	[p14l1921t2047r2140b2136],
24	.	.	O	.	_	0	SENT_200	[p14l1921t2047r2140b2136],

1	Lovastatin	NNP	O	Lovastatin	nsubjpass	11	SENT_201	[p14l13t2153r422b2222],
2	was	VBD	O	be	auxpass	4	SENT_201	[p14l464t2175r610b2222],
3	not	RB	O	not	neg	4	SENT_201	[p14l653t2164r777b2222],
4	marketed	VBN	O	market	_	0	SENT_201	[p14l817t2153r1180b2222],
5	in	IN	O	in	_	0	SENT_201	[p14l1221t2153r1295b2221],
6	the	DT	O	the	det	7	SENT_201	[p14l1336t2153r1453b2222],
7	Netherlands	NNP	LOCATION	Netherlands	prep_in	4	SENT_201	[p14l1494t2153r1964b2222],
8	and	CC	O	and	_	0	SENT_201	[p14l2008t2153r2146b2222],
9	therefore	RB	O	therefore	advmod	4	SENT_201	[p14l13t2259r364b2327],
10	not	RB	O	not	neg	11	SENT_201	[p14l431t2270r555b2327],
11	dispensed	VBN	O	dispense	conj_and	4	SENT_201	[p14l620t2259r1003b2347],
12	to	TO	O	to	_	0	SENT_201	[p14l1068t2269r1141b2327],
13	the	DT	O	the	det	15	SENT_201	[p14l1207t2259r1324b2327],
14	study	NN	O	study	nn	15	SENT_201	[p14l1394t2259r1599b2347],
15	participants	NNS	O	participant	prep_to	11	SENT_201	[p14l1664t2259r2140b2347],
16	.	.	O	.	_	0	SENT_201	[p14l1664t2259r2140b2347],

1	Cerivastatin	NNP	O	Cerivastatin	nsubjpass	4	SENT_202	[p14l14t2367r481b2435],
2	is	VBZ	O	be	auxpass	4	SENT_202	[p14l517t2367r577b2435],
3	also	RB	O	also	advmod	4	SENT_202	[p14l618t2367r769b2435],
4	metabolized	VBN	O	metabolize	_	0	SENT_202	[p14l806t2367r1285b2435],
5	by	IN	O	by	_	0	SENT_202	[p14l1319t2367r1414b2455],
6	other	JJ	O	other	amod	9	SENT_202	[p14l1452t2367r1652b2435],
7	cytochrome	NN	O	cytochrome	nn	9	SENT_202	[p14l1687t2367r2145b2455],
8	P450	NN	O	p450	nn	9	SENT_202	[p14l13t2472r211b2541],
9	enzymes	NNS	O	enzyme	agent	4	SENT_202	[p14l260t2494r620b2561],
10	,	,	O	,	_	0	SENT_202	[p14l260t2494r620b2561],
11	such	JJ	O	such	_	0	SENT_202	[p14l674t2472r847b2541],
12	as	IN	O	as	_	0	SENT_202	[p14l897t2494r972b2541],
13	CYP2C8	NN	O	cyp2c8	prep_such_as	9	SENT_202	[p14l1022t2473r1391b2553],
14	,	,	O	,	_	0	SENT_202	[p14l1022t2473r1391b2553],
15	and	CC	O	and	cc	4	SENT_202	[p14l1445t2472r1582b2541],
16	therefore	RB	O	therefore	advmod	4	SENT_202	[p14l1629t2472r1980b2541],
17	the	DT	O	the	det	18	SENT_202	[p14l2028t2472r2144b2541],
18	effect	NN	O	effect	nsubj	26	SENT_202	[p14l14t2578r233b2646],
19	of	IN	O	of	_	0	SENT_202	[p14l273t2578r357b2646],
20	CYP3A4	NN	O	cyp3a4	nn	21	SENT_202	[p14l390t2578r743b2647],
21	inhibition	NN	O	inhibition	prep_of	18	SENT_202	[p14l783t2578r1162b2646],
22	on	IN	O	on	_	0	SENT_202	[p14l1203t2600r1296b2646],
23	Cerivastatin	NN	MISC	cerivastatin	nn	24	SENT_202	[p14l1336t2578r1782b2647],
24	levels	NNS	O	level	prep_on	21	SENT_202	[p14l1821t2578r2042b2647],
25	is	VBZ	O	be	aux	26	SENT_202	[p14l2083t2578r2144b2646],
26	limited	VBN	O	limit	ccomp	4	SENT_202	[p14l13t2686r290b2754],
27	because	IN	O	because	mark	32	SENT_202	[p14l328t2686r636b2754],
28	other	JJ	O	other	amod	29	SENT_202	[p14l678t2686r877b2754],
29	routes	NNS	O	route	nsubj	32	SENT_202	[p14l914t2696r1150b2754],
30	of	IN	O	of	_	0	SENT_202	[p14l1193t2686r1277b2754],
31	metabolism	NN	O	metabolism	prep_of	29	SENT_202	[p14l1310t2686r1767b2754],
32	compensate	VB	O	compensate	advcl	26	SENT_202	[p14l1806t2707r2143b2774, p14l17t2803r162b2861],
33	this	DT	O	this	det	34	SENT_202	[p14l248t2793r385b2861],
34	inhibition	NN	O	inhibition	dobj	32	SENT_202	[p14l471t2773r909b2861],
35	.7	CD	NUMBER	.7	num	34	SENT_202	[p14l471t2773r909b2861],
36	Moreover	RB	O	moreover	advmod	32	SENT_202	[p14l996t2795r1395b2873],
37	,	,	O	,	_	0	SENT_202	[p14l996t2795r1395b2873],
38	the	DT	O	the	det	39	SENT_202	[p14l1483t2793r1600b2861],
39	number	NN	O	number	dobj	26	SENT_202	[p14l1686t2793r1984b2861],
40	of	IN	O	of	_	0	SENT_202	[p14l2068t2793r2152b2861],
41	participants	NNS	O	participant	prep_of	39	SENT_202	[p14l12t2899r467b2988],
42	who	WP	O	who	nsubjpass	44	SENT_202	[p14l534t2899r697b2968],
43	were	VBD	O	be	auxpass	44	SENT_202	[p14l762t2921r948b2968],
44	prescribed	VBN	O	prescribe	rcmod	41	SENT_202	[p14l1013t2899r1421b2987],
45	Cerivastatin	NNP	MISC	Cerivastatin	nsubj	47	SENT_202	[p14l1486t2899r1931b2968],
46	was	VBD	O	be	cop	47	SENT_202	[p14l1997t2921r2144b2968],
47	small	JJ	O	small	ccomp	44	SENT_202	[p14l17t3005r244b3085],
48	,	,	O	,	_	0	SENT_202	[p14l17t3005r244b3085],
49	due	JJ	O	due	_	0	SENT_202	[p14l281t3005r418b3073],
50	to	TO	O	to	_	0	SENT_202	[p14l451t3016r524b3073],
51	its	PRP$	O	its	poss	52	SENT_202	[p14l558t3005r646b3073],
52	withdrawal	NN	O	withdrawal	prep_due_to	41	SENT_202	[p14l681t3005r1116b3073],
53	from	IN	O	from	_	0	SENT_202	[p14l1150t3005r1338b3073],
54	the	DT	O	the	det	55	SENT_202	[p14l1370t3005r1486b3073],
55	market	NN	O	market	prep_from	41	SENT_202	[p14l1520t3005r1791b3073],
56	in	IN	O	in	_	0	SENT_202	[p14l1822t3005r1896b3072],
57	2001	CD	DATE	2001	prep_in	55	SENT_202	[p14l1929t3006r2140b3073],
58	.	.	O	.	_	0	SENT_202	[p14l1929t3006r2140b3073],

1	During	IN	O	during	_	0	SENT_203	[p14l13t3110r286b3198],
2	the	DT	O	the	det	4	SENT_203	[p14l310t3110r427b3178],
3	study	NN	O	study	nn	4	SENT_203	[p14l454t3110r658b3198],
4	period	NN	O	period	prep_during	11	SENT_203	[p14l681t3110r950b3198],
5	,	,	O	,	_	0	SENT_203	[p14l681t3110r950b3198],
6	212	CD	NUMBER	212	num	7	SENT_203	[p14l978t3111r1119b3177],
7	participants	NNS	O	participant	nsubj	11	SENT_203	[p14l1142t3110r1597b3198],
8	were	VBD	O	be	cop	11	SENT_203	[p14l1622t3132r1808b3178],
9	incident	NN	O	incident	nn	11	SENT_203	[p14l1832t3110r2147b3178],
10	pravastatin	NN	O	pravastatin	nn	11	SENT_203	[p14l12t3218r438b3306],
11	users	NNS	O	user	_	0	SENT_203	[p14l471t3239r689b3286],
12	.	.	O	.	_	0	SENT_203	[p14l471t3239r689b3286],

1	No	DT	O	no	det	3	SENT_204	[p14l727t3220r843b3286],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_204	[p14l881t3218r1285b3306],
3	associations	NNS	O	association	nsubj	23	SENT_204	[p14l1319t3218r1786b3286],
4	between	IN	O	between	_	0	SENT_204	[p14l1820t3218r2145b3286],
5	the	DT	O	the	det	6	SENT_204	[p14l13t3323r130b3391],
6	CYP3A4	NN	O	cyp3a4	prep_between	3	SENT_204	[p14l184t3316r658b3391],
7	*	CD	NUMBER	*	num	8	SENT_204	[p14l184t3316r658b3391],
8	IB	NN	O	ib	nsubjpass	18	SENT_204	[p14l184t3316r658b3391],
9	or	CC	O	or	_	0	SENT_204	[p14l708t3345r787b3391],
10	ABCBI	NN	O	abcbus	nn	12	SENT_204	[p14l827t3323r1118b3391],
11	C3435T	NN	O	c3435t	nn	12	SENT_204	[p14l1175t3322r1491b3391],
12	polymorphisms	NNS	O	polymorphism	nsubjpass	18	SENT_204	[p14l1538t3323r2144b3411],
13	and	CC	O	and	_	0	SENT_204	[p14l15t3429r153b3497],
14	the	DT	O	the	det	16	SENT_204	[p14l185t3429r302b3497],
15	study	NN	O	study	nn	16	SENT_204	[p14l340t3429r544b3518],
16	outcome	NN	O	outcome	nsubjpass	18	SENT_204	[p14l580t3440r913b3497],
17	were	VBD	O	be	auxpass	18	SENT_204	[p14l946t3451r1132b3498],
18	found	VBN	O	find	rcmod	6	SENT_204	[p14l1167t3429r1393b3497],
19	for	IN	O	for	_	0	SENT_204	[p14l1425t3429r1538b3497],
20	the	DT	O	the	det	22	SENT_204	[p14l1569t3429r1686b3497],
21	pravastatin	NN	O	pravastatin	nn	22	SENT_204	[p14l1719t3429r2146b3517],
22	users	NNS	O	user	prep_for	18	SENT_204	[p14l12t3557r209b3604],
23	(	VBP	O	(	_	0	SENT_204	[p14l250t3536r530b3620],
24	results	VBZ	O	result	ccomp	23	SENT_204	[p14l250t3536r530b3620],
25	not	RB	O	not	neg	24	SENT_204	[p14l567t3546r691b3604],
26	shown	VBN	O	show	dep	24	SENT_204	[p14l728t3536r1026b3620],
27	)	NN	O	)	dobj	26	SENT_204	[p14l728t3536r1026b3620],
28	.	.	O	.	_	0	SENT_204	[p14l728t3536r1026b3620],

1	The	DT	O	the	det	3	SENT_205	[p15l102t18r251b87],
2	CYP3A4	NN	O	cyp3a4	nn	3	SENT_205	[p15l285t19r615b87],
3	gene	NN	O	gene	nsubjpass	5	SENT_205	[p15l645t40r825b107],
4	is	VBZ	O	be	auxpass	5	SENT_205	[p15l855t18r915b87],
5	expressed	VBN	O	express	_	0	SENT_205	[p15l947t18r1328b107],
6	both	CC	O	both	dep	5	SENT_205	[p15l1355t18r1528b87],
7	in	IN	O	in	_	0	SENT_205	[p15l1555t18r1629b86],
8	the	DT	O	the	det	9	SENT_205	[p15l1658t18r1774b87],
9	liver	NN	O	liver	prep_in	5	SENT_205	[p15l1804t18r1980b87],
10	and	CC	O	and	_	0	SENT_205	[p15l2008t18r2146b87],
11	the	DT	O	the	det	12	SENT_205	[p15l13t124r130b193],
12	wall	NN	O	wall	prep_in	5	SENT_205	[p15l164t124r330b193],
13	of	IN	O	of	_	0	SENT_205	[p15l367t124r451b193],
14	the	DT	O	the	det	15	SENT_205	[p15l480t124r597b193],
15	intestine	NN	O	intestine	prep_of	12	SENT_205	[p15l633t124r983b193],
16	.	.	O	.	_	0	SENT_205	[p15l633t124r983b193],

1	Simvastatin	NNP	O	Simvastatin	nsubj	9	SENT_206	[p15l1026t124r1482b193],
2	and	CC	O	and	_	0	SENT_206	[p15l1520t124r1657b193],
3	atorvastatin	NN	O	atorvastatin	conj_and	1	SENT_206	[p15l1694t124r2146b193],
4	are	VBP	O	be	cop	7	SENT_206	[p15l15t253r129b300],
5	both	DT	O	both	det	7	SENT_206	[p15l170t231r343b300],
6	lipophilic	JJ	O	lipophilic	amod	7	SENT_206	[p15l383t231r755b320],
7	drugs	NNS	O	drug	_	0	SENT_206	[p15l799t231r1010b320],
8	and	CC	O	and	_	0	SENT_206	[p15l1054t231r1191b300],
9	oxidized	VBN	O	oxidize	conj_and	7	SENT_206	[p15l1232t231r1567b300],
10	to	TO	O	to	_	0	SENT_206	[p15l1607t242r1679b300],
11	inactive	JJ	O	inactive	amod	15	SENT_206	[p15l1720t231r2026b300],
12	or	CC	O	or	_	0	SENT_206	[p15l2068t253r2147b300],
13	modestly	RB	O	modestly	advmod	14	SENT_206	[p15l13t336r369b424],
14	active	JJ	O	active	amod	15	SENT_206	[p15l443t336r670b404],
15	metabolites	NNS	O	metabolite	prep_to	9	SENT_206	[p15l743t336r1191b404],
16	by	IN	O	by	_	0	SENT_206	[p15l1263t336r1358b424],
17	CYP3A4	NN	O	cyp3a4	prep_by	9	SENT_206	[p15l1432t336r1805b405],
18	.	.	O	.	_	0	SENT_206	[p15l1432t336r1805b405],

1	Before	IN	O	before	_	0	SENT_207	[p15l1882t336r2145b404],
2	entering	VBG	O	enter	prepc_before	13	SENT_207	[p15l14t444r331b532],
3	the	DT	O	the	det	4	SENT_207	[p15l380t444r496b512],
4	circulation	NN	O	circulation	dobj	2	SENT_207	[p15l546t444r983b524],
5	,	,	O	,	_	0	SENT_207	[p15l546t444r983b524],
6	the	DT	O	the	det	7	SENT_207	[p15l1034t444r1151b512],
7	majority	NN	O	majority	nsubjpass	13	SENT_207	[p15l1199t444r1529b532],
8	of	IN	O	of	_	0	SENT_207	[p15l1578t444r1662b512],
9	simvastatin	NN	O	simvastatin	prep_of	7	SENT_207	[p15l1707t444r2146b512],
10	and	CC	O	and	_	0	SENT_207	[p15l15t549r153b618],
11	atorvastatin	NN	O	atorvastatin	prep_of	7	SENT_207	[p15l241t549r692b618],
12	is	VBZ	O	be	auxpass	13	SENT_207	[p15l779t549r840b618],
13	metabolized	VBN	O	metabolize	_	0	SENT_207	[p15l928t549r1427b630],
14	,	,	O	,	_	0	SENT_207	[p15l928t549r1427b630],
15	resulting	VBG	O	result	xcomp	13	SENT_207	[p15l1516t549r1856b638],
16	in	IN	O	in	_	0	SENT_207	[p15l1944t549r2017b617],
17	a	DT	O	a	det	18	SENT_207	[p15l2106t571r2147b618],
18	bioavailability	NN	O	bioavailability	prep_in	15	SENT_207	[p15l12t655r575b744],
19	of	IN	O	of	_	0	SENT_207	[p15l599t655r683b723],
20	ﬁve	NN	O	ﬁve	prep_of	18	SENT_207	[p15l700t655r841b724],
21	and	CC	O	and	_	0	SENT_207	[p15l866t655r1004b723],
22	twelve	CD	NUMBER	twelve	prep_in	15	SENT_207	[p15l1026t655r1282b724],
23	per	IN	O	per	_	0	SENT_207	[p15l1304t677r1430b744],
24	cent	NN	O	cent	prep_per	22	SENT_207	[p15l1451t666r1633b736],
25	,	,	O	,	_	0	SENT_207	[p15l1451t666r1633b736],
26	respectively	RB	O	respectively	advmod	15	SENT_207	[p15l1657t655r2140b744],
27	.	.	O	.	_	0	SENT_207	[p15l1657t655r2140b744],

1	This	DT	O	this	det	3	SENT_208	[p15l13t762r183b830],
2	low	JJ	O	low	amod	3	SENT_208	[p15l217t762r358b830],
3	bioavailability	NN	O	bioavailability	nsubj	6	SENT_208	[p15l389t762r953b850],
4	is	VBZ	O	be	cop	6	SENT_208	[p15l985t762r1046b830],
5	an	DT	O	a	det	6	SENT_208	[p15l1082t783r1170b830],
6	explanation	NN	O	explanation	_	0	SENT_208	[p15l1203t762r1657b850],
7	why	WRB	O	why	advmod	18	SENT_208	[p15l1690t762r1854b850],
8	inhibition	NN	O	inhibition	nsubj	18	SENT_208	[p15l1887t762r2143b830, p15l13t867r164b936],
9	of	IN	O	of	_	0	SENT_208	[p15l197t867r280b936],
10	CYP3A4	NN	O	cyp3a4	nn	13	SENT_208	[p15l308t868r661b936],
11	and	CC	O	and	_	0	SENT_208	[p15l696t867r833b936],
12	genetic	JJ	O	genetic	conj_and	10	SENT_208	[p15l866t867r1144b956],
13	variation	NN	O	variation	prep_of	8	SENT_208	[p15l1179t867r1523b936],
14	in	IN	O	in	_	0	SENT_208	[p15l1555t867r1629b935],
15	the	DT	O	the	det	17	SENT_208	[p15l1661t867r1778b936],
16	CYP3A4	NN	O	cyp3a4	nn	17	SENT_208	[p15l1816t868r2145b936],
17	gene	NN	O	gene	prep_in	13	SENT_208	[p15l14t995r195b1062],
18	has	VBZ	O	have	rcmod	6	SENT_208	[p15l224t973r350b1041],
19	a	DT	O	a	det	21	SENT_208	[p15l382t995r422b1041],
20	substantial	JJ	O	substantial	amod	21	SENT_208	[p15l452t973r865b1041],
21	impact	NN	O	impact	dobj	18	SENT_208	[p15l894t973r1160b1062],
22	on	IN	O	on	_	0	SENT_208	[p15l1189t995r1282b1041],
23	the	DT	O	the	det	24	SENT_208	[p15l1311t973r1427b1041],
24	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	21	SENT_208	[p15l1454t973r2144b1061],
25	of	IN	O	of	_	0	SENT_208	[p15l14t1079r98b1148],
26	these	DT	O	these	det	27	SENT_208	[p15l127t1079r325b1148],
27	drugs	NNS	O	drug	prep_of	24	SENT_208	[p15l363t1079r595b1168],
28	.	.	O	.	_	0	SENT_208	[p15l363t1079r595b1168],

1	ABCBl	NN	O	abcbl	nsubj	18	SENT_209	[p15l102t1184r406b1253],
2	is	VBZ	O	be	auxpass	3	SENT_209	[p15l462t1184r522b1252],
3	expressed	VBN	O	express	_	0	SENT_209	[p15l572t1184r954b1272],
4	in	IN	O	in	_	0	SENT_209	[p15l1001t1184r1075b1251],
5	the	DT	O	the	det	6	SENT_209	[p15l1122t1184r1239b1252],
6	wall	NN	O	wall	prep_in	3	SENT_209	[p15l1286t1184r1451b1252],
7	of	IN	O	of	_	0	SENT_209	[p15l1501t1184r1584b1252],
8	the	DT	O	the	det	9	SENT_209	[p15l1626t1184r1742b1252],
9	intestine	NN	O	intestine	prep_of	6	SENT_209	[p15l1791t1184r2142b1265],
10	,	,	O	,	_	0	SENT_209	[p15l1791t1184r2142b1265],
11	kidney	NN	O	kidney	appos	9	SENT_209	[p15l12t1292r291b1380],
12	,	,	O	,	_	0	SENT_209	[p15l12t1292r291b1380],
13	liver	NN	O	liver	conj_and	11	SENT_209	[p15l316t1292r507b1372],
14	,	,	O	,	_	0	SENT_209	[p15l316t1292r507b1372],
15	and	CC	O	and	_	0	SENT_209	[p15l534t1292r672b1360],
16	brain	NN	O	brain	conj_and	11	SENT_209	[p15l691t1292r891b1360],
17	and	CC	O	and	_	0	SENT_209	[p15l914t1292r1052b1360],
18	protects	VBZ	O	protect	conj_and	3	SENT_209	[p15l1071t1302r1378b1380],
19	against	IN	O	against	_	0	SENT_209	[p15l1403t1292r1678b1380],
20	xenobiotics	NNS	O	xenobiotic	prep_against	18	SENT_209	[p15l1698t1292r2144b1360],
21	by	IN	O	by	_	0	SENT_209	[p15l12t1397r108b1486],
22	transporting	VBG	O	transport	prepc_by	18	SENT_209	[p15l141t1397r611b1486],
23	these	DT	O	these	dobj	22	SENT_209	[p15l645t1397r843b1466],
24	out	IN	O	out	_	0	SENT_209	[p15l878t1408r1000b1466],
25	of	IN	O	of	_	0	SENT_209	[p15l1033t1397r1117b1466],
26	the	DT	O	the	det	27	SENT_209	[p15l1144t1397r1261b1466],
27	body	NN	O	body	prep_out_of	22	SENT_209	[p15l1293t1397r1500b1486],
28	.	.	O	.	_	0	SENT_209	[p15l1293t1397r1500b1486],

1	For	IN	O	for	_	0	SENT_210	[p15l1538t1399r1672b1466],
2	simvastatin	NN	O	simvastatin	prep_for	22	SENT_210	[p15l1707t1397r2146b1466],
3	and	CC	O	and	_	0	SENT_210	[p15l15t1503r153b1571],
4	atorvastatin	NN	O	atorvastatin	prep_for	22	SENT_210	[p15l189t1503r661b1583],
5	,	,	O	,	_	0	SENT_210	[p15l189t1503r661b1583],
6	the	DT	O	the	det	7	SENT_210	[p15l700t1503r817b1571],
7	effects	NNS	O	effect	nsubj	22	SENT_210	[p15l854t1503r1108b1571],
8	of	IN	O	of	_	0	SENT_210	[p15l1147t1503r1230b1570],
9	ABCB1	NN	O	abcb1	prep_of	7	SENT_210	[p15l1259t1503r1562b1571],
10	in	IN	O	in	_	0	SENT_210	[p15l1605t1503r1680b1570],
11	the	DT	O	the	det	12	SENT_210	[p15l1715t1503r1831b1571],
12	wall	NN	O	wall	prep_in	9	SENT_210	[p15l1866t1503r2031b1571],
13	of	IN	O	of	_	0	SENT_210	[p15l2068t1503r2152b1571],
14	the	DT	O	the	det	15	SENT_210	[p15l13t1610r130b1678],
15	intestine	NN	O	intestine	prep_of	12	SENT_210	[p15l156t1610r485b1678],
16	and	CC	O	and	_	0	SENT_210	[p15l514t1610r651b1678],
17	in	IN	O	in	_	0	SENT_210	[p15l676t1610r750b1677],
18	the	DT	O	the	det	19	SENT_210	[p15l775t1610r891b1678],
19	liver	NN	O	liver	prep_in	9	SENT_210	[p15l919t1610r1094b1678],
20	are	VBP	O	be	cop	22	SENT_210	[p15l1120t1631r1234b1678],
21	most	RBS	O	most	advmod	22	SENT_210	[p15l1261t1620r1450b1678],
22	relevant	JJ	O	relevant	_	0	SENT_210	[p15l1473t1610r1803b1678],
23	.	.	O	.	_	0	SENT_210	[p15l1473t1610r1803b1678],

1	ABCBl	NN	O	abcbl	_	0	SENT_211	[p15l1833t1610r2137b1679],

1	Pharmacoepidemiology	NNP	O	Pharmacoepidemiology	nn	4	SENT_212	[p15l236t1841r1001b1912],
2	and	CC	O	and	_	0	SENT_212	[p15l1030t1841r1152b1897],
3	Drug	NNP	O	Drug	nn	4	SENT_212	[p15l1175t1843r1342b1912],
4	Safety	NNP	O	Safety	_	0	SENT_212	[p15l1372t1841r1578b1913],
5	,	,	O	,	_	0	SENT_212	[p15l1372t1841r1578b1913],
6	2010	CD	DATE	2010	appos	4	SENT_212	[p15l1611t1841r1787b1907],
7	;	:	O	;	_	0	SENT_212	[p15l1611t1841r1787b1907],
8	19	CD	NUMBER	19	dep	4	SENT_212	[p15l1823t1840r1913b1897],
9	:	:	O	:	_	0	SENT_212	[p15l1823t1840r1913b1897],
10	75-81	CD	NUMBER	75-81	num	11	SENT_212	[p15l1948t1841r2138b1897],
11	DOI	NNP	O	DOI	dep	8	SENT_212	[p15l1564t1929r1720b1985],
12	:	:	O	:	_	0	SENT_212	[p15l1564t1929r1720b1985],
13	10.1002	CD	NUMBER	10.1002	dep	11	SENT_212	[p15l1762t1929r2144b2001],
14	/	:	O	/	punct	11	SENT_212	[p15l1762t1929r2144b2001],
15	pds	NNS	O	pd	dep	8	SENT_212	[p15l1762t1929r2144b2001],

1	80	CD	NUMBER	80	_	0	SENT_213	[p15l477t2076r516b2105],
2	M.	NNP	NUMBER	M.	nn	5	SENT_213	[p15l1359t2084r1394b2105],
3	L.	NNP	PERSON	L.	nn	5	SENT_213	[p15l1412t2084r1439b2105],
4	BECKER	NNP	PERSON	BECKER	nn	5	SENT_213	[p15l1457t2084r1582b2105],
5	ETAL	NNP	O	ETAL	dep	1	SENT_213	[p15l1597t2083r1682b2105],
6	.	.	O	.	_	0	SENT_213	[p15l1597t2083r1682b2105],

1	transports	NNS	O	transport	nn	2	SENT_214	[p15l8t2216r391b2294],
2	simvastatin	NN	O	simvastatin	_	0	SENT_214	[p15l463t2206r904b2274],
3	and	CC	O	and	_	0	SENT_214	[p15l972t2206r1110b2274],
4	atorvastatin	NN	O	atorvastatin	conj_and	2	SENT_214	[p15l1177t2206r1631b2275],
5	out	IN	O	out	_	0	SENT_214	[p15l1699t2216r1822b2274],
6	of	IN	O	of	_	0	SENT_214	[p15l1888t2206r1973b2274],
7	the	DT	O	the	det	9	SENT_214	[p15l2032t2206r2150b2274],
8	intestine	NN	O	intestine	nn	9	SENT_214	[p15l8t2313r339b2381],
9	wall	NN	O	wall	conj_and	9	SENT_214	[p15l359t2313r525b2381],
10	into	IN	O	into	_	0	SENT_214	[p15l546t2313r695b2381],
11	the	DT	O	the	det	12	SENT_214	[p15l718t2313r835b2381],
12	lumen	NN	O	luman	prep_into	9	SENT_214	[p15l857t2313r1121b2393],
13	,	,	O	,	_	0	SENT_214	[p15l857t2313r1121b2393],
14	and	CC	O	and	_	0	SENT_214	[p15l1148t2313r1286b2381],
15	out	IN	O	out	_	0	SENT_214	[p15l1308t2323r1431b2381],
16	of	IN	O	of	_	0	SENT_214	[p15l1452t2312r1536b2381],
17	the	DT	O	the	det	18	SENT_214	[p15l1550t2313r1667b2381],
18	hepatocytes	NNS	O	hepatocyte	prep_of	2	SENT_214	[p15l1688t2313r2148b2401],
19	into	IN	O	into	_	0	SENT_214	[p15l8t2418r158b2487],
20	the	DT	O	the	det	21	SENT_214	[p15l182t2418r299b2487],
21	bile	NN	O	bile	prep_into	18	SENT_214	[p15l322t2418r488b2487],
22	.	.	O	.	_	0	SENT_214	[p15l322t2418r488b2487],

1	After	IN	O	after	_	0	SENT_215	[p15l517t2418r724b2487],
2	transportation	NN	O	transportation	prep_after	17	SENT_215	[p15l745t2418r1291b2507],
3	into	IN	O	into	_	0	SENT_215	[p15l1314t2418r1463b2487],
4	the	DT	O	the	det	5	SENT_215	[p15l1488t2418r1605b2487],
5	lumen	NN	O	luman	prep_into	2	SENT_215	[p15l1630t2418r1874b2487],
6	or	CC	O	or	_	0	SENT_215	[p15l1899t2440r1979b2487],
7	into	IN	O	into	_	0	SENT_215	[p15l2000t2418r2149b2487],
8	the	DT	O	the	det	9	SENT_215	[p15l8t2524r125b2592],
9	bile	NN	O	bile	conj_or	5	SENT_215	[p15l194t2524r362b2605],
10	,	,	O	,	_	0	SENT_215	[p15l194t2524r362b2605],
11	the	DT	O	the	det	12	SENT_215	[p15l435t2524r552b2592],
12	simvastatin	NN	O	simvastatin	nsubj	17	SENT_215	[p15l627t2524r1068b2593],
13	and	CC	O	and	_	0	SENT_215	[p15l1139t2524r1278b2592],
14	atorvastatin	NN	O	atorvastatin	conj_and	12	SENT_215	[p15l1349t2524r1803b2593],
15	is	VBZ	O	be	cop	17	SENT_215	[p15l1872t2524r1933b2592],
16	still	RB	O	still	advmod	17	SENT_215	[p15l2008t2524r2150b2592],
17	available	JJ	O	available	_	0	SENT_215	[p15l10t2632r358b2700],
18	for	IN	O	for	_	0	SENT_215	[p15l381t2632r495b2700],
19	reabsorption	NN	O	reabsorption	prep_for	17	SENT_215	[p15l514t2632r1005b2720],
20	and	CC	O	and	_	0	SENT_215	[p15l1029t2632r1167b2700],
21	uptake	NN	O	uptake	prep_for	17	SENT_215	[p15l1187t2632r1447b2720],
22	in	IN	O	in	_	0	SENT_215	[p15l1470t2632r1544b2699],
23	the	DT	O	the	det	24	SENT_215	[p15l1566t2632r1683b2700],
24	circulation	NN	O	circulation	prep_in	17	SENT_215	[p15l1707t2632r2146b2700],
25	.	.	O	.	_	0	SENT_215	[p15l1707t2632r2146b2700],

1	This	DT	DATE	this	nsubj	3	SENT_216	[p15l8t2736r178b2804],
2	may	MD	DATE	may	aux	3	SENT_216	[p15l211t2758r378b2824],
3	explain	VB	O	explain	_	0	SENT_216	[p15l410t2736r696b2824],
4	why	WRB	O	why	advmod	14	SENT_216	[p15l728t2736r893b2824],
5	the	DT	O	the	det	6	SENT_216	[p15l925t2736r1042b2804],
6	effect	NN	O	effect	nsubj	14	SENT_216	[p15l1075t2736r1296b2804],
7	of	IN	O	of	_	0	SENT_216	[p15l1327t2736r1412b2804],
8	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_216	[p15l1435t2736r2043b2824],
9	in	IN	O	in	_	0	SENT_216	[p15l2076t2736r2151b2803],
10	the	DT	O	the	det	12	SENT_216	[p15l8t2844r125b2912],
11	ABCBI	NN	O	abcbus	nn	12	SENT_216	[p15l165t2844r457b2913],
12	gene	NN	O	gene	prep_in	8	SENT_216	[p15l511t2865r693b2932],
13	was	VBD	O	be	cop	14	SENT_216	[p15l737t2865r885b2912],
14	smaller	JJR	O	smaller	advcl	3	SENT_216	[p15l936t2844r1222b2912],
15	than	IN	O	than	_	0	SENT_216	[p15l1266t2844r1433b2912],
16	the	DT	O	the	det	17	SENT_216	[p15l1478t2844r1595b2912],
17	effect	NN	O	effect	prep_than	14	SENT_216	[p15l1643t2844r1863b2912],
18	of	IN	O	of	_	0	SENT_216	[p15l1909t2843r1994b2912],
19	the	DT	O	the	det	20	SENT_216	[p15l2032t2844r2150b2912],
20	polymorphism	NN	O	polymorphism	prep_of	17	SENT_216	[p15l7t2949r580b3038],
21	in	IN	O	in	_	0	SENT_216	[p15l619t2949r693b3017],
22	the	DT	O	the	det	25	SENT_216	[p15l733t2949r850b3017],
23	C	NN	O	c	nn	25	SENT_216	[p15l896t2951r958b3018],
24	YP3A4	NN	O	yp3a4	nn	25	SENT_216	[p15l963t2950r1227b3017],
25	gene	NN	O	gene	prep_in	20	SENT_216	[p15l1268t2971r1470b3038],
26	.	.	O	.	_	0	SENT_216	[p15l1268t2971r1470b3038],

1	In	IN	O	in	_	0	SENT_217	[p15l1515t2951r1594b3017],
2	patients	NNS	O	patient	prep_in	24	SENT_217	[p15l1633t2949r1937b3038],
3	with	IN	O	with	_	0	SENT_217	[p15l1979t2949r2151b3018],
4	the	DT	O	the	det	7	SENT_217	[p15l8t3054r122b3122],
5	ABCBI	NNP	O	ABCBI	nn	7	SENT_217	[p15l149t3055r436b3123],
6	3435TT	NNP	O	3435TT	nn	7	SENT_217	[p15l479t3054r782b3123],
7	genotype	NN	O	genotype	prep_with	2	SENT_217	[p15l817t3064r1184b3142],
8	,	,	O	,	_	0	SENT_217	[p15l817t3064r1184b3142],
9	the	DT	O	the	det	11	SENT_217	[p15l1220t3054r1334b3122],
10	intracellular	JJ	O	intracellular	amod	11	SENT_217	[p15l1368t3054r1827b3122],
11	simvastatin	NN	O	simvastatin	nsubj	24	SENT_217	[p15l1862t3054r2148b3122, p15l8t3162r175b3230],
12	and	CC	O	and	_	0	SENT_217	[p15l203t3161r338b3230],
13	atorvastatin	NN	O	atorvastatin	nn	14	SENT_217	[p15l365t3162r802b3230],
14	concentrations	NNS	O	concentration	nsubj	24	SENT_217	[p15l829t3162r1378b3230],
15	in	IN	O	in	_	0	SENT_217	[p15l1406t3162r1478b3229],
16	the	DT	O	the	det	18	SENT_217	[p15l1504t3162r1618b3230],
17	intestine	NN	O	intestine	nn	18	SENT_217	[p15l1644t3162r1963b3230],
18	wall	NN	O	wall	prep_in	11	SENT_217	[p15l1988t3162r2150b3230],
19	and	CC	O	and	_	0	SENT_217	[p15l10t3268r145b3337],
20	hepatocyte	NN	O	hepatocyte	conj_and	18	SENT_217	[p15l174t3268r584b3357],
21	are	VBP	O	be	cop	24	SENT_217	[p15l617t3290r730b3337],
22	probably	RB	O	probably	advmod	23	SENT_217	[p15l759t3268r1096b3357],
23	higher	JJR	O	higher	advmod	24	SENT_217	[p15l1127t3268r1370b3357],
24	due	JJ	O	due	_	0	SENT_217	[p15l1400t3268r1535b3337],
25	to	TO	O	to	_	0	SENT_217	[p15l1565t3279r1637b3337],
26	the	DT	O	the	det	29	SENT_217	[p15l1668t3268r1782b3337],
27	impaired	JJ	O	impaired	amod	29	SENT_217	[p15l1813t3268r2151b3357],
28	efﬂux	NN	O	efﬂux	nn	29	SENT_217	[p15l9t3373r228b3441],
29	functioning	NN	O	functioning	prep_to	24	SENT_217	[p15l256t3373r691b3461],
30	of	IN	O	of	_	0	SENT_217	[p15l720t3373r803b3441],
31	the	DT	O	the	det	33	SENT_217	[p15l823t3373r937b3441],
32	ABCBl	NNP	O	ABCBl	nn	33	SENT_217	[p15l965t3373r1264b3442],
33	transporter	NN	O	transporter	prep_of	29	SENT_217	[p15l1299t3383r1721b3461],
34	.	.	O	.	_	0	SENT_217	[p15l1299t3383r1721b3461],

1	Therefore	RB	O	therefore	advmod	8	SENT_218	[p15l1753t3373r2148b3454],
2	,	,	O	,	_	0	SENT_218	[p15l1753t3373r2148b3454],
3	more	JJR	O	more	amod	4	SENT_218	[p15l8t3502r207b3549],
4	simvastatin	NN	O	simvastatin	nsubj	8	SENT_218	[p15l274t3480r715b3549],
5	and	CC	O	and	_	0	SENT_218	[p15l780t3481r918b3549],
6	atorvastatin	NN	O	atorvastatin	nsubj	8	SENT_218	[p15l982t3481r1436b3549],
7	is	VBZ	O	be	cop	8	SENT_218	[p15l1498t3480r1559b3549],
8	available	JJ	O	available	_	0	SENT_218	[p15l1627t3481r1975b3549],
9	for	IN	O	for	_	0	SENT_218	[p15l2039t3480r2153b3549],
10	metabolism	NN	O	metabolism	prep_for	8	SENT_218	[p16l8t25r467b93],
11	by	IN	O	by	_	0	SENT_218	[p16l490t25r586b113],
12	CYP3A4	NN	O	cyp3a4	prep_by	8	SENT_218	[p16l614t25r969b94],
13	and	CC	O	and	cc	8	SENT_218	[p16l998t25r1156b106],
14	,	,	O	,	_	0	SENT_218	[p16l998t25r1156b106],
15	consequently	RB	O	consequently	advmod	28	SENT_218	[p16l1187t25r1718b113],
16	,	,	O	,	_	0	SENT_218	[p16l1187t25r1718b113],
17	the	DT	O	the	det	18	SENT_218	[p16l1748t25r1865b93],
18	effects	NNS	O	effect	dep	24	SENT_218	[p16l1893t25r2149b93],
19	of	IN	O	of	_	0	SENT_218	[p16l9t133r94b202],
20	the	DT	O	the	det	21	SENT_218	[p16l160t133r277b202],
21	C	NN	O	c	prep_of	18	SENT_218	[p16l355t135r417b202],
22	YP3A4	NN	O	yp3a4	dep	24	SENT_218	[p16l422t126r765b201],
23	*	CD	NUMBER	*	num	22	SENT_218	[p16l422t126r765b201],
24	I	PRP	O	I	dep	28	SENT_218	[p16l422t126r765b201],
25	B	NN	O	b	dep	24	SENT_218	[p16l773t136r832b201],
26	polymorphism	NN	O	polymorphism	nsubj	28	SENT_218	[p16l904t133r1478b222],
27	is	VBZ	O	be	cop	28	SENT_218	[p16l1549t133r1609b202],
28	stronger	JJR	O	stronger	ccomp	8	SENT_218	[p16l1688t143r2006b222],
29	in	IN	O	in	_	0	SENT_218	[p16l2076t133r2151b201],
30	patients	NNS	O	patient	prep_in	28	SENT_218	[p16l7t239r310b328],
31	with	IN	O	with	_	0	SENT_218	[p16l361t239r533b308],
32	the	DT	O	the	det	35	SENT_218	[p16l582t239r699b308],
33	ABCB1	NN	O	abcb1	nn	35	SENT_218	[p16l742t240r1034b308],
34	3435TT	NN	O	3435tt	nn	35	SENT_218	[p16l1093t239r1404b308],
35	genotype	NN	O	genotype	prep_with	30	SENT_218	[p16l1454t250r1811b328],
36	than	IN	O	than	dep	28	SENT_218	[p16l1860t239r2028b308],
37	in	IN	O	in	_	0	SENT_218	[p16l2076t239r2151b307],
38	patients	NNS	O	patient	prep_in	28	SENT_218	[p16l7t344r310b432],
39	with	IN	O	with	_	0	SENT_218	[p16l348t344r520b412],
40	the	DT	O	the	det	42	SENT_218	[p16l555t344r673b412],
41	CC	NN	O	cc	nn	42	SENT_218	[p16l710t344r835b413],
42	genotype	NN	O	genotype	prep_with	38	SENT_218	[p16l874t354r1250b432],
43	.	.	O	.	_	0	SENT_218	[p16l874t354r1250b432],

1	In	IN	O	in	_	0	SENT_219	[p16l97t453r176b519],
2	our	PRP$	O	we	poss	3	SENT_219	[p16l218t473r347b520],
3	study	NN	O	study	prep_in	5	SENT_219	[p16l390t452r596b540],
4	we	PRP	O	we	nsubj	5	SENT_219	[p16l638t473r749b520],
5	found	VBD	O	find	_	0	SENT_219	[p16l791t452r1018b520],
6	an	DT	O	a	det	7	SENT_219	[p16l1060t473r1148b520],
7	association	NN	O	association	dobj	5	SENT_219	[p16l1192t452r1625b520],
8	between	IN	O	between	_	0	SENT_219	[p16l1665t452r1992b520],
9	the	DT	O	the	det	13	SENT_219	[p16l2032t452r2150b520],
10	CYP3A4	NN	O	cyp3a4	nn	13	SENT_219	[p16l13t551r489b627],
11	*	CD	NUMBER	*	num	13	SENT_219	[p16l13t551r489b627],
12	IB	NNP	O	IB	nn	13	SENT_219	[p16l13t551r489b627],
13	polymorphism	NN	O	polymorphism	prep_between	7	SENT_219	[p16l541t558r1115b647],
14	and	CC	O	and	_	0	SENT_219	[p16l1169t558r1307b627],
15	a	DT	O	a	det	17	SENT_219	[p16l1360t580r1401b627],
16	dose	NN	O	dose	nn	17	SENT_219	[p16l1453t558r1629b626],
17	decrease	NN	O	decrease	prep_between	7	SENT_219	[p16l1683t558r2018b627],
18	or	CC	O	or	_	0	SENT_219	[p16l2072t580r2152b626],
19	switch	NN	O	switch	conj_or	17	SENT_219	[p16l11t663r262b732],
20	to	TO	O	to	_	0	SENT_219	[p16l291t673r364b731],
21	another	DT	O	another	det	22	SENT_219	[p16l398t663r691b731],
22	cholesterol	NN	O	cholesterol	prep_to	5	SENT_219	[p16l719t663r1147b731],
23	lowering	VBG	O	lower	partmod	22	SENT_219	[p16l1178t663r1522b751],
24	drug	NN	O	drug	dobj	23	SENT_219	[p16l1554t663r1729b751],
25	in	IN	O	in	_	0	SENT_219	[p16l1760t663r1834b730],
26	women	NNS	O	woman	prep_in	23	SENT_219	[p16l1864t684r2151b732],
27	using	VBG	O	use	partmod	26	SENT_219	[p16l7t771r217b859],
28	simvastatin	NN	O	simvastatin	dobj	27	SENT_219	[p16l255t771r695b839],
29	or	CC	O	or	_	0	SENT_219	[p16l730t792r810b839],
30	atorvastatin	NN	O	atorvastatin	conj_or	28	SENT_219	[p16l844t771r1317b839],
31	.	.	O	.	_	0	SENT_219	[p16l844t771r1317b839],

1	It	PRP	O	it	nsubjpass	4	SENT_220	[p16l1355t773r1414b839],
2	has	VBZ	O	have	aux	4	SENT_220	[p16l1445t771r1573b839],
3	been	VBN	O	be	auxpass	4	SENT_220	[p16l1607t771r1791b839],
4	reported	VBN	O	report	_	0	SENT_220	[p16l1824t771r2152b859],
5	that	IN	O	that	complm	9	SENT_220	[p16l8t876r155b945],
6	CYP3A4	NN	O	cyp3a4	nn	7	SENT_220	[p16l181t876r536b945],
7	activity	NN	O	activity	nsubj	9	SENT_220	[p16l566t876r855b965],
8	is	VBZ	O	be	cop	9	SENT_220	[p16l883t876r944b945],
9	higher	JJR	O	higher	ccomp	4	SENT_220	[p16l972t876r1223b965],
10	in	IN	O	in	_	0	SENT_220	[p16l1249t876r1323b944],
11	women	NNS	O	woman	prep_in	9	SENT_220	[p16l1350t898r1636b945],
12	compared	VBN	O	compare	_	0	SENT_220	[p16l1664t876r2050b965],
13	to	TO	O	to	prepc_compared_to	11	SENT_220	[p16l2076t887r2149b945],
14	men	NNS	O	man	pobj	11	SENT_220	[p16l8t963r363b1064],
15	,27	CD	NUMBER	,27	number	16	SENT_220	[p16l8t963r363b1064],
16	’28	CD	NUMBER	’28	dep	14	SENT_220	[p16l8t963r363b1064],
17	and	CC	O	and	cc	4	SENT_220	[p16l393t984r531b1052],
18	therefore	RB	O	therefore	advmod	4	SENT_220	[p16l557t983r909b1052],
19	polymorphisms	NNS	O	polymorphism	nsubj	25	SENT_220	[p16l935t984r1544b1072],
20	in	IN	O	in	_	0	SENT_220	[p16l1571t984r1645b1051],
21	the	DT	O	the	det	23	SENT_220	[p16l1671t984r1788b1052],
22	CYP3A4	NN	O	cyp3a4	nn	23	SENT_220	[p16l1819t984r2150b1053],
23	gene	NN	O	gene	prep_in	19	SENT_220	[p16l9t1111r190b1178],
24	may	MD	O	may	aux	25	SENT_220	[p16l216t1111r382b1178],
25	have	VB	O	have	ccomp	4	SENT_220	[p16l407t1089r590b1158],
26	a	DT	O	a	det	28	SENT_220	[p16l616t1111r657b1158],
27	larger	JJR	O	larger	amod	28	SENT_220	[p16l681t1089r909b1178],
28	effect	NN	O	effect	dobj	25	SENT_220	[p16l933t1089r1153b1158],
29	in	IN	O	in	_	0	SENT_220	[p16l1177t1089r1251b1157],
30	women	NNS	O	woman	prep_in	28	SENT_220	[p16l1276t1111r1582b1158],
31	.	.	O	.	_	0	SENT_220	[p16l1276t1111r1582b1158],

1	However	RB	O	however	advmod	20	SENT_221	[p16l1612t1091r1982b1170],
2	,	,	O	,	_	0	SENT_221	[p16l1612t1091r1982b1170],
3	in	IN	O	in	_	0	SENT_221	[p16l2010t1089r2084b1157],
4	a	DT	O	a	det	5	SENT_221	[p16l2112t1111r2152b1158],
5	study	NN	O	study	prep_in	20	SENT_221	[p16l11t1194r217b1282],
6	on	IN	O	on	_	0	SENT_221	[p16l304t1216r398b1262],
7	human	JJ	O	human	amod	9	SENT_221	[p16l482t1194r748b1262],
8	liver	NN	O	liver	nn	9	SENT_221	[p16l833t1194r1010b1262],
9	samples	NNS	O	sample	prep_on	5	SENT_221	[p16l1096t1194r1405b1282],
10	no	DT	O	no	det	13	SENT_221	[p16l1492t1215r1586b1262],
11	sex	NN	O	sex	nn	13	SENT_221	[p16l1676t1215r1799b1262],
12	related	JJ	O	related	amod	13	SENT_221	[p16l1883t1194r2151b1262],
13	differences	NNS	O	difference	nsubjpass	20	SENT_221	[p16l9t1302r439b1370],
14	in	IN	O	in	_	0	SENT_221	[p16l503t1302r577b1369],
15	CYP3A4	NN	O	cyp3a4	nn	16	SENT_221	[p16l640t1302r994b1370],
16	content	NN	O	content	prep_in	13	SENT_221	[p16l1058t1312r1346b1370],
17	and	CC	O	and	_	0	SENT_221	[p16l1409t1302r1547b1370],
18	activity	NN	O	activity	prep_in	13	SENT_221	[p16l1610t1302r1899b1390],
19	were	VBD	O	be	auxpass	20	SENT_221	[p16l1962t1323r2150b1370],
20	found	VBN	O	find	_	0	SENT_221	[p16l8t1407r256b1488],
21	,	,	O	,	_	0	SENT_221	[p16l8t1407r256b1488],
22	and	CC	O	and	_	0	SENT_221	[p16l316t1407r454b1476],
23	differences	NNS	O	difference	nsubj	54	SENT_221	[p16l510t1407r940b1476],
24	may	MD	O	may	aux	54	SENT_221	[p16l996t1429r1163b1496],
25	also	RB	O	also	advmod	54	SENT_221	[p16l1221t1407r1373b1476],
26	be	VB	O	be	cop	54	SENT_221	[p16l1428t1407r1519b1476],
27	attributable	JJ	O	attributable	acomp	54	SENT_221	[p16l1577t1407r2021b1476],
28	to	TO	O	to	_	0	SENT_221	[p16l2076t1418r2149b1476],
29	differences	NNS	O	difference	prep_to	27	SENT_221	[p16l9t1513r439b1582],
30	in	IN	O	in	_	0	SENT_221	[p16l486t1513r561b1581],
31	ABCBI	NN	O	abcbus	nn	32	SENT_221	[p16l606t1513r911b1582],
32	expression	NN	O	expression	prep_in	29	SENT_221	[p16l966t1513r1382b1602],
33	between	IN	O	between	_	0	SENT_221	[p16l1426t1513r1753b1582],
34	men	NNS	O	man	prep_between	32	SENT_221	[p16l1798t1535r1966b1582],
35	and	CC	O	and	_	0	SENT_221	[p16l2013t1513r2151b1582],
36	women	NNS	O	woman	conj_and	34	SENT_221	[p16l8t1599r484b1689],
37	.16	CD	NUMBER	.16	number	38	SENT_221	[p16l8t1599r484b1689],
38	’29	CD	NUMBER	’29	num	34	SENT_221	[p16l8t1599r484b1689],
39	Indeed	RB	O	indeed	advmod	54	SENT_221	[p16l519t1621r805b1702],
40	,	,	O	,	_	0	SENT_221	[p16l519t1621r805b1702],
41	ABCBI	NN	ORGANIZATION	abcbus	nn	42	SENT_221	[p16l843t1621r1147b1689],
42	expression	NN	O	expression	nsubjpass	44	SENT_221	[p16l1191t1621r1607b1709],
43	was	VBD	O	be	auxpass	44	SENT_221	[p16l1641t1642r1788b1689],
44	reported	VBN	O	report	parataxis	54	SENT_221	[p16l1824t1621r2152b1709],
45	to	TO	O	to	aux	47	SENT_221	[p16l8t1735r81b1793],
46	be	VB	O	be	cop	47	SENT_221	[p16l104t1725r195b1793],
47	lower	JJR	O	lower	xcomp	44	SENT_221	[p16l219t1725r440b1793],
48	in	IN	O	in	_	0	SENT_221	[p16l462t1725r536b1792],
49	women	NNS	O	woman	prep_in	47	SENT_221	[p16l559t1746r846b1793],
50	than	IN	O	than	mark	51	SENT_221	[p16l869t1725r1036b1793],
51	in	IN	O	in	advcl	47	SENT_221	[p16l1060t1725r1134b1792],
52	men	NNS	O	man	pobj	51	SENT_221	[p16l1157t1746r1345b1806],
53	,	,	O	,	_	0	SENT_221	[p16l1157t1746r1345b1806],
54	leading	VBG	O	lead	conj_and	20	SENT_221	[p16l1373t1725r1659b1813],
55	to	TO	O	to	aux	56	SENT_221	[p16l1683t1735r1757b1793],
56	increased	VBN	O	increase	xcomp	54	SENT_221	[p16l1781t1725r2151b1793],
57	intracellular	JJ	O	intracellular	amod	59	SENT_221	[p16l8t1833r485b1901],
58	drug	NN	O	drug	nn	59	SENT_221	[p16l531t1833r706b1921],
59	concentrations	NNS	O	concentration	dobj	56	SENT_221	[p16l755t1833r1325b1901],
60	and	CC	O	and	_	0	SENT_221	[p16l1376t1832r1515b1901],
61	thereby	RB	O	thereby	dep	54	SENT_221	[p16l1561t1833r1853b1921],
62	potentially	RB	O	potentially	dep	61	SENT_221	[p16l1900t1843r2148b1921, p16l8t1938r208b2027],
63	have	VB	O	have	conj_and	54	SENT_221	[p16l272t1938r453b2007],
64	a	DT	O	a	det	66	SENT_221	[p16l520t1960r560b2007],
65	higher	JJR	O	higher	amod	66	SENT_221	[p16l622t1938r874b2027],
66	susceptibility	NN	O	susceptibility	dobj	63	SENT_221	[p16l939t1938r1458b2027],
67	for	IN	O	for	_	0	SENT_221	[p16l1523t1938r1636b2007],
68	changes	NNS	O	change	prep_for	66	SENT_221	[p16l1699t1938r2011b2027],
69	in	IN	O	in	_	0	SENT_221	[p16l2076t1938r2151b2006],
70	CYP3A4	NN	O	cyp3a4	nn	71	SENT_221	[p16l9t2043r364b2112],
71	activity	NN	O	activity	prep_in	68	SENT_221	[p16l402t2043r705b2131],
72	.	.	O	.	_	0	SENT_221	[p16l402t2043r705b2131],

1	In	IN	O	in	_	0	SENT_222	[p16l97t2153r176b2218],
2	population	NN	O	population	prep_in	9	SENT_222	[p16l232t2151r910b2239],
3	—	CD	NUMBER	—	num	2	SENT_222	[p16l232t2151r910b2239],
4	based	VBN	O	base	partmod	2	SENT_222	[p16l232t2151r910b2239],
5	studies	NNS	O	study	dobj	4	SENT_222	[p16l969t2151r1257b2231],
6	,	,	O	,	_	0	SENT_222	[p16l969t2151r1257b2231],
7	bias	NN	O	bias	nsubj	9	SENT_222	[p16l1316t2151r1472b2219],
8	may	MD	O	may	aux	9	SENT_222	[p16l1531t2172r1697b2239],
9	affect	VB	O	affect	_	0	SENT_222	[p16l1757t2151r1977b2219],
10	the	DT	O	the	det	12	SENT_222	[p16l2032t2151r2150b2219],
11	obtained	VBN	O	obtain	amod	12	SENT_222	[p16l9t2256r346b2325],
12	results	NNS	O	result	dobj	9	SENT_222	[p16l381t2256r656b2325],
13	.	.	O	.	_	0	SENT_222	[p16l381t2256r656b2325],

1	In	IN	O	in	_	0	SENT_223	[p16l699t2258r778b2324],
2	the	DT	O	the	det	4	SENT_223	[p16l815t2256r932b2325],
3	patient	NN	O	patient	nn	4	SENT_223	[p16l970t2256r1238b2345],
4	records	NNS	O	record	prep_in	9	SENT_223	[p16l1274t2256r1583b2337],
5	,	,	O	,	_	0	SENT_223	[p16l1274t2256r1583b2337],
6	we	PRP	O	we	nsubj	9	SENT_223	[p16l1625t2278r1735b2325],
7	could	MD	O	could	aux	9	SENT_223	[p16l1775t2256r1991b2325],
8	not	RB	O	not	neg	9	SENT_223	[p16l2027t2267r2152b2325],
9	retrieve	VB	O	retrieve	_	0	SENT_223	[p16l7t2362r303b2431],
10	the	DT	O	the	det	11	SENT_223	[p16l324t2362r442b2431],
11	reasons	NNS	O	reason	dobj	9	SENT_223	[p16l462t2384r753b2431],
12	for	IN	O	for	mark	15	SENT_223	[p16l777t2362r890b2431],
13	all	DT	O	all	det	14	SENT_223	[p16l911t2362r1004b2431],
14	dose	NN	O	dose	nsubj	17	SENT_223	[p16l1027t2362r1202b2431],
15	decreases	VBZ	O	decrease	advcl	9	SENT_223	[p16l1225t2362r1597b2431],
16	or	CC	O	or	_	0	SENT_223	[p16l1621t2384r1701b2431],
17	switches	VBZ	O	switch	conj_or	15	SENT_223	[p16l1723t2362r2054b2431],
18	to	TO	O	to	_	0	SENT_223	[p16l2076t2373r2149b2431],
19	other	JJ	O	other	amod	20	SENT_223	[p16l9t2470r210b2538],
20	cholesterol	NN	O	cholesterol	prep_to	15	SENT_223	[p16l262t2470r690b2538],
21	lowering	VBG	O	lower	partmod	20	SENT_223	[p16l744t2470r1088b2558],
22	drugs	NNS	O	drug	dobj	21	SENT_223	[p16l1144t2470r1377b2558],
23	.	.	O	.	_	0	SENT_223	[p16l1144t2470r1377b2558],

1	We	PRP	O	we	nsubj	2	SENT_224	[p16l1434t2472r1562b2538],
2	assumed	VBD	O	assume	_	0	SENT_224	[p16l1618t2470r1953b2538],
3	that	IN	O	that	complm	7	SENT_224	[p16l2004t2470r2152b2538],
4	these	DT	O	these	det	5	SENT_224	[p16l8t2575r207b2644],
5	events	NNS	O	event	nsubjpass	7	SENT_224	[p16l275t2586r518b2644],
6	were	VBD	O	be	auxpass	7	SENT_224	[p16l587t2597r775b2644],
7	associated	VBN	O	associate	ccomp	2	SENT_224	[p16l844t2575r1245b2644],
8	with	IN	O	with	_	0	SENT_224	[p16l1312t2575r1484b2644],
9	elevated	JJ	O	elevated	amod	12	SENT_224	[p16l1551t2575r1873b2644],
10	statin	NN	O	statin	nn	12	SENT_224	[p16l1943t2575r2151b2644],
11	plasma	NN	O	plasma	nn	12	SENT_224	[p16l7t2682r286b2771],
12	levels	NNS	O	level	prep_with	7	SENT_224	[p16l306t2682r551b2763],
13	,	,	O	,	_	0	SENT_224	[p16l306t2682r551b2763],
14	resulting	VBG	O	result	xcomp	2	SENT_224	[p16l575t2682r917b2771],
15	in	IN	O	in	_	0	SENT_224	[p16l939t2682r1014b2750],
16	adverse	JJ	O	adverse	amod	18	SENT_224	[p16l1037t2682r1331b2751],
17	drug	NN	O	drug	nn	18	SENT_224	[p16l1355t2682r1530b2771],
18	reactions	NNS	O	reaction	prep_in	14	SENT_224	[p16l1551t2682r1903b2750],
19	or	CC	O	or	_	0	SENT_224	[p16l1928t2704r2008b2750],
20	too	RB	O	too	advmod	21	SENT_224	[p16l2027t2692r2150b2750],
21	strong	JJ	O	strong	amod	22	SENT_224	[p16l11t2799r250b2877],
22	reductions	NNS	O	reduction	prep_in	14	SENT_224	[p16l285t2788r692b2857],
23	in	IN	O	in	_	0	SENT_224	[p16l730t2788r804b2856],
24	cholesterol	NN	O	cholesterol	nn	25	SENT_224	[p16l840t2788r1269b2857],
25	levels	NNS	O	level	prep_in	22	SENT_224	[p16l1305t2788r1549b2857],
26	.	.	O	.	_	0	SENT_224	[p16l1305t2788r1549b2857],

1	However	RB	O	however	advmod	9	SENT_225	[p16l1590t2790r1960b2869],
2	,	,	O	,	_	0	SENT_225	[p16l1590t2790r1960b2869],
3	part	NN	O	part	nsubjpass	9	SENT_225	[p16l1998t2799r2152b2877],
4	of	IN	O	of	_	0	SENT_225	[p16l9t2893r94b2961],
5	the	DT	O	the	det	6	SENT_225	[p16l119t2893r236b2961],
6	events	NNS	O	event	prep_of	3	SENT_225	[p16l271t2903r514b2961],
7	will	MD	O	will	aux	9	SENT_225	[p16l549t2893r698b2961],
8	be	VB	O	be	auxpass	9	SENT_225	[p16l730t2893r821b2961],
9	caused	VBN	O	cause	_	0	SENT_225	[p16l855t2893r1120b2961],
10	by	IN	O	by	_	0	SENT_225	[p16l1151t2893r1247b2981],
11	other	JJ	O	other	amod	12	SENT_225	[p16l1282t2893r1482b2961],
12	reasons	NNS	O	reason	agent	9	SENT_225	[p16l1512t2914r1826b2974],
13	,	,	O	,	_	0	SENT_225	[p16l1512t2914r1826b2974],
14	such	JJ	O	such	_	0	SENT_225	[p16l1865t2893r2039b2961],
15	as	IN	O	as	_	0	SENT_225	[p16l2073t2914r2149b2961],
16	ineffective	JJ	O	ineffective	amod	17	SENT_225	[p16l8t3001r421b3069],
17	cholesterol	NN	O	cholesterol	prep_such_as	12	SENT_225	[p16l460t3001r889b3069],
18	lowering	VBG	O	lower	partmod	17	SENT_225	[p16l928t3001r1271b3089],
19	due	JJ	O	due	_	0	SENT_225	[p16l1311t3001r1449b3069],
20	to	TO	O	to	_	0	SENT_225	[p16l1487t3011r1560b3069],
21	too	RB	O	too	advmod	22	SENT_225	[p16l1598t3011r1720b3069],
22	low	JJ	O	low	amod	23	SENT_225	[p16l1760t3001r1901b3069],
23	statin	NN	O	statin	prep_due_to	25	SENT_225	[p16l1943t3001r2151b3069],
24	plasma	NN	O	plasma	nn	25	SENT_225	[p16l7t3106r286b3195],
25	levels	NNS	O	level	dobj	18	SENT_225	[p16l317t3106r561b3175],
26	.	.	O	.	_	0	SENT_225	[p16l317t3106r561b3175],

1	For	IN	O	for	_	0	SENT_226	[p16l599t3108r734b3175],
2	those	DT	O	those	det	3	SENT_226	[p16l765t3106r969b3175],
3	events	NNS	O	event	prep_for	28	SENT_226	[p16l1003t3117r1246b3175],
4	that	IN	O	that	complm	7	SENT_226	[p16l1282t3106r1429b3175],
5	we	PRP	O	we	nsubj	7	SENT_226	[p16l1461t3128r1571b3175],
6	could	MD	O	could	aux	7	SENT_226	[p16l1606t3106r1823b3175],
7	retrieve	VB	O	retrieve	dep	3	SENT_226	[p16l1853t3106r2150b3175],
8	the	DT	O	the	det	9	SENT_226	[p16l8t3211r125b3279],
9	reason	NN	O	reason	dobj	7	SENT_226	[p16l153t3232r409b3279],
10	of	IN	O	of	_	0	SENT_226	[p16l439t3211r523b3279],
11	the	DT	O	the	det	12	SENT_226	[p16l544t3211r662b3279],
12	change	NN	O	change	prep_of	9	SENT_226	[p16l693t3211r967b3299],
13	in	IN	O	in	_	0	SENT_226	[p16l997t3211r1071b3278],
14	medication	NN	O	medication	prep_in	12	SENT_226	[p16l1100t3211r1536b3279],
15	in	IN	O	in	_	0	SENT_226	[p16l1564t3211r1638b3278],
16	the	DT	O	the	det	17	SENT_226	[p16l1666t3211r1784b3279],
17	patients	NNS	O	patient	prep_in	7	SENT_226	[p16l1812t3211r2140b3299],
18	’	IN	O	’	_	0	SENT_226	[p16l1812t3211r2140b3299],
19	ﬁles	NNS	O	ﬁles	prep_’	7	SENT_226	[p16l9t3319r190b3400],
20	,	,	O	,	_	0	SENT_226	[p16l9t3319r190b3400],
21	only	RB	O	only	advmod	23	SENT_226	[p16l261t3319r431b3407],
22	a	DT	O	a	det	23	SENT_226	[p16l501t3340r541b3387],
23	minority	NN	O	minority	nsubj	28	SENT_226	[p16l607t3319r943b3407],
24	of	IN	O	of	_	0	SENT_226	[p16l1012t3319r1096b3387],
25	the	DT	O	the	det	26	SENT_226	[p16l1157t3319r1274b3387],
26	events	NNS	O	event	prep_of	23	SENT_226	[p16l1342t3329r1585b3387],
27	was	VBD	O	be	cop	28	SENT_226	[p16l1654t3340r1801b3387],
28	due	JJ	O	due	_	0	SENT_226	[p16l1871t3319r2009b3387],
29	to	TO	O	to	_	0	SENT_226	[p16l2076t3329r2149b3387],
30	ineffectiveness	NN	O	ineffectiveness	prep_to	28	SENT_226	[p16l8t3424r610b3493],
31	.	.	O	.	_	0	SENT_226	[p16l8t3424r610b3493],

1	This	DT	DATE	this	nsubj	4	SENT_227	[p16l649t3424r819b3493],
2	may	MD	DATE	may	aux	4	SENT_227	[p16l854t3446r1021b3513],
3	have	VB	O	have	aux	4	SENT_227	[p16l1054t3424r1235b3493],
4	given	VBN	O	give	_	0	SENT_227	[p16l1270t3424r1481b3513],
5	an	DT	O	a	det	6	SENT_227	[p16l1517t3446r1605b3493],
6	underestimation	NN	O	underestimation	dobj	4	SENT_227	[p16l1638t3424r2148b3493, p16l8t3530r159b3598],
7	of	IN	O	of	_	0	SENT_227	[p16l189t3530r273b3598],
8	the	DT	O	the	det	10	SENT_227	[p16l296t3530r413b3598],
9	true	JJ	O	true	amod	10	SENT_227	[p16l443t3540r593b3598],
10	effect	NN	O	effect	prep_of	6	SENT_227	[p16l624t3530r863b3598],
11	.	.	O	.	_	0	SENT_227	[p16l624t3530r863b3598],

1	On	IN	O	on	_	0	SENT_228	[p16l899t3531r1014b3599],
2	the	DT	O	the	det	4	SENT_228	[p16l1044t3530r1161b3598],
3	other	JJ	O	other	amod	4	SENT_228	[p16l1192t3530r1392b3598],
4	hand	NN	O	hand	prep_on	10	SENT_228	[p16l1419t3530r1629b3611],
5	,	,	O	,	_	0	SENT_228	[p16l1419t3530r1629b3611],
6	we	PRP	O	we	nsubj	10	SENT_228	[p16l1663t3552r1773b3599],
7	probably	RB	O	probably	advmod	10	SENT_228	[p16l1802t3530r2150b3619],
8	will	MD	O	will	aux	10	SENT_228	[p16l8t3636r158b3705],
9	have	VB	O	have	aux	10	SENT_228	[p16l196t3636r378b3705],
10	missed	VBN	O	miss	_	0	SENT_228	[p16l417t3636r688b3705],
11	events	NNS	O	event	dobj	10	SENT_228	[p16l726t3647r970b3705],
12	of	IN	O	of	_	0	SENT_228	[p16l1012t3636r1096b3705],
13	adverse	JJ	O	adverse	amod	15	SENT_228	[p16l1130t3636r1424b3705],
14	drug	NN	O	drug	nn	15	SENT_228	[p16l1465t3636r1640b3725],
15	reactions	NNS	O	reaction	prep_of	11	SENT_228	[p16l1678t3636r2031b3705],
16	or	CC	O	or	_	0	SENT_228	[p16l2072t3658r2152b3705],
17	too	RB	O	too	advmod	18	SENT_228	[p16l8t3751r130b3809],
18	strong	JJ	O	strong	amod	19	SENT_228	[p16l164t3752r402b3829],
19	reduction	NN	O	reduction	conj_or	11	SENT_228	[p16l432t3741r803b3809],
20	in	IN	O	in	_	0	SENT_228	[p16l833t3741r907b3808],
21	cholesterol	NN	O	cholesterol	nn	22	SENT_228	[p16l937t3741r1366b3809],
22	levels	NNS	O	level	prep_in	19	SENT_228	[p16l1397t3741r1641b3822],
23	,	,	O	,	_	0	SENT_228	[p16l1397t3741r1641b3822],
24	because	RB	O	because	advmod	22	SENT_228	[p16l1674t3741r2005b3822],
25	,	,	O	,	_	0	SENT_228	[p16l1674t3741r2005b3822],
26	for	IN	O	for	_	0	SENT_228	[p16l2039t3741r2153b3809],
27	example	NN	O	example	prep_for	22	SENT_228	[p17l9t24r359b112],
28	,	,	O	,	_	0	SENT_228	[p17l9t24r359b112],
29	people	NNS	O	people	appos	22	SENT_228	[p17l413t24r673b112],
30	stopped	VBD	O	stop	rcmod	29	SENT_228	[p17l728t24r1029b112],
31	using	VBG	O	use	xcomp	30	SENT_228	[p17l1077t24r1287b112],
32	statins	NNS	O	statin	dobj	31	SENT_228	[p17l1343t24r1586b92],
33	at	IN	O	at	advmod	31	SENT_228	[p17l1641t34r1709b92],
34	all	DT	O	all	pobj	33	SENT_228	[p17l1761t24r1874b92],
35	.	.	O	.	_	0	SENT_228	[p17l1761t24r1874b92],

1	In	IN	O	in	_	0	SENT_229	[p17l1930t26r2010b91],
2	an	DT	O	a	det	4	SENT_229	[p17l2062t45r2151b92],
3	additional	JJ	O	additional	amod	4	SENT_229	[p17l10t129r400b198],
4	analysis	NN	O	analysis	prep_in	6	SENT_229	[p17l425t129r735b218],
5	we	PRP	O	we	nsubj	6	SENT_229	[p17l761t151r871b198],
6	censored	VBD	O	censor	_	0	SENT_229	[p17l895t129r1242b198],
7	participants	NNS	O	participant	dobj	6	SENT_229	[p17l1263t129r1720b218],
8	at	IN	O	at	_	0	SENT_229	[p17l1747t140r1815b198],
9	the	DT	O	the	det	10	SENT_229	[p17l1836t130r1953b198],
10	time	NN	O	time	prep_at	6	SENT_229	[p17l1977t129r2150b198],
11	of	IN	O	of	_	0	SENT_229	[p17l9t234r94b302],
12	the	DT	O	the	det	14	SENT_229	[p17l137t234r254b302],
13	ﬁrst	NN	O	ﬁrst	nn	14	SENT_229	[p17l307t234r456b302],
14	prescription	NN	O	prescription	prep_of	10	SENT_229	[p17l504t234r974b322],
15	for	IN	O	for	_	0	SENT_229	[p17l1024t234r1138b302],
16	a	DT	O	a	det	18	SENT_229	[p17l1188t256r1228b302],
17	CYP3A4	NN	O	cyp3a4	nn	18	SENT_229	[p17l1279t234r1633b303],
18	inhibitor	NN	O	inhibitor	prep_for	6	SENT_229	[p17l1684t234r2023b302],
19	or	CC	O	or	_	0	SENT_229	[p17l2072t256r2152b302],
20	inducer	NN	O	inducer	conj_or	18	SENT_229	[p17l8t342r315b410],
21	.	.	O	.	_	0	SENT_229	[p17l8t342r315b410],

1	Other	JJ	O	other	amod	2	SENT_230	[p17l345t342r566b410],
2	factors	NNS	O	factor	nsubj	8	SENT_230	[p17l588t342r851b410],
3	such	JJ	O	such	_	0	SENT_230	[p17l880t342r1054b410],
4	as	IN	O	as	_	0	SENT_230	[p17l1079t363r1154b410],
5	diet	NN	O	diet	prep_such_as	2	SENT_230	[p17l1180t342r1326b410],
6	may	MD	O	may	aux	8	SENT_230	[p17l1348t363r1514b430],
7	have	VB	O	have	aux	8	SENT_230	[p17l1538t342r1720b410],
8	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_230	[p17l1743t342r2152b410],

1	Copyright	NN	O	copyright	nn	5	SENT_231	[p17l9t587r333b659],
2	©	CD	NUMBER	©	num	5	SENT_231	[p17l366t587r434b656],
3	2009	CD	DATE	2009	num	5	SENT_231	[p17l469t587r624b644],
4	John	NNP	PERSON	John	nn	5	SENT_231	[p17l655t587r805b643],
5	Wiley	NNP	PERSON	Wiley	_	0	SENT_231	[p17l832t587r1026b659],
6	&	CC	O	&	_	0	SENT_231	[p17l1057t587r1114b643],
7	Sons	NNP	O	Sons	conj_and	5	SENT_231	[p17l1146t587r1314b653],
8	,	,	O	,	_	0	SENT_231	[p17l1146t587r1314b653],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_231	[p17l1345t587r1472b643],
10	.	.	O	.	_	0	SENT_231	[p17l1345t587r1472b643],

1	KEY	JJ	O	key	amod	2	SENT_232	[p17l68t878r247b937],
2	POINTS	NNS	O	point	_	0	SENT_232	[p17l280t876r584b938],

1	o	NN	O	o	nsubj	20	SENT_233	[p17l70t1044r105b1079],
2	The	DT	O	the	det	8	SENT_233	[p17l156t1017r306b1085],
3	C	NN	O	c	nn	8	SENT_233	[p17l348t1019r409b1086],
4	YP3A4	NN	O	yp3a4	nn	8	SENT_233	[p17l414t1010r757b1085],
5	*	NN	O	*	nn	8	SENT_233	[p17l414t1010r757b1085],
6	1	CD	NUMBER	1	num	8	SENT_233	[p17l414t1010r757b1085],
7	B	NN	O	b	nn	8	SENT_233	[p17l765t1020r824b1085],
8	polymorphism	NN	O	polymorphism	nsubjpass	13	SENT_233	[p17l860t1017r1433b1106],
9	variant	JJ	O	variant	amod	11	SENT_233	[p17l1469t1017r1738b1086],
10	G	NN	O	g	nn	11	SENT_233	[p17l1775t1018r1842b1086],
11	allele	NN	O	allele	dep	8	SENT_233	[p17l1881t1017r2089b1085],
12	is	VBZ	O	be	auxpass	13	SENT_233	[p17l156t1124r217b1192],
13	associated	VBN	O	associate	rcmod	1	SENT_233	[p17l279t1124r679b1192],
14	with	IN	O	with	_	0	SENT_233	[p17l737t1124r909b1193],
15	a	DT	O	a	det	17	SENT_233	[p17l969t1146r1009b1192],
16	lower	JJR	O	lower	amod	17	SENT_233	[p17l1066t1124r1287b1193],
17	incidence	NN	O	incidence	prep_with	13	SENT_233	[p17l1342t1124r1717b1192],
18	of	IN	O	of	_	0	SENT_233	[p17l1777t1124r1862b1192],
19	dose	NN	O	dose	prep_of	17	SENT_233	[p17l1914t1124r2090b1192],
20	decreases	VBZ	O	decrease	_	0	SENT_233	[p17l157t1231r528b1300],
21	or	CC	O	or	_	0	SENT_233	[p17l584t1253r664b1300],
22	switching	NN	O	switching	conj_or	20	SENT_233	[p17l719t1231r1093b1320],
23	during	IN	O	during	_	0	SENT_233	[p17l1149t1231r1400b1320],
24	simvastatin	NN	O	simvastatin	nn	27	SENT_233	[p17l1457t1231r1898b1300],
25	and	CC	O	and	_	0	SENT_233	[p17l1953t1231r2091b1300],
26	atorvastatin	NN	O	atorvastatin	nn	27	SENT_233	[p17l158t1338r611b1407],
27	therapy	NN	O	therapy	prep_during	22	SENT_233	[p17l646t1338r952b1427],
28	.	.	O	.	_	0	SENT_233	[p17l646t1338r952b1427],

1	Dose	NN	O	dose	nsubj	2	SENT_234	[p17l156t1440r353b1507],
2	decreases	VBZ	O	decrease	_	0	SENT_234	[p17l389t1439r760b1507],
3	or	CC	O	or	_	0	SENT_234	[p17l796t1460r876b1507],
4	switching	NN	O	switching	nsubj	5	SENT_234	[p17l911t1439r1286b1527],
5	indicates	VBZ	O	indicate	conj_or	2	SENT_234	[p17l1320t1439r1665b1507],
6	that	IN	O	that	complm	11	SENT_234	[p17l1700t1439r1847b1507],
7	statin	NN	O	statin	nn	8	SENT_234	[p17l1883t1439r2090b1507],
8	levels	NNS	O	level	nsubj	13	SENT_234	[p17l156t1546r378b1614],
9	are	VBP	O	be	cop	11	SENT_234	[p17l431t1567r546b1614],
10	too	RB	O	too	advmod	11	SENT_234	[p17l596t1556r718b1614],
11	high	JJ	O	high	ccomp	5	SENT_234	[p17l768t1545r941b1634],
12	and	CC	O	and	_	0	SENT_234	[p17l992t1545r1130b1614],
13	result	VBP	O	result	conj_and	11	SENT_234	[p17l1178t1546r1395b1614],
14	in	IN	O	in	_	0	SENT_234	[p17l1444t1545r1518b1613],
15	adverse	JJ	O	adverse	amod	17	SENT_234	[p17l1569t1545r1863b1614],
16	drug	NN	O	drug	nn	17	SENT_234	[p17l1914t1545r2089b1634],
17	reactions	NNS	O	reaction	prep_in	13	SENT_234	[p17l155t1653r507b1721],
18	or	CC	O	or	_	0	SENT_234	[p17l542t1674r621b1721],
19	a	DT	O	a	det	22	SENT_234	[p17l654t1674r694b1721],
20	too	RB	O	too	advmod	21	SENT_234	[p17l725t1663r847b1721],
21	strong	JJ	O	strong	amod	22	SENT_234	[p17l883t1663r1121b1741],
22	reduction	NN	O	reduction	prep_in	13	SENT_234	[p17l1153t1653r1523b1721],
23	in	IN	O	in	_	0	SENT_234	[p17l1555t1653r1629b1720],
24	cholesterol	NN	O	cholesterol	nn	25	SENT_234	[p17l1661t1653r2089b1721],
25	level	NN	O	level	prep_in	22	SENT_234	[p17l156t1760r362b1829],
26	.	.	O	.	_	0	SENT_234	[p17l156t1760r362b1829],

1	No	DT	O	no	det	2	SENT_235	[p17l155t1862r272b1929],
2	associations	NNS	O	association	nsubjpass	4	SENT_235	[p17l343t1860r811b1929],
3	were	VBD	O	be	auxpass	4	SENT_235	[p17l882t1882r1069b1929],
4	found	VBN	O	find	_	0	SENT_235	[p17l1138t1860r1365b1929],
5	for	IN	O	for	_	0	SENT_235	[p17l1432t1860r1546b1929],
6	the	DT	O	the	det	9	SENT_235	[p17l1612t1860r1729b1929],
7	ABCBI	NNP	O	ABCBI	nn	9	SENT_235	[p17l1791t1861r2083b1929],
8	C3435T	NN	O	c3435t	nn	9	SENT_235	[p17l157t1967r475b2036],
9	polymorphism	NN	O	polymorphism	prep_for	4	SENT_235	[p17l509t1968r1101b2056],
10	.	.	O	.	_	0	SENT_235	[p17l509t1968r1101b2056],

1	The	DT	O	the	det	2	SENT_236	[p17l156t2068r306b2136],
2	effect	NN	O	effect	nsubj	10	SENT_236	[p17l370t2068r591b2136],
3	of	IN	O	of	_	0	SENT_236	[p17l653t2068r738b2136],
4	the	DT	O	the	det	5	SENT_236	[p17l794t2068r911b2136],
5	CYP3A4	NN	O	cyp3a4	prep_of	2	SENT_236	[p17l980t2060r1456b2137],
6	*	CD	NUMBER	*	num	9	SENT_236	[p17l980t2060r1456b2137],
7	]	NN	O	]	nn	9	SENT_236	[p17l980t2060r1456b2137],
8	B	NN	O	b	nn	9	SENT_236	[p17l980t2060r1456b2137],
9	polymorphism	NN	O	polymorphism	dep	5	SENT_236	[p17l1519t2068r2092b2156],
10	seems	VBZ	O	seem	_	0	SENT_236	[p17l159t2197r391b2243],
11	to	TO	O	to	aux	13	SENT_236	[p17l425t2185r498b2243],
12	be	VB	O	be	cop	13	SENT_236	[p17l529t2175r620b2243],
13	stronger	JJR	O	stronger	xcomp	10	SENT_236	[p17l656t2185r974b2264],
14	in	IN	O	in	_	0	SENT_236	[p17l1003t2175r1077b2242],
15	patients	NNS	O	patient	prep_in	13	SENT_236	[p17l1108t2175r1411b2264],
16	with	IN	O	with	_	0	SENT_236	[p17l1445t2175r1617b2243],
17	the	DT	O	the	det	20	SENT_236	[p17l1648t2175r1765b2243],
18	ABCBI	NNP	O	ABCBI	nn	20	SENT_236	[p17l1791t2175r2083b2244],
19	3435	CD	NUMBER	3435	num	20	SENT_236	[p17l158t2282r345b2351],
20	CT	NNP	O	CT	prep_with	15	SENT_236	[p17l386t2283r507b2351],
21	or	CC	O	or	_	0	SENT_236	[p17l537t2304r617b2350],
22	TT	NN	O	tt	nn	23	SENT_236	[p17l651t2284r768b2350],
23	genotype	NN	O	genotype	conj_or	20	SENT_236	[p17l805t2292r1181b2371],
24	.	.	O	.	_	0	SENT_236	[p17l805t2292r1181b2371],

1	CYP3A4	NN	O	cyp3a4	nn	3	SENT_237	[p17l10t2590r364b2658],
2	enzyme	NN	O	enzyme	nn	3	SENT_237	[p17l426t2611r729b2678],
3	activity	NN	O	activity	nsubj	5	SENT_237	[p17l793t2590r1082b2678],
4	as	RB	O	as	advmod	5	SENT_237	[p17l1146t2611r1221b2658],
5	well	RB	O	well	_	0	SENT_237	[p17l1284t2590r1470b2658],
6	.	.	O	.	_	0	SENT_237	[p17l1284t2590r1470b2658],

1	However	RB	O	however	advmod	5	SENT_238	[p17l1537t2591r1907b2671],
2	,	,	O	,	_	0	SENT_238	[p17l1537t2591r1907b2671],
3	it	PRP	O	it	nsubj	5	SENT_238	[p17l1971t2589r2025b2658],
4	is	VBZ	O	be	cop	5	SENT_238	[p17l2086t2590r2146b2658],
5	unlikely	JJ	O	unlikely	_	0	SENT_238	[p17l8t2695r328b2784],
6	that	IN	O	that	complm	10	SENT_238	[p17l382t2695r529b2764],
7	CYP3A4	NN	O	cyp3a4	nn	8	SENT_238	[p17l583t2696r937b2764],
8	genotype	NN	O	genotype	nsubjpass	10	SENT_238	[p17l993t2706r1349b2784],
9	is	VBZ	O	be	auxpass	10	SENT_238	[p17l1404t2695r1464b2764],
10	associated	VBN	O	associate	ccomp	5	SENT_238	[p17l1522t2695r1923b2764],
11	with	IN	O	with	_	0	SENT_238	[p17l1976t2695r2148b2764],
12	these	DT	O	these	det	13	SENT_238	[p17l8t2802r207b2870],
13	factors	NNS	O	factor	prep_with	10	SENT_238	[p17l236t2802r498b2870],
14	and	CC	O	and	_	0	SENT_238	[p17l529t2802r667b2870],
15	we	PRP	O	we	nsubj	18	SENT_238	[p17l694t2823r805b2870],
16	are	VBP	O	be	cop	18	SENT_238	[p17l835t2823r950b2870],
17	not	RB	O	not	neg	18	SENT_238	[p17l978t2812r1102b2870],
18	aware	JJ	O	aware	conj_and	5	SENT_238	[p17l1130t2823r1358b2870],
19	of	IN	O	of	_	0	SENT_238	[p17l1388t2802r1472b2870],
20	studies	NNS	O	study	prep_of	18	SENT_238	[p17l1496t2801r1761b2870],
21	reporting	VBG	O	report	partmod	20	SENT_238	[p17l1789t2802r2147b2890],
22	these	DT	O	these	det	23	SENT_238	[p17l8t2907r207b2975],
23	associations	NNS	O	association	dobj	21	SENT_238	[p17l272t2907r762b2975],
24	.	.	O	.	_	0	SENT_238	[p17l272t2907r762b2975],

1	Therefore	RB	O	therefore	advmod	7	SENT_239	[p17l828t2907r1234b2988],
2	,	,	O	,	_	0	SENT_239	[p17l828t2907r1234b2988],
3	they	PRP	O	they	nsubjpass	7	SENT_239	[p17l1299t2907r1465b2996],
4	will	MD	O	will	aux	7	SENT_239	[p17l1528t2907r1677b2976],
5	be	VB	O	be	auxpass	7	SENT_239	[p17l1738t2907r1829b2975],
6	evenly	RB	O	evenly	advmod	7	SENT_239	[p17l1893t2907r2147b2996],
7	distributed	VBN	O	distribute	_	0	SENT_239	[p17l10t3014r426b3082],
8	between	IN	O	between	_	0	SENT_239	[p17l472t3014r799b3082],
9	both	DT	O	both	det	11	SENT_239	[p17l844t3014r1018b3082],
10	genotype	NN	O	genotype	nn	11	SENT_239	[p17l1066t3024r1422b3102],
11	groups	NNS	O	group	prep_between	7	SENT_239	[p17l1471t3035r1754b3102],
12	,	,	O	,	_	0	SENT_239	[p17l1471t3035r1754b3102],
13	not	RB	O	not	neg	14	SENT_239	[p17l1806t3024r1930b3082],
14	confounding	VBG	O	confound	xcomp	7	SENT_239	[p17l1977t3035r2145b3082, p17l9t3119r360b3208],
15	the	DT	O	the	det	16	SENT_239	[p17l388t3120r505b3188],
16	association	NN	O	association	dobj	14	SENT_239	[p17l536t3120r968b3188],
17	in	IN	O	in	_	0	SENT_239	[p17l996t3120r1070b3187],
18	this	DT	O	this	det	19	SENT_239	[p17l1098t3120r1235b3188],
19	study	NN	O	study	prep_in	14	SENT_239	[p17l1268t3120r1488b3208],
20	.	.	O	.	_	0	SENT_239	[p17l1268t3120r1488b3208],

1	Both	CC	O	both	preconj	3	SENT_240	[p17l1520t3120r1709b3188],
2	the	DT	O	the	det	3	SENT_240	[p17l1737t3120r1853b3188],
3	patient	NN	O	patient	nsubjpass	8	SENT_240	[p17l1881t3120r2149b3208],
4	and	CC	O	and	_	0	SENT_240	[p17l11t3225r149b3293],
5	the	DT	O	the	det	6	SENT_240	[p17l188t3225r305b3293],
6	prescriber	NN	O	prescriber	conj_and	3	SENT_240	[p17l345t3225r739b3314],
7	were	VBD	O	be	auxpass	8	SENT_240	[p17l778t3247r965b3294],
8	blinded	VBN	O	blind	_	0	SENT_240	[p17l1005t3225r1300b3293],
9	to	TO	O	to	_	0	SENT_240	[p17l1339t3236r1411b3293],
10	the	DT	O	the	det	11	SENT_240	[p17l1453t3225r1570b3293],
11	genotype	NN	O	genotype	prep_to	8	SENT_240	[p17l1612t3236r1968b3314],
12	and	CC	O	and	_	0	SENT_240	[p17l2011t3225r2149b3293],
13	misclassiﬁcations	NNS	O	misclassiﬁcations	nsubj	16	SENT_240	[p17l8t3331r697b3399],
14	were	VBD	O	be	cop	16	SENT_240	[p17l764t3353r950b3400],
15	therefore	RB	O	therefore	advmod	16	SENT_240	[p17l1015t3331r1367b3399],
16	random	JJ	O	random	conj_and	8	SENT_240	[p17l1431t3331r1749b3399],
17	.	.	O	.	_	0	SENT_240	[p17l1431t3331r1749b3399],

1	Random	NNP	O	Random	nn	2	SENT_241	[p17l1818t3331r2150b3399],
2	misclassiﬁcation	NN	O	misclassiﬁcation	nsubj	3	SENT_241	[p17l9t3439r662b3507],
3	gives	VBZ	O	give	_	0	SENT_241	[p17l689t3439r887b3527],
4	a	DT	O	a	det	5	SENT_241	[p17l918t3460r958b3507],
5	dilution	NN	O	dilution	dobj	3	SENT_241	[p17l984t3439r1287b3507],
6	of	IN	O	of	_	0	SENT_241	[p17l1314t3439r1398b3507],
7	the	DT	O	the	det	9	SENT_241	[p17l1418t3439r1535b3507],
8	true	JJ	O	true	amod	9	SENT_241	[p17l1562t3449r1711b3507],
9	effect	NN	O	effect	prep_of	5	SENT_241	[p17l1739t3438r1979b3519],
10	,	,	O	,	_	0	SENT_241	[p17l1739t3438r1979b3519],
11	and	CC	O	and	cc	3	SENT_241	[p17l2011t3439r2149b3507],
12	therefore	RB	O	therefore	advmod	3	SENT_241	[p17l8t3544r361b3612],
13	the	DT	O	the	det	15	SENT_241	[p17l389t3544r506b3612],
14	effect	NN	O	effect	nn	15	SENT_241	[p17l536t3544r756b3612],
15	sizes	NNS	O	size	nsubj	23	SENT_241	[p17l786t3544r969b3612],
16	in	IN	O	in	_	0	SENT_241	[p17l999t3544r1073b3612],
17	our	PRP$	O	we	poss	18	SENT_241	[p17l1101t3566r1230b3612],
18	study	NN	O	study	prep_in	15	SENT_241	[p17l1259t3544r1465b3633],
19	were	VBD	O	be	cop	23	SENT_241	[p17l1495t3566r1681b3613],
20	most	RBS	O	most	advmod	21	SENT_241	[p17l1710t3555r1899b3612],
21	likely	JJ	O	likely	amod	23	SENT_241	[p17l1926t3544r2147b3633],
22	an	DT	O	a	det	23	SENT_241	[p17l11t3672r99b3719],
23	underestimation	NN	O	underestimation	ccomp	3	SENT_241	[p17l135t3650r787b3719],
24	.	.	O	.	_	0	SENT_241	[p17l135t3650r787b3719],

1	We	PRP	O	we	nsubj	2	SENT_242	[p17l826t3652r954b3719],
2	identiﬁed	VBD	O	identiﬁed	_	0	SENT_242	[p17l991t3650r1361b3719],
3	all	DT	O	all	det	7	SENT_242	[p17l1398t3651r1492b3719],
4	simvastatin	NN	O	simvastatin	nn	7	SENT_242	[p17l1532t3650r1973b3719],
5	and	CC	O	and	_	0	SENT_242	[p17l2011t3651r2149b3719],
6	atorvastatin	NN	O	atorvastatin	nn	7	SENT_242	[p18l11t26r464b95],
7	users	NNS	O	user	dobj	2	SENT_242	[p18l549t48r746b94],
8	in	IN	O	in	_	0	SENT_242	[p18l834t26r908b94],
9	the	DT	O	the	det	11	SENT_242	[p18l994t26r1111b94],
10	Rotterdam	NNP	LOCATION	Rotterdam	nn	11	SENT_242	[p18l1198t26r1612b94],
11	Study	NNP	O	Study	prep_in	2	SENT_242	[p18l1699t26r1922b115],
12	and	CC	O	and	_	0	SENT_242	[p18l2011t26r2149b94],
13	information	NN	O	information	nsubjpass	15	SENT_242	[p18l9t133r471b201],
14	was	VBD	O	be	auxpass	15	SENT_242	[p18l559t154r706b201],
15	collected	VBN	O	collect	conj_and	2	SENT_242	[p18l797t133r1151b201],
16	prospectively	RB	O	prospectively	advmod	15	SENT_242	[p18l1237t133r1762b221],
17	without	IN	O	without	_	0	SENT_242	[p18l1851t133r2150b201],
18	knowledge	NN	O	knowledge	prep_without	15	SENT_242	[p18l8t239r434b327],
19	of	IN	O	of	_	0	SENT_242	[p18l472t238r556b307],
20	the	DT	O	the	det	22	SENT_242	[p18l584t239r702b307],
21	study	NN	O	study	nn	22	SENT_242	[p18l741t239r947b327],
22	hypothesis	NN	O	hypothesis	prep_of	18	SENT_242	[p18l983t239r1420b327],
23	.	.	O	.	_	0	SENT_242	[p18l983t239r1420b327],

1	To	TO	O	to	aux	2	SENT_243	[p18l98t346r196b413],
2	conclude	VB	O	conclude	purpcl	17	SENT_243	[p18l225t344r598b425],
3	,	,	O	,	_	0	SENT_243	[p18l225t344r598b425],
4	simvastatin	NN	O	simvastatin	nn	7	SENT_243	[p18l633t344r1073b413],
5	and	CC	O	and	_	0	SENT_243	[p18l1103t344r1241b413],
6	atorvastatin	NN	O	atorvastatin	nn	7	SENT_243	[p18l1270t344r1723b413],
7	users	NNS	O	user	nsubj	17	SENT_243	[p18l1749t366r1947b413],
8	with	IN	O	with	_	0	SENT_243	[p18l1976t344r2149b413],
9	the	DT	O	the	det	11	SENT_243	[p18l8t450r126b518],
10	CYP3A4	NN	O	cyp3a4	nn	11	SENT_243	[p18l153t451r483b519],
11	*	NN	O	*	nn	16	SENT_243	[p18l490t443r562b518],
12	1	CD	NUMBER	1	num	13	SENT_243	[p18l490t443r562b518],
13	B	NN	O	b	npadvmod	14	SENT_243	[p18l570t453r629b518],
14	variant	JJ	O	variant	amod	16	SENT_243	[p18l652t450r921b519],
15	G	NN	O	g	nn	16	SENT_243	[p18l943t451r1010b519],
16	allele	NN	O	allele	prep_with	7	SENT_243	[p18l1033t450r1242b518],
17	have	VBP	O	have	_	0	SENT_243	[p18l1264t450r1446b519],
18	a	DT	O	a	det	22	SENT_243	[p18l1470t472r1510b518],
19	two	CD	NUMBER	two	num	20	SENT_243	[p18l1530t461r1674b519],
20	times	NNS	O	time	npadvmod	21	SENT_243	[p18l1696t450r1905b518],
21	lower	JJR	O	lower	amod	22	SENT_243	[p18l1929t450r2150b519],
22	risk	NN	O	risk	dobj	17	SENT_243	[p18l7t558r156b626],
23	for	IN	O	for	_	0	SENT_243	[p18l176t558r289b626],
24	a	DT	O	a	det	26	SENT_243	[p18l311t579r352b626],
25	dose	NN	O	dose	nn	26	SENT_243	[p18l374t558r549b626],
26	decrease	NN	O	decrease	prep_for	22	SENT_243	[p18l573t558r907b626],
27	or	CC	O	or	_	0	SENT_243	[p18l932t579r1011b626],
28	switch	NN	O	switch	conj_or	26	SENT_243	[p18l1035t558r1286b626],
29	to	TO	O	to	_	0	SENT_243	[p18l1308t568r1380b626],
30	another	DT	O	another	det	31	SENT_243	[p18l1406t558r1698b626],
31	cholesterol	NN	O	cholesterol	prep_to	17	SENT_243	[p18l1720t557r2148b626],
32	lowering	VBG	O	lower	partmod	31	SENT_243	[p18l9t664r352b753],
33	drug	NN	O	drug	dobj	32	SENT_243	[p18l393t664r589b753],
34	.	.	O	.	_	0	SENT_243	[p18l393t664r589b753],

1	The	DT	O	the	det	3	SENT_244	[p18l633t664r782b733],
2	ABCBI	NNP	O	ABCBI	nn	3	SENT_244	[p18l816t665r1108b733],
3	C1236T	NN	O	c1236t	nsubj	12	SENT_244	[p18l1156t664r1487b745],
4	,	,	O	,	_	0	SENT_244	[p18l1156t664r1487b745],
5	G2677A/T	NN	O	g2677a/t	nsubj	12	SENT_244	[p18l1531t664r1966b745],
6	,	,	O	,	_	0	SENT_244	[p18l1531t664r1966b745],
7	and	CC	O	and	_	0	SENT_244	[p18l2011t664r2149b733],
8	C3435T	NN	O	c3435t	nn	9	SENT_244	[p18l10t770r328b839],
9	polymorphisms	NNS	O	polymorphism	nsubj	12	SENT_244	[p18l381t771r989b859],
10	did	VBD	O	do	aux	12	SENT_244	[p18l1045t771r1168b839],
11	not	RB	O	not	neg	12	SENT_244	[p18l1222t781r1346b839],
12	affect	VB	O	affect	_	0	SENT_244	[p18l1401t770r1620b839],
13	the	DT	O	the	det	14	SENT_244	[p18l1674t771r1791b839],
14	risk	NN	O	risk	dobj	12	SENT_244	[p18l1845t771r2010b839],
15	.	.	O	.	_	0	SENT_244	[p18l1845t771r2010b839],

1	In	IN	O	in	_	0	SENT_245	[p18l2069t772r2148b838],
2	women	NNS	O	woman	nn	11	SENT_245	[p18l9t898r295b945],
3	and	CC	O	and	_	0	SENT_245	[p18l360t876r498b944],
4	in	IN	O	in	conj_and	2	SENT_245	[p18l560t876r634b944],
5	patients	NNS	O	patient	pobj	4	SENT_245	[p18l696t876r999b964],
6	with	IN	O	with	_	0	SENT_245	[p18l1064t876r1236b945],
7	the	DT	O	the	det	8	SENT_245	[p18l1298t876r1415b944],
8	ABCB	NN	O	abcb	prep_with	5	SENT_245	[p18l1472t877r1764b945],
9	]	CD	NUMBER	]	num	8	SENT_245	[p18l1472t877r1764b945],
10	3435TT	NN	O	3435tt	nn	11	SENT_245	[p18l1837t876r2148b945],
11	genotype	NN	O	genotype	prep_in	28	SENT_245	[p18l10t993r366b1071],
12	the	DT	O	the	det	13	SENT_245	[p18l393t982r510b1051],
13	effects	NNS	O	effect	nsubj	28	SENT_245	[p18l538t982r792b1051],
14	of	IN	O	of	_	0	SENT_245	[p18l822t982r906b1051],
15	the	DT	O	the	det	20	SENT_245	[p18l926t982r1043b1051],
16	CYP3A4	NN	O	cyp3a4	nn	20	SENT_245	[p18l1075t975r1484b1052],
17	*	NN	O	*	nn	20	SENT_245	[p18l1075t975r1484b1052],
18	I	NN	O	i	nn	20	SENT_245	[p18l1075t975r1484b1052],
19	B	NN	O	b	nn	20	SENT_245	[p18l1492t985r1551b1050],
20	polymorphism	NN	O	polymorphism	prep_of	13	SENT_245	[p18l1576t982r2150b1071],
21	on	IN	O	on	_	0	SENT_245	[p18l10t1111r104b1158],
22	the	DT	O	the	det	23	SENT_245	[p18l134t1090r251b1158],
23	risk	NN	O	risk	prep_on	20	SENT_245	[p18l280t1090r428b1158],
24	of	IN	O	of	_	0	SENT_245	[p18l457t1090r542b1158],
25	these	DT	O	these	det	26	SENT_245	[p18l565t1090r764b1158],
26	events	NNS	O	event	prep_of	23	SENT_245	[p18l795t1100r1038b1158],
27	were	VBD	O	be	cop	28	SENT_245	[p18l1071t1111r1258b1158],
28	stronger	JJR	O	stronger	_	0	SENT_245	[p18l1292t1100r1625b1178],
29	,	,	O	,	_	0	SENT_245	[p18l1292t1100r1625b1178],
30	although	IN	O	although	mark	36	SENT_245	[p18l1661t1090r2001b1178],
31	the	DT	O	the	det	33	SENT_245	[p18l2030t1090r2147b1158],
32	interaction	NN	O	interaction	nn	33	SENT_245	[p18l9t1195r428b1264],
33	term	NN	O	term	nsubj	36	SENT_245	[p18l463t1206r642b1264],
34	did	VBD	O	do	aux	36	SENT_245	[p18l678t1195r801b1264],
35	not	RB	O	not	neg	36	SENT_245	[p18l835t1206r959b1264],
36	reach	VB	O	reach	advcl	28	SENT_245	[p18l993t1195r1205b1264],
37	statistical	JJ	O	statistical	amod	38	SENT_245	[p18l1243t1195r1609b1264],
38	signiﬁcance	NN	O	signiﬁcance	dobj	36	SENT_245	[p18l1649t1195r2132b1284],
39	.	.	O	.	_	0	SENT_245	[p18l1649t1195r2132b1284],

1	ACKNOWLEDGEMENTS	NNS	O	acknowledgement	_	0	SENT_246	[p18l8t1445r1090b1513],

1	This	DT	O	this	det	2	SENT_247	[p18l8t1597r163b1660],
2	study	NN	O	study	nsubjpass	4	SENT_247	[p18l214t1597r401b1678],
3	was	VBD	O	be	auxpass	4	SENT_247	[p18l448t1617r581b1660],
4	supported	VBN	O	support	_	0	SENT_247	[p18l632t1597r980b1678],
5	by	IN	O	by	prep	4	SENT_247	[p18l1024t1597r1111b1678],
6	the	DT	O	the	det	9	SENT_247	[p18l1158t1597r1264b1660],
7	Netherlands	NNP	O	Netherlands	nn	9	SENT_247	[p18l1310t1597r1739b1660],
8	Genomics	NNP	O	Genomics	nn	9	SENT_247	[p18l1789t1597r2146b1660],
9	Initiative	NNP	O	Initiative	dep	5	SENT_247	[p18l9t1694r328b1757],
10	(	CD	NUMBER	(	num	11	SENT_247	[p18l393t1694r1062b1771],
11	NGI	NNP	O	NGI	dep	9	SENT_247	[p18l393t1694r1062b1771],
12	)	CD	NUMBER	)	num	11	SENT_247	[p18l393t1694r1062b1771],
13	/	:	O	/	punct	9	SENT_247	[p18l393t1694r1062b1771],
14	Netherlands	NNP	LOCATION	Netherlands	nn	15	SENT_247	[p18l393t1694r1062b1771],
15	Organisation	NNP	LOCATION	Organisation	dep	9	SENT_247	[p18l1127t1694r1585b1775],
16	for	IN	O	for	_	0	SENT_247	[p18l1648t1694r1751b1757],
17	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	20	SENT_247	[p18l1814t1694r2146b1757],
18	Research	NNP	ORGANIZATION	Research	nn	20	SENT_247	[p18l8t1791r334b1854],
19	(	CD	NUMBER	(	num	20	SENT_247	[p18l370t1792r634b1868],
20	NWO	NNP	ORGANIZATION	NWO	prep_for	15	SENT_247	[p18l370t1792r634b1868],
21	)	CD	NUMBER	)	num	23	SENT_247	[p18l370t1792r634b1868],
22	project	NN	O	project	nn	23	SENT_247	[p18l669t1791r918b1872],
23	number	NN	O	number	dep	20	SENT_247	[p18l949t1791r1222b1854],
24	050-060-810	CD	NUMBER	050-060-810	dep	23	SENT_247	[p18l1254t1791r1730b1854],
25	.	.	O	.	_	0	SENT_247	[p18l1254t1791r1730b1854],

1	REFERENCES	NNS	O	reference	_	0	SENT_248	[p18l9t2033r618b2101],

1	1	LS	NUMBER	1	_	0	SENT_249	[p18l51t2199r92b2249],
2	.	.	O	.	_	0	SENT_249	[p18l51t2199r92b2249],

1	Scandinavian	JJ	O	scandinavian	amod	5	SENT_250	[p18l135t2199r515b2249],
2	Simvastatin	NNP	O	Simvastatin	nn	5	SENT_250	[p18l542t2199r874b2249],
3	Survival	NNP	O	Survival	nn	5	SENT_250	[p18l901t2199r1135b2249],
4	Study	NNP	O	Study	nn	5	SENT_250	[p18l1163t2199r1325b2264],
5	Group	NNP	O	Group	_	0	SENT_250	[p18l1351t2199r1545b2264],
6	.	.	O	.	_	0	SENT_250	[p18l1351t2199r1545b2264],

1	Randomised	JJ	O	randomised	amod	2	SENT_251	[p18l1573t2199r1928b2249],
2	trial	NN	O	trial	_	0	SENT_251	[p18l1952t2199r2065b2249],
3	of	IN	O	of	_	0	SENT_251	[p18l2092t2199r2153b2249],
4	cholesterol	NN	O	cholesterol	nn	5	SENT_251	[p18l133t2280r445b2330],
5	lowering	NN	O	lowering	prep_of	2	SENT_251	[p18l468t2280r718b2345],
6	in	IN	O	in	_	0	SENT_251	[p18l741t2280r796b2329],
7	4444	CD	DATE	4444	num	8	SENT_251	[p18l819t2280r959b2329],
8	patients	NNS	O	patient	prep_in	5	SENT_251	[p18l982t2280r1203b2345],
9	with	IN	O	with	_	0	SENT_251	[p18l1227t2280r1352b2330],
10	coronary	JJ	O	coronary	amod	12	SENT_251	[p18l1376t2296r1626b2345],
11	heart	NN	O	heart	nn	12	SENT_251	[p18l1650t2280r1793b2330],
12	disease	NN	O	disease	prep_with	8	SENT_251	[p18l1816t2280r2035b2330],
13	:	:	O	:	_	0	SENT_251	[p18l1816t2280r2035b2330],
14	the	DT	O	the	det	21	SENT_251	[p18l2063t2280r2148b2330],
15	Scandinavian	JJ	O	scandinavian	amod	21	SENT_251	[p18l135t2359r516b2410],
16	Simvastatin	NNP	O	Simvastatin	nn	21	SENT_251	[p18l584t2359r918b2410],
17	Survival	NNP	O	Survival	nn	21	SENT_251	[p18l987t2359r1221b2410],
18	Study	NNP	O	Study	nn	21	SENT_251	[p18l1291t2359r1453b2424],
19	(	CD	NUMBER	(	num	21	SENT_251	[p18l1524t2360r1656b2421],
20	4S	NN	O	4	nn	21	SENT_251	[p18l1524t2360r1656b2421],
21	)	NN	O	)	dep	2	SENT_251	[p18l1524t2360r1656b2421],
22	.	.	O	.	_	0	SENT_251	[p18l1524t2360r1656b2421],

1	Lancet	NNP	O	Lancet	_	0	SENT_252	[p18l1726t2361r1923b2410],
2	1994	CD	DATE	1994	num	1	SENT_252	[p18l1995t2360r2146b2419],
3	;	:	O	;	_	0	SENT_252	[p18l1995t2360r2146b2419],
4	344	CD	NUMBER	344	number	5	SENT_252	[p18l133t2439r443b2500],
5	(	CD	NUMBER	(	dep	1	SENT_252	[p18l133t2439r443b2500],
6	8934	CD	NUMBER	8934	num	7	SENT_252	[p18l133t2439r443b2500],
7	)	NN	O	)	dep	5	SENT_252	[p18l133t2439r443b2500],
8	:	:	O	:	_	0	SENT_252	[p18l133t2439r443b2500],
9	1383-1389	CD	DATE	1383-1389	dep	5	SENT_252	[p18l480t2439r807b2489],
10	.	.	O	.	_	0	SENT_252	[p18l480t2439r807b2489],

1	2	LS	NUMBER	2	_	0	SENT_253	[p18l45t2519r92b2569],
2	.	.	O	.	_	0	SENT_253	[p18l45t2519r92b2569],

1	Armitage	NNP	O	Armitage	nn	3	SENT_254	[p18l133t2519r401b2584],
2	J.	NNP	O	J.	nn	3	SENT_254	[p18l434t2520r474b2569],
3	The	NNP	O	The	_	0	SENT_254	[p18l510t2519r619b2569],
4	safety	NN	O	safety	dep	3	SENT_254	[p18l655t2519r821b2584],
5	of	IN	O	of	_	0	SENT_254	[p18l855t2518r916b2569],
6	statins	NNS	O	statin	prep_of	4	SENT_254	[p18l947t2519r1124b2569],
7	in	IN	O	in	_	0	SENT_254	[p18l1157t2519r1212b2568],
8	clinical	JJ	O	clinical	amod	9	SENT_254	[p18l1245t2519r1454b2569],
9	practice	NN	O	practice	prep_in	6	SENT_254	[p18l1486t2519r1726b2584],
10	.	.	O	.	_	0	SENT_254	[p18l1486t2519r1726b2584],

1	Lancet	NNP	O	Lancet	_	0	SENT_255	[p18l1761t2521r1958b2569],
2	2007	CD	DATE	2007	num	1	SENT_255	[p18l1989t2519r2146b2578],
3	;	:	O	;	_	0	SENT_255	[p18l1989t2519r2146b2578],

1	Pharmacoepidemiology	NNP	O	Pharmacoepidemiology	nn	4	SENT_256	[p18l232t2821r999b2892],
2	and	CC	O	and	_	0	SENT_256	[p18l1029t2821r1151b2877],
3	Drug	NNP	O	Drug	nn	4	SENT_256	[p18l1174t2823r1342b2892],
4	Safety	NNP	O	Safety	_	0	SENT_256	[p18l1371t2821r1579b2893],
5	,	,	O	,	_	0	SENT_256	[p18l1371t2821r1579b2893],
6	2010	CD	DATE	2010	appos	4	SENT_256	[p18l1611t2821r1788b2887],
7	;	:	O	;	_	0	SENT_256	[p18l1611t2821r1788b2887],
8	19	CD	NUMBER	19	dep	4	SENT_256	[p18l1824t2820r1915b2877],
9	:	:	O	:	_	0	SENT_256	[p18l1824t2820r1915b2877],
10	75-81	CD	NUMBER	75-81	num	11	SENT_256	[p18l1950t2821r2141b2877],
11	DOI	NNP	O	DOI	dep	8	SENT_256	[p18l1564t2909r1721b2965],
12	:	:	O	:	_	0	SENT_256	[p18l1564t2909r1721b2965],
13	10.1002	CD	NUMBER	10.1002	dep	11	SENT_256	[p18l1763t2909r2147b2981],
14	/	:	O	/	punct	11	SENT_256	[p18l1763t2909r2147b2981],
15	pds	NNS	O	pd	dep	8	SENT_256	[p18l1763t2909r2147b2981],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_257	[p18l417t3062r528b3090],
2	,	,	O	,	_	0	SENT_257	[p18l417t3062r528b3090],
3	ABCBl	NN	O	abcbl	appos	1	SENT_257	[p18l543t3062r642b3090],
4	,	,	O	,	_	0	SENT_257	[p18l543t3062r642b3090],
5	AND	CC	O	and	_	0	SENT_257	[p18l658t3065r720b3085],
6	STATIN	JJ	O	statin	amod	7	SENT_257	[p18l735t3064r838b3085],
7	THERAPY	NN	O	therapy	conj_and	1	SENT_257	[p18l852t3065r985b3085],
8	81	CD	NUMBER	81	dep	1	SENT_257	[p18l1707t3056r1742b3085],

1	.	.	O	.	_	0	SENT_258	[p19l80t98r88b107],

1	Jacobson	NNP	PERSON	Jacobson	nn	2	SENT_259	[p19l129t56r389b107],
2	TA	NNP	O	TA	_	0	SENT_259	[p19l429t57r530b107],
3	.	.	O	.	_	0	SENT_259	[p19l429t57r530b107],

1	Comparative	JJ	O	comparative	amod	4	SENT_260	[p19l574t56r939b121],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_260	[p19l978t56r1453b121],
3	interaction	NN	O	interaction	nn	4	SENT_260	[p19l1494t56r1800b107],
4	proﬁles	NNS	O	proﬁles	nsubj	13	SENT_260	[p19l1838t56r2050b121],
5	of	IN	O	of	_	0	SENT_260	[p19l2091t56r2153b107],
6	pravastatin	NN	O	pravastatin	prep_of	4	SENT_260	[p19l129t137r455b202],
7	,	,	O	,	_	0	SENT_260	[p19l129t137r455b202],
8	simvastatin	NN	O	simvastatin	prep_of	4	SENT_260	[p19l494t137r830b196],
9	,	,	O	,	_	0	SENT_260	[p19l494t137r830b196],
10	and	CC	O	and	_	0	SENT_260	[p19l867t137r968b187],
11	atorvastatin	NN	O	atorvastatin	prep_of	4	SENT_260	[p19l1003t137r1333b187],
12	when	WRB	O	when	dep	6	SENT_260	[p19l1367t137r1520b187],
13	coadministered	VBN	O	coadminister	_	0	SENT_260	[p19l1554t137r1989b187],
14	with	IN	O	with	_	0	SENT_260	[p19l2024t137r2149b187],
15	cytochrome	NN	O	cytochrome	nn	17	SENT_260	[p19l130t216r465b281],
16	P450	NN	O	p450	nn	17	SENT_260	[p19l490t216r635b267],
17	inhibitors	NNS	O	inhibitor	prep_with	13	SENT_260	[p19l661t216r947b266],
18	.	.	O	.	_	0	SENT_260	[p19l661t216r947b266],

1	Am	NNP	O	Am	nn	3	SENT_261	[p19l972t217r1070b266],
2	J	NNP	O	J	nn	3	SENT_261	[p19l1094t218r1130b267],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_261	[p19l1155t216r1370b267],
4	2004	CD	DATE	2004	num	3	SENT_261	[p19l1396t217r1553b275],
5	;	:	O	;	_	0	SENT_261	[p19l1396t217r1553b275],
6	94	CD	NUMBER	94	number	7	SENT_261	[p19l1582t216r1749b278],
7	(	CD	NUMBER	(	dep	3	SENT_261	[p19l1582t216r1749b278],
8	9	CD	NUMBER	9	num	9	SENT_261	[p19l1582t216r1749b278],
9	)	NN	O	)	dep	7	SENT_261	[p19l1582t216r1749b278],
10	:	:	O	:	_	0	SENT_261	[p19l1582t216r1749b278],
11	1140-1146	CD	DATE	1140-1146	dep	7	SENT_261	[p19l1787t216r2113b267],
12	.	.	O	.	_	0	SENT_261	[p19l1787t216r2113b267],

1	.	.	O	.	_	0	SENT_262	[p19l80t339r88b347],

1	Flockhart	NNP	O	Flockhart	nn	2	SENT_263	[p19l129t297r403b347],
2	DA	NNP	O	DA	_	0	SENT_263	[p19l430t297r542b347],
3	.	.	O	.	_	0	SENT_263	[p19l430t297r542b347],

1	Drug	NN	O	drug	nn	2	SENT_264	[p19l574t298r718b362],
2	Interactions	NNS	O	interaction	_	0	SENT_264	[p19l747t297r1098b347],
3	:	:	O	:	_	0	SENT_264	[p19l747t297r1098b347],
4	cytochrome	NN	O	cytochrome	nn	7	SENT_264	[p19l1131t297r1466b362],
5	P450	NN	O	p450	nn	7	SENT_264	[p19l1494t297r1639b347],
6	Drug	NN	O	drug	nn	7	SENT_264	[p19l1667t298r1811b362],
7	Interaction	NN	O	interaction	dep	2	SENT_264	[p19l1840t297r2149b347],
8	Table	NNP	O	Table	dep	7	SENT_264	[p19l129t377r300b427],
9	.	.	O	.	_	0	SENT_264	[p19l129t377r300b427],

1	Indiana	NNP	ORGANIZATION	Indiana	nn	3	SENT_265	[p19l336t376r550b427],
2	University	NNP	ORGANIZATION	University	nn	3	SENT_265	[p19l581t377r878b442],
3	School	NNP	ORGANIZATION	School	_	0	SENT_265	[p19l913t377r1108b427],
4	of	IN	ORGANIZATION	of	_	0	SENT_265	[p19l1141t376r1202b427],
5	Medicine	NNP	ORGANIZATION	Medicine	prep_of	3	SENT_265	[p19l1230t377r1516b436],
6	;	:	O	;	_	0	SENT_265	[p19l1230t377r1516b436],
7	August	NNP	DATE	August	dep	3	SENT_265	[p19l1551t377r1756b442],
8	2007	CD	DATE	2007	num	7	SENT_265	[p19l1789t377r1943b427],
9	.	.	O	.	_	0	SENT_265	[p19l1789t377r1943b427],

1	http	NN	O	http	_	0	SENT_266	[p19l1977t377r2150b442],
2	:	:	O	:	_	0	SENT_266	[p19l1977t377r2150b442],
3	/	:	O	/	dep	1	SENT_266	[p19l1977t377r2150b442],
4	/	:	O	/	punct	1	SENT_266	[p19l1977t377r2150b442],
5	medicine.iupui.edu/ﬂockhart/table.htm	NN	O	medicine.iupui.edu/ﬂockhart/table.htm	nn	6	SENT_266	[p19l130t456r1240b521],
6	[	NN	O	[	dep	7	SENT_266	[p19l1270t456r1538b517],
7	accessed	VBD	O	access	dep	1	SENT_266	[p19l1270t456r1538b517],
8	28	CD	DATE	28	dobj	7	SENT_266	[p19l1564t457r1630b507],
9	January	NNP	DATE	January	tmod	7	SENT_266	[p19l1658t457r1878b521],
10	2009	CD	DATE	2009	num	9	SENT_266	[p19l1905t457r2083b517],
11	]	CD	NUMBER	]	nsubj	7	SENT_266	[p19l1905t457r2083b517],
12	.	.	O	.	_	0	SENT_266	[p19l1905t457r2083b517],

1	.	.	O	.	_	0	SENT_267	[p19l80t579r88b587],

1	Prueksaritanont	JJ	O	prueksaritanont	amod	2	SENT_268	[p19l129t538r578b587],
2	T	NN	O	t	_	0	SENT_268	[p19l604t539r656b596],
3	,	,	O	,	_	0	SENT_268	[p19l604t539r656b596],
4	Gorham	NNP	ORGANIZATION	Gorham	nn	5	SENT_268	[p19l687t538r919b588],
5	LM	NNP	ORGANIZATION	LM	appos	2	SENT_268	[p19l946t539r1067b596],
6	,	,	O	,	_	0	SENT_268	[p19l946t539r1067b596],
7	Ma	NNP	O	Ma	nn	8	SENT_268	[p19l1097t539r1191b588],
8	B	NNP	O	B	appos	2	SENT_268	[p19l1218t539r1279b596],
9	,	,	O	,	_	0	SENT_268	[p19l1218t539r1279b596],
10	et	FW	O	et	nn	11	SENT_268	[p19l1310t547r1361b588],
11	al.	FW	O	al.	appos	2	SENT_268	[p19l1387t538r1455b588],
12	.	.	O	.	_	0	SENT_268	[p19l1387t538r1455b588],

1	In	FW	O	in	nn	3	SENT_269	[p19l1486t539r1544b587],
2	vitro	FW	O	vitro	nn	3	SENT_269	[p19l1569t538r1702b587],
3	metabolism	NN	O	metabolism	_	0	SENT_269	[p19l1731t538r2064b587],
4	of	IN	O	of	_	0	SENT_269	[p19l2092t538r2153b587],
5	simvastatin	NN	O	simvastatin	prep_of	3	SENT_269	[p19l132t616r452b666],
6	in	IN	O	in	_	0	SENT_269	[p19l490t616r544b666],
7	humans	NNS	O	human	nn	8	SENT_269	[p19l581t616r801b666],
8	identiﬁcation	NN	O	identiﬁcation	prep_in	3	SENT_269	[p19l840t616r1216b666],
9	of	IN	O	of	_	0	SENT_269	[p19l1255t616r1317b666],
10	metabolizing	VBG	O	metabolize	prepc_of	3	SENT_269	[p19l1350t616r1722b681],
11	enzymes	NNS	O	enzyme	dobj	10	SENT_269	[p19l1761t632r2008b681],
12	and	CC	O	and	_	0	SENT_269	[p19l2048t616r2148b666],
13	effect	NN	O	effect	dobj	10	SENT_269	[p19l130t696r290b747],
14	of	IN	O	of	_	0	SENT_269	[p19l334t696r396b747],
15	the	DT	O	the	det	16	SENT_269	[p19l434t697r520b747],
16	drug	NN	O	drug	prep_of	3	SENT_269	[p19l565t697r692b762],
17	on	IN	O	on	_	0	SENT_269	[p19l737t712r806b747],
18	hepatic	JJ	O	hepatic	amod	19	SENT_269	[p19l849t697r1053b762],
19	P450s	NNS	O	p450	prep_on	3	SENT_269	[p19l1098t697r1285b747],
20	.	.	O	.	_	0	SENT_269	[p19l1098t697r1285b747],

1	Drug	NN	O	drug	nn	3	SENT_270	[p19l1330t698r1480b761],
2	Metab	NNP	O	Metab	nn	3	SENT_270	[p19l1521t696r1704b747],
3	Dispos	NNP	O	Dispos	_	0	SENT_270	[p19l1746t698r1944b761],
4	1997	CD	DATE	1997	num	3	SENT_270	[p19l1994t697r2145b756],
5	;	:	O	;	_	0	SENT_270	[p19l1994t697r2145b756],
6	25	CD	NUMBER	25	number	7	SENT_270	[p19l129t776r332b837],
7	(	CD	NUMBER	(	dep	3	SENT_270	[p19l129t776r332b837],
8	10	CD	NUMBER	10	num	9	SENT_270	[p19l129t776r332b837],
9	)	NN	O	)	dep	7	SENT_270	[p19l129t776r332b837],
10	:	:	O	:	_	0	SENT_270	[p19l129t776r332b837],
11	1191-1199	CD	DATE	1191-1199	dep	7	SENT_270	[p19l370t777r697b826],
12	.	.	O	.	_	0	SENT_270	[p19l370t777r697b826],

1	.	.	O	.	_	0	SENT_271	[p19l80t898r88b906],

1	J	NN	O	j	nn	3	SENT_272	[p19l129t858r155b907],
2	acobsen	NN	O	acobsen	nn	3	SENT_272	[p19l158t857r386b907],
3	W	NN	O	w	_	0	SENT_272	[p19l403t858r479b915],
4	,	,	O	,	_	0	SENT_272	[p19l403t858r479b915],
5	Kuhn	NN	PERSON	kuhn	nn	6	SENT_272	[p19l502t857r656b906],
6	B	NN	O	b	appos	3	SENT_272	[p19l675t858r736b915],
7	,	,	O	,	_	0	SENT_272	[p19l675t858r736b915],
8	Soldner	NNP	O	Soldner	nn	9	SENT_272	[p19l759t857r980b907],
9	A	NNP	O	A	appos	3	SENT_272	[p19l996t857r1061b915],
10	,	,	O	,	_	0	SENT_272	[p19l996t857r1061b915],
11	et	FW	O	et	nn	12	SENT_272	[p19l1084t867r1135b907],
12	al.	FW	O	al.	appos	3	SENT_272	[p19l1152t857r1220b907],
13	.	.	O	.	_	0	SENT_272	[p19l1152t857r1220b907],

1	Lactonization	NN	MISC	lactonization	nsubj	6	SENT_273	[p19l1241t857r1635b907],
2	is	VBZ	O	be	cop	6	SENT_273	[p19l1653t857r1698b906],
3	the	DT	O	the	det	6	SENT_273	[p19l1718t857r1803b906],
4	critical	JJ	O	critical	amod	6	SENT_273	[p19l1823t857r2020b906],
5	ﬁrst	JJ	O	ﬁrst	amod	6	SENT_273	[p19l2040t857r2149b906],
6	step	NN	O	step	_	0	SENT_273	[p19l132t944r242b1001],
7	in	IN	O	in	_	0	SENT_273	[p19l301t936r355b985],
8	the	DT	O	the	det	9	SENT_273	[p19l414t936r499b986],
9	disposition	NN	O	disposition	prep_in	6	SENT_273	[p19l559t936r871b1001],
10	of	IN	O	of	_	0	SENT_273	[p19l930t936r991b986],
11	the	DT	O	the	det	12	SENT_273	[p19l1045t936r1130b986],
12	3	CD	NUMBER	3	prep_of	9	SENT_273	[p19l1191t936r2149b1001],
13	.	.	O	.	_	0	SENT_273	[p19l1191t936r2149b1001],

1	—	NN	O	—	_	0	SENT_274	[p19l1191t936r2149b1001],
2	.	.	O	.	_	0	SENT_274	[p19l1191t936r2149b1001],

1	hydroXy	NN	O	hydroxy	_	0	SENT_275	[p19l1191t936r2149b1001],
2	.	.	O	.	_	0	SENT_275	[p19l1191t936r2149b1001],

1	—	NN	O	—	_	0	SENT_276	[p19l1191t936r2149b1001],
2	.	.	O	.	_	0	SENT_276	[p19l1191t936r2149b1001],

1	3	LS	NUMBER	3	_	0	SENT_277	[p19l1191t936r2149b1001],
2	.	.	O	.	_	0	SENT_277	[p19l1191t936r2149b1001],

1	—	NN	O	—	_	0	SENT_278	[p19l1191t936r2149b1001],
2	.	.	O	.	_	0	SENT_278	[p19l1191t936r2149b1001],

1	methylglutaryl	NN	O	methylglutaryl	_	0	SENT_279	[p19l1191t936r2149b1001],
2	.	.	O	.	_	0	SENT_279	[p19l1191t936r2149b1001],

1	—	NN	O	—	_	0	SENT_280	[p19l1191t936r2149b1001],
2	.	.	O	.	_	0	SENT_280	[p19l1191t936r2149b1001],

1	CoA	NN	O	coa	nn	4	SENT_281	[p19l1191t936r2149b1001],
2	reductase	NN	O	reductase	nn	4	SENT_281	[p19l129t1015r398b1065],
3	inhibitor	NN	O	inhibitor	nn	4	SENT_281	[p19l436t1015r682b1065],
4	atorvastatin	NN	O	atorvastatin	_	0	SENT_281	[p19l719t1015r1063b1066],
5	.	.	O	.	_	0	SENT_281	[p19l719t1015r1063b1066],

1	Drug	NN	O	drug	nn	3	SENT_282	[p19l1102t1017r1252b1079],
2	Metab	NNP	O	Metab	nn	3	SENT_282	[p19l1287t1015r1470b1065],
3	Dispos	NNP	O	Dispos	_	0	SENT_282	[p19l1507t1017r1704b1079],
4	2000	CD	DATE	2000	num	3	SENT_282	[p19l1743t1016r1899b1075],
5	;	:	O	;	_	0	SENT_282	[p19l1743t1016r1899b1075],
6	28	CD	NUMBER	28	number	7	SENT_282	[p19l1940t1015r2143b1077],
7	(	CD	NUMBER	(	dep	3	SENT_282	[p19l1940t1015r2143b1077],
8	11	CD	NUMBER	11	num	9	SENT_282	[p19l1940t1015r2143b1077],
9	)	NN	O	)	dep	7	SENT_282	[p19l1940t1015r2143b1077],
10	:	:	O	:	_	0	SENT_282	[p19l1940t1015r2143b1077],
11	1369-1378	CD	DATE	1369-1378	dep	7	SENT_282	[p19l136t1096r463b1147],
12	.	.	O	.	_	0	SENT_282	[p19l136t1096r463b1147],

1	.	.	O	.	_	0	SENT_283	[p19l80t1217r88b1225],

1	Neuvonen	NNP	O	Neuvonen	nn	2	SENT_284	[p19l129t1176r421b1225],
2	PJ	NNP	O	PJ	_	0	SENT_284	[p19l450t1176r530b1234],
3	,	,	O	,	_	0	SENT_284	[p19l450t1176r530b1234],
4	Niemi	NNP	PERSON	Niemi	nn	5	SENT_284	[p19l562t1175r739b1225],
5	M	NNP	O	M	appos	2	SENT_284	[p19l768t1176r845b1234],
6	,	,	O	,	_	0	SENT_284	[p19l768t1176r845b1234],
7	Backman	NNP	PERSON	Backman	nn	8	SENT_284	[p19l877t1175r1146b1225],
8	JT.	NNP	O	JT.	appos	2	SENT_284	[p19l1175t1176r1272b1234],
9	,	,	O	,	_	0	SENT_284	[p19l1175t1176r1272b1234],
10	Drug	NNP	O	Drug	nn	11	SENT_284	[p19l1304t1176r1448b1240],
11	interactions	NNS	O	interaction	appos	2	SENT_284	[p19l1478t1175r1810b1225],
12	with	IN	O	with	_	0	SENT_284	[p19l1841t1175r1966b1225],
13	lipidlowering	NN	O	lipidlowering	nn	14	SENT_284	[p19l1995t1175r2146b1240, p19l130t1256r380b1321],
14	drugs	NNS	O	drug	prep_with	11	SENT_284	[p19l410t1256r581b1321],
15	:	:	O	:	_	0	SENT_284	[p19l410t1256r581b1321],
16	mechanisms	NNS	O	mechanism	dep	2	SENT_284	[p19l615t1256r965b1306],
17	and	CC	O	and	_	0	SENT_284	[p19l997t1256r1098b1306],
18	clinical	JJ	O	clinical	amod	19	SENT_284	[p19l1127t1256r1336b1306],
19	relevance	NN	O	relevance	dep	2	SENT_284	[p19l1365t1256r1649b1306],
20	.	.	O	.	_	0	SENT_284	[p19l1365t1256r1649b1306],

1	Clin	NNP	O	Clin	nn	3	SENT_285	[p19l1686t1256r1803b1306],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_285	[p19l1832t1256r2150b1306],
3	Ther	NNP	O	Ther	_	0	SENT_285	[p19l133t1335r265b1385],
4	2006	CD	DATE	2006	num	3	SENT_285	[p19l289t1335r445b1394],
5	;	:	O	;	_	0	SENT_285	[p19l289t1335r445b1394],
6	80	CD	NUMBER	80	number	7	SENT_285	[p19l475t1335r642b1396],
7	(	CD	NUMBER	(	dep	3	SENT_285	[p19l475t1335r642b1396],
8	6	CD	NUMBER	6	num	9	SENT_285	[p19l475t1335r642b1396],
9	)	NN	O	)	dep	7	SENT_285	[p19l475t1335r642b1396],
10	:	:	O	:	_	0	SENT_285	[p19l475t1335r642b1396],
11	565-581	CD	NUMBER	565-581	dep	7	SENT_285	[p19l674t1335r935b1385],
12	.	.	O	.	_	0	SENT_285	[p19l674t1335r935b1385],

1	.	.	O	.	_	0	SENT_286	[p19l80t1457r88b1465],

1	Bottorff	NNP	PERSON	Bottorff	nn	2	SENT_287	[p19l129t1415r361b1465],
2	M	NNP	O	M	_	0	SENT_287	[p19l389t1416r466b1474],
3	,	,	O	,	_	0	SENT_287	[p19l389t1416r466b1474],
4	Hansten	NNP	PERSON	Hansten	nn	9	SENT_287	[p19l501t1416r733b1465],
5	P.	NNP	PERSON	P.	nn	9	SENT_287	[p19l766t1416r810b1465],
6	Long	NNP	PERSON	Long	nn	9	SENT_287	[p19l846t1416r1152b1480],
7	—	NN	O	—	nn	9	SENT_287	[p19l846t1416r1152b1480],
8	term	NN	O	term	nn	9	SENT_287	[p19l846t1416r1152b1480],
9	safety	NN	O	safety	appos	2	SENT_287	[p19l1186t1415r1352b1480],
10	of	IN	O	of	_	0	SENT_287	[p19l1386t1415r1447b1465],
11	hepatic	JJ	O	hepatic	amod	17	SENT_287	[p19l1475t1415r1679b1480],
12	hydroxymethyl	NN	O	hydroxymethyl	nn	17	SENT_287	[p19l1713t1415r2148b1480],
13	glutaryl	NN	O	glutaryl	nn	17	SENT_287	[p19l130t1495r350b1560],
14	coenzyme	NN	O	coenzyme	nn	17	SENT_287	[p19l387t1510r675b1560],
15	A	NN	O	a	nn	17	SENT_287	[p19l711t1495r761b1544],
16	reductase	NN	O	reductase	nn	17	SENT_287	[p19l796t1495r1065b1545],
17	inhibitors	NNS	O	inhibitor	prep_of	9	SENT_287	[p19l1102t1495r1390b1545],
18	:	:	O	:	_	0	SENT_287	[p19l1102t1495r1390b1545],
19	the	DT	O	the	det	20	SENT_287	[p19l1430t1495r1516b1545],
20	role	NN	O	role	dep	2	SENT_287	[p19l1552t1495r1662b1545],
21	of	IN	O	of	_	0	SENT_287	[p19l1699t1495r1760b1545],
22	metabolismmonograph	NN	O	metabolismmonograph	prep_of	20	SENT_287	[p19l1792t1494r2146b1545, p19l130t1574r454b1639],
23	for	IN	O	for	_	0	SENT_287	[p19l468t1574r551b1624],
24	physicians	NNS	O	physician	prep_for	22	SENT_287	[p19l564t1574r879b1639],
25	.	.	O	.	_	0	SENT_287	[p19l564t1574r879b1639],

1	Arch	NNP	O	Arch	nn	3	SENT_288	[p19l893t1574r1032b1624],
2	Intern	NNP	O	Intern	nn	3	SENT_288	[p19l1046t1576r1220b1624],
3	Med	NNP	O	Med	_	0	SENT_288	[p19l1233t1574r1364b1624],
4	2000	CD	DATE	2000	num	3	SENT_288	[p19l1377t1575r1534b1634],
5	;	:	O	;	_	0	SENT_288	[p19l1377t1575r1534b1634],
6	160	CD	NUMBER	160	number	7	SENT_288	[p19l1555t1574r1791b1636],
7	(	CD	NUMBER	(	dep	3	SENT_288	[p19l1555t1574r1791b1636],
8	15	CD	NUMBER	15	num	9	SENT_288	[p19l1555t1574r1791b1636],
9	)	NN	O	)	dep	7	SENT_288	[p19l1555t1574r1791b1636],
10	:	:	O	:	_	0	SENT_288	[p19l1555t1574r1791b1636],
11	2273-2280	CD	DATE	2273-2280	dep	7	SENT_288	[p19l1813t1575r2144b1625],
12	.	.	O	.	_	0	SENT_288	[p19l1813t1575r2144b1625],

1	.	.	O	.	_	0	SENT_289	[p19l80t1696r88b1705],

1	Zineh	NNP	O	Zineh	nn	2	SENT_290	[p19l129t1654r295b1705],
2	I.	NNP	O	I.	_	0	SENT_290	[p19l318t1656r354b1705],
3	HMG	NN	O	hmg	dep	2	SENT_290	[p19l382t1655r705b1705],
4	.	.	O	.	_	0	SENT_290	[p19l382t1655r705b1705],

1	—	NN	O	—	_	0	SENT_291	[p19l382t1655r705b1705],
2	.	.	O	.	_	0	SENT_291	[p19l382t1655r705b1705],

1	CoA	NN	O	coa	nn	4	SENT_292	[p19l382t1655r705b1705],
2	reductase	NN	O	reductase	nn	4	SENT_292	[p19l727t1654r996b1705],
3	inhibitor	NN	O	inhibitor	nn	4	SENT_292	[p19l1020t1654r1267b1705],
4	pharmacogenomics	NNS	O	pharmacogenomic	_	0	SENT_292	[p19l1287t1654r1858b1719],
5	:	:	O	:	_	0	SENT_292	[p19l1287t1654r1858b1719],
6	overview	NN	O	overview	dep	4	SENT_292	[p19l1888t1654r2148b1705],
7	and	CC	O	and	_	0	SENT_292	[p19l131t1734r231b1784],
8	implications	NNS	O	implication	dep	4	SENT_292	[p19l257t1734r607b1799],
9	for	IN	O	for	_	0	SENT_292	[p19l635t1734r717b1784],
10	practice	NN	O	practice	prep_for	6	SENT_292	[p19l741t1734r982b1799],
11	.	.	O	.	_	0	SENT_292	[p19l741t1734r982b1799],

1	Future	JJ	DATE	future	amod	2	SENT_293	[p19l1010t1736r1200b1784],
2	Medicine	NN	DATE	medicine	_	0	SENT_293	[p19l1225t1734r1491b1784],
3	2005	CD	DATE	2005	num	2	SENT_293	[p19l1519t1734r1675b1793],
4	;	:	O	;	_	0	SENT_293	[p19l1519t1734r1675b1793],
5	1	CD	NUMBER	1	num	6	SENT_293	[p19l1707t1734r1836b1796],
6	(	NN	O	(	dep	2	SENT_293	[p19l1707t1734r1836b1796],
7	2	CD	NUMBER	2	number	8	SENT_293	[p19l1707t1734r1836b1796],
8	)	CD	NUMBER	)	dep	6	SENT_293	[p19l1707t1734r1836b1796],
9	:	:	O	:	_	0	SENT_293	[p19l1707t1734r1836b1796],
10	191-206	CD	NUMBER	191-206	dep	6	SENT_293	[p19l1873t1734r2129b1785],
11	.	.	O	.	_	0	SENT_293	[p19l1873t1734r2129b1785],

1	Amirimani	JJ	PERSON	amirimani	amod	2	SENT_294	[p19l129t1815r441b1865],
2	B	NN	PERSON	b	_	0	SENT_294	[p19l457t1816r518b1874],
3	,	,	O	,	_	0	SENT_294	[p19l457t1816r518b1874],
4	Ning	NN	O	ning	nn	5	SENT_294	[p19l536t1815r677b1880],
5	B	NN	O	b	appos	2	SENT_294	[p19l693t1816r753b1874],
6	,	,	O	,	_	0	SENT_294	[p19l693t1816r753b1874],
7	Deitz	NNP	PERSON	Deitz	nn	8	SENT_294	[p19l771t1815r924b1865],
8	AC	NN	O	ac	appos	2	SENT_294	[p19l940t1815r1050b1874],
9	,	,	O	,	_	0	SENT_294	[p19l940t1815r1050b1874],
10	et	FW	O	et	nn	11	SENT_294	[p19l1070t1825r1121b1865],
11	al.	FW	O	al.	appos	2	SENT_294	[p19l1134t1815r1201b1865],
12	.	.	O	.	_	0	SENT_294	[p19l1134t1815r1201b1865],

1	Increased	VBN	O	increase	amod	3	SENT_295	[p19l1221t1815r1494b1865],
2	transcriptional	JJ	O	transcriptional	amod	3	SENT_295	[p19l1509t1814r1920b1880],
3	activity	NN	O	activity	_	0	SENT_295	[p19l1938t1815r2148b1880],
4	of	IN	O	of	_	0	SENT_295	[p19l130t1894r191b1944],
5	the	DT	O	the	det	6	SENT_295	[p19l222t1894r308b1944],
6	CYP3A4	NN	O	cyp3a4	prep_of	3	SENT_295	[p19l344t1890r708b1945],
7	*	CD	NUMBER	*	num	10	SENT_295	[p19l344t1890r708b1945],
8	1B	NN	O	1b	nn	10	SENT_295	[p19l344t1890r708b1945],
9	promoter	NN	O	promoter	nn	10	SENT_295	[p19l747t1902r1010b1959],
10	variant	NN	O	variant	dep	6	SENT_295	[p19l1044t1894r1253b1945],
11	.	.	O	.	_	0	SENT_295	[p19l1044t1894r1253b1945],

1	Environ	NNP	O	Environ	nn	3	SENT_296	[p19l1292t1896r1515b1945],
2	Mol	NNP	O	Mol	nn	3	SENT_296	[p19l1549t1894r1665b1944],
3	Mutagen	NNP	O	Mutagen	_	0	SENT_296	[p19l1697t1896r1952b1958],
4	2003	CD	DATE	2003	num	3	SENT_296	[p19l1988t1895r2146b1954],
5	;	:	O	;	_	0	SENT_296	[p19l1988t1895r2146b1954],
6	42	CD	NUMBER	42	number	7	SENT_296	[p19l130t1974r297b2036],
7	(	CD	NUMBER	(	dep	3	SENT_296	[p19l130t1974r297b2036],
8	4	CD	NUMBER	4	num	9	SENT_296	[p19l130t1974r297b2036],
9	)	NN	O	)	dep	7	SENT_296	[p19l130t1974r297b2036],
10	:	:	O	:	_	0	SENT_296	[p19l130t1974r297b2036],
11	299-305	CD	NUMBER	299-305	dep	7	SENT_296	[p19l329t1975r590b2025],
12	.	.	O	.	_	0	SENT_296	[p19l329t1975r590b2025],

1	Westlind	NNP	MISC	Westlind	nn	2	SENT_297	[p19l128t2054r382b2104],
2	A	NNP	MISC	A	_	0	SENT_297	[p19l398t2054r463b2113],
3	,	,	O	,	_	0	SENT_297	[p19l398t2054r463b2113],
4	Lofberg	NNP	ORGANIZATION	Lofberg	nn	5	SENT_297	[p19l483t2053r711b2119],
5	L	NNP	ORGANIZATION	L	appos	2	SENT_297	[p19l728t2055r786b2113],
6	,	,	O	,	_	0	SENT_297	[p19l728t2055r786b2113],
7	Tindberg	NNP	O	Tindberg	nn	8	SENT_297	[p19l806t2054r1062b2119],
8	N	NNP	O	N	appos	2	SENT_297	[p19l1080t2055r1145b2113],
9	,	,	O	,	_	0	SENT_297	[p19l1080t2055r1145b2113],
10	et	FW	O	et	nn	11	SENT_297	[p19l1167t2063r1218b2104],
11	al.	FW	O	al.	appos	2	SENT_297	[p19l1233t2054r1300b2104],
12	.	.	O	.	_	0	SENT_297	[p19l1233t2054r1300b2104],

1	Interindividual	JJ	O	interindividual	amod	2	SENT_298	[p19l1322t2054r1744b2104],
2	differences	NNS	O	difference	_	0	SENT_298	[p19l1763t2053r2076b2104],
3	in	IN	O	in	_	0	SENT_298	[p19l2094t2054r2148b2103],
4	hepatic	JJ	O	hepatic	amod	5	SENT_298	[p19l129t2133r333b2198],
5	expression	NN	O	expression	prep_in	2	SENT_298	[p19l350t2133r653b2198],
6	of	IN	O	of	_	0	SENT_298	[p19l669t2133r731b2183],
7	CYP	NN	O	cyp	prep_of	2	SENT_298	[p19l741t2134r884b2184],
8	.	.	O	.	_	0	SENT_298	[p19l741t2134r884b2184],

1	A4	NN	O	a4	_	0	SENT_299	[p19l903t2134r1003b2183],
2	:	:	O	:	_	0	SENT_299	[p19l903t2134r1003b2183],
3	relationship	NN	O	relationship	dep	1	SENT_299	[p19l1022t2133r1358b2198],
4	to	TO	O	to	_	0	SENT_299	[p19l1374t2141r1427b2183],
5	genetic	JJ	O	genetic	amod	6	SENT_299	[p19l1444t2133r1648b2198],
6	polymorphism	NN	O	polymorphism	prep_to	3	SENT_299	[p19l1663t2133r2080b2198],
7	in	IN	O	in	_	0	SENT_299	[p19l2095t2133r2148b2183],
8	the	DT	O	the	det	10	SENT_299	[p19l129t2213r215b2263],
9	5	CD	NUMBER	5	num	10	SENT_299	[p19l250t2209r323b2264],
10	’	NN	O	’	prep_in	6	SENT_299	[p19l250t2209r323b2264],
11	upstream	JJ	O	upstream	amod	13	SENT_299	[p19l359t2221r620b2278],
12	regulatory	JJ	O	regulatory	amod	13	SENT_299	[p19l653t2213r945b2278],
13	region	NN	O	region	dep	3	SENT_299	[p19l979t2213r1175b2278],
14	.	.	O	.	_	0	SENT_299	[p19l979t2213r1175b2278],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_300	[p19l1211t2213r1460b2263],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_300	[p19l1493t2213r1723b2277],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_300	[p19l1755t2215r1858b2264],
4	Commun	NNP	ORGANIZATION	Commun	_	0	SENT_300	[p19l1897t2214r2148b2264],
5	1999	CD	DATE	1999	num	4	SENT_300	[p19l136t2293r287b2351],
6	;	:	O	;	_	0	SENT_300	[p19l136t2293r287b2351],
7	259	CD	NUMBER	259	num	8	SENT_300	[p19l316t2293r519b2354],
8	(	NN	O	(	dep	4	SENT_300	[p19l316t2293r519b2354],
9	1	CD	NUMBER	1	num	10	SENT_300	[p19l316t2293r519b2354],
10	)	NN	O	)	dep	8	SENT_300	[p19l316t2293r519b2354],
11	:	:	O	:	_	0	SENT_300	[p19l316t2293r519b2354],
12	201-205	CD	NUMBER	201-205	dep	8	SENT_300	[p19l551t2293r813b2343],
13	.	.	O	.	_	0	SENT_300	[p19l551t2293r813b2343],

1	Rebbeck	NNP	O	Rebbeck	nn	2	SENT_301	[p19l129t2373r380b2422],
2	TR	NN	O	tr	_	0	SENT_301	[p19l412t2374r517b2431],
3	,	,	O	,	_	0	SENT_301	[p19l412t2374r517b2431],
4	Jaffe	NNP	PERSON	Jaffe	nn	5	SENT_301	[p19l553t2372r689b2423],
5	JM	NN	O	jm	appos	2	SENT_301	[p19l723t2374r828b2431],
6	,	,	O	,	_	0	SENT_301	[p19l723t2374r828b2431],
7	Walker	NNP	PERSON	Walker	nn	8	SENT_301	[p19l863t2373r1069b2422],
8	AH	NNP	O	AH	appos	2	SENT_301	[p19l1102t2373r1218b2431],
9	,	,	O	,	_	0	SENT_301	[p19l1102t2373r1218b2431],
10	et	FW	O	et	nn	11	SENT_301	[p19l1256t2382r1307b2422],
11	al.	FW	O	al.	appos	2	SENT_301	[p19l1339t2373r1407b2422],
12	.	.	O	.	_	0	SENT_301	[p19l1339t2373r1407b2422],

1	Modiﬁcation	NN	O	modiﬁcation	_	0	SENT_302	[p19l1445t2372r1813b2422],
2	of	IN	O	of	_	0	SENT_302	[p19l1847t2372r1909b2422],
3	clinical	JJ	O	clinical	amod	4	SENT_302	[p19l1939t2373r2148b2422],
4	presentation	NN	O	presentation	prep_of	1	SENT_302	[p19l128t2451r478b2516],
5	of	IN	O	of	_	0	SENT_302	[p19l499t2451r561b2501],
6	prostate	NN	O	prostate	nn	7	SENT_302	[p19l575t2459r801b2516],
7	tumors	NNS	O	tumor	prep_of	1	SENT_302	[p19l821t2459r1016b2501],
8	by	IN	O	by	_	0	SENT_302	[p19l1037t2451r1107b2516],
9	a	DT	O	a	det	12	SENT_302	[p19l1130t2467r1159b2501],
10	novel	JJ	O	novel	amod	12	SENT_302	[p19l1179t2451r1334b2502],
11	genetic	JJ	O	genetic	amod	12	SENT_302	[p19l1355t2451r1559b2516],
12	variant	NN	O	variant	prep_by	1	SENT_302	[p19l1581t2451r1778b2501],
13	in	IN	O	in	_	0	SENT_302	[p19l1797t2451r1851b2501],
14	CYP3A4	NN	O	cyp3a4	prep_in	12	SENT_302	[p19l1872t2451r2144b2502],
15	.	.	O	.	_	0	SENT_302	[p19l1872t2451r2144b2502],

1	J	NNP	O	J	nn	4	SENT_303	[p19l128t2534r164b2582],
2	Natl	NNP	O	Natl	nn	4	SENT_303	[p19l182t2532r308b2582],
3	Cancer	NNP	O	Cancer	nn	4	SENT_303	[p19l335t2533r544b2582],
4	Inst	NNP	O	Inst	_	0	SENT_303	[p19l565t2534r674b2581],
5	1998	CD	DATE	1998	num	4	SENT_303	[p19l704t2532r855b2590],
6	;	:	O	;	_	0	SENT_303	[p19l704t2532r855b2590],
7	90	CD	NUMBER	90	number	8	SENT_303	[p19l884t2531r1087b2593],
8	(	CD	NUMBER	(	dep	4	SENT_303	[p19l884t2531r1087b2593],
9	16	CD	NUMBER	16	num	10	SENT_303	[p19l884t2531r1087b2593],
10	)	NN	O	)	dep	8	SENT_303	[p19l884t2531r1087b2593],
11	:	:	O	:	_	0	SENT_303	[p19l884t2531r1087b2593],
12	1225-1229	CD	DATE	1225-1229	dep	8	SENT_303	[p19l1125t2531r1452b2582],
13	.	.	O	.	_	0	SENT_303	[p19l1125t2531r1452b2582],

1	Felix	NNP	PERSON	Felix	nn	2	SENT_304	[p19l129t2611r274b2661],
2	CA	NNP	O	CA	_	0	SENT_304	[p19l315t2611r426b2670],
3	,	,	O	,	_	0	SENT_304	[p19l315t2611r426b2670],
4	Walker	NNP	PERSON	Walker	nn	5	SENT_304	[p19l467t2611r674b2661],
5	AH	NNP	O	AH	appos	2	SENT_304	[p19l712t2611r828b2670],
6	,	,	O	,	_	0	SENT_304	[p19l712t2611r828b2670],
7	Lange	NNP	PERSON	Lange	nn	9	SENT_304	[p19l869t2612r1046b2676],
8	B	NNP	O	B	nn	9	SENT_304	[p19l1086t2612r1174b2670],
9	]	NN	O	]	appos	2	SENT_304	[p19l1086t2612r1174b2670],
10	,	,	O	,	_	0	SENT_304	[p19l1086t2612r1174b2670],
11	et	FW	O	et	nn	12	SENT_304	[p19l1218t2621r1269b2661],
12	al.	FW	O	al.	appos	2	SENT_304	[p19l1307t2611r1374b2661],
13	.	.	O	.	_	0	SENT_304	[p19l1307t2611r1374b2661],

1	Association	NNP	O	Association	_	0	SENT_305	[p19l1417t2611r1754b2661],
2	of	IN	O	of	_	0	SENT_305	[p19l1793t2611r1855b2661],
3	CYP3A4	NNP	O	CYP3A4	nn	4	SENT_305	[p19l1890t2611r2148b2661],
4	genotype	NN	O	genotype	prep_of	1	SENT_305	[p19l130t2698r389b2756],
5	with	IN	O	with	_	0	SENT_305	[p19l420t2691r546b2741],
6	treatment	NN	O	treatment	nn	9	SENT_305	[p19l576t2691r1065b2741],
7	—	NN	O	—	nn	9	SENT_305	[p19l576t2691r1065b2741],
8	related	JJ	O	related	amod	9	SENT_305	[p19l576t2691r1065b2741],
9	leukemia	NN	O	leukemia	prep_with	1	SENT_305	[p19l1097t2691r1372b2741],
10	.	.	O	.	_	0	SENT_305	[p19l1097t2691r1372b2741],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_306	[p19l1406t2692r1540b2741],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_306	[p19l1570t2691r1695b2741],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_306	[p19l1720t2691r1873b2741],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_306	[p19l1902t2692r1988b2741],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_306	[p19l2025t2691r2146b2741],
6	1998	CD	DATE	1998	num	5	SENT_306	[p19l136t2771r287b2829],
7	;	:	O	;	_	0	SENT_306	[p19l136t2771r287b2829],
8	95	CD	NUMBER	95	number	9	SENT_306	[p19l317t2770r519b2831],
9	(	CD	NUMBER	(	dep	5	SENT_306	[p19l317t2770r519b2831],
10	22	CD	NUMBER	22	num	11	SENT_306	[p19l317t2770r519b2831],
11	)	NN	O	)	dep	9	SENT_306	[p19l317t2770r519b2831],
12	:	:	O	:	_	0	SENT_306	[p19l317t2770r519b2831],
13	13176-13181	CD	NUMBER	13176-13181	dep	9	SENT_306	[p19l557t2770r955b2820],
14	.	.	O	.	_	0	SENT_306	[p19l557t2770r955b2820],

1	Hesselink	NNP	ORGANIZATION	Hesselink	nn	2	SENT_307	[p19l130t2849r411b2899],
2	DA	NNP	ORGANIZATION	DA	_	0	SENT_307	[p19l446t2850r560b2908],
3	,	,	O	,	_	0	SENT_307	[p19l446t2850r560b2908],
4	van	NNP	PERSON	van	nn	6	SENT_307	[p19l600t2865r699b2899],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_307	[p19l738t2849r931b2899],
6	RH	NNP	O	RH	appos	2	SENT_307	[p19l966t2850r1078b2908],
7	,	,	O	,	_	0	SENT_307	[p19l966t2850r1078b2908],
8	van	NNP	PERSON	van	nn	11	SENT_307	[p19l1118t2865r1217b2899],
9	der	NNP	PERSON	der	nn	11	SENT_307	[p19l1255t2849r1346b2898],
10	Heiden	NNP	PERSON	Heiden	nn	11	SENT_307	[p19l1381t2849r1586b2899],
11	IP	NNP	O	IP	appos	2	SENT_307	[p19l1623t2850r1691b2907],
12	,	,	O	,	_	0	SENT_307	[p19l1623t2850r1691b2907],
13	et	FW	O	et	nn	14	SENT_307	[p19l1732t2859r1784b2899],
14	al.	FW	O	al.	appos	2	SENT_307	[p19l1819t2849r1886b2899],
15	.	.	O	.	_	0	SENT_307	[p19l1819t2849r1886b2899],

1	Genetic	JJ	O	genetic	amod	2	SENT_308	[p19l1928t2849r2147b2899],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_308	[p19l129t2929r570b2994],
3	of	IN	O	of	_	0	SENT_308	[p19l610t2928r671b2979],
4	the	DT	O	the	det	7	SENT_308	[p19l704t2929r789b2979],
5	CYP3A4	NN	O	cyp3a4	nn	7	SENT_308	[p19l827t2929r1101b2988],
6	,	,	O	,	_	0	SENT_308	[p19l827t2929r1101b2988],
7	CYP3A5	NN	O	cyp3a5	prep_of	2	SENT_308	[p19l1141t2928r1415b2988],
8	,	,	O	,	_	0	SENT_308	[p19l1141t2928r1415b2988],
9	and	CC	O	and	_	0	SENT_308	[p19l1455t2929r1556b2979],
10	MDR	NN	O	mdr	nn	11	SENT_308	[p19l1592t2929r1806b2978],
11	—	NN	O	—	prep_of	2	SENT_308	[p19l1592t2929r1806b2978],
12	1	CD	NUMBER	1	num	13	SENT_308	[p19l1592t2929r1806b2978],
13	genes	NNS	O	gene	dep	2	SENT_308	[p19l1849t2944r2008b2994],
14	and	CC	O	and	_	0	SENT_308	[p19l2048t2929r2148b2979],
15	pharmacokinetics	NNS	O	pharmacokinetic	dep	2	SENT_308	[p19l128t3008r631b3073],
16	of	IN	O	of	_	0	SENT_308	[p19l655t3008r717b3058],
17	the	DT	O	the	det	20	SENT_308	[p19l734t3008r819b3058],
18	calcineurin	NN	O	calcineurin	nn	20	SENT_308	[p19l842t3008r1159b3058],
19	inhibitors	NNS	O	inhibitor	nn	20	SENT_308	[p19l1181t3008r1451b3058],
20	cyclosporine	NN	O	cyclosporine	prep_of	13	SENT_308	[p19l1475t3008r1838b3073],
21	and	CC	O	and	_	0	SENT_308	[p19l1861t3008r1961b3058],
22	tacro	NN	O	tacro	nn	24	SENT_308	[p19l1983t3016r2146b3058],
23	—	NN	O	—	nn	24	SENT_308	[p19l1983t3016r2146b3058],
24	limus	NN	O	limus	prep_of	13	SENT_308	[p19l130t3089r301b3138],
25	.	.	O	.	_	0	SENT_308	[p19l130t3089r301b3138],

1	Clin	NNP	O	Clin	nn	3	SENT_309	[p19l334t3089r451b3139],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_309	[p19l476t3089r794b3138],
3	Ther	NNP	O	Ther	_	0	SENT_309	[p19l821t3089r954b3138],
4	2003	CD	DATE	2003	num	3	SENT_309	[p19l977t3089r1134b3147],
5	;	:	O	;	_	0	SENT_309	[p19l977t3089r1134b3147],
6	74	CD	NUMBER	74	number	7	SENT_309	[p19l1163t3088r1331b3150],
7	(	CD	NUMBER	(	dep	3	SENT_309	[p19l1163t3088r1331b3150],
8	3	CD	NUMBER	3	num	9	SENT_309	[p19l1163t3088r1331b3150],
9	)	NN	O	)	dep	7	SENT_309	[p19l1163t3088r1331b3150],
10	:	:	O	:	_	0	SENT_309	[p19l1163t3088r1331b3150],
11	245-254	CD	NUMBER	245-254	dep	7	SENT_309	[p19l1362t3089r1624b3138],
12	.	.	O	.	_	0	SENT_309	[p19l1362t3089r1624b3138],

1	Benet	NNP	PERSON	Benet	nn	2	SENT_310	[p19l129t3168r296b3217],
2	LZ	NNP	O	LZ	_	0	SENT_310	[p19l322t3168r424b3226],
3	,	,	O	,	_	0	SENT_310	[p19l322t3168r424b3226],
4	Cummins	NNP	ORGANIZATION	Cummins	nn	5	SENT_310	[p19l455t3167r730b3217],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_310	[p19l759t3167r863b3226],
6	,	,	O	,	_	0	SENT_310	[p19l759t3167r863b3226],
7	Wu	NNP	O	Wu	nn	8	SENT_310	[p19l892t3168r991b3217],
8	CY	NNP	O	CY	appos	5	SENT_310	[p19l1021t3167r1122b3217],
9	.	.	O	.	_	0	SENT_310	[p19l1021t3167r1122b3217],

1	Unmasking	VBG	O	unmask	_	0	SENT_311	[p19l1154t3167r1480b3232],
2	the	DT	O	the	det	4	SENT_311	[p19l1509t3167r1594b3217],
3	dynamic	JJ	O	dynamic	amod	4	SENT_311	[p19l1623t3167r1866b3232],
4	interplay	NN	O	interplay	dobj	1	SENT_311	[p19l1895t3167r2147b3232],
5	between	IN	O	between	_	0	SENT_311	[p19l129t3248r366b3298],
6	efﬂux	NN	O	efﬂux	nn	7	SENT_311	[p19l386t3248r550b3298],
7	transporters	NNS	O	transporter	prep_between	4	SENT_311	[p19l569t3255r903b3313],
8	and	CC	O	and	_	0	SENT_311	[p19l925t3248r1025b3298],
9	metabolic	JJ	O	metabolic	amod	10	SENT_311	[p19l1044t3248r1324b3298],
10	enzymes	NNS	O	enzyme	prep_between	4	SENT_311	[p19l1345t3263r1607b3313],
11	.	.	O	.	_	0	SENT_311	[p19l1345t3263r1607b3313],

1	Int	NN	O	int	nn	2	SENT_312	[p19l1628t3250r1710b3298],
2	J	NN	O	j	_	0	SENT_312	[p19l1726t3249r1761b3298],
3	Pharm	NNP	O	Pharm	dep	2	SENT_312	[p19l1775t3248r1968b3298],
4	2004	CD	DATE	2004	num	3	SENT_312	[p19l1988t3248r2146b3307],
5	;	:	O	;	_	0	SENT_312	[p19l1988t3248r2146b3307],
6	277	CD	NUMBER	277	number	7	SENT_312	[p19l129t3327r405b3388],
7	(	CD	NUMBER	(	dep	2	SENT_312	[p19l129t3327r405b3388],
8	1-2	CD	NUMBER	1-2	num	9	SENT_312	[p19l129t3327r405b3388],
9	)	NN	O	)	dep	7	SENT_312	[p19l129t3327r405b3388],
10	:	:	O	:	_	0	SENT_312	[p19l129t3327r405b3388],
11	3-9	CD	NUMBER	3-9	dep	7	SENT_312	[p19l437t3328r554b3378],
12	.	.	O	.	_	0	SENT_312	[p19l437t3328r554b3378],

1	Cummins	NNP	ORGANIZATION	Cummins	nn	2	SENT_313	[p19l130t3406r404b3456],
2	CL	NN	ORGANIZATION	cl	_	0	SENT_313	[p19l449t3406r553b3465],
3	,	,	O	,	_	0	SENT_313	[p19l449t3406r553b3465],
4	Wu	NNP	O	Wu	nn	5	SENT_313	[p19l597t3407r696b3456],
5	CY	NNP	O	CY	appos	2	SENT_313	[p19l740t3406r842b3465],
6	,	,	O	,	_	0	SENT_313	[p19l740t3406r842b3465],
7	Benet	NNP	PERSON	Benet	nn	8	SENT_313	[p19l888t3407r1054b3455],
8	LZ	NNP	O	LZ	appos	5	SENT_313	[p19l1095t3407r1196b3456],
9	.	.	O	.	_	0	SENT_313	[p19l1095t3407r1196b3456],

1	Sex-related	JJ	O	sex-related	amod	2	SENT_314	[p19l1244t3406r1566b3456],
2	differences	NNS	O	difference	nsubjpass	13	SENT_314	[p19l1609t3406r1922b3456],
3	in	IN	O	in	_	0	SENT_314	[p19l1966t3406r2020b3455],
4	the	DT	O	the	det	5	SENT_314	[p19l2062t3406r2148b3456],
5	clearance	NN	O	clearance	prep_in	2	SENT_314	[p19l130t3486r398b3536],
6	of	IN	O	of	_	0	SENT_314	[p19l430t3485r491b3536],
7	cytochrome	NN	O	cytochrome	nn	10	SENT_314	[p19l517t3486r851b3551],
8	P450	NN	O	p450	nn	10	SENT_314	[p19l882t3485r1026b3536],
9	3A4	NN	O	3a4	nn	10	SENT_314	[p19l1059t3486r1177b3536],
10	substrates	NNS	O	substrate	prep_of	5	SENT_314	[p19l1210t3486r1486b3536],
11	may	MD	O	may	aux	13	SENT_314	[p19l1517t3501r1638b3551],
12	be	VB	O	be	auxpass	13	SENT_314	[p19l1668t3486r1734b3536],
13	caused	VBN	O	cause	_	0	SENT_314	[p19l1765t3486r1958b3536],
14	by	IN	O	by	_	0	SENT_314	[p19l1987t3486r2056b3551],
15	Pglycoprotein	NN	PERSON	pglycoprotein	agent	13	SENT_314	[p19l2086t3487r2146b3535, p19l130t3565r503b3630],
16	.	.	O	.	_	0	SENT_314	[p19l2086t3487r2146b3535, p19l130t3565r503b3630],

1	Clin	NNP	O	Clin	nn	3	SENT_315	[p19l536t3565r653b3616],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_315	[p19l679t3565r997b3615],
3	Ther	NNP	O	Ther	_	0	SENT_315	[p19l1024t3565r1157b3615],
4	2002	CD	DATE	2002	num	3	SENT_315	[p19l1180t3566r1337b3624],
5	;	:	O	;	_	0	SENT_315	[p19l1180t3566r1337b3624],
6	72	CD	NUMBER	72	number	7	SENT_315	[p19l1366t3565r1533b3627],
7	(	CD	NUMBER	(	dep	3	SENT_315	[p19l1366t3565r1533b3627],
8	5	CD	NUMBER	5	num	9	SENT_315	[p19l1366t3565r1533b3627],
9	)	NN	O	)	dep	7	SENT_315	[p19l1366t3565r1533b3627],
10	:	:	O	:	_	0	SENT_315	[p19l1366t3565r1533b3627],
11	474-489	CD	NUMBER	474-489	dep	7	SENT_315	[p19l1564t3566r1826b3616],
12	.	.	O	.	_	0	SENT_315	[p19l1564t3566r1826b3616],

1	Copyright	NN	O	copyright	nn	5	SENT_316	[p20l6t88r330b160],
2	©	CD	NUMBER	©	num	5	SENT_316	[p20l363t89r431b157],
3	2009	CD	DATE	2009	num	5	SENT_316	[p20l466t88r622b145],
4	John	NNP	PERSON	John	nn	5	SENT_316	[p20l652t88r802b144],
5	Wiley	NNP	PERSON	Wiley	_	0	SENT_316	[p20l830t88r1023b160],
6	&	CC	O	&	_	0	SENT_316	[p20l1054t88r1111b144],
7	Sons	NNP	O	Sons	conj_and	5	SENT_316	[p20l1143t88r1312b154],
8	,	,	O	,	_	0	SENT_316	[p20l1143t88r1312b154],
9	Ltd.	NNP	ORGANIZATION	Ltd.	appos	5	SENT_316	[p20l1343t88r1469b144],
10	17	CD	NUMBER	17	num	9	SENT_316	[p20l12t174r89b224],
11	.	.	O	.	_	0	SENT_316	[p20l12t174r89b224],

1	Marzolini	NNP	PERSON	Marzolini	nn	2	SENT_317	[p20l130t173r410b224],
2	C	NNP	O	C	_	0	SENT_317	[p20l443t174r502b233],
3	,	,	O	,	_	0	SENT_317	[p20l443t174r502b233],
4	Paus	NNP	PERSON	Paus	nn	5	SENT_317	[p20l536t175r666b224],
5	E	NNP	O	E	appos	2	SENT_317	[p20l698t175r756b233],
6	,	,	O	,	_	0	SENT_317	[p20l698t175r756b233],
7	Buclin	NNP	O	Buclin	nn	8	SENT_317	[p20l790t173r980b224],
8	T	NN	O	t	appos	2	SENT_317	[p20l1010t175r1062b233],
9	,	,	O	,	_	0	SENT_317	[p20l1010t175r1062b233],
10	Kim	NNP	PERSON	Kim	nn	11	SENT_317	[p20l1097t173r1222b223],
11	RB	NN	O	rb	appos	2	SENT_317	[p20l1252t175r1359b224],
12	.	.	O	.	_	0	SENT_317	[p20l1252t175r1359b224],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_318	[p20l1394t173r1839b238],
2	in	IN	O	in	_	0	SENT_318	[p20l1871t173r1925b223],
3	human	JJ	O	human	amod	6	SENT_318	[p20l1956t173r2149b224],
4	MDR1	NN	O	mdr1	nn	6	SENT_318	[p20l130t254r320b303],
5	(	CD	NUMBER	(	num	6	SENT_318	[p20l354t254r837b319],
6	P	NN	O	p	prep_in	1	SENT_318	[p20l354t254r837b319],
7	—	CD	NUMBER	—	num	9	SENT_318	[p20l354t254r837b319],
8	glycoprotein	NN	O	glycoprotein	nn	9	SENT_318	[p20l354t254r837b319],
9	)	NN	O	)	dep	1	SENT_318	[p20l354t254r837b319],
10	:	:	O	:	_	0	SENT_318	[p20l354t254r837b319],
11	recent	JJ	O	recent	amod	12	SENT_318	[p20l867t261r1043b304],
12	advances	NNS	O	advance	dep	1	SENT_318	[p20l1068t254r1324b304],
13	and	CC	O	and	_	0	SENT_318	[p20l1353t254r1453b304],
14	clinical	JJ	O	clinical	amod	15	SENT_318	[p20l1479t254r1688b304],
15	relevance	NN	O	relevance	conj_and	12	SENT_318	[p20l1713t254r1998b304],
16	.	.	O	.	_	0	SENT_318	[p20l1713t254r1998b304],

1	Clin	NNP	O	Clin	nn	3	SENT_319	[p20l2031t254r2148b304],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_319	[p20l130t333r447b383],
3	Ther	NNP	O	Ther	_	0	SENT_319	[p20l474t333r607b383],
4	2004	CD	DATE	2004	num	3	SENT_319	[p20l630t334r788b392],
5	;	:	O	;	_	0	SENT_319	[p20l630t334r788b392],
6	75	CD	NUMBER	75	number	7	SENT_319	[p20l816t333r984b394],
7	(	CD	NUMBER	(	dep	3	SENT_319	[p20l816t333r984b394],
8	1	CD	NUMBER	1	num	9	SENT_319	[p20l816t333r984b394],
9	)	NN	O	)	dep	7	SENT_319	[p20l816t333r984b394],
10	:	:	O	:	_	0	SENT_319	[p20l816t333r984b394],
11	13-33	CD	DATE	13-33	dep	7	SENT_319	[p20l1021t334r1206b383],
12	.	.	O	.	_	0	SENT_319	[p20l1021t334r1206b383],

1	Hofman	NNP	PERSON	Hofman	nn	2	SENT_320	[p20l131t412r362b462],
2	A	NNP	O	A	_	0	SENT_320	[p20l405t412r470b471],
3	,	,	O	,	_	0	SENT_320	[p20l405t412r470b471],
4	Breteler	NNP	PERSON	Breteler	nn	5	SENT_320	[p20l515t412r746b462],
5	MM	NN	O	mm	appos	2	SENT_320	[p20l787t413r927b471],
6	,	,	O	,	_	0	SENT_320	[p20l787t413r927b471],
7	van	NN	PERSON	van	nn	9	SENT_320	[p20l973t428r1072b462],
8	Duijn	NNP	PERSON	Duijn	nn	9	SENT_320	[p20l1115t412r1276b477],
9	CM	NN	O	cm	appos	2	SENT_320	[p20l1319t412r1443b471],
10	,	,	O	,	_	0	SENT_320	[p20l1319t412r1443b471],
11	et	FW	O	et	nn	12	SENT_320	[p20l1490t422r1541b462],
12	al.	FW	O	al.	appos	2	SENT_320	[p20l1581t412r1649b462],
13	.	.	O	.	_	0	SENT_320	[p20l1581t412r1649b462],

1	The	DT	O	the	det	3	SENT_321	[p20l1696t412r1805b462],
2	Rotterdam	NNP	LOCATION	Rotterdam	nn	3	SENT_321	[p20l1848t412r2150b462],
3	study	NN	O	study	_	0	SENT_321	[p20l133t493r298b558],
4	:	:	O	:	_	0	SENT_321	[p20l133t493r298b558],
5	objectives	NNS	O	objective	nsubj	8	SENT_321	[p20l334t492r619b558],
6	and	CC	O	and	_	0	SENT_321	[p20l651t493r751b543],
7	design	NN	O	design	conj_and	5	SENT_321	[p20l781t493r966b558],
8	update	VBP	O	update	dep	3	SENT_321	[p20l994t493r1198b558],
9	.	.	O	.	_	0	SENT_321	[p20l994t493r1198b558],

1	Eur	NNP	MISC	Eur	nn	3	SENT_322	[p20l1231t494r1340b543],
2	J	NNP	O	J	nn	3	SENT_322	[p20l1366t494r1402b543],
3	Epidemiol	NNP	O	Epidemiol	_	0	SENT_322	[p20l1426t492r1720b557],
4	2007	CD	DATE	2007	num	3	SENT_322	[p20l1750t493r1908b552],
5	;	:	O	;	_	0	SENT_322	[p20l1750t493r1908b552],
6	22	CD	NUMBER	22	number	7	SENT_322	[p20l1940t492r2144b555],
7	(	CD	NUMBER	(	dep	3	SENT_322	[p20l1940t492r2144b555],
8	11	CD	NUMBER	11	num	9	SENT_322	[p20l1940t492r2144b555],
9	)	NN	O	)	dep	7	SENT_322	[p20l1940t492r2144b555],
10	:	:	O	:	_	0	SENT_322	[p20l1940t492r2144b555],
11	819-829	CD	NUMBER	819-829	dep	7	SENT_322	[p20l133t574r392b624],
12	.	.	O	.	_	0	SENT_322	[p20l133t574r392b624],

1	Hofman	NNP	PERSON	Hofman	nn	2	SENT_323	[p20l131t654r362b704],
2	A	NNP	O	A	_	0	SENT_323	[p20l389t654r454b713],
3	,	,	O	,	_	0	SENT_323	[p20l389t654r454b713],
4	Grobbee	NNP	O	Grobbee	nn	5	SENT_323	[p20l485t654r727b704],
5	DE	NN	O	de	appos	2	SENT_323	[p20l754t655r863b713],
6	,	,	O	,	_	0	SENT_323	[p20l754t655r863b713],
7	de	FW	PERSON	de	nn	9	SENT_323	[p20l894t654r958b704],
8	Jong	FW	PERSON	jong	nn	9	SENT_323	[p20l985t655r1117b719],
9	PT	NN	O	pt	appos	2	SENT_323	[p20l1145t655r1236b713],
10	,	,	O	,	_	0	SENT_323	[p20l1145t655r1236b713],
11	van	NN	O	van	nn	14	SENT_323	[p20l1267t670r1366b704],
12	den	NN	O	den	nn	14	SENT_323	[p20l1394t654r1495b704],
13	Ouweland	NNP	O	Ouweland	nn	14	SENT_323	[p20l1523t654r1814b704],
14	FA	NNP	O	FA	appos	2	SENT_323	[p20l1840t654r1938b704],
15	.	.	O	.	_	0	SENT_323	[p20l1840t654r1938b704],

1	Determinants	NNS	O	determinant	_	0	SENT_324	[p20l1969t655r2147b704, p20l131t733r354b783],
2	of	IN	O	of	_	0	SENT_324	[p20l377t733r438b783],
3	disease	NN	O	disease	prep_of	1	SENT_324	[p20l456t733r660b783],
4	and	CC	O	and	_	0	SENT_324	[p20l683t733r783b783],
5	disability	NN	O	disability	prep_of	1	SENT_324	[p20l805t733r1069b798],
6	in	IN	O	in	_	0	SENT_324	[p20l1090t733r1144b783],
7	the	DT	O	the	det	8	SENT_324	[p20l1165t733r1250b783],
8	elderly	JJ	O	elderly	prep_in	1	SENT_324	[p20l1273t733r1485b798],
9	:	:	O	:	_	0	SENT_324	[p20l1273t733r1485b798],
10	the	DT	O	the	det	13	SENT_324	[p20l1511t733r1596b783],
11	Rotterdam	NNP	LOCATION	Rotterdam	nn	13	SENT_324	[p20l1618t733r1919b783],
12	Elderly	NNP	O	Elderly	nn	13	SENT_324	[p20l1940t733r2148b798],
13	Study	NNP	O	Study	dep	1	SENT_324	[p20l133t814r304b879],
14	.	.	O	.	_	0	SENT_324	[p20l133t814r304b879],

1	Eur	NNP	MISC	Eur	nn	3	SENT_325	[p20l333t815r442b864],
2	J	NNP	O	J	nn	3	SENT_325	[p20l463t815r499b864],
3	Epidemiol	NNP	O	Epidemiol	_	0	SENT_325	[p20l519t814r814b878],
4	1991	CD	DATE	1991	num	3	SENT_325	[p20l846t814r997b873],
5	;	:	O	;	_	0	SENT_325	[p20l846t814r997b873],
6	7	CD	NUMBER	7	number	7	SENT_325	[p20l1025t814r1157b875],
7	(	CD	NUMBER	(	dep	3	SENT_325	[p20l1025t814r1157b875],
8	4	CD	NUMBER	4	num	9	SENT_325	[p20l1025t814r1157b875],
9	)	NN	O	)	dep	7	SENT_325	[p20l1025t814r1157b875],
10	:	:	O	:	_	0	SENT_325	[p20l1025t814r1157b875],
11	403-422	CD	NUMBER	403-422	dep	7	SENT_325	[p20l1187t814r1450b864],
12	.	.	O	.	_	0	SENT_325	[p20l1187t814r1450b864],

1	WHO	WP	O	who	_	0	SENT_326	[p20l130t894r309b944],
2	.	.	O	.	_	0	SENT_326	[p20l130t894r309b944],

1	Collaborating	VBG	O	collaborate	_	0	SENT_327	[p20l335t893r712b958],
2	Centre	NNP	O	Centre	dobj	1	SENT_327	[p20l736t894r918b944],
3	for	IN	O	for	_	0	SENT_327	[p20l941t893r1021b943],
4	Drug	NNP	O	Drug	nn	6	SENT_327	[p20l1042t894r1182b958],
5	Statistics	NNPS	O	Statistics	nn	6	SENT_327	[p20l1206t893r1450b944],
6	Methodology	NNP	O	Methodology	prep_for	2	SENT_327	[p20l1473t893r1854b958],
7	.	.	O	.	_	0	SENT_327	[p20l1473t893r1854b958],

1	Complete	JJ	O	complete	amod	3	SENT_328	[p20l1880t893r2148b958],
2	ATC	NN	ORGANIZATION	atc	nn	3	SENT_328	[p20l131t973r258b1023],
3	index	NN	O	index	_	0	SENT_328	[p20l280t973r428b1023],
4	2009	CD	DATE	2009	dep	3	SENT_328	[p20l449t973r595b1024],
5	.	.	O	.	_	0	SENT_328	[p20l449t973r595b1024],

1	Oslo	NNP	LOCATION	Oslo	_	0	SENT_329	[p20l620t973r759b1032],
2	,	,	O	,	_	0	SENT_329	[p20l620t973r759b1032],
3	2009	CD	DATE	2009	appos	1	SENT_329	[p20l782t973r929b1024],
4	.	.	O	.	_	0	SENT_329	[p20l782t973r929b1024],

1	http://www.whocc.no/atcddd/indexdatabase/	NN	O	http://www.whocc.no/atcddd/indexdatabase/	nn	2	SENT_330	[p20l951t973r2151b1038],
2	[	NN	O	[	nsubj	3	SENT_330	[p20l136t1054r403b1114],
3	accessed	VBD	O	access	_	0	SENT_330	[p20l136t1054r403b1114],
4	28	CD	DATE	28	num	5	SENT_330	[p20l429t1054r495b1104],
5	January	NNP	DATE	January	tmod	3	SENT_330	[p20l523t1055r743b1119],
6	2009	CD	DATE	2009	num	7	SENT_330	[p20l770t1054r948b1114],
7	]	CD	NUMBER	]	dobj	3	SENT_330	[p20l770t1054r948b1114],
8	.	.	O	.	_	0	SENT_330	[p20l770t1054r948b1114],

1	Fang	NNP	PERSON	Fang	nn	2	SENT_331	[p20l130t1134r269b1198],
2	Y	NN	PERSON	y	_	0	SENT_331	[p20l288t1134r343b1192],
3	,	,	O	,	_	0	SENT_331	[p20l288t1134r343b1192],
4	van	NN	PERSON	van	nn	7	SENT_331	[p20l364t1149r464b1183],
5	Meurs	NNP	PERSON	Meurs	nn	7	SENT_331	[p20l482t1134r661b1183],
6	J	NNP	PERSON	J	nn	7	SENT_331	[p20l680t1134r706b1184],
7	B	NNP	PERSON	B	appos	2	SENT_331	[p20l708t1134r768b1193],
8	,	,	O	,	_	0	SENT_331	[p20l708t1134r768b1193],
9	d’Alesio	NNP	O	d’Alesio	nn	10	SENT_331	[p20l790t1133r1032b1183],
10	A	NNP	O	A	appos	2	SENT_331	[p20l1050t1134r1115b1192],
11	,	,	O	,	_	0	SENT_331	[p20l1050t1134r1115b1192],
12	et	FW	O	et	nn	13	SENT_331	[p20l1136t1143r1188b1183],
13	al.	FW	O	al.	appos	2	SENT_331	[p20l1203t1133r1271b1183],
14	.	.	O	.	_	0	SENT_331	[p20l1203t1133r1271b1183],

1	Promoter	NN	O	promoter	nn	6	SENT_332	[p20l1293t1134r1559b1183],
2	and	CC	O	and	_	0	SENT_332	[p20l1576t1133r1676b1183],
3	3	CD	NUMBER	3	nn	6	SENT_332	[p20l1696t1133r2147b1184, p20l130t1214r311b1279],
4	’	NN	O	’	nn	6	SENT_332	[p20l1696t1133r2147b1184, p20l130t1214r311b1279],
5	untranslatedregion	NN	O	untranslatedregion	nn	6	SENT_332	[p20l1696t1133r2147b1184, p20l130t1214r311b1279],
6	haplotypes	NNS	O	haplotype	nsubj	13	SENT_332	[p20l334t1214r642b1279],
7	in	IN	O	in	_	0	SENT_332	[p20l668t1214r722b1263],
8	the	DT	O	the	det	12	SENT_332	[p20l746t1214r831b1264],
9	vitamin	NN	O	vitamin	nn	12	SENT_332	[p20l855t1214r1073b1264],
10	d	NN	O	d	nn	12	SENT_332	[p20l1097t1214r1130b1264],
11	receptor	NN	O	receptor	nn	12	SENT_332	[p20l1154t1221r1389b1279],
12	gene	NN	O	gene	prep_in	6	SENT_332	[p20l1413t1230r1545b1279],
13	predispose	VB	O	predispose	_	0	SENT_332	[p20l1569t1214r1873b1279],
14	to	TO	O	to	_	0	SENT_332	[p20l1898t1222r1951b1264],
15	osteoporotic	JJ	O	osteoporotic	amod	16	SENT_332	[p20l1977t1222r2147b1264, p20l130t1293r330b1358],
16	fracture	NN	O	fracture	prep_to	13	SENT_332	[p20l357t1293r593b1343],
17	:	:	O	:	_	0	SENT_332	[p20l357t1293r593b1343],
18	the	DT	O	the	det	20	SENT_332	[p20l623t1293r708b1343],
19	Rotterdam	NNP	LOCATION	Rotterdam	nn	20	SENT_332	[p20l733t1293r1035b1343],
20	Study	NNP	O	Study	dep	16	SENT_332	[p20l1061t1293r1233b1358],
21	.	.	O	.	_	0	SENT_332	[p20l1061t1293r1233b1358],

1	Am	VBP	O	be	dep	4	SENT_333	[p20l1257t1294r1355b1343],
2	J	NN	O	j	nn	4	SENT_333	[p20l1378t1295r1414b1344],
3	Hum	NNP	O	Hum	nn	4	SENT_333	[p20l1434t1295r1572b1343],
4	Genet	NNP	O	Genet	_	0	SENT_333	[p20l1599t1294r1768b1344],
5	2005	CD	DATE	2005	num	4	SENT_333	[p20l1791t1293r1948b1352],
6	;	:	O	;	_	0	SENT_333	[p20l1791t1293r1948b1352],
7	77	CD	NUMBER	77	num	8	SENT_333	[p20l1976t1293r2144b1355],
8	(	CD	NUMBER	(	dep	4	SENT_333	[p20l1976t1293r2144b1355],
9	5	CD	NUMBER	5	num	10	SENT_333	[p20l1976t1293r2144b1355],
10	)	NN	O	)	dep	8	SENT_333	[p20l1976t1293r2144b1355],
11	:	:	O	:	_	0	SENT_333	[p20l1976t1293r2144b1355],
12	807-823	CD	NUMBER	807-823	dep	8	SENT_333	[p20l133t1375r392b1425],
13	.	.	O	.	_	0	SENT_333	[p20l133t1375r392b1425],

1	Kajinami	NNP	LOCATION	Kajinami	nn	2	SENT_334	[p20l132t1454r394b1519],
2	K	NNP	LOCATION	K	_	0	SENT_334	[p20l437t1455r501b1513],
3	,	,	O	,	_	0	SENT_334	[p20l437t1455r501b1513],
4	Brousseau	NNP	PERSON	Brousseau	nn	5	SENT_334	[p20l544t1455r840b1504],
5	ME	NNP	O	ME	appos	2	SENT_334	[p20l881t1455r1002b1514],
6	,	,	O	,	_	0	SENT_334	[p20l881t1455r1002b1514],
7	Ordovas	NNP	O	Ordovas	nn	8	SENT_334	[p20l1047t1454r1281b1505],
8	JM	NN	O	jm	appos	2	SENT_334	[p20l1324t1455r1428b1513],
9	,	,	O	,	_	0	SENT_334	[p20l1324t1455r1428b1513],
10	Schaefer	NNP	PERSON	Schaefer	nn	11	SENT_334	[p20l1474t1454r1722b1505],
11	EJ	NNP	O	EJ	appos	2	SENT_334	[p20l1761t1455r1845b1505],
12	.	.	O	.	_	0	SENT_334	[p20l1761t1455r1845b1505],

1	CYP3A4	NN	O	cyp3a4	nn	2	SENT_335	[p20l1891t1454r2149b1505],
2	genotypes	NNS	O	genotype	conj_and	2	SENT_335	[p20l132t1542r417b1599],
3	and	CC	O	and	_	0	SENT_335	[p20l453t1534r554b1584],
4	plasma	NN	O	plasma	nn	6	SENT_335	[p20l586t1534r789b1599],
5	lipoprotein	NN	O	lipoprotein	nn	6	SENT_335	[p20l822t1534r1135b1599],
6	levels	NNS	O	level	conj_and	2	SENT_335	[p20l1169t1534r1331b1584],
7	before	IN	O	before	_	0	SENT_335	[p20l1365t1534r1546b1584],
8	and	CC	O	and	_	0	SENT_335	[p20l1582t1534r1682b1584],
9	after	IN	O	after	_	0	SENT_335	[p20l1717t1534r1847b1584],
10	treatment	NN	O	treatment	prep_before	2	SENT_335	[p20l1880t1541r2150b1584],
11	with	IN	O	with	_	0	SENT_335	[p20l131t1615r256b1665],
12	atorvastatin	NN	O	atorvastatin	prep_with	2	SENT_335	[p20l275t1615r605b1665],
13	in	IN	O	in	_	0	SENT_335	[p20l624t1615r678b1664],
14	primary	JJ	O	primary	amod	15	SENT_335	[p20l695t1615r921b1680],
15	hypercholesterolernia	NN	O	hypercholesterolernium	prep_in	2	SENT_335	[p20l939t1615r1569b1680],
16	.	.	O	.	_	0	SENT_335	[p20l939t1615r1569b1680],

1	Am	NNP	O	Am	nn	3	SENT_336	[p20l1586t1615r1684b1665],
2	J	NNP	O	J	nn	3	SENT_336	[p20l1701t1616r1737b1665],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_336	[p20l1755t1615r1971b1665],
4	2004	CD	DATE	2004	num	3	SENT_336	[p20l1989t1615r2146b1674],
5	;	:	O	;	_	0	SENT_336	[p20l1989t1615r2146b1674],
6	93	CD	NUMBER	93	number	7	SENT_336	[p20l131t1694r298b1755],
7	(	CD	NUMBER	(	dep	3	SENT_336	[p20l131t1694r298b1755],
8	1	CD	NUMBER	1	num	9	SENT_336	[p20l131t1694r298b1755],
9	)	NN	O	)	dep	7	SENT_336	[p20l131t1694r298b1755],
10	:	:	O	:	_	0	SENT_336	[p20l131t1694r298b1755],
11	104-107	CD	NUMBER	104-107	dep	7	SENT_336	[p20l336t1694r590b1744],
12	.	.	O	.	_	0	SENT_336	[p20l336t1694r590b1744],

1	Fiegenbaum	NNP	PERSON	Fiegenbaum	nn	2	SENT_337	[p20l130t1773r483b1838],
2	M	NN	O	m	_	0	SENT_337	[p20l508t1775r584b1833],
3	,	,	O	,	_	0	SENT_337	[p20l508t1775r584b1833],
4	da	NN	PERSON	da	nn	6	SENT_337	[p20l615t1773r681b1824],
5	Silveira	NNP	PERSON	Silveira	nn	6	SENT_337	[p20l709t1773r928b1824],
6	FR	NN	O	fr	appos	2	SENT_337	[p20l953t1775r1054b1833],
7	,	,	O	,	_	0	SENT_337	[p20l953t1775r1054b1833],
8	Van	NNP	PERSON	Van	nn	10	SENT_337	[p20l1084t1775r1194b1824],
9	der	NNP	O	der	nn	10	SENT_337	[p20l1221t1773r1311b1824],
10	Sand	NNP	O	Sand	appos	2	SENT_337	[p20l1339t1773r1478b1824],
11	CR	NN	O	cr	dep	10	SENT_337	[p20l1505t1774r1613b1833],
12	,	,	O	,	_	0	SENT_337	[p20l1505t1774r1613b1833],
13	et	FW	O	et	nn	14	SENT_337	[p20l1644t1783r1695b1824],
14	al.	FW	O	al.	appos	2	SENT_337	[p20l1720t1773r1788b1824],
15	.	.	O	.	_	0	SENT_337	[p20l1720t1773r1788b1824],

1	The	DT	O	the	det	2	SENT_338	[p20l1818t1773r1927b1823],
2	role	NN	O	role	_	0	SENT_338	[p20l1954t1773r2064b1823],
3	of	IN	O	of	_	0	SENT_338	[p20l2092t1773r2154b1824],
4	common	JJ	O	common	amod	5	SENT_338	[p20l131t1869r380b1903],
5	variants	NNS	O	variant	prep_of	2	SENT_338	[p20l403t1853r625b1903],
6	of	IN	O	of	_	0	SENT_338	[p20l654t1853r716b1903],
7	ABCB1	NN	O	abcb1	nn	9	SENT_338	[p20l738t1853r981b1912],
8	,	,	O	,	_	0	SENT_338	[p20l738t1853r981b1912],
9	CYP3A4	NN	O	cyp3a4	prep_of	2	SENT_338	[p20l1011t1853r1283b1912],
10	,	,	O	,	_	0	SENT_338	[p20l1011t1853r1283b1912],
11	and	CC	O	and	_	0	SENT_338	[p20l1315t1853r1415b1903],
12	CYP3A5	NN	O	cyp3a5	nn	13	SENT_338	[p20l1442t1853r1698b1903],
13	genes	NNS	O	gene	conj_and	9	SENT_338	[p20l1728t1869r1887b1918],
14	in	IN	O	in	_	0	SENT_338	[p20l1915t1853r1969b1903],
15	lipidlowering	VBG	O	lipidlower	prepc_in	2	SENT_338	[p20l1996t1853r2147b1918, p20l131t1934r380b1999],
16	efﬁcacy	NN	O	efﬁcacy	dobj	15	SENT_338	[p20l403t1934r625b1999],
17	and	CC	O	and	_	0	SENT_338	[p20l649t1934r749b1984],
18	safety	NN	O	safety	conj_and	16	SENT_338	[p20l772t1933r938b1999],
19	of	IN	O	of	_	0	SENT_338	[p20l961t1933r1022b1984],
20	simvastatin	NN	O	simvastatin	nn	21	SENT_338	[p20l1041t1934r1362b1984],
21	treatment	NN	O	treatment	prep_of	16	SENT_338	[p20l1383t1941r1666b1984],
22	.	.	O	.	_	0	SENT_338	[p20l1383t1941r1666b1984],

1	Clin	NNP	O	Clin	nn	3	SENT_339	[p20l1695t1934r1812b1984],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_339	[p20l1832t1934r2151b1984],
3	Ther	NNP	O	Ther	_	0	SENT_339	[p20l134t2013r266b2063],
4	2005	CD	DATE	2005	num	3	SENT_339	[p20l290t2013r447b2072],
5	;	:	O	;	_	0	SENT_339	[p20l290t2013r447b2072],
6	78	CD	NUMBER	78	number	7	SENT_339	[p20l475t2013r642b2074],
7	(	CD	NUMBER	(	dep	3	SENT_339	[p20l475t2013r642b2074],
8	5	CD	NUMBER	5	num	9	SENT_339	[p20l475t2013r642b2074],
9	)	NN	O	)	dep	7	SENT_339	[p20l475t2013r642b2074],
10	:	:	O	:	_	0	SENT_339	[p20l475t2013r642b2074],
11	551-558	CD	NUMBER	551-558	dep	7	SENT_339	[p20l674t2013r935b2063],
12	.	.	O	.	_	0	SENT_339	[p20l674t2013r935b2063],

1	Kajinarni	NNP	PERSON	Kajinarni	nn	2	SENT_340	[p20l132t2092r394b2157],
2	K	NNP	PERSON	K	_	0	SENT_340	[p20l414t2093r477b2152],
3	,	,	O	,	_	0	SENT_340	[p20l414t2093r477b2152],
4	Brousseau	NNP	PERSON	Brousseau	nn	5	SENT_340	[p20l498t2093r793b2142],
5	ME	NNP	O	ME	appos	2	SENT_340	[p20l811t2093r931b2151],
6	,	,	O	,	_	0	SENT_340	[p20l811t2093r931b2151],
7	Ordovas	NNP	O	Ordovas	nn	9	SENT_340	[p20l953t2092r1188b2142],
8	J	NNP	O	J	nn	9	SENT_340	[p20l1206t2093r1232b2142],
9	M	NN	O	m	appos	2	SENT_340	[p20l1234t2093r1311b2151],
10	,	,	O	,	_	0	SENT_340	[p20l1234t2093r1311b2151],
11	Schaefer	NNP	PERSON	Schaefer	nn	12	SENT_340	[p20l1333t2092r1581b2142],
12	EJ	NNP	O	EJ	appos	2	SENT_340	[p20l1597t2093r1681b2142],
13	.	.	O	.	_	0	SENT_340	[p20l1597t2093r1681b2142],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_341	[p20l1703t2092r2148b2157],
2	in	IN	O	in	_	0	SENT_341	[p20l130t2173r185b2222],
3	the	DT	O	the	det	6	SENT_341	[p20l210t2173r296b2223],
4	multidrug	JJ	O	multidrug	amod	6	SENT_341	[p20l322t2173r602b2238],
5	resistance	NN	O	resistance	nn	6	SENT_341	[p20l627t2173r962b2223],
6	—	NN	O	—	prep_in	1	SENT_341	[p20l627t2173r962b2223],
7	1	CD	NUMBER	1	number	8	SENT_341	[p20l627t2173r962b2223],
8	(	CD	NUMBER	(	num	12	SENT_341	[p20l996t2173r1236b2235],
9	MDR1	NN	O	mdr1	nn	12	SENT_341	[p20l996t2173r1236b2235],
10	)	NN	O	)	nn	12	SENT_341	[p20l996t2173r1236b2235],
11	gene	NN	O	gene	nn	12	SENT_341	[p20l1265t2188r1396b2238],
12	inﬂuence	NN	O	inﬂuence	dep	1	SENT_341	[p20l1423t2172r1683b2223],
13	the	DT	O	the	det	14	SENT_341	[p20l1709t2173r1795b2223],
14	response	NN	O	response	dep	12	SENT_341	[p20l1820t2188r2069b2238],
15	to	TO	O	to	_	0	SENT_341	[p20l2095t2181r2148b2223],
16	atorvastatin	NN	O	atorvastatin	nn	17	SENT_341	[p20l132t2252r461b2303],
17	treatment	NN	O	treatment	prep_to	12	SENT_341	[p20l480t2260r750b2302],
18	in	IN	O	in	_	0	SENT_341	[p20l768t2252r822b2302],
19	a	DT	O	a	det	23	SENT_341	[p20l843t2268r873b2302],
20	gender	NN	O	gender	nn	23	SENT_341	[p20l891t2252r1323b2317],
21	—	NN	O	—	nn	23	SENT_341	[p20l891t2252r1323b2317],
22	speciﬁc	NN	O	speciﬁc	nn	23	SENT_341	[p20l891t2252r1323b2317],
23	manner	NN	O	manner	prep_in	17	SENT_341	[p20l1344t2268r1567b2302],
24	.	.	O	.	_	0	SENT_341	[p20l1344t2268r1567b2302],

1	Am	NNP	O	Am	nn	3	SENT_342	[p20l1585t2253r1683b2302],
2	J	NNP	O	J	nn	3	SENT_342	[p20l1700t2254r1736b2303],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_342	[p20l1754t2252r1970b2303],
4	2004	CD	DATE	2004	num	3	SENT_342	[p20l1989t2252r2146b2312],
5	;	:	O	;	_	0	SENT_342	[p20l1989t2252r2146b2312],
6	93	CD	NUMBER	93	number	7	SENT_342	[p20l131t2332r298b2393],
7	(	CD	NUMBER	(	dep	3	SENT_342	[p20l131t2332r298b2393],
8	8	CD	NUMBER	8	num	9	SENT_342	[p20l131t2332r298b2393],
9	)	NN	O	)	dep	7	SENT_342	[p20l131t2332r298b2393],
10	:	:	O	:	_	0	SENT_342	[p20l131t2332r298b2393],
11	1046-1050	CD	DATE	1046-1050	dep	7	SENT_342	[p20l336t2332r662b2382],
12	.	.	O	.	_	0	SENT_342	[p20l336t2332r662b2382],

1	Aarnoudse	NNP	ORGANIZATION	Aarnoudse	nn	2	SENT_343	[p20l130t2411r437b2461],
2	AL	NNP	ORGANIZATION	AL	_	0	SENT_343	[p20l479t2412r588b2470],
3	,	,	O	,	_	0	SENT_343	[p20l479t2412r588b2470],
4	van	NNP	PERSON	van	nn	6	SENT_343	[p20l633t2427r733b2461],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_343	[p20l777t2411r970b2461],
6	RH	NNP	O	RH	appos	2	SENT_343	[p20l1010t2412r1122b2470],
7	,	,	O	,	_	0	SENT_343	[p20l1010t2412r1122b2470],
8	Dieleman	NNP	PERSON	Dieleman	nn	9	SENT_343	[p20l1167t2411r1444b2461],
9	J	NNP	PERSON	J	appos	2	SENT_343	[p20l1485t2412r1511b2461],
10	,	,	O	,	_	0	SENT_343	[p20l1516t2453r1526b2470],
11	et	FW	O	et	nn	12	SENT_343	[p20l1573t2421r1624b2461],
12	al.	FW	O	al.	appos	2	SENT_343	[p20l1664t2411r1732b2461],
13	.	.	O	.	_	0	SENT_343	[p20l1664t2411r1732b2461],

1	MDR1	NN	O	mdr1	nn	3	SENT_344	[p20l1777t2411r1967b2461],
2	gene	NN	O	gene	nn	3	SENT_344	[p20l2016t2427r2149b2476],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	5	SENT_344	[p20l130t2492r571b2557],
4	are	VBP	O	be	auxpass	5	SENT_344	[p20l607t2507r690b2542],
5	associated	VBN	O	associate	_	0	SENT_344	[p20l724t2492r1016b2542],
6	with	IN	O	with	_	0	SENT_344	[p20l1048t2492r1174b2542],
7	neuropsychiatric	JJ	O	neuropsychiatric	amod	9	SENT_344	[p20l1206t2491r1679b2557],
8	adverse	JJ	O	adverse	amod	9	SENT_344	[p20l1714t2492r1928b2542],
9	effects	NNS	O	effect	prep_with	5	SENT_344	[p20l1962t2491r2148b2542],
10	of	IN	O	of	_	0	SENT_344	[p20l131t2571r193b2621],
11	meﬂoquine	NN	O	meﬂoquine	prep_of	9	SENT_344	[p20l214t2571r547b2636],
12	.	.	O	.	_	0	SENT_344	[p20l214t2571r547b2636],

1	Clin	NNP	O	Clin	nn	3	SENT_345	[p20l580t2571r697b2622],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_345	[p20l723t2571r1041b2621],
3	Ther	NNP	O	Ther	_	0	SENT_345	[p20l1068t2571r1200b2621],
4	2006	CD	DATE	2006	num	3	SENT_345	[p20l1224t2571r1381b2630],
5	;	:	O	;	_	0	SENT_345	[p20l1224t2571r1381b2630],
6	80	CD	NUMBER	80	number	7	SENT_345	[p20l1411t2571r1577b2633],
7	(	CD	NUMBER	(	dep	3	SENT_345	[p20l1411t2571r1577b2633],
8	4	CD	NUMBER	4	num	9	SENT_345	[p20l1411t2571r1577b2633],
9	)	NN	O	)	dep	7	SENT_345	[p20l1411t2571r1577b2633],
10	:	:	O	:	_	0	SENT_345	[p20l1411t2571r1577b2633],
11	367-374	CD	NUMBER	367-374	dep	7	SENT_345	[p20l1610t2571r1870b2622],
12	.	.	O	.	_	0	SENT_345	[p20l1610t2571r1870b2622],

1	Aarnoudse	NNP	O	Aarnoudse	nn	2	SENT_346	[p20l130t2651r437b2701],
2	AJ	NNP	O	AJ	_	0	SENT_346	[p20l463t2651r555b2710],
3	,	,	O	,	_	0	SENT_346	[p20l463t2651r555b2710],
4	Dieleman	NNP	PERSON	Dieleman	nn	5	SENT_346	[p20l584t2651r861b2701],
5	JP	NNP	O	JP	appos	2	SENT_346	[p20l885t2652r959b2710],
6	,	,	O	,	_	0	SENT_346	[p20l885t2652r959b2710],
7	Visser	NNP	PERSON	Visser	nn	8	SENT_346	[p20l987t2651r1165b2701],
8	LE	NNP	PERSON	LE	appos	2	SENT_346	[p20l1188t2652r1290b2710],
9	,	,	O	,	_	0	SENT_346	[p20l1188t2652r1290b2710],
10	et	FW	O	et	nn	11	SENT_346	[p20l1320t2661r1371b2701],
11	al.	FW	O	al.	appos	2	SENT_346	[p20l1395t2651r1462b2701],
12	.	.	O	.	_	0	SENT_346	[p20l1395t2651r1462b2701],

1	Common	JJ	O	common	amod	5	SENT_347	[p20l1493t2651r1757b2701],
2	ATP-binding	JJ	O	atp-binding	amod	5	SENT_347	[p20l1781t2651r2149b2716],
3	cassette	NN	O	cassette	nn	5	SENT_347	[p20l131t2739r351b2782],
4	B1	NN	O	b1	nn	5	SENT_347	[p20l393t2732r468b2781],
5	variants	NNS	O	variant	nsubjpass	7	SENT_347	[p20l515t2732r737b2782],
6	are	VBP	O	be	auxpass	7	SENT_347	[p20l782t2747r865b2782],
7	associated	VBN	O	associate	_	0	SENT_347	[p20l909t2732r1201b2782],
8	with	IN	O	with	_	0	SENT_347	[p20l1242t2732r1367b2782],
9	increased	VBN	O	increase	amod	12	SENT_347	[p20l1408t2732r1677b2782],
10	digoxin	NN	O	digoxin	nn	12	SENT_347	[p20l1719t2732r1935b2797],
11	serum	NN	O	serum	nn	12	SENT_347	[p20l1978t2747r2150b2782],
12	concentration	NN	O	concentration	prep_with	7	SENT_347	[p20l131t2812r533b2862],
13	.	.	O	.	_	0	SENT_347	[p20l131t2812r533b2862],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	2	SENT_348	[p20l560t2811r1014b2876],
2	Genomics	NNP	O	Genomics	_	0	SENT_348	[p20l1040t2813r1322b2862],
3	2008	CD	DATE	2008	num	2	SENT_348	[p20l1348t2812r1505b2871],
4	;	:	O	;	_	0	SENT_348	[p20l1348t2812r1505b2871],
5	18	CD	NUMBER	18	number	6	SENT_348	[p20l1537t2811r1702b2874],
6	(	CD	NUMBER	(	dep	2	SENT_348	[p20l1537t2811r1702b2874],
7	4	CD	NUMBER	4	num	8	SENT_348	[p20l1537t2811r1702b2874],
8	)	NN	O	)	dep	6	SENT_348	[p20l1537t2811r1702b2874],
9	:	:	O	:	_	0	SENT_348	[p20l1537t2811r1702b2874],
10	299-305	CD	NUMBER	299-305	dep	6	SENT_348	[p20l1733t2811r1994b2863],
11	.	.	O	.	_	0	SENT_348	[p20l1733t2811r1994b2863],

1	Tanaka	NNP	PERSON	Tanaka	nn	4	SENT_349	[p20l130t2891r335b2942],
2	E.	NNP	O	E.	nn	4	SENT_349	[p20l366t2893r423b2942],
3	Gender	NN	O	gender	nn	4	SENT_349	[p20l459t2891r886b2942],
4	—	NN	O	—	_	0	SENT_349	[p20l459t2891r886b2942],
5	related	JJ	O	related	amod	6	SENT_349	[p20l459t2891r886b2942],
6	differences	NNS	O	difference	dep	4	SENT_349	[p20l918t2891r1230b2942],
7	in	IN	O	in	_	0	SENT_349	[p20l1264t2891r1318b2941],
8	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	6	SENT_349	[p20l1349t2891r1852b2956],
9	and	CC	O	and	_	0	SENT_349	[p20l1887t2891r1988b2942],
10	their	PRP$	O	they	poss	12	SENT_349	[p20l2019t2891r2150b2941],
11	clinical	JJ	O	clinical	amod	12	SENT_349	[p20l131t2971r340b3021],
12	signiﬁcance	NN	O	signiﬁcance	conj_and	8	SENT_349	[p20l369t2971r719b3036],
13	.	.	O	.	_	0	SENT_349	[p20l369t2971r719b3036],

1	J	NNP	O	J	nn	4	SENT_350	[p20l748t2973r783b3022],
2	Clin	NNP	O	Clin	nn	4	SENT_350	[p20l808t2971r926b3022],
3	Pharm	NNP	O	Pharm	nn	4	SENT_350	[p20l951t2971r1144b3021],
4	Ther	NNP	O	Ther	_	0	SENT_350	[p20l1173t2971r1306b3021],
5	1999	CD	DATE	1999	num	4	SENT_350	[p20l1335t2971r1486b3030],
6	;	:	O	;	_	0	SENT_350	[p20l1335t2971r1486b3030],
7	24	CD	NUMBER	24	number	8	SENT_350	[p20l1514t2971r1682b3033],
8	(	CD	NUMBER	(	dep	4	SENT_350	[p20l1514t2971r1682b3033],
9	5	CD	NUMBER	5	num	10	SENT_350	[p20l1514t2971r1682b3033],
10	)	NN	O	)	dep	8	SENT_350	[p20l1514t2971r1682b3033],
11	:	:	O	:	_	0	SENT_350	[p20l1514t2971r1682b3033],
12	339-346	CD	NUMBER	339-346	dep	8	SENT_350	[p20l1715t2971r1974b3022],
13	.	.	O	.	_	0	SENT_350	[p20l1715t2971r1974b3022],

1	Parkinson	NNP	O	Parkinson	nn	2	SENT_351	[p20l130t3052r413b3102],
2	A	NNP	O	A	_	0	SENT_351	[p20l435t3052r500b3111],
3	,	,	O	,	_	0	SENT_351	[p20l435t3052r500b3111],
4	Mudra	NNP	PERSON	Mudra	nn	5	SENT_351	[p20l525t3052r715b3102],
5	DR	NN	O	dr	appos	2	SENT_351	[p20l736t3053r848b3111],
6	,	,	O	,	_	0	SENT_351	[p20l736t3053r848b3111],
7	Johnson	NNP	PERSON	Johnson	nn	8	SENT_351	[p20l873t3052r1105b3102],
8	C	NNP	O	C	appos	2	SENT_351	[p20l1128t3052r1188b3111],
9	,	,	O	,	_	0	SENT_351	[p20l1128t3052r1188b3111],
10	et	FW	O	et	nn	11	SENT_351	[p20l1215t3062r1266b3102],
11	al.	FW	O	al.	appos	2	SENT_351	[p20l1286t3052r1354b3102],
12	.	.	O	.	_	0	SENT_351	[p20l1286t3052r1354b3102],

1	The	DT	O	the	det	2	SENT_352	[p20l1380t3052r1489b3102],
2	effects	NNS	O	effect	_	0	SENT_352	[p20l1513t3051r1699b3102],
3	of	IN	O	of	_	0	SENT_352	[p20l1723t3051r1785b3102],
4	gender	NN	O	gender	nn	8	SENT_352	[p20l1803t3052r2008b3117],
5	,	,	O	,	_	0	SENT_352	[p20l1803t3052r2008b3117],
6	age	NN	O	age	dep	8	SENT_352	[p20l2035t3067r2146b3117],
7	,	,	O	,	_	0	SENT_352	[p20l2035t3067r2146b3117],
8	ethnicity	NN	O	ethnicity	prep_of	2	SENT_352	[p20l131t3131r390b3196],
9	,	,	O	,	_	0	SENT_352	[p20l131t3131r390b3196],
10	and	CC	O	and	_	0	SENT_352	[p20l422t3131r522b3181],
11	liver	NN	O	liver	nn	12	SENT_352	[p20l549t3131r677b3181],
12	cirrhosis	NN	O	cirrhosis	conj_and	8	SENT_352	[p20l705t3131r947b3181],
13	on	IN	O	on	_	0	SENT_352	[p20l976t3147r1045b3181],
14	cytochrome	NN	O	cytochrome	nn	17	SENT_352	[p20l1073t3131r1408b3196],
15	P450	NN	O	p450	nn	17	SENT_352	[p20l1435t3131r1579b3182],
16	enzyme	NN	O	enzyme	nn	17	SENT_352	[p20l1608t3147r1828b3196],
17	activity	NN	O	activity	prep_on	2	SENT_352	[p20l1857t3131r2067b3196],
18	in	IN	O	in	_	0	SENT_352	[p20l2095t3131r2149b3181],
19	human	JJ	O	human	amod	21	SENT_352	[p20l130t3211r324b3261],
20	liver	NN	O	liver	nn	21	SENT_352	[p20l352t3211r481b3261],
21	microsomes	NNS	O	microsome	prep_in	2	SENT_352	[p20l508t3211r851b3261],
22	and	CC	O	and	_	0	SENT_352	[p20l883t3211r983b3261],
23	inducibility	NN	O	inducibility	conj_and	21	SENT_352	[p20l1012t3211r1340b3276],
24	in	IN	O	in	prep	2	SENT_352	[p20l1369t3211r1423b3261],
25	cultured	VBN	O	culture	partmod	2	SENT_352	[p20l1453t3211r1686b3261],
26	human	JJ	O	human	amod	27	SENT_352	[p20l1714t3211r1908b3261],
27	hepatocytes	NNS	O	hepatocyte	dobj	25	SENT_352	[p20l1935t3211r2147b3276, p20l131t3299r289b3356],
28	.	.	O	.	_	0	SENT_352	[p20l1935t3211r2147b3276, p20l131t3299r289b3356],

1	Toxicol	NNP	O	Toxicol	nn	3	SENT_353	[p20l321t3291r526b3341],
2	Appl	NNP	O	Appl	nn	3	SENT_353	[p20l546t3291r685b3355],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_353	[p20l709t3291r1027b3341],
4	2004	CD	DATE	2004	num	3	SENT_353	[p20l1052t3291r1209b3351],
5	;	:	O	;	_	0	SENT_353	[p20l1052t3291r1209b3351],
6	199	CD	NUMBER	199	number	7	SENT_353	[p20l1241t3291r1440b3353],
7	(	CD	NUMBER	(	dep	3	SENT_353	[p20l1241t3291r1440b3353],
8	3	CD	NUMBER	3	num	9	SENT_353	[p20l1241t3291r1440b3353],
9	)	NN	O	)	dep	7	SENT_353	[p20l1241t3291r1440b3353],
10	:	:	O	:	_	0	SENT_353	[p20l1241t3291r1440b3353],
11	193-209	CD	NUMBER	193-209	dep	7	SENT_353	[p20l1478t3291r1733b3342],
12	.	.	O	.	_	0	SENT_353	[p20l1478t3291r1733b3342],

1	Shimada	NNP	PERSON	Shimada	nn	2	SENT_354	[p20l132t3371r380b3422],
2	T	NN	O	t	_	0	SENT_354	[p20l397t3373r449b3430],
3	,	,	O	,	_	0	SENT_354	[p20l397t3373r449b3430],
4	Yamazaki	NN	PERSON	yamazakus	nn	5	SENT_354	[p20l470t3371r750b3421],
5	H	NN	PERSON	h	appos	2	SENT_354	[p20l770t3373r834b3430],
6	,	,	O	,	_	0	SENT_354	[p20l770t3373r834b3430],
7	Mimura	NNP	PERSON	Mimura	nn	8	SENT_354	[p20l855t3372r1085b3421],
8	M	NNP	O	M	appos	2	SENT_354	[p20l1102t3373r1179b3430],
9	,	,	O	,	_	0	SENT_354	[p20l1102t3373r1179b3430],
10	et	FW	O	et	nn	11	SENT_354	[p20l1200t3381r1252b3421],
11	al.	FW	O	al.	appos	2	SENT_354	[p20l1267t3372r1336b3421],
12	.	.	O	.	_	0	SENT_354	[p20l1267t3372r1336b3421],

1	Interindividual	JJ	O	interindividual	amod	2	SENT_355	[p20l1357t3371r1779b3421],
2	variations	NNS	O	variation	_	0	SENT_355	[p20l1798t3372r2076b3422],
3	in	IN	O	in	_	0	SENT_355	[p20l2095t3372r2149b3421],
4	human	JJ	O	human	amod	7	SENT_355	[p20l130t3450r324b3500],
5	liver	NN	O	liver	nn	7	SENT_355	[p20l349t3450r478b3500],
6	cytochrome	NN	O	cytochrome	nn	7	SENT_355	[p20l503t3450r838b3515],
7	P	NN	O	p	prep_in	2	SENT_355	[p20l864t3450r1032b3501],
8	—	CD	NUMBER	—	number	9	SENT_355	[p20l864t3450r1032b3501],
9	450	CD	NUMBER	450	num	10	SENT_355	[p20l864t3450r1032b3501],
10	enzymes	NNS	O	enzyme	dep	7	SENT_355	[p20l1059t3466r1306b3515],
11	involved	VBN	O	involve	partmod	7	SENT_355	[p20l1333t3450r1579b3501],
12	in	IN	O	in	_	0	SENT_355	[p20l1605t3450r1659b3500],
13	the	DT	O	the	det	14	SENT_355	[p20l1684t3450r1770b3500],
14	oxidation	NN	O	oxidation	prep_in	11	SENT_355	[p20l1797t3450r2066b3501],
15	of	IN	O	of	_	0	SENT_355	[p20l2092t3450r2154b3500],
16	drugs	NNS	O	drug	nn	18	SENT_355	[p20l131t3530r302b3595],
17	,	,	O	,	_	0	SENT_355	[p20l131t3530r302b3595],
18	carcinogens	NNS	O	carcinogen	prep_of	14	SENT_355	[p20l326t3530r664b3595],
19	and	CC	O	and	_	0	SENT_355	[p20l687t3530r787b3580],
20	toxic	JJ	O	toxic	amod	21	SENT_355	[p20l807t3530r947b3580],
21	chemicals	NNS	O	chemical	prep_of	14	SENT_355	[p20l970t3530r1269b3580],
22	:	:	O	:	_	0	SENT_355	[p20l970t3530r1269b3580],
23	studies	NNS	O	study	dep	2	SENT_355	[p20l1297t3530r1490b3580],
24	with	IN	O	with	_	0	SENT_355	[p20l1512t3530r1637b3580],
25	liver	NN	O	liver	nn	26	SENT_355	[p20l1657t3530r1786b3580],
26	microsomes	NNS	O	microsome	prep_with	23	SENT_355	[p20l1805t3530r2148b3580],
27	of	IN	O	of	_	0	SENT_355	[p20l131t3610r193b3661],
28	30	CD	NUMBER	30	num	29	SENT_355	[p20l205t3611r273b3661],
29	Japanese	JJ	MISC	japanese	prep_of	26	SENT_355	[p20l289t3612r541b3676],
30	and	CC	O	and	_	0	SENT_355	[p20l558t3611r659b3661],
31	30	CD	NUMBER	30	num	32	SENT_355	[p20l676t3611r743b3661],
32	Caucasians	NNPS	MISC	Caucasians	prep_of	26	SENT_355	[p20l761t3611r1093b3661],
33	.	.	O	.	_	0	SENT_355	[p20l761t3611r1093b3661],

1	J	NNP	O	J	nn	4	SENT_356	[p20l1111t3612r1147b3661],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_356	[p20l1158t3611r1476b3661],
3	Exp	NNP	O	Exp	nn	4	SENT_356	[p20l1489t3613r1599b3675],
4	Ther	NNP	O	Ther	_	0	SENT_356	[p20l1619t3611r1751b3661],
5	1994	CD	DATE	1994	num	4	SENT_356	[p20l1771t3611r1922b3670],
6	;	:	O	;	_	0	SENT_356	[p20l1771t3611r1922b3670],
7	270	CD	NUMBER	270	num	8	SENT_356	[p20l1941t3610r2144b3673],
8	(	NN	O	(	dep	4	SENT_356	[p20l1941t3610r2144b3673],
9	1	CD	NUMBER	1	num	10	SENT_356	[p20l1941t3610r2144b3673],
10	)	NN	O	)	dep	8	SENT_356	[p20l1941t3610r2144b3673],
11	:	:	O	:	_	0	SENT_356	[p20l1941t3610r2144b3673],
12	414-423	CD	NUMBER	414-423	dep	8	SENT_356	[p20l130t3691r392b3741],
13	.	.	O	.	_	0	SENT_356	[p20l130t3691r392b3741],

1	Pharmacoepidemiology	NNP	O	Pharmacoepidemiology	nn	4	SENT_357	[p21l230t123r998b194],
2	and	CC	O	and	_	0	SENT_357	[p21l1028t123r1150b179],
3	Drug	NNP	O	Drug	nn	4	SENT_357	[p21l1173t125r1341b194],
4	Safety	NNP	O	Safety	_	0	SENT_357	[p21l1371t123r1578b195],
5	,	,	O	,	_	0	SENT_357	[p21l1371t123r1578b195],
6	2010	CD	DATE	2010	appos	4	SENT_357	[p21l1611t123r1788b189],
7	;	:	O	;	_	0	SENT_357	[p21l1611t123r1788b189],
8	19	CD	NUMBER	19	dep	4	SENT_357	[p21l1824t122r1915b179],
9	:	:	O	:	_	0	SENT_357	[p21l1824t122r1915b179],
10	75-81	CD	NUMBER	75-81	num	11	SENT_357	[p21l1950t123r2141b179],
11	DOI	NNP	O	DOI	dep	8	SENT_357	[p21l1564t211r1721b267],
12	:	:	O	:	_	0	SENT_357	[p21l1564t211r1721b267],
13	10.1002	CD	NUMBER	10.1002	dep	11	SENT_357	[p21l1763t211r2147b283],
14	/	:	O	/	punct	11	SENT_357	[p21l1763t211r2147b283],
15	pds	NNS	O	pd	dep	8	SENT_357	[p21l1763t211r2147b283],

